Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CTRB2		ENSG00000168928	"Chymotrypsinogen B2"	Q6GPI1	16	75204096-75207185	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5240	"pancreas: 3761.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.0;HDLM-2: 1.9;U-2 OS: 9.0;U-251 MG: 1.9;U-266/84: 2.6;U-698: 2.4"	"Cancer enriched"	"Detected in single"	1696	"pancreatic cancer: 540.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"							"unprognostic (9.41e-4)"			"unprognostic (2.20e-1)"	"unprognostic (1.28e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.57e-2)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	3761.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.0	0.0	1.9	0.1	2.6	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	3231	"pancreas: 3541.6"	"Cell line enriched"	"Detected in some"	5	"AN3-CA: 15.8"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	17000000	17000000			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.0	3541.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.3	0.0	1.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
PNLIPRP1	PLRP1	ENSG00000187021	"Pancreatic lipase related protein 1"	P54315	10	116590385-116609175	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2629	"pancreas: 516.5"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.1;U-2 OS: 1.7;U-266/84: 4.3"	"Cancer enriched"	"Detected in single"	475	"pancreatic cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to digestive system"	210000	210000						"unprognostic (1.21e-1)"	"unprognostic (4.08e-3)"						"unprognostic (1.40e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	516.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CTRB1	CTRB	ENSG00000168925	"Chymotrypsinogen B1"	P17538	16	75219000-75226338	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	2272	"pancreas: 1908.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;HDLM-2: 4.9;U-2 OS: 2.4;U-251 MG: 1.6"	"Cancer enriched"	"Detected in some"	1905	"pancreatic cancer: 962.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"										"unprognostic (1.76e-1)"				"unprognostic (2.62e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (2.96e-1)"		"unprognostic (1.17e-2)"		0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	1908.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.2	1.6	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase family member 3A"	P09093	1	22001656-22012539	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2051	"pancreas: 2541.2"	"Cell line enriched"	"Detected in single"	24	"MOLT-4: 21.1"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"			Cytosol	Cytosol	"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	2541.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1895	"pancreas: 3207.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;HDLM-2: 2.7;U-2 OS: 4.5;U-251 MG: 1.0;U-266/84: 1.5"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.4"	"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	13000000	13000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1708	"pancreas: 3057.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;HDLM-2: 1.7;RPMI-8226: 6.9;U-2 OS: 4.1;U-251 MG: 1.5;U-266/84: 2.5"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7"	"Low lineage specificity"	"Detected in many"											"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	26000000000	26000000000	Vesicles	Vesicles	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavourable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favourable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (3.12e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	1.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	1.5	0.0	2.5	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase family member 2A"	P08217	1	15456728-15472091	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1559	"pancreas: 2376.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HEL: 1.2;HL-60: 1.0;HMC-1: 4.9;K-562: 1.1;U-2 OS: 1.6"	"Cancer enriched"	"Detected in single"	3819	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"														"Secreted to digestive system"						"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	2376.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.7	1.2	0.0	0.0	0.0	1.0	4.9	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1551	"pancreas: 4260.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.3;U-2 OS: 3.0;U-266/84: 2.4"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA010512	Enhanced				"Secreted to digestive system"	1100000	1100000			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	4260.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.4	2.7	0.4	1.3	1.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.0	0.0	1.0	0.0	2.4	1.0	0.0	0.9	0.0	0.5	0.4	1.3	0.1	0.2	0.0	0.3	1.1	0.1	0.4	0.5	0.3	0.0	2.7	1.3	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322111-120327789	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	933	"pancreas: 2360.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;Hep G2: 6.3;U-2 OS: 4.6"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Group enriched"	"Detected in many"	19	"NK-cells: 1.3;T-cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	3900000	3900000			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	1.1	2360.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	2.5	0.9	0.2	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.5	0.0	0.3	1.3	0.3	1.6	0.0	0.0	0.2	0.0	0.6	0.0	1.0	0.2	4.6	0.6	0.6	0.0	1.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.3	0.0	0.0	2.5	0.9	0.0	1.3	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	708	"pancreas: 6267.9"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 37.2"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"					"Group enriched"	"Detected in some"	6	"basophil: 5.6;T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.6;T-cells: 5.1"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	27000000000	27000000000	Vesicles	Vesicles	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favourable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	6267.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.6	0.0	0.7	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.5	2.1	0.0	1.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.3										
SYCN	"FLJ27441, INSSA1, SYL"	ENSG00000179751	Syncollin	Q0VAF6	19	39202831-39204266	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	681	"pancreas: 1347.2"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.3;U-266/84: 2.4"	"Cancer enriched"	"Detected in single"	842	"pancreatic cancer: 369.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047654	Enhanced				"Intracellular and membrane"	1100000	1100000			"HPA047654: AB_2680112"											"unprognostic (8.02e-2)"							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1347.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	590	"pancreas: 3628.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;EFO-21: 2.9;HDLM-2: 3.0;U-2 OS: 5.1;U-251 MG: 1.5;U-266/84: 2.4"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	6600000	6600000			"CAB026158: , HPA038069: AB_2675816, HPA046340: "	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	0.2	1.7	0.1	0.1	0.2	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	3628.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.8	1.1	6.1	1.0	3.1	3.5	0.9	0.0	0.0	0.0	0.0	2.7	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.1	3.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.1	0.0	1.5	0.0	2.4	0.6	0.0	0.0	0.0	6.1	0.7	1.1	3.0	0.9	2.2	0.9	1.3	2.6	0.3	1.8	0.9	3.5	4.5	3.1	1.0	1.1	0.6	0.9	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266827-130289798	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	529	"pancreas: 1357.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.4;CACO-2: 7.3;RH-30: 6.1;SCLC-21H: 3.3"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	1500000	1500000	"Golgi apparatus"	"Golgi apparatus"	"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	7.3	0.0	0.0	1.0	0.0	0.0	1.4	0.0	0.1	1.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.4	0.0	6.1	0.1	0.1	0.6	3.3	0.0	0.2	0.0	2.0	0.0	0.2	0.0	0.0	1.1	0.8	0.6	0.0	0.7	0.2	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438439-15449242	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	417	"pancreas: 1443.7"	"Cell line enhanced"	"Detected in some"		"A-431: 3.6"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046920	Enhanced				"Secreted to digestive system"					"HPA046920: AB_2679865"	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1443.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.4	3.4	0.7	1.5	0.6	0.1	3.6	0.6	0.5	0.7	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.0	1.7	0.5	1.1	0.0	0.5	0.0	0.1	0.2	1.1	0.5	0.4	0.3	0.1	0.9	0.2	1.7	0.2	0.0	0.0	0.0	0.0	0.1	1.7	0.2	0.5	1.0	1.6	0.4	0.0	0.5	0.1	0.3	0.0	0.1	0.4	1.0	0.4	0.2	0.2	0.3	0.1	0.9	0.4	1.4	0.9	0.2	0.8	1.6	0.3	0.8	0.8	0.3	3.4	0.4	0.4	0.4	0.2	0.2	0.3	0.3	0.6	0.1	1.1	0.3	0.4	1.7	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AQP12B	INSSA3	ENSG00000185176	"Aquaporin 12B"	A6NM10	2	240676418-240682906	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	386	"pancreas: 82.5"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042216	Supported									"HPA042216: AB_2677905"			"unprognostic (1.30e-1)"							"unprognostic (2.87e-2)"	"unprognostic (1.68e-1)"			"unprognostic (3.41e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GP2	ZAP75	ENSG00000169347	"Glycoprotein 2"	P55259	16	20309572-20327808	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	354	"pancreas: 1812.8"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in many"	14	"pancreatic cancer: 320.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015739, HPA016668"	Enhanced				"Intracellular and membrane"	27000	27000			"HPA015739: AB_1849905, HPA016668: AB_1849907"	"unprognostic (2.14e-2)"		"unprognostic (1.97e-2)"	"unprognostic (5.68e-2)"			"unprognostic (4.29e-2)"	"unprognostic (1.63e-1)"			"unprognostic (2.84e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0.0	5.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.4	1812.8	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.4	1.4	2.3	0.9	0.6	0.8	0.3	0.5	0.3	0.6	1.0	0.0	0.2	1.3	0.3	0.0	0.5	0.2	1.3	0.7	1.3	1.4	0.4	0.6	0.1	0.4	0.7	0.3	0.2	0.4	1.3	0.2	0.0	0.4	0.9	0.0	0.3	0.1	0.0	0.0	0.7	0.8	0.5	0.0	0.4	0.6	0.1	1.2	0.7	0.7	1.8	0.1	0.2	0.7	0.5	0.6	1.4	0.2	0.5	0.5	0.0	1.1	2.2	0.8	1.0	0.7	0.8	0.3	0.3	0.6	0.3	2.0	0.9	0.7	0.8	0.3	0.5	0.6	0.7	0.7	0.1	1.4	0.7	0.7	2.3	0.6	0.2	1.4	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.4"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavourable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.4	2.7	1.5	1.0	4.5	0.9	0.5	0.6	0.8	1.3	0.8	1.3	2.2	0.8	3.0	1.0	8.2	0.3	2.6	1.6	2.2	0.6	2.9	0.6	0.9	8.4	2.2	5.4	0.8	0.5	0.8	1.3	1.1	0.8	1.8	1.3	4.4	7.3	1.4	2.4	1.3	0.9	0.5	3.8	7.6	1.9	1.0	0.9	0.4	1.4	4.0	0.6	2.1	2.8	2.5	0.6	0.6	4.5	1.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2
CTRL		ENSG00000141086	"Chymotrypsin like"	P40313	16	67927640-67932414	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	281	"pancreas: 639.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA034504, HPA034505"	Enhanced				"Secreted to digestive system"					"HPA034504: AB_2674196, HPA034505: AB_10602212"	"unprognostic (3.03e-5)"	"unprognostic (3.53e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.20e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.29e-3)"	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	639.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1.1	1.1	0.7	0.0	2.2	0.5	0.5	3.7	1.1	0.3	0.2	0.1	1.8	0.3	0.7	1.1	1.3	2.3	1.4	0.7	0.4	0.7	1.0	5.6	0.7	3.1	1.4	6.3	0.7	1.1	1.4	0.3	0.9	2.5	1.2	0.2	3.9	1.0	0.0	1.5	1.0	0.6	1.0	0.7	2.7	6.2	2.2	2.8	0.5	4.5	0.0	0.9	2.6	1.4	1.3	0.7	0.6	1.2	4.3	1.6	0.1	2.0	0.5	1.6	6.5	2.7	3.6	0.2	0.8	0.8	0.6	0.7	0.3	1.5	0.7	0.2	0.3	1.1	0.5	0.9	0.6	0.5	2.2	1.1	0.0	0.7	1.1	0.0	0.5	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1
RBPJL	"RBP-L, RBPSUHL, SUH, SUHL"	ENSG00000124232	"Recombination signal binding protein for immunoglobulin kappa J region like"	Q9UBG7	20	45306851-45317824	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	279	"pancreas: 188.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 4.7;SK-MEL-30: 1.2;U-937: 2.6"	"Group enriched"	"Detected in some"	22	"liver cancer: 1.2;ovarian cancer: 1.2;pancreatic cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"thalamus: 0.5"	CAB006846	Enhanced									"CAB006846: "	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"		"unprognostic (1.34e-2)"	"unprognostic (6.09e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.92e-3)"	"unprognostic (2.48e-7)"	"unprognostic (5.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (3.49e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.2	0.0	0.8	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.0	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CUZD1	"ERG-1, UO-44"	ENSG00000138161	"CUB and zona pellucida like domains 1"	Q86UP6	10	122832149-122850793	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	200	"pancreas: 650.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.1;LHCN-M2: 7.9"	"Cancer enriched"	"Detected in some"	54	"pancreatic cancer: 32.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;T-cells: 3.2"	"Low region specificity"	"Detected in single"							"HPA068479, HPA068660, HPA074117"	Enhanced		Approved	Nucleoli,Vesicles				Nucleoli	Nucleoli	"HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663"	"unprognostic (4.68e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.52e-5)"	"unprognostic (8.08e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.75e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.83e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	650.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	3.2	0.2	1.6	1.6	1.7	0.0	0.4	0.8	1.0	2.5	0.7	0.3	1.7	1.8	3.6	0.9	0.7	1.0	1.7	0.0	1.5	2.6	2.2	2.2	3.5	4.6	0.8	0.3	0.0	3.7	1.1	0.3	1.5	7.1	1.7	1.3	1.5	7.9	0.4	1.9	2.7	1.7	1.3	0.0	4.0	0.6	1.3	1.3	1.8	0.7	0.8	0.4	1.1	1.3	1.9	3.5	0.0	2.4	0.9	0.0	1.9	1.4	3.1	1.2	5.8	0.0	0.0	0.1	0.3	0.8	0.1	1.3	0.6	0.9	1.1	0.1	1.1	1.4	0.7	0.0	0.0	0.2	0.2	3.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase family member 3B"	P08861	1	21977021-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"pancreas: 1614.4"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"			Cytosol	Cytosol	"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1614.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.9	5.3	8.2	3.0	2.3	3.2	0.9	0.6	4.9	1.7	1.3	2.5	1.5	2.2	1.1	1.8	1.7	1.7	5.3	2.7	5.4	2.6	1.4	1.6	1.0	0.5	0.0	2.4	4.1	2.4	4.9	3.9	1.3	1.9	3.2	2.3	2.4	1.4	0.0	2.4	2.5	5.5	0.4	2.5	2.1	1.5	1.3	3.5	3.6	0.9	4.2	0.0	3.6	3.1	1.7	3.4	0.8	0.3	2.5	2.8	3.6	2.9	1.6	2.3	1.0	4.8	4.7	2.4	1.8	4.7	0.6	5.1	2.5	1.8	3.1	3.0	2.0	3.7	2.2	2.8	1.4	5.9	3.2	3.0	8.2	2.3	1.7	5.3	2.9	0.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161341	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	193	"pancreas: 514.0"	"Group enriched"	"Detected in some"	9	"EFO-21: 52.5;U-2 OS: 68.8;U-698: 21.7"	"Cancer enriched"	"Detected in single"	7166	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	13	"midbrain: 1.7"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"					"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							0.4	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	514.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	2.6	0.1	0.1	0.1	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.8	0.0	5.2	0.0	2.4	21.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CELA2B	"ELA2B, RP11-265F14.2"	ENSG00000215704	"Chymotrypsin like elastase family member 2B"	P08218	1	15465909-15491400	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	188	"pancreas: 697.9"	"Cell line enriched"	"Detected in some"	5	"U-138 MG: 9.1"	"Cancer enriched"	"Detected in single"	574	"pancreatic cancer: 69.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.7"														"Secreted to digestive system"						"unprognostic (4.36e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.66e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.22e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-2)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	697.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.5	0.0	0.1	1.5	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.9	1.8	0.7	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	9.1	0.0	0.0	0.0	0.9	0.1	0.3	0.4	0.0	0.0	3.7	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AQP12A	AQP12	ENSG00000184945	"Aquaporin 12A"	Q8IXF9	2	240691845-240698483	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	182	"pancreas: 65.3"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042216	Supported									"HPA042216: AB_2677905"			"unprognostic (9.82e-2)"							"unprognostic (1.63e-2)"	"unprognostic (9.48e-2)"			"unprognostic (2.14e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTF1A	"bHLHa29, PTF1-p48"	ENSG00000168267	"Pancreas specific transcription factor, 1a"	Q7RTS3	10	23192327-23194252	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	154	"pancreas: 129.8"	"Cell line enriched"	"Detected in single"	11	"U-2 OS: 7.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022612			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB022612: "										"unprognostic (2.02e-1)"	"unprognostic (1.85e-1)"			"unprognostic (4.49e-1)"	"unprognostic (1.80e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	129.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
INS-IGF2		ENSG00000129965	"INS-IGF2 readthrough"	F8WCM5	11	2132538-2161209	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	148	"pancreas: 467.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.1;SH-SY5Y: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB019430	Enhanced				"Secreted to digestive system"					"CAB019430: AB_10691857"					"unprognostic (1.33e-1)"						"unprognostic (2.34e-1)"							0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.3	0.0	0.4	467.6	0.0	0.1	3.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.3	0.1	0.3	0.0	0.0	0.0
SERPINI2	"MEPI, PANCPIN, PI14, TSA2004"	ENSG00000114204	"Serpin family I member 2"	O75830	3	167441789-167479004	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	73	"pancreas: 184.7"	"Cell line enriched"	"Detected in some"	6	"THP-1: 13.8"	"Cancer enriched"	"Detected in some"	6	"pancreatic cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.5"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to digestive system"						"unprognostic (1.88e-2)"	"unprognostic (2.23e-3)"		"unprognostic (1.14e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.17e-2)"		"unprognostic (1.29e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.76e-5)"	"unprognostic (5.35e-2)"	"unprognostic (4.16e-2)"			0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	184.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	13.8	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	2.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SPINK1	"PCTT, PSTI, Spink3, TATI"	ENSG00000164266	"Serine peptidase inhibitor, Kazal type 1"	P00995	5	147824568-147831786	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"pancreas: 1767.1"	"Group enriched"	"Detected in some"	8	"CACO-2: 43.1;RT4: 118.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 513.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026366, HPA027498"	Enhanced				"Secreted to digestive system"	7900000	7900000			"CAB026366: , HPA027498: AB_10603115"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.79e-4)"	"unprognostic (8.34e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (5.44e-7)"	"unprognostic (7.98e-2)"	"unprognostic (2.07e-1)"		"prognostic favourable (2.15e-5)"	0.3	0.0	0.3	1.6	0.3	0.0	0.3	0.3	0.3	0.3	6.0	0.3	0.3	6.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.0	2.0	13.3	0.4	0.3	0.3	0.3	0.3	1767.1	0.0	0.3	0.3	0.3	1.4	6.4	0.3	0.3	0.3	0.3	0.0	6.9	1.0	0.3	0.3	25.8	0.4	0.3	0.3	0.3	0.3	0.3	13.1	2.2	0.7	0.5	1.9	0.5	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	10.7	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	118.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.3	0.5	0.2	2.1	0.0	0.0	1.9	0.4	0.2	0.4	0.5	0.2	0.4	0.4	0.3	0.1	0.7	0.5	0.6	1.8	0.3	0.4	0.5	0.1	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"intestine: 354.2;pancreas: 502.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.2;EFO-21: 11.5;HDLM-2: 10.6;NB-4: 11.9;RPMI-8226: 15.3;SH-SY5Y: 10.0;U-2 OS: 19.0;U-266/84: 10.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	22000000	22000000	Cytosol	Cytosol	"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				0.2	0.4	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0.0	1.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	15.3	0.0	0.0	1.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	3.7	7.1	0.0	10.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819148-50823787	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"pancreas: 742.6;salivary gland: 473.0"	"Cell line enriched"	"Detected in some"	23	"RPMI-8226: 28.8"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 20.0;pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 10.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	14	"B-cells: 10.9"														"Secreted to digestive system"	4300000	4300000				"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.2	2.5	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	3.8	0.1	0.1	0.1	0.1	0.1	0.1	742.6	0.0	0.1	0.1	0.1	0.2	1.9	0.1	473.0	0.1	0.1	1.8	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	1.2	0.2	0.2	0.1	0.1	10.9	0.7	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.2	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	10.9	0.0	0.0	0.2	3.8	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PPY	PNP	ENSG00000108849	"Pancreatic polypeptide"	P01298	17	43940804-43942468	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"pancreas: 275.8"	"Group enriched"	"Detected in some"	4	"BEWO: 7.0;EFO-21: 6.5;U-2 OS: 7.2"	"Cancer enriched"	"Detected in some"	132	"pancreatic cancer: 630.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 4.1"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016735, HPA032122"	Enhanced				"Secreted to blood"					"CAB016735: , HPA032122: AB_2674164"		"unprognostic (5.12e-3)"			"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"			"unprognostic (1.65e-2)"		"unprognostic (7.56e-3)"			"unprognostic (8.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.42e-1)"	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	275.8	7.5	0.1	0.1	0.1	0.1	2.5	0.1	0.1	0.1	0.1	2.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	1.0	0.0	7.2	0.8	0.9	0.0	0.5	1.4	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
G6PC2	IGRP	ENSG00000152254	"Glucose-6-phosphatase catalytic subunit 2"	Q9NQR9	2	168901240-168910000	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	35	"pancreas: 28.8;retina: 12.1"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.1"	"Cancer enriched"	"Detected in single"	92	"pancreatic cancer: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"														"unprognostic (6.42e-2)"				"unprognostic (2.39e-2)"		"unprognostic (6.04e-2)"		"unprognostic (9.05e-2)"		"unprognostic (2.97e-1)"		"unprognostic (3.10e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0
IAPP	"AMYLIN, DAP, IAP"	ENSG00000121351	"Islet amyloid polypeptide"	P10997	12	21354959-21379978	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	34	"pancreas: 63.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;U-2 OS: 4.8;U-698: 1.6"	"Cancer enriched"	"Detected in single"	76	"pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000352, HPA053194"	Enhanced				"Secreted to blood"					"CAB000352: AB_2121635, HPA053194: AB_2682076"							"unprognostic (5.52e-3)"				"unprognostic (1.00e-1)"	"unprognostic (4.16e-1)"		"unprognostic (1.74e-1)"	"unprognostic (1.91e-1)"			0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	63.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	1.3	1.8	0.6	0.7	0.7	0.1	0.1	0.0	0.9	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.3	0.0	0.2	0.1	0.5	0.4	0.2	1.1	0.0	0.1	0.6	0.0	0.0	0.2	0.3	0.1	0.1	0.5	0.9	0.1	0.3	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.3	4.8	0.1	0.7	0.5	1.1	1.6	0.2	0.2	0.1	1.8	0.6	0.1	0.4	0.2	0.1	0.4	0.5	0.2	0.3	0.7	0.4	0.7	1.5	0.7	0.2	1.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AMY2A	AMY2	ENSG00000243480	"Amylase, alpha 2A (pancreatic)"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"pancreas: 1849.4"	"Cell line enhanced"	"Detected in some"		"THP-1: 1.0;U-2 OS: 1.2"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	77000000	77000000			"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.9	1849.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	59.9	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228940	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"intestine: 40.9;pancreas: 163.4"	"Cell line enriched"	"Detected in single"	6	"Hep G2: 4.9"	"Group enriched"	"Detected in some"	42	"colorectal cancer: 6.4;liver cancer: 3.2;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced									"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.2	0.0	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	40.9	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	163.4	0.0	0.2	0.2	0.2	0.2	19.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.0	4.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.6	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750466-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"pancreas: 984.9"	"Cell line enriched"	"Detected in some"	8	"PC-3: 121.9"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	82	"basophil: 39.0"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 39.0"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	490000000	490000000	Vesicles	Vesicles	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	0.3	0.3	1.6	1.7	1.5	0.2	0.2	2.8	4.2	0.9	8.2	0.0	0.0	2.8	0.2	0.2	2.9	0.2	4.8	0.4	1.2	0.7	0.3	0.4	0.2	0.2	0.3	1.6	0.7	984.9	0.2	0.1	0.2	2.3	0.2	2.3	0.0	0.6	0.2	0.2	2.0	23.9	0.3	0.2	0.2	0.8	0.3	0.0	0.0	0.2	6.6	3.5	0.2	1.3	0.0	0.1	39.0	0.4	0.1	0.3	0.1	1.7	2.0	0.1	0.0	0.0	0.9	0.0	4.8	1.1	0.5	0.2	4.7	0.4	0.0	0.0	2.1	2.1	0.0	4.4	1.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	15.9	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	121.9	0.0	0.0	0.0	0.0	0.2	0.0	12.3	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	39.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	1.5	2.8	4.2	1.2	0.7	0.3	1.6	2.3	0.0
CCKBR		ENSG00000110148	"Cholecystokinin B receptor"	P32239	11	6259736-6272127	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 12.9;pancreas: 34.7;stomach 1: 21.4"	"Cell line enriched"	"Detected in some"	9	"NTERA-2: 39.2"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 9.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 15.5;basal ganglia: 15.3;cerebral cortex: 31.4;hippocampal formation: 26.8;olfactory region: 19.2"												"unprognostic (2.82e-1)"			"unprognostic (4.62e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.19e-1)"		"unprognostic (1.95e-1)"	"unprognostic (6.34e-4)"	"unprognostic (8.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-2)"		0.3	0.4	6.5	0.3	5.6	0.3	0.3	10.8	12.9	0.3	0.3	0.0	0.0	0.6	0.4	0.3	0.3	0.6	0.4	0.3	3.3	0.8	0.3	0.3	0.3	0.3	1.0	6.9	0.3	34.7	0.3	0.4	0.4	2.1	0.9	0.3	0.3	0.3	0.4	0.4	0.8	0.3	0.3	0.3	0.3	21.4	0.6	0.0	0.0	0.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.5	5.6	10.8	12.9	3.3	0.8	1.0	6.9	2.1	0.0
SLC22A31		ENSG00000259803	"Solute carrier family 22 member 31"		16	89195761-89201664	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	21	"brain: 39.3;lung: 50.7;pancreas: 69.7"	"Group enriched"	"Detected in some"	5	"BEWO: 23.2;Hep G2: 18.6;NB-4: 9.5;RPMI-8226: 11.2;THP-1: 6.1"	"Group enriched"	"Detected in many"	9	"liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4"	"Region enriched"	"Detected in some"	23	"cerebellum: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.71e-3)"	"unprognostic (2.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.89e-1)"	0.1	0.3	0.0	0.3	0.4	1.1	0.1	39.3	0.1	0.3	0.5	0.0	0.0	0.6	0.2	0.5	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.3	50.7	2.5	0.0	0.0	0.7	69.7	0.1	0.0	0.1	1.7	0.2	0.1	0.4	0.7	0.2	0.1	0.3	0.3	0.1	0.3	1.0	0.5	1.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	1.1	0.0	0.0	23.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	18.6	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	9.5	0.5	2.3	0.0	2.6	11.2	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	39.3	0.1	0.1	0.0	0.0	0.0	1.7	0.0
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283152-287215	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"pancreas: 286.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;HEK 293: 11.3;Hep G2: 8.4;Karpas-707: 3.9;MCF7: 6.0;SH-SY5Y: 4.9"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"					"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	0.3	0.3	2.1	0.2	1.5	0.3	0.2	15.3	3.0	0.2	0.7	4.3	0.2	2.9	0.2	0.3	0.2	0.2	0.8	0.4	2.8	3.0	0.2	0.2	0.2	0.2	4.0	0.5	0.4	286.5	0.2	0.2	0.5	2.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	1.0	0.2	5.4	0.2	10.2	0.3	2.8	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	5.1	0.2	0.6	0.1	11.3	0.0	0.3	8.4	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	3.9	0.2	6.0	0.2	0.6	0.4	0.0	0.1	0.0	1.1	0.0	0.0	2.2	4.9	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.5	15.3	3.0	2.8	3.0	4.0	0.5	2.2	2.8
BHLHA15	"bHLHa15, BHLHB8, MIST1"	ENSG00000180535	"Basic helix-loop-helix family member a15"	Q7RTS1	7	98211427-98212979	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"pancreas: 145.8;salivary gland: 95.2"	"Group enriched"	"Detected in some"	8	"Karpas-707: 16.7;RPMI-8226: 31.0;U-266/70: 37.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	7	"B-cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034083, HPA047834"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"CAB034083: AB_2065216, HPA047834: AB_2680172"	"unprognostic (2.80e-2)"	"unprognostic (9.45e-3)"	"unprognostic (8.10e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.10e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.70e-4)"	"unprognostic (3.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.25e-3)"	0.1	0.1	0.2	0.8	0.2	0.0	0.1	0.1	0.2	0.3	1.2	0.0	3.5	0.9	0.1	0.1	0.4	0.1	0.8	0.1	0.3	0.2	0.3	4.7	0.5	1.8	0.1	0.0	0.0	145.8	0.0	0.4	0.0	0.0	1.6	0.1	0.0	95.2	6.8	0.4	0.2	0.8	0.0	0.1	1.9	6.2	0.1	0.0	0.0	0.2	1.2	2.7	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	1.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	16.7	0.0	0.3	0.0	0.0	0.5	0.5	0.2	0.0	31.0	0.0	0.0	1.8	0.7	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	37.1	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.0
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867109	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"pancreas: 38.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.5;HMC-1: 25.0;U-937: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"			"Centriolar satellite"	"Centriolar satellite"	"HPA071587: AB_2732182, HPA074326: AB_2732251"	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.2	0.0	0.4	0.3	0.8	0.0	0.0	0.2	1.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.5	0.2	0.4	0.0	38.5	0.0	0.9	0.1	0.5	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.5	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.1	0.0	0.1	2.2	0.0	0.0	15.5	0.0	0.0	0.0	0.2	0.0	0.0	25.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	3.1	1.0	0.0	0.0	0.0	0.0	3.9	0.0	0.6	1.0	0.2	0.0	0.0	0.0	0.3	0.0	5.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.8	0.2	1.2	0.7	0.0	0.2	0.4	0.5	0.2
C2CD4B	"FAM148B, NLF2"	ENSG00000205502	"C2 calcium dependent domain containing 4B"	A6NLJ0	15	62163535-62165283	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"pancreas: 192.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;HUVEC TERT2: 6.1;NTERA-2: 2.5;SCLC-21H: 1.8;TIME: 1.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046880	Uncertain									"HPA046880: AB_10959458"	"unprognostic (6.60e-2)"	"prognostic favourable (4.22e-4)"	"unprognostic (2.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.16e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.24e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.48e-1)"	12.1	1.0	0.2	4.3	0.5	3.0	7.9	0.1	0.7	1.7	2.0	0.3	0.4	2.2	3.7	3.2	3.2	1.2	5.0	2.0	0.3	0.3	0.7	1.7	9.2	0.7	0.5	0.0	1.6	192.0	0.7	2.5	1.4	0.6	2.2	0.6	0.5	0.9	1.0	2.8	1.6	1.8	1.5	0.9	0.4	7.8	1.0	0.2	4.6	0.9	4.1	0.6	3.9	4.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.3	0.3	0.3	0.5	0.0	0.6	0.2
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142873-162152404	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"pancreas: 202.8"	"Group enriched"	"Detected in some"	5	"EFO-21: 37.1;U-2 OS: 52.8"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"pons and medulla: 3.7"	"Region enhanced"	"Detected in single"		"midbrain: 2.0"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				1.0	0.1	0.2	0.6	0.2	1.1	0.2	0.2	1.8	0.2	6.6	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	3.4	0.2	0.2	0.2	0.2	0.2	0.2	202.8	0.0	0.2	0.2	0.5	0.2	12.6	0.2	0.2	0.2	0.2	2.5	11.0	0.2	0.2	0.2	2.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.0	2.9	0.0	1.4	8.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.5	0.2
OR6T1		ENSG00000181499	"Olfactory receptor family 6 subfamily T member 1"	Q8NGN1	11	123942785-123943873	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	16	"pancreas: 4.5;testis: 1.7"	"Cell line enriched"	"Detected in single"	4	"hTCEpi: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA060893	Uncertain									"HPA060893: AB_2684380"	"unprognostic (9.30e-4)"																	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC008687.4		ENSG00000268655			19	49017496-49020523	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	14	"pancreas: 13.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.6;HEK 293: 3.9;SiHa: 2.6;U-2 OS: 3.0;U-251 MG: 2.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.06e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.23e-1)"		"unprognostic (5.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.85e-1)"	"unprognostic (7.96e-4)"	"unprognostic (9.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	13.7	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.4	1.0			0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.6	0.2	0.0	0.6	0.2	0.0	0.7	0.3	0.1	0.0	0.0	0.6	1.3	0.7	0.1	0.3	0.3	0.1	0.0	0.1	2.6	3.9	0.0	0.4	0.1	0.1	0.7	0.6	0.0	0.1	0.1	0.0	0.0	0.7	1.5	0.0	0.2	0.0	0.2	0.2	0.1	1.5	0.4	1.2	0.0	0.1	0.4	0.2	2.6	0.2	0.2	0.3	0.3	0.0	0.6	3.0	0.0	2.7	1.2	2.2	1.2	0.5	1.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0										
ONECUT1	"HNF-6, HNF6, HNF6A"	ENSG00000169856	"One cut homeobox 1"	Q9UBC0	15	52756989-52791078	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"gallbladder: 40.1;liver: 59.9;pancreas: 46.3"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;Hep G2: 4.0;MCF7: 5.1;RT4: 4.0;WM-115: 3.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 2.9;pancreatic cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Low region specificity"	"Detected in all"			HPA003457	Enhanced									"HPA003457: AB_1079525"		"unprognostic (5.12e-2)"		"unprognostic (2.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.05e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.03e-1)"		"unprognostic (1.70e-7)"	"unprognostic (9.76e-3)"	"unprognostic (2.11e-1)"		"unprognostic (1.17e-1)"	0.1	0.1	0.5	0.0	0.1	1.2	0.1	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	40.1	0.1	0.2	0.2	0.1	59.9	0.1	0.0	0.1	0.0	0.1	46.3	0.0	0.1	0.0	1.4	0.1	0.0	3.5	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	1.2	3.3	1.4	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.4	0.2	2.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.2	0.2	1.4	4.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	5.1	0.0	0.0	2.5	0.3	0.9	0.2	0.0	0.0	4.0	1.7	0.0	0.5	0.1	0.4	1.0	0.2	0.0	2.1	2.7	0.0	0.4	0.3	0.1	0.3	0.4	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.9	0.3	0.2	0.2	0.1	0.0	1.4	0.0
REG1A	"PSP, PSPS, PSPS1, PTP, REG"	ENSG00000115386	"Regenerating family member 1 alpha"	P05451	2	79120362-79123419	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"pancreas: 1772.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;EFO-21: 11.7;HDLM-2: 9.3;NB-4: 6.7;RPMI-8226: 18.9;SH-SY5Y: 8.1;U-2 OS: 18.9;U-251 MG: 6.3;U-266/84: 6.3"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 313.8;pancreatic cancer: 1268.4;stomach cancer: 521.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB025138, HPA045549, HPA045579"	Enhanced				"Secreted to digestive system"	61000000	61000000			"CAB025138: , HPA045549: AB_2679365, HPA045579: "			"unprognostic (1.89e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.45e-1)"	"unprognostic (2.10e-1)"		"unprognostic (1.63e-1)"	"unprognostic (5.52e-2)"		"unprognostic (3.54e-3)"	"unprognostic (5.53e-2)"	"unprognostic (5.54e-2)"			0.3	0.1	0.3	2.8	0.4	0.0	0.3	0.3	0.3	0.3	37.9	0.3	0.3	129.0	0.3	0.3	0.3	0.1	1.3	0.3	0.3	0.0	14.6	0.3	0.3	0.3	0.3	0.3	0.3	1772.6	0.0	0.3	0.3	0.3	0.3	4.5	0.3	0.3	0.4	0.3	0.1	74.7	2.5	0.3	0.3	15.9	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.0	18.9	0.0	0.0	0.9	8.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.9	1.3	6.3	0.0	6.3	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
TEX11	"TGC1, TSGA3"	ENSG00000120498	"Testis expressed 11"	Q8IYF3	X	70528940-70908731	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"pancreas: 36.4;testis: 22.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;K-562: 3.7;NTERA-2: 1.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002950	Approved									"HPA002950: AB_1080249"	"unprognostic (6.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.87e-3)"	"unprognostic (7.77e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.30e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	36.4	0.0	0.1	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.2	22.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	1.0	0.2	0.8	2.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.7	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.8	0.2	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.0	0.8	0.1	0.1	2.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261463	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5"	"Cell line enhanced"	"Detected in many"		"REH: 18.7;SCLC-21H: 19.6;U-138 MG: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favourable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0.0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18.0	8.2	1.1	37.0	2.0	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	11.1	0.2	1.4	0.6	0.4	0.4	1.0	0.3	4.1	2.6	2.7	0.4	0.5	0.4	2.7	0.2	1.4	0.7	0.4	1.5	9.1	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.6	0.4	1.9	0.0	0.0	3.3	0.4	5.9	0.1	0.1	7.9	3.6	18.7	5.4	1.5	0.6	2.1	19.6	4.2	1.8	0.5	0.1	6.0	0.1	0.0	20.4	8.9	1.9	3.3	2.2	3.3	2.7	4.7	1.1	1.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.2	9.6	29.7	38.3	12.3	32.7	18.0	8.2	25.1	4.5
CFC1	"CRYPTIC, HTX2"	ENSG00000136698	"Cripto, FRL-1, cryptic family 1"	P0CG37	2	130592168-130599575	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4"	"Group enriched"	"Detected in some"	21	"RPMI-8226: 19.1;SCLC-21H: 10.9"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 4.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Uncertain				"Secreted - unknown location"					"HPA041773: AB_2677664"					"unprognostic (6.65e-2)"						"unprognostic (2.19e-3)"	"unprognostic (1.11e-3)"			"unprognostic (2.01e-1)"			0.1	0.1	0.9	0.0	2.1	0.0	0.0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0.0	1.2	0.1	0.3	0.2	13.0	0.1	0.0	0.0	0.0	2.5		0.1	21.9	0.0	22.4	0.0		7.6	0.3		0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	9.4	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1										
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781017-35793675	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"epididymis: 123.5;pancreas: 103.6"	"Cell line enriched"	"Detected in single"	17	"T-47d: 13.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA073155	Enhanced				"Secreted in male reproductive system"					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.1	1.6	0.0	0.2	0.0	0.8	0.1	0.9	0.1	0.1	0.0	9.6	0.0	0.1	123.5	0.1	0.1	0.0	0.1	1.8	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	103.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	13.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.1	0.9	1.8	0.1	0.2	0.0	0.0	0.0
ECE2	"KIAA0604, MGC2408"	ENSG00000145194	"Endothelin converting enzyme 2"	O60344	3	184276011-184293031	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	12	"adrenal gland: 14.4;brain: 25.1;pancreas: 29.0;pituitary gland: 7.6"	"Cell line enriched"	"Detected in some"	8	"REH: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043346	Uncertain									"HPA043346: AB_10794181"	"unprognostic (2.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavourable (8.41e-5)"	"unprognostic (1.37e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.63e-9)"	"unprognostic (3.66e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.25e-2)"	0.7	14.4	9.1	0.9	17.1	0.7	0.7	17.6	10.5	0.7	1.1	2.2	0.0	0.8	0.7	1.6	0.8	0.9	0.7	1.5	4.6	25.1	0.7	0.7	0.7	0.7	10.3	3.0	0.7	29.0	0.7	7.6	0.7	7.5	1.6	0.9	1.4	1.1	1.1	0.7	0.7	0.8	0.9	2.9	0.7	1.0	0.8	3.3	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	17.1	17.6	5.2	4.6	25.1	10.3	3.0	7.5	3.3
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;Hep G2: 19.9;HHSteC: 9.0;U-937: 28.3"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	270000	270000	"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	19.9	9.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
FBXW12	"Fbw12, FBXO35"	ENSG00000164049	"F-box and WD repeat domain containing 12"	Q6X9E4	3	48372219-48401259	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"pancreas: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HEK 293: 1.7;SH-SY5Y: 1.0;THP-1: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037491, HPA037492"	Uncertain									"HPA037491: AB_2675504, HPA037492: AB_2675505"	"unprognostic (5.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.36e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.9	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1		0.1	12.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.8	1.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960758-42963880	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 83.9;pancreas: 100.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 10.3;SCLC-21H: 12.2;T-47d: 7.8"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 17.7"	"Low region specificity"	"Detected in all"			HPA027501	Enhanced		Approved	Cytosol		150000	150000	Cytosol	Cytosol	"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favourable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0.0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0.0	2.5	0.1	0.4	5.2	0.0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2.0	0.9	0.0	1.2	0.3	0.5	0.4	1.8	5.0	0.6	0.2	0.3	0.4	2.0	0.8	1.2	0.1	0.1	1.6	0.2	0.4	0.5	0.3	0.3	0.2	2.0	1.6	1.3	1.0	10.3	0.0	1.1	2.4	0.4	0.0	0.4	0.2	0.0	1.4	1.9	0.3	2.2	2.0	3.7	0.2	0.5	1.7	1.6	1.0	0.8	0.2	12.2	1.7	0.1	1.7	0.6	7.8	3.5	0.4	0.9	0.9	0.5	1.0	1.3	1.1	1.4	0.2	2.0	1.0	0.0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2.0	0.0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1
REG1B	"PSPS2, REGH, REGI-BETA, REGL"	ENSG00000172023	"Regenerating family member 1 beta"	P48304	2	79085030-79088019	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"pancreas: 969.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 7.3;HDLM-2: 4.5;RPMI-8226: 3.2;U-2 OS: 17.1;U-251 MG: 4.2;U-266/84: 3.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 201.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045549, HPA045579"	Supported				"Secreted to digestive system"	37000000	37000000			"HPA045549: AB_2679365, HPA045579: AB_2679374"			"unprognostic (4.08e-1)"								"unprognostic (1.09e-1)"		"unprognostic (3.51e-3)"	"unprognostic (9.20e-2)"				0.5	0.1	0.3	3.7	0.4	0.7	0.3	0.3	0.3	0.3	14.3	0.3	0.3	88.2	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.1	0.5	0.3	0.3	0.3	0.3	0.3	0.3	969.2	0.0	0.3	0.3	0.3	0.3	13.2	0.3	0.3	0.3	0.3	1.6	56.3	13.0	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.1	4.2	0.0	3.8	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3
BRSK2	"C11orf7, PEN11B, STK29"	ENSG00000174672	"BR serine/threonine kinase 2"	Q8IWQ3	11	1389899-1462689	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 34.9;pancreas: 78.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.9;AN3-CA: 9.7;CACO-2: 7.7;HAP1: 7.2;NTERA-2: 15.0;SCLC-21H: 35.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073690			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA073690: "	"unprognostic (5.47e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.42e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.17e-7)"	"unprognostic (3.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.86e-1)"	1.5	3.5	13.6	1.5	12.8	1.3	1.3	30.8	34.9	1.3	1.5	10.0	0.0	1.7	1.4	1.3	1.3	1.4	1.9	1.5	15.6	10.6	1.4	1.3	1.4	1.3	8.3	17.2	1.4	78.8	1.6	4.6	1.8	9.5	1.6	1.4	2.2	1.6	1.4	1.5	1.5	1.9	1.4	6.5	1.3	1.9	5.5	9.2	0.0	1.9	0.0	1.3	1.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.9	8.9	9.7	0.1	0.3	0.0	0.1	0.1	0.7	0.3	7.7	0.5	0.0	1.3	0.1	0.0	7.2	0.0	0.6	0.9	3.8	0.0	0.0	0.1	0.4	0.0	0.3	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.9	0.0	0.0	15.0	1.2	0.0	0.0	0.0	0.1	0.1	35.0	5.2	1.7	0.1	2.4	0.2	0.4	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	13.6	12.8	30.8	23.3	15.6	10.6	8.3	17.2	9.5	9.2
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027602-200177424	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 38.7;liver: 36.1;pancreas: 100.4"	"Cell line enhanced"	"Detected in some"		"A549: 19.3;HAP1: 11.7;HMC-1: 5.1;HUVEC TERT2: 16.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.5"					"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	2.9	0.2	0.2	4.5	0.3	0.0	2.6	0.2	0.2	2.3	23.8	0.2	0.6	8.1	3.5	1.3	0.7	1.3	5.7	0.5	0.2	0.4	0.4	36.1	1.6	0.7	0.3	0.3	1.0	100.4	0.0	0.3	0.3	0.3	1.1	6.3	0.3	0.5	1.3	1.0	0.7	38.7	1.8	0.4	0.3	0.6	0.6	0.2	0.2	0.8	0.3	0.4	0.8	1.1	1.3	1.4	5.5	1.2	1.5	1.1	0.3	0.0	19.3	0.0	0.1	0.0	0.2	0.5	0.0	0.3	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.5	11.7	0.0	0.0	2.5	0.8	0.0	0.2	2.0	0.4	0.0	5.1	0.1	0.0	0.0	0.1	16.1	0.0	0.3	0.0	0.5	0.0	0.3	0.8	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.7	0.3	0.1	0.8	0.2	0.1	0.1	2.7	1.7	2.0	0.3	0.1	0.1	5.5	1.2	1.1	0.6	0.7	0.7	0.7	1.0	0.8	0.4	1.3	1.1	1.0	4.2	1.5	0.5	1.4	0.9	0.3	0.2	0.3	0.2	0.2	0.2	0.4	0.3	0.3	0.3	0.2
CFC1B		ENSG00000152093	"Cripto, FRL-1, cryptic family 1B"	P0CG36	2	130521197-130528604	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"brain: 3.4;pancreas: 13.0;pituitary gland: 8.1"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 2.2;U-2 OS: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041773	Approved				"Secreted - unknown location"					"HPA041773: AB_2677664"																		0.3	0.1	0.4	0.1	1.6	0.1	0.1	1.5	0.5	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.3	0.1	3.4	0.2	0.1	0.2	0.1	0.6	0.1	0.1	13.0	0.1	8.1	0.1	1.0	0.8	0.7	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.6	1.5	0.5	0.1	3.4	0.6	0.1	1.0	0.1
ERO1B	"ERO1-L(beta), Ero1beta, ERO1LB"	ENSG00000086619	"Endoplasmic reticulum oxidoreductase 1 beta"	Q86YB8	1	236215555-236281985	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"pancreas: 160.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028085	Enhanced				"Intracellular and membrane"					"HPA028085: AB_10601214"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.49e-2)"	"prognostic favourable (7.53e-5)"	"unprognostic (1.73e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.90e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.09e-3)"	2.7	2.5	3.2	4.3	4.8	2.6	6.9	7.4	4.0	2.4	3.3	2.0	5.7	4.4	2.5	10.1	1.4	2.1	4.1	2.9	3.3	2.7	3.7	11.6	2.5	3.5	4.0	1.7	3.4	160.4	5.4	8.5	2.2	3.9	2.7	1.4	1.4	9.0	3.2	1.9	1.7	2.7	2.2	3.0	4.1	17.7	10.9	4.1	4.1	12.5	0.8	2.7	2.4	2.3	2.9	7.2	12.9	1.9	1.3	2.8	0.9	1.9	2.2	3.8	3.2	3.0	2.0	4.6	2.9	2.8	2.1	1.8	0.6	2.0	5.2	8.1	4.6	0.9	1.8	2.6	3.0	5.2	11.3	1.5	0.3	2.0	8.2	2.1	0.9	3.5	5.6	3.7	7.0	2.5	0.8	13.2	2.8	1.0	0.9	0.9	1.5	0.7	10.8	2.7	1.3	4.2	4.5	7.9	4.6	9.4	3.2	7.7	7.7	9.4	2.3	3.1	2.7	3.2	3.8	9.2	0.5	3.0	4.4	3.1	4.8	12.9	1.9	3.2	2.8	1.9	2.5	1.9	1.5	1.9	1.9	2.9	2.3	2.2	3.9	1.3	0.8	7.2	1.4	0.9	3.2	4.8	7.4	4.0	3.3	2.7	4.0	1.7	3.9	4.1
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 186.3;liver: 252.2;pancreas: 286.1"	"Group enriched"	"Detected in some"	4	"RH-30: 55.9;RT4: 14.7;U-266/70: 34.5;U-266/84: 43.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	6	"B-cells: 12.8;dendritic cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		620000	620000	Mitochondria	Mitochondria	"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	1.8	2.5	18.5	1.6	14.7	0.6	2.9	11.4	16.2	1.5	3.1	24.9	0.3	17.8	1.3	2.2	3.0	1.7	5.0	5.5	15.2	10.3	186.3	252.2	1.2	2.1	20.6	14.3	17.6	286.1	0.7	1.2	7.8	14.5	1.7	1.7	1.5	5.5	2.1	13.5	13.9	10.8	2.7	26.1	3.5	10.0	8.0	18.4	0.7	6.6	2.5	3.1	2.2	2.0	12.8	6.9	0.3	1.5	0.1	1.5	0.8	3.4	1.7	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	5.7	8.8	0.3	0.0	0.6	4.4	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.2	5.1	0.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.1	3.1	0.0	0.1	55.9	0.4	0.9	14.7	6.5	1.1	1.8	0.1	0.3	0.7	5.8	0.0	0.0	0.1	0.0	1.7	34.5	43.6	0.2	0.4	0.1	0.3	0.0	1.1	0.3	0.3	1.5	0.0	12.8	0.0	0.3	6.9	5.9	0.0	1.5	0.0	0.1	0.6	6.8	0.0	0.8	18.5	14.7	11.4	16.2	15.2	10.3	20.6	14.3	14.5	18.4
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066571	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 55.4;liver: 146.5;pancreas: 80.1"	"Group enriched"	"Detected in some"	9	"EFO-21: 19.4;Hep G2: 27.5;T-47d: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.2;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					1000000	1000000			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	0.2	0.0	0.3	0.1	0.5	0.0	3.2	0.4	1.1	0.3	0.3	0.2	8.4	0.2	1.1	10.7	0.1	1.9	3.2	0.7	0.6	0.3	55.4	146.5	4.9	0.1	0.9	0.2	0.4	80.1	2.6	3.2	0.2	0.4	5.3	0.0	0.4	4.1	8.5	8.5	0.0	0.2	0.1	0.9	0.3	6.9	0.8	0.3	0.1	4.3	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.1	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.1	0.0	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	2.0	0.1	0.1	0.0	0.1	13.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.6	0.2	0.5	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.5	0.4	1.1	0.6	0.3	0.9	0.2	0.4	0.3
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781191	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2"	"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 5.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA055564	Approved									"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.2	0.0	0.2	1.8	0.2	0.0	0.2	0.2	0.2	0.2	12.8	0.2	0.2	14.8	0.2	0.4	0.2	0.1	14.9	0.2	0.2	0.1	2.2	27.2	0.2	0.2	0.2	0.2	0.2	14.2	0.0	0.2	0.2	0.2	0.2	14.2	0.2	0.2	0.2	0.2	0.0	24.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	1.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.1	0.7	5.7	0.0	0.2	0.3	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.1	1.3	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
TMED6	"MGC23911, p24g5, p24gamma5"	ENSG00000157315	"Transmembrane p24 trafficking protein 6"	Q8WW62	16	69343248-69351809	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"pancreas: 144.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 17.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA012532	Approved									"HPA012532: AB_1858065"	"unprognostic (6.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.31e-3)"	"prognostic favourable (7.74e-5)"	"unprognostic (9.84e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.52e-3)"	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	0.2	0.4	0.9	0.2	2.0	2.7	0.3	4.5	0.2	5.6	0.3	0.2	0.2	0.1	6.1	3.1	0.7	0.2	0.2	0.2	1.0	144.2	0.0	0.2	0.2	0.2	0.2	1.7	0.2	0.2	3.5	0.2	0.1	2.8	0.2	0.2	0.3	16.6	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.2	0.0	0.6	0.0	2.0	0.2	0.7	1.9	1.6	1.1	0.1	0.1	1.0	2.3	0.1	0.0	0.3	2.4	1.0	4.8	0.8	0.0	1.2	0.2	0.2	0.4	0.7	2.0	2.4	0.8	17.3	0.1	3.0	1.1	0.2	0.9	0.1	0.3	0.1	1.6	0.6	0.3	1.9	1.3	3.3	2.2	1.8	2.6	1.4	1.8	0.7	2.0	3.8	1.5	3.1	1.1	1.2	0.6	2.1	2.1	2.7	1.5	0.9	1.5	1.6	1.5	5.2	1.4	2.5	0.9	0.0	0.4	0.0	0.8	0.6	1.5	0.6	2.0	0.4	0.2	0.3	0.5	2.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
A4GNT	alpha4GnT	ENSG00000118017	Alpha-1,4-N-acetylglucosaminyltransferase	Q9UNA3	3	138123718-138132387	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"gallbladder: 25.9;pancreas: 7.0;stomach 1: 25.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.6;BJ: 3.7"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 2.5;stomach cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA008017	Enhanced				"Intracellular and membrane"					"HPA008017: AB_1078073"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"			"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.48e-3)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	25.9	0.1	0.1	0.1	1.5	0.4	0.3	0.1	0.1	0.1	0.2	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	25.0	0.1	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.6	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 53.0;pancreas: 161.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.76e-4)"	6.5	7.1	12.1	3.8	18.8	2.2	5.5	9.6	22.4	9.8	4.6	42.5	2.7	3.4	9.3	5.6	7.6	8.6	9.1	5.9	16.9	12.4	6.8	12.1	7.3	2.8	28.8	15.0	11.4	161.1	12.8	4.2	6.3	26.4	6.5	4.7	6.9	5.3	9.9	6.2	7.2	3.6	11.7	53.0	5.7	4.9	4.1	21.4	0.0	6.3	2.3	2.8	6.7	5.5	4.0	2.2	0.7	3.2	2.2	6.7	1.1	3.9	4.6	9.6	14.7	32.0	34.5	0.4	21.2	18.5	10.3	8.4	3.6	6.2	0.7	5.2	38.3	6.9	10.3	6.1	8.5	2.3	5.5	2.3	7.9	4.3	15.8	0.8	0.5	29.9	9.5	13.2	12.8	8.9	0.8	0.4	18.9	14.2	0.6	1.9	6.2	10.4	1.8	4.3	0.8	4.4	2.2	12.5	14.0	7.9	1.0	2.3	10.2	2.7	12.1	18.6	2.0	19.4	6.8	0.3	0.3	0.4	8.7	1.2	13.0	0.6	2.0	0.7	2.0	3.2	5.2	4.0	6.7	5.3	2.2	1.8	3.1	2.7	0.0	2.2	1.3	1.3	6.3	1.1	12.1	18.8	9.6	21.7	16.9	12.4	28.8	15.0	26.4	21.4
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell line enhanced"	"Detected in some"		"A-431: 39.6;HDLM-2: 20.7;U-87 MG: 83.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favourable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.3	20.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0
CELA1	ELA1	ENSG00000139610	"Chymotrypsin like elastase family member 1"	Q9UNI1	12	51328443-51346679	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 6.3;blood: 12.6;pancreas: 11.8"	"Cell line enriched"	"Detected in some"	4	"BEWO: 10.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Cell type enhanced"	"Detected in many"		"basophil: 9.0;naive CD4 T-cell: 12.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.0;T-cells: 12.6"	"Low region specificity"	"Detected in all"												"Secreted - unknown location"						"unprognostic (3.54e-2)"	"unprognostic (1.64e-1)"		"unprognostic (4.73e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.70e-1)"		"unprognostic (1.52e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.59e-2)"		"unprognostic (3.83e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"			0.0	6.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1		0.0	11.8	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.6			0.0		0.3	0.0	0.0	0.3	0.9	9.0	1.6	0.2	12.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	9.0	1.6	0.1	1.1	0.8	0.4	0.3	2.7	0.8	0.9	0.0	12.6	5.9	0.2	0.2	0.9	0.0	0.3	1.3										
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570246-37582616	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3"	"Group enriched"	"Detected in some"	13	"CACO-2: 45.9;Hep G2: 25.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5"	"Group enriched"	"Detected in many"	51	"dendritic cells: 100.5;monocytes: 129.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	3.1	0.4	0.6	4.3	0.5	1.8	0.6	0.4	0.5	0.5	12.6	0.5	0.4	6.1	1.0	1.9	0.8	0.6	91.7	0.7	0.4	0.4	35.3	1.0	2.3	7.9	0.5	0.4	0.6	87.3	0.0	0.4	0.9	0.5	0.5	13.0	0.5	1.8	0.4	0.4	0.9	43.0	0.4	0.5	8.3	1.5	0.6	0.4	4.5	0.5	1.0	9.6	0.7	0.6	0.6	100.5	2.2	129.0	0.1	0.2	70.1	1.1	0.6	0.4	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	45.9	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	25.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.4	0.2	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.7	0.8	1.0	0.7	0.7	2.7	0.9	0.4	1.8	0.3	0.0	0.1	0.1	1.2	0.0	0.5	0.6	129.0	0.6	0.1	47.0	0.2	0.6	0.1	0.2	100.5	0.2	0.2	0.1	2.2	0.1	2.9	0.8	0.2	70.1	0.6	0.5	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.4
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20803278	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"pancreas: 809.6"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 73.2;RT4: 28.7;TIME: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.0;myeloid DC: 16.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 16.1;monocytes: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	1500000000	1500000000	Vesicles	Vesicles	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	79.2	48.4	28.7	12.0	38.5	1.6	59.7	4.0	32.2	21.3	33.7	57.8	63.6	16.8	13.6	49.1	19.3	24.3	37.5	70.3	41.2	21.6	33.8	8.6	94.3	23.5	39.0	16.0	19.2	809.6	6.7	4.1	79.0	25.1	23.0	39.8	106.4	15.9	35.6	31.7	10.8	20.6	26.6	52.3	34.5	87.9	86.5	27.1	7.8	11.2	14.3	7.2	29.0	10.9	0.0	16.1	1.3	8.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	73.2	7.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	28.7	0.3	0.3	0.0	0.2	0.0	0.0	0.0	38.0	0.0	0.6	0.4	0.0	0.1	0.0	0.0	1.0	0.0	1.0	1.3	8.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	2.0	28.7	38.5	4.0	32.2	41.2	21.6	39.0	16.0	25.1	27.1
SPACA3	"ALLP17, CT54, LYC3, LYZL3, SLLP1"	ENSG00000141316	"Sperm acrosome associated 3"	Q8IXA5	17	32970376-32997877	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"pancreas: 15.0;testis: 45.6"	"Cell line enriched"	"Detected in some"	17	"U-266/70: 45.9"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"basal ganglia: 0.4"	HPA023633	Enhanced				"Secreted in male reproductive system"					"HPA023633: AB_1857407"	"unprognostic (6.48e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.31e-2)"		"unprognostic (3.37e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.70e-4)"			"unprognostic (3.86e-2)"	"unprognostic (1.79e-1)"		"unprognostic (4.63e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	15.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	45.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.9	0.9	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPATA45	"C1orf227, LOC149643"	ENSG00000185523	"Spermatogenesis associated 45"	Q537H7	1	212830141-212847649	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 4.4;pancreas: 4.4;testis: 14.2"	"Cell line enhanced"	"Detected in many"		"U-698: 4.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"eosinophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049921	Uncertain									"HPA049921: AB_2680953"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-3)"	0.1	0.1	0.4	0.0	0.3	0.1	0.3	0.1	0.2	0.1	0.2			0.0	0.3	0.9	0.0	0.9	0.4	0.1	0.3	0.3	0.2	0.4	0.4	0.8	0.4		0.1	4.4	0.0	0.4	0.2		0.2	0.0		0.1	0.0	0.0	0.0	0.2	0.6	0.5	0.5	0.1	14.2			0.3		0.4	0.0	0.1	2.8	0.7	4.4	0.9	0.5	1.2	0.5	0.4	3.9	0.9	2.6	0.7	2.0	2.5	0.4	0.0	0.8	1.1	0.7	0.6	0.9	0.0	0.0	0.3	1.7	0.0	1.0	3.6	0.0	0.0	0.0	2.0	1.2	0.0	1.6	1.5	0.0	0.4	0.0	0.0	0.0	1.8	2.3	2.5	0.2	0.8	0.6	1.4	2.0	0.2	0.0	2.0	0.4	0.9	2.7	1.5	0.0	0.0	0.6	1.3	0.0	0.9	0.1	1.8	1.1	1.1	1.7	4.3	0.2	1.6	1.1	0.0	0.4	4.4	0.7	0.9	0.9	0.3	0.1	0.0	0.7	2.8	0.6	1.2	2.4	0.5	0.7	0.1	0.3	0.5										
AC008687.1		ENSG00000267335			19	49022953-49036895	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"pancreas: 8.2;pituitary gland: 19.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 7.2;U-251 MG: 10.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA038925	Uncertain		Approved	Cytosol	"Secreted - unknown location"			Cytosol	Cytosol	"HPA038925: AB_2676272"																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	8.2	0.0	19.9	0.5		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.9	0.2	0.1	0.2	0.0	1.8	0.0	0.0	0.1	0.3	0.1	1.2	0.0	0.3	0.0	1.0	0.0	0.0	0.6	0.2	0.9	0.0	0.9	0.1	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.5	0.2	0.0	0.0	0.1	1.2	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.4	0.1	0.5	0.2	0.4	0.0	2.6	2.3	0.6	10.4	0.5	2.4	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC131097.2		ENSG00000216921			2	241893985-241902551	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"pancreas: 27.6;tongue: 59.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.9;REH: 6.5;SCLC-21H: 4.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA073342			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA073342: "	"unprognostic (9.31e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.75e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.29e-1)"	2.7	0.3	4.9	0.6	4.4	0.2	1.6	1.7	2.4	0.8	0.6	0.6	0.6	0.1	0.6	0.6	3.8	0.5	0.9	0.6	2.1	2.3	0.6	0.6	0.6	0.6	3.9	0.6	1.4	27.6	0.0	0.6	0.6	0.6	2.6	0.0	0.6	4.4	4.0	3.7	2.6	0.6	0.6	0.6	0.6	0.1	0.8	0.6	1.1	6.4	59.2	2.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.5	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.9	1.5	0.2	0.5	0.0	6.5	0.0	0.6	0.0	0.0	4.2	0.2	0.0	0.6	0.0	0.0	1.0	1.2	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.4	1.7	2.4	2.1	2.3	3.9	0.6	0.6	0.6
AC213203.1		ENSG00000277475			Unmapped	31698-32528	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"blood: 10.5;pancreas: 5.8;testis: 13.3"	"Cell line enhanced"	"Detected in some"		"A549: 10.4;HeLa: 3.2;HMC-1: 8.3;SCLC-21H: 6.9"									"Cell type enriched"	"Detected in single"	27	"eosinophil: 10.5"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 10.5"																																					0.0	0.5		0.0		0.0	0.0		0.4	0.0	0.0			1.0	0.0	0.0	0.4	0.2	0.0	0.3			0.8	0.0	1.2	0.0			0.5	5.8	0.0		0.0		0.0	0.0		1.0	0.0	0.0	0.0	0.8	0.0		0.2	1.5	13.3			0.0		0.0	0.0		0.3	0.0	10.5	0.0	0.0	0.3	0.1	2.1	10.4	1.3	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.4	0.9	0.2	0.4	0.0	0.6	0.0	0.0	0.1	0.0	1.1	0.6	3.2	0.0	0.0	0.1	8.3	0.1	0.0	0.2	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.2	1.2	0.0	1.0	0.0	0.0	0.0	0.0	6.9	0.1	1.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.0	0.4	0.6	0.2	0.2	0.0	0.0	0.0	0.0	10.5	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105084577	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"pancreas: 48.9;salivary gland: 31.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.6;ASC TERT1: 30.9;fHDF/TERT166: 35.1;HHSteC: 19.9;HSkMC: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	4.2	1.2	3.2	2.7	1.9	0.7	2.7	5.3	2.7	5.5	2.2	0.9	3.3	2.4	2.9	3.2	1.5	2.6	2.7	2.9	1.6	2.0	0.7	0.4	2.7	2.0	2.0	2.1	1.0	48.9	0.7	2.8	1.1	2.5	3.6	2.3	4.8	31.6	4.5	1.0	1.5	1.3	5.4	5.3	1.2	3.7	0.8	1.3	0.0	2.2	1.4	3.0	3.9	2.2	0.2	1.3	0.0	0.1	0.0	0.1	0.1	4.3	0.4	0.2	9.4	22.6	30.9	0.5	14.0	9.0	1.8	4.8	0.5	0.0	0.0	0.5	35.1	0.0	0.0	0.3	2.3	0.0	0.1	0.2	0.0	1.1	19.9	1.7	0.0	25.0	1.1	4.7	8.9	1.0	0.7	12.6	3.6	0.0	0.0	0.1	0.5	0.1	0.0	0.0	1.3	0.0	0.0	3.3	1.6	0.0	2.9	7.1	2.0	14.9	0.1	1.4	1.3	0.0	0.7	15.7	4.1	0.0	5.7	6.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.2	1.9	5.3	2.4	1.6	2.0	2.0	2.1	2.5	1.3
C2CD4A	"FAM148A, NLF1"	ENSG00000198535	"C2 calcium dependent domain containing 4A"	Q8NCU7	15	62066977-62070917	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"endometrium 1: 6.8;liver: 25.9;pancreas: 20.4;pituitary gland: 21.9"	"Cell line enriched"	"Detected in some"	18	"RPTEC TERT1: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (3.85e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-3)"	"unprognostic (5.49e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.72e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.35e-1)"	0.3	1.0	0.5	1.3	0.4	0.3	0.5	0.2	0.7	1.0	1.2	0.1	0.1	2.2	6.8	0.3	0.2	0.1	0.9	0.2	0.4	0.9	2.5	25.9	2.0	0.3	0.3	0.1	0.4	20.4	0.0	21.9	0.8	1.3	1.1	1.4	0.2	1.2	0.1	0.8	1.1	1.1	0.1	0.4	0.2	2.2	0.2	0.1	1.2	0.9	0.1	1.2	1.3	0.1	0.8	0.9	2.5	0.5	0.9	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	25.8	0.6	1.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.5	0.4	0.4	0.2	0.4	0.5	0.4	0.2	0.1	0.8	0.5	0.3	2.5	0.9	0.2	0.9	1.0	0.1	0.5	0.4	0.2	0.4	0.4	0.9	0.3	0.1	1.3	0.1
CNPY1		ENSG00000146910	"Canopy FGF signaling regulator 1"	Q3B7I2	7	155474206-155555450	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"brain: 21.1;pancreas: 8.5"	"Cell line enriched"	"Detected in some"	8	"AF22: 26.0"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.6"	"Region enriched"	"Detected in some"	17	"cerebellum: 21.1"	"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	29	"cerebellum: 215.6"					HPA047400	Uncertain									"HPA047400: AB_10960413"					"unprognostic (4.28e-3)"	"unprognostic (2.12e-1)"					"unprognostic (4.18e-2)"		"unprognostic (8.27e-12)"	"unprognostic (1.44e-1)"	"unprognostic (2.16e-1)"			0.1	0.0	0.2	0.1	0.3	0.7	0.1	21.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.9	0.1	0.2	8.5	0.0	0.2	0.1	1.2	0.1	0.1	0.5	0.2	0.1	0.1	1.2	0.5	0.1	0.5	0.1	0.2	2.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.2	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	21.1	0.5	0.2	0.2	0.9	0.1	1.2	0.4
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406853-39451536	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adipose tissue: 17.3;liver: 49.2;pancreas: 21.4"	"Group enriched"	"Detected in some"	23	"ASC diff: 6.4;Hep G2: 22.9"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					290000	290000			"HPA021136: "	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	17.3	0.0	0.2	1.9	1.0	0.2	3.9	0.4	0.2	0.0	1.6	0.0	0.0	0.2	0.1	0.5	0.3	0.1	1.3	0.5	1.0	0.2	0.1	49.2	1.4	0.5	0.1	0.0	0.2	21.4	0.2	0.2	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.4	0.5	0.6	0.3	0.0	0.0	1.5	2.5	0.2	0.0	0.1	0.4	0.0	0.3	0.2	0.5	2.5	2.3	0.7	0.4	0.4	0.2	0.0	0.2	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	22.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.7	0.2	0.3	0.4	0.2	0.4	0.2	0.2	0.1	0.5	0.2	0.4	2.3	0.4	0.5	2.5	0.1	0.2	0.2	1.0	0.4	0.2	1.0	0.2	0.1	0.0	0.4	0.2
PM20D1	"Cps1, FLJ32569"	ENSG00000162877	"Peptidase M20 domain containing 1"	Q6GTS8	1	205828022-205850132	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"pancreas: 103.5"	"Cell line enriched"	"Detected in single"	9	"Karpas-707: 6.4"	"Cancer enriched"	"Detected in some"	32	"urothelial cancer: 30.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.5"	"Low region specificity"	"Detected in all"												"Secreted to digestive system"	3000000	3000000				"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.83e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.50e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-2)"	0.5	0.0	0.0	0.5	0.2	0.0	0.6	0.1	0.4	0.0	0.2	0.6	0.4	0.0	0.2	0.3	0.0	0.1	0.0	0.3	0.3	0.0	3.2	0.1	0.2	0.5	0.2	0.0	0.3	103.5	0.0	0.0	0.1	0.4	0.8	0.0	0.3	0.2	0.4	0.0	14.3	0.1	0.1	0.1	0.4	1.2	0.2	0.1	0.1	0.1	0.1	0.4	1.5	0.3	0.3	0.0	0.8	0.2	0.0	4.5	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.3	0.3	0.9	2.4	0.0	0.2	0.3	0.9	0.0	0.0	0.2	0.0	4.5	1.0	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.0	0.4	0.1
SCGB2B2	"SCGB4A2, SCGBL"	ENSG00000205209	"Secretoglobin family 2B member 2"	Q4G0G5	19	34593329-34675699	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"epididymis: 4.1;pancreas: 12.7;skin 1: 5.9;testis: 15.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA046806	Uncertain				"Secreted - unknown location"					"HPA046806: AB_10962373"	"unprognostic (9.99e-2)"	"unprognostic (3.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-5)"	"unprognostic (4.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	0.6	0.7	0.7	0.6	0.6	0.0	1.2	0.6	0.9	0.6	0.6	0.6	0.6	0.7	0.6	4.1	1.3	0.7	0.6	0.6	0.7	0.7	0.6	0.7	0.7	0.6	0.6	0.6	0.6	12.7	0.3	0.6	0.6	1.0	0.6	0.2	0.6	0.6	0.6	1.1	5.9	0.6	0.6	0.9	0.6	0.4	15.9	0.6	0.6	1.0	0.6	0.6	1.0	0.6	0.6	0.3	1.4	0.3	0.3	0.8	0.1	0.7	1.3	1.2	0.7	0.8	0.4	1.4	0.8	0.8	0.3	0.4	4.0	0.6	0.5	0.6	0.1	0.7	1.3	1.2	0.3	1.5	0.6	0.7	2.1	1.0	0.4	0.3	0.9	0.5	1.3	0.1	0.7	0.0	0.2	4.3	0.3	1.3	0.6	1.9	0.5	0.7	1.0	1.0	0.5	0.8	1.5	1.2	1.1	0.8	0.7	0.6	1.3	0.5	0.8	1.5	1.0	1.0	0.3	3.8	1.8	1.3	0.5	0.2	2.3	1.4	0.3	0.1	0.8	0.0	0.4	0.3	0.5	0.3	0.3	0.6	0.8	0.5	0.3	0.3	0.1	0.1	0.3	0.1	0.7	0.6	0.6	0.9	0.7	0.7	0.6	0.6	1.0	0.6
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319095-28328685	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 228.7"	"Cell line enhanced"	"Detected in all"		"CACO-2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	2.0	11.5	3.1	2.8	3.3	1.7	3.4	2.9	4.9	2.6	4.2	2.2	1.2	4.7	2.9	1.9	3.1	4.0	8.1	1.6	2.4	3.0	2.2	33.7	12.5	3.4	2.4	2.7	8.2	228.7	1.7	0.6	2.0	7.7	6.9	3.8	3.2	1.5	2.8	5.7	3.6	3.2	3.4	4.0	1.7	13.2	31.5	1.3	4.6	1.3	3.9	2.5	12.5	6.0	9.0	13.8	1.7	2.3	8.2	10.0	4.6	9.9	25.1	48.1	23.7	6.4	9.2	15.8	9.6	6.2	15.3	20.5	71.0	7.6	27.3	10.6	3.7	10.7	30.5	16.4	12.1	12.8	21.4	10.2	13.1	30.2	5.8	16.2	8.2	18.7	2.1	15.0	6.2	4.6	21.4	20.6	5.1	16.8	25.3	15.3	21.2	6.5	20.4	52.9	24.6	18.8	45.4	34.7	15.2	15.4	12.3	7.8	21.6	7.5	3.0	16.5	13.1	14.1	17.6	16.6	32.7	24.9	3.3	11.7	9.7	0.4	2.0	1.7	7.3	2.3	8.5	9.0	6.2	8.8	13.8	5.1	10.0	9.3	0.9	8.2	0.8	8.0	5.8	4.6	3.1	3.3	2.9	4.2	2.4	3.0	2.4	2.7	7.7	1.3
AMY2B	AMY2	ENSG00000240038	"Amylase, alpha 2B (pancreatic)"	P19961	1	103553815-103579534	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 939.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.3;EFO-21: 11.6"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in many"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	75000000	75000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	1.7	0.5	0.8	0.8	1.5	0.4	1.0	2.6	0.8	0.9	0.9	0.8	0.8	0.5	0.8	1.0	0.8	1.5	0.9	1.1	0.8	0.5	1.5	1.1	1.0	1.1	1.0	0.9	1.2	939.9	0.8	1.1	0.8	0.8	0.9	0.4	0.9	145.7	1.0	1.7	1.3	0.9	0.8	0.8	1.0	0.4	0.8	0.8	0.8	2.4	1.1	0.8	0.8	0.8	1.8	2.6	1.9	8.5	0.1	1.1	1.9	0.0	0.6	1.2	0.0	6.3	11.3	1.2	0.9	0.9	0.7	1.7	0.0	0.2	1.1	11.6	0.3	1.3	0.1	1.4	1.6	1.4	1.7	2.0	4.3	0.8	0.9	2.6	2.8	7.7	7.5	0.8	1.3	0.2	0.0	3.4	0.9	0.0	2.0	0.5	0.1	1.6	0.6	0.0	5.0	6.5	2.1	3.1	0.5	2.6	1.2	0.8	0.1	1.5	0.9	0.4	1.0	0.5	0.7	3.9	0.1	0.3	2.1	1.9	0.2	0.0	8.5	1.7	0.8	3.9	0.6	1.7	0.3	0.4	2.6	1.8	1.1	0.4	1.9	0.1	3.6	0.8	0.3	1.9	0.8	1.5	2.6	0.8	0.8	0.5	1.0	0.9	0.8	0.8
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 14.3;pancreas: 7.9;thyroid gland: 26.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 6.2;Karpas-707: 11.0;SH-SY5Y: 3.8;U-266/70: 16.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in many"	8	"hypothalamus: 13.5;pons and medulla: 14.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"pons and medulla: 10.1"					HPA059886		Supported			"Secreted to blood"					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.5	0.2	0.0	1.6	1.6	0.3	1.5	1.5	0.8	0.3	1.5	0.0	0.0	0.9	0.4	0.3	0.3	0.2	0.3	0.9	0.0	13.5	0.4	1.1	1.3	1.0	0.7	0.2	0.2	7.9	0.3	2.7	0.4	14.3	0.4	0.5	1.8	0.7	0.2	1.2	0.3	0.8	0.4	3.9	0.9	0.3	1.4	0.3	0.6	26.0	0.0	0.3	0.3	0.0	0.2	0.3	1.1	0.2	1.8	1.2	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.3	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	2.0	0.4	0.0	11.0	0.0	0.0	0.0	0.6	3.0	0.1	0.5	0.0	0.2	0.0	0.0	1.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.6	0.6	0.4	2.2	0.0	0.0	0.0	0.2	1.1	0.8	0.1	1.2	0.0	0.5	0.7	0.3	0.2	1.2	1.1	0.6	1.8	0.0	0.0	0.1	0.4	0.0	1.6	1.5	0.8	0.0	13.5	0.7	0.2	14.3	0.3
GPHA2	"A2, GPA2, MGC126572, ZSIG51"	ENSG00000149735	"Glycoprotein hormone alpha 2"	Q96T91	11	64934471-64935888	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 98.0"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 21.2"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA067068			Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA067068: "	"unprognostic (1.13e-1)"	"unprognostic (8.31e-3)"		"unprognostic (1.51e-2)"		"unprognostic (9.22e-4)"		"unprognostic (7.88e-3)"		"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.70e-1)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	6.7	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.7	98.0	0.0	15.1	0.1	0.2	0.7	0.0	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	4.2	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	21.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.1	0.2	0.1
GPR148	PGR6	ENSG00000173302	"G protein-coupled receptor 148"	Q8TDV2	2	130729070-130730336	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 2.6;pancreas: 1.1;pituitary gland: 2.2;stomach 1: 3.5"	"Group enriched"	"Detected in some"	11	"CACO-2: 2.5;SCLC-21H: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA060527	Uncertain									"HPA060527: AB_2684307"											"unprognostic (7.16e-4)"				"unprognostic (3.38e-1)"			0.0	0.2	0.1	0.0	0.4	0.0	0.0	2.6	0.4	0.0	0.2			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1		0.0	1.1	0.0	2.2	0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL22RA1	"CRF2-9, IL22R"	ENSG00000142677	"Interleukin 22 receptor subunit alpha 1"	Q8N6P7	1	24119771-24143121	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 123.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.1;CAPAN-2: 5.7;HaCaT: 6.0;Hep G2: 9.3;U-266/70: 5.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.68e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.78e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.64e-2)"	0.2	0.1	0.2	1.1	0.3	0.0	0.8	0.6	0.3	1.2	10.9	0.2	0.5	7.8	0.4	0.6	5.2	0.4	3.2	0.2	0.2	0.0	2.8	2.0	0.4	0.1	0.2	0.1	0.4	123.4	0.0	1.0	0.4	0.4	0.4	3.9	0.2	0.9	0.3	0.2	12.9	22.3	0.1	0.2	0.2	1.2	0.3	0.3	0.1	0.7	4.6	3.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.7	0.1	3.3	2.4	0.0	0.0	0.0	0.0	0.3	0.0	1.2	1.6	1.9	13.1	5.7	0.0	1.1	0.3	6.0	0.8	3.5	0.6	4.3	0.0	0.0	1.7	9.3	0.0	0.0	0.0	0.0	2.1	0.5	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.2	1.2	0.0	0.1	0.2	0.0	0.7	0.1	0.1	1.7	0.0	1.9	0.8	0.0	0.0	0.0	2.0	0.1	0.1	5.1	1.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.6	0.3	0.2	0.0	0.2	0.1	0.4	0.3
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 33.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	35	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 12.1"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"					"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.2	0.0	0.6	4.5	1.1	0.0	0.2	1.2	0.9	0.6	26.6	0.2	1.5	0.0	0.7	19.0	0.4	0.1	0.2	0.2	0.6	0.7	3.6	0.2	0.3	0.2	0.2	0.2	2.0	46.5	0.0	0.3	0.3	0.2	0.6	15.1	0.3	0.5	1.6	0.2	0.0	0.8	0.4	0.2	0.2	0.4	2.1	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.0	0.0	12.1	0.0	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.5	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.6	1.1	1.2	0.9	0.6	0.7	0.2	0.2	0.2	0.2
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1, nephrin"	O60500	19	35825964-35869287	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 20.2;pancreas: 21.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 5.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced									"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	3.4	0.0		0.0	21.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4			0.0		1.9	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.8	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.4	0.1	0.0	0.1	0.0	0.0										
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289135-296107	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 148.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol				Cytosol	Cytosol	"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.12e-4)"	5.6	1.8	6.0	16.7	9.3	6.3	10.5	2.9	7.7	12.7	5.6	3.3	10.4	21.1	6.9	14.9	5.6	8.4	8.3	4.4	6.3	1.7	14.8	17.0	15.7	24.6	7.6	2.5	3.5	148.7	2.6	3.6	3.4	8.0	8.5	3.0	7.1	8.9	21.8	5.6	2.4	23.2	5.2	10.1	24.2	4.7	2.3	7.5	6.3	18.0	6.4	15.4	7.3	8.7	2.3	2.5	4.9	4.2	6.9	8.5	2.7	3.4	3.7	7.0	7.7	2.8	2.5	5.3	2.7	2.2	1.6	1.4	3.2	9.8	0.0	3.5	3.3	2.1	0.6	1.2	0.2	8.3	2.6	1.6	2.4	4.2	3.6	0.2	15.1	9.4	1.0	0.6	0.4	5.3	6.5	10.5	0.8	4.9	14.3	7.6	5.4	0.6	13.5	1.4	4.8	3.7	1.2	0.0	1.6	1.0	5.1	4.7	3.7	1.9	4.9	3.3	4.7	1.0	0.3	22.8	0.6	3.6	0.5	2.7	3.8	1.5	0.9	1.2	8.5	4.2	7.2	2.1	1.3	4.7	0.6	2.3	3.1	6.1	4.9	6.9	3.2	2.5	0.2	2.7	6.0	9.3	2.9	7.7	6.3	1.7	7.6	2.5	8.0	7.5
PRDX4	AOE37-2	ENSG00000123131	"Peroxiredoxin 4"	Q13162	X	23664262-23686399	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 127.6;pancreas: 320.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008659, CAB027389, CAB047362"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	11000000	11000000	"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"CAB008659: AB_1620984, CAB027389: , CAB047362: "	"unprognostic (3.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (7.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.10e-2)"	11.6	14.8	3.8	7.0	6.4	3.9	11.2	3.3	5.4	13.2	10.7	6.5	17.4	8.9	11.5	10.5	13.1	9.6	12.9	17.6	3.8	4.0	11.8	127.6	8.9	16.9	7.2	4.0	14.6	320.8	6.1	15.8	21.9	7.4	9.3	11.4	8.0	25.4	14.1	7.8	7.2	10.6	8.8	8.1	12.6	12.8	25.2	6.1	4.7	12.0	10.0	15.0	10.8	8.7	27.9	31.4	2.0	39.3	24.1	22.7	21.3	24.2	33.5	14.2	27.4	77.4	39.6	20.0	32.7	35.7	29.7	43.4	35.1	30.6	20.9	15.4	42.4	29.4	40.8	20.3	28.5	12.7	78.5	14.8	29.6	44.3	32.3	19.0	14.1	41.9	26.3	28.9	29.0	37.2	28.5	77.1	27.4	36.1	9.7	29.8	49.0	49.2	13.5	35.5	117.8	26.5	8.5	20.8	17.7	30.1	35.8	24.1	37.8	24.3	24.5	21.2	14.0	54.7	24.5	25.3	30.6	22.3	38.0	24.7	30.2	1.7	20.6	2.0	17.8	32.2	21.8	27.9	22.7	18.6	31.4	16.2	16.4	16.7	1.5	24.1	39.3	22.0	22.1	21.3	3.8	6.4	3.3	5.4	3.8	4.0	7.2	4.0	7.4	6.1
SCGB1C2		ENSG00000268320	"Secretoglobin family 1C member 2"	P0DMR2	17	137526-139067	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	6	"blood: 4.5;pancreas: 3.6"	"Group enriched"	"Detected in some"	18	"PC-3: 1.4;U-266/70: 2.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Group enriched"	"Detected in some"	18	"basophil: 2.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"														"Secreted - unknown location"															"unprognostic (4.65e-2)"								0.0	0.0		0.7		0.6	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.6			0.0	0.0	0.1	0.0			0.0	3.6	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	2.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.5										
SCTR		ENSG00000080293	"Secretin receptor"	P47872	2	119439843-119525301	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"intestine: 13.5;pancreas: 35.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.3"					"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"midbrain: 1.2;pons and medulla: 1.3;thalamus: 1.5"	HPA007269	Uncertain									"HPA007269: AB_1856640"	"unprognostic (1.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.38e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			13.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.2	4.1	0.0	0.0		0.0	35.3	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.2			0.2		0.0	0.0	0.0	0.5	0.1	3.8	0.3	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	8.0	0.7	0.5	0.1	0.0	0.8	0.0	0.1	0.0	1.4	0.3	0.5	0.0	0.3	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.3	0.6	0.0	0.9	0.3	0.1	0.0	0.0	0.1	3.8	0.3	0.9	0.3	0.2	0.4	0.3	0.3	0.0	0.0	0.5	0.3	0.2	1.2	0.3	0.3	0.1	0.4	0.0										
SLC30A8	"ZnT-8, ZNT8"	ENSG00000164756	"Solute carrier family 30 member 8"	Q8IWU4	8	116950273-117176714	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 37.1"	"Group enriched"	"Detected in some"	34	"U-266/70: 29.8;U-266/84: 20.8"	"Group enriched"	"Detected in some"	28	"breast cancer: 10.6;pancreatic cancer: 15.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA076165	Enhanced									"HPA076165: AB_2732304"	"unprognostic (2.14e-2)"		"unprognostic (1.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"		"unprognostic (5.57e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.66e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.16e-3)"	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.1	0.1	0.1	0.1	0.1	0.1	37.1	0.0	0.3	0.1	0.1	0.1	0.0	5.0	6.4	0.1	0.1	0.3	0.4	0.1	0.1	0.1	0.6	2.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.5	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	29.8	20.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	268727-283010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 60.4;intestine: 31.7;pancreas: 45.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;HEK 293: 18.4;MCF7: 23.6;SCLC-21H: 8.3;SH-SY5Y: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA078260: AB_2732375"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	3.7	3.1	37.3	1.8	15.6	1.0	1.1	43.3	60.4	1.0	1.8	3.7	0.0	31.7	1.1	2.3	1.1	1.0	0.9	3.6	29.0	27.4	1.0	0.9	1.0	1.0	21.2	21.4	1.0	45.3	0.9	1.7	2.4	12.7	1.1	1.2	0.6	1.3	1.3	2.0	0.9	12.0	1.3	8.6	1.0	9.3	2.0	2.0	0.0	0.9	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.1	2.0	0.0	0.6	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.0	0.6	0.4	0.1	5.1	0.0	0.0	0.0	18.4	0.0	0.3	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.2	0.2	0.0	23.6	0.0	0.3	2.5	0.0	0.0	0.0	0.4	0.0	0.0	8.3	10.3	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.3	15.6	43.3	43.8	29.0	27.4	21.2	21.4	12.7	2.0
CGB1		ENSG00000267631	"Chorionic gonadotropin beta subunit 1"	A6NKQ9	19	49035610-49036895	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 8.4"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 20.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038925, HPA038934"	Uncertain		Approved	Cytosol	"Secreted to blood"			Cytosol	Cytosol	"HPA038925: AB_2676272, HPA038934: AB_2676277"																		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	8.4	0.0	1.4	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.9	0.1	0.1	0.0	0.0	0.5	0.3	4.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CNIH3	"CNIH-3, FLJ38993"	ENSG00000143786	"Cornichon family AMPA receptor auxiliary protein 3"	Q8TBE1	1	224434660-224740549	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"brain: 16.1;pancreas: 21.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.8;hTEC/SVTERT24-B: 24.9;NTERA-2: 9.1;U-266/70: 13.2;U-87 MG: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.03e-1)"	"unprognostic (3.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.63e-1)"	2.0	0.8	7.0	0.5	5.1	0.2	1.3	1.0	16.1	1.7	0.6	0.6	0.0	0.8	1.5	0.9	0.6	1.9	1.2	0.6	9.8	5.0	1.5	0.6	0.9	0.9	5.4	8.0	3.6	21.7	0.3	0.7	0.4	3.5	0.9	0.7	0.2	0.6	1.1	0.7	0.4	0.6	1.0	1.4	0.6	0.6	3.9	0.1	0.2	1.0	0.0	0.9	0.7	0.9	0.9	0.3	0.0	0.0	1.8	0.9	0.1	0.2	0.2	0.3	0.3	0.3	0.5	0.1	1.8	9.8	0.2	0.5	0.0	2.2	0.0	0.9	4.2	0.0	0.0	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.7	0.3	0.0	24.9	0.3	0.0	0.0	0.0	1.4	0.0	0.0	3.0	9.1	1.1	0.0	0.5	0.0	1.5	0.9	0.3	0.2	0.0	0.0	6.1	0.0	0.2	0.0	0.0	2.3	0.0	0.2	13.2	0.5	0.0	29.6	0.1	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.3	0.3	0.0	0.6	0.0	1.8	0.0	0.0	0.9	0.1	7.0	5.1	1.0	11.1	9.8	5.0	5.4	8.0	3.5	0.1
CRACR2B	"EFCAB4A, MGC45840"	ENSG00000177685	"Calcium release activated channel regulator 2B"	Q8N4Y2	11	826144-831991	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"pancreas: 71.2;salivary gland: 149.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 12.8;NB-4: 14.1;SK-BR-3: 49.8;U-266/70: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.3"	"Group enriched"	"Detected in many"	4	"B-cells: 8.3;granulocytes: 6.6;NK-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046217	Approved									"HPA046217: AB_10960833"	"unprognostic (8.87e-2)"	"unprognostic (4.89e-2)"	"prognostic unfavourable (1.81e-5)"	"unprognostic (4.47e-3)"	"unprognostic (8.20e-3)"	"unprognostic (5.27e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.49e-3)"	"unprognostic (9.25e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-1)"	"unprognostic (5.15e-3)"	1.8	1.5	0.7	4.9	0.8	3.7	15.6	0.7	0.8	2.8	7.2	0.9	10.0	6.3	1.2	2.1	2.1	1.2	9.6	3.5	0.9	0.0	3.1	0.9	4.8	1.3	0.6	0.6	0.7	71.2	3.1	5.1	0.8	1.4	9.5	4.4	1.1	149.6	21.4	1.1	4.5	9.7	1.3	0.8	2.8	15.7	1.2	0.6	0.7	1.1	4.7	9.3	7.4	2.6	8.3	1.0	6.6	1.3	3.0	0.6	0.5	1.8	1.2	0.2	0.5	0.2	0.1	5.4	0.1	0.0	0.0	0.0	1.6	6.0	0.0	2.3	0.0	1.2	0.9	0.1	0.0	12.8	0.5	6.4	1.4	3.9	0.0	4.6	0.1	0.1	0.2	0.0	0.0	0.2	7.8	4.5	0.0	3.0	0.1	14.1	0.3	0.1	1.1	0.2	11.2	4.1	1.2	1.1	0.7	0.1	49.8	0.0	7.8	4.2	0.1	0.6	0.2	0.1	0.1	12.6	1.1	1.7	2.2	6.3	0.0	4.8	1.3	6.6	0.4	0.0	0.0	8.3	0.0	0.6	0.0	2.9	0.0	0.0	0.3	3.0	0.5	1.0	0.0	0.5	0.7	0.8	0.7	0.8	0.9	0.0	0.6	0.6	1.4	0.6
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845752	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 15.6;brain: 30.3;pancreas: 23.4"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;HAP1: 7.5;HMC-1: 5.3;NTERA-2: 4.5;RT4: 8.0;SCLC-21H: 11.9;SH-SY5Y: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain									"HPA048767: AB_2680515"	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.7	15.6	13.4	1.1	15.9	0.9	0.9	1.9	30.3	1.3	3.6	7.9	0.0	2.4	1.4	0.8	0.8	0.9	1.9	0.8	17.5	9.9	1.1	0.9	1.0	0.7	7.1	21.3	0.9	23.4	0.7	1.5	1.8	10.8	0.8	4.6	0.0	1.0	0.8	0.7	0.9	2.4	1.9	12.7	0.7	1.5	2.1	10.3	0.0	1.6	0.0	0.8	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	8.0	11.9	4.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.9	1.9	30.3	17.5	9.9	7.1	21.3	10.8	10.3
ERP27	"C12orf46, ERp27, FLJ32115, PDIA8"	ENSG00000139055	"Endoplasmic reticulum protein 27"	Q96DN0	12	14914035-14939082	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 182.8"	"Cell line enriched"	"Detected in some"	5	"RT4: 44.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039636, HPA052851"	Enhanced				"Intracellular and membrane"					"HPA039636: AB_10795403, HPA052851: AB_2681972"	"unprognostic (9.02e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.55e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.45e-2)"	0.1	0.1	0.0	0.6	0.4	0.4	0.8	0.0	0.2	0.7	0.1	0.1	1.0	0.0	0.1	7.2	1.1	9.1	0.0	0.6	0.0	0.0	11.6	0.1	5.7	0.4	0.0	0.0	1.8	182.8	0.1	1.3	7.7	0.3	4.2	0.1	1.0	5.1	0.5	0.0	0.4	0.5	0.0	0.5	0.9	0.5	0.4	0.0	0.1	36.0	1.9	1.0	3.6	0.1	2.1	2.9	4.7	5.2	1.4	8.1	3.1	1.5	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	8.9	0.6	0.9	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.8	0.0	6.9	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	3.1	1.3	2.2	0.0	0.0	0.6	0.0	0.1	0.3	44.2	0.0	0.0	0.0	7.3	0.0	0.3	1.6	1.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	3.4	4.2	4.7	6.3	4.8	8.1	2.1	5.6	4.2	2.9	2.0	7.2	7.6	2.0	1.4	5.2	0.3	6.8	3.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686432-37745247	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.7;kidney: 66.2;pancreas: 18.6"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 52.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"					"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.0"	"Group enriched"	"Detected in some"	5	"basal ganglia: 0.7;hypothalamus: 2.3"	"Low region specificity"	"Detected in some"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favourable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favourable (2.51e-6)"	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.1	4.5	0.0	4.8	3.8	0.9	7.8	0.0	2.8	34.7	0.0	0.0		66.2	7.7	3.7	0.0	0.0	0.0	0.8	18.6	1.6	0.0	0.6	0.0	1.6	3.4	0.0	0.0	3.8	0.0	0.0	5.5	0.3	0.0	0.0	3.7	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.8	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	52.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
IFITM5	"BRIL, fragilis4, Hrmp1"	ENSG00000206013	"Interferon induced transmembrane protein 5"	A6NNB3	11	298200-299526	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 11.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HMC-1: 1.3;Karpas-707: 4.9;NB-4: 1.0;PC-3: 1.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (9.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.46e-2)"		"unprognostic (4.20e-2)"	"unprognostic (4.42e-2)"		"unprognostic (8.31e-2)"	"unprognostic (7.99e-3)"		"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"		"unprognostic (4.90e-2)"	0.1	0.0	0.1	0.3	0.1	2.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.3	2.2	0.3	0.1	0.1	0.1	11.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.4	0.1	0.1	0.5	0.0	0.2	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.2	1.0	0.0	1.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MATN4		ENSG00000124159	"Matrilin 4"	O95460	20	45293445-45308529	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 21.5;pancreas: 27.1;seminal vesicle: 17.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 6.9;SK-MEL-30: 2.2;U-937: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (1.54e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.53e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.63e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.38e-2)"	0.6	0.0	0.1	0.0	0.2	0.1	2.4	0.0	0.2	1.4	0.0	0.0	21.5	0.0	0.6	0.6	0.2	0.1	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.3	0.0	0.1	0.2	0.0	1.9	1.5	17.7	0.0	4.1	0.0	0.0	0.3	0.0	0.4	1.6	0.0	0.2	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.4	0.4	3.1	0.3	0.1	0.3	0.0	0.0	0.0	1.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	6.9	0.3	1.0	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.1	0.3	2.2	0.1	0.6	0.0	0.2	0.9	0.0	0.1	0.1	0.6	0.2	0.2	3.5	0.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 61.2;pancreas: 15.6;salivary gland: 35.4"	"Cell line enriched"	"Detected in single"	7	"RH-30: 5.0"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"					"Low region specificity"	"Detected in all"			HPA055697	Enhanced		Approved	Vesicles,Cytosol				Vesicles	Vesicles	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.2	0.1	0.1	2.5	0.1	0.2	1.3	0.1	0.1	0.1	28.8	0.0	0.0	15.0	0.1	0.4	0.1	0.3	7.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.1	15.6	0.0	0.1	0.0	0.1	0.1	1.4	0.7	35.4	0.0	0.1	0.2	61.2	0.0	0.5	1.5	0.7	1.0	0.0	0.0	0.1	1.7	0.8	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.0
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010651	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 43.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;EFO-21: 11.1;HEK 293: 8.8;RPMI-8226: 24.2;SCLC-21H: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	Nucleoplasm	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.1	6.0	0.2	0.1	9.0	0.1	0.1	0.3	0.0	7.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	43.3	0.0	3.2	0.1	0.2	0.8	3.7	0.1	1.9	0.1	0.1	0.1	7.3	0.1	0.2	0.1	2.7	1.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	3.8	0.0	11.5	0.0	0.0	8.6	0.0	0.0	0.1	0.0	5.0	1.6	0.9	11.1	0.0	0.2	2.0	1.5	0.9	1.4	8.8	0.0	0.7	2.3	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	3.6	1.9	0.0	6.4	0.6	0.1	0.0	0.7	0.0	1.7	24.2	4.3	0.4	13.0	0.0	1.6	1.4	0.2	3.6	2.9	0.0	0.0	0.0	0.0	0.0	3.6	1.8	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938210-1943326	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 195.6;liver: 94.8;pancreas: 107.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 85.8;neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 195.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: "	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	7.9	4.0	5.2	9.0	6.3	27.3	5.1	3.2	6.1	5.2	13.1	5.6	7.5	8.7	7.9	13.5	16.9	9.6	13.5	13.7	4.7	4.1	24.9	94.8	9.6	15.6	5.5	4.1	7.3	107.2	2.9	3.9	11.6	4.1	11.0	5.1	6.2	4.7	9.4	20.5	8.0	17.0	14.3	4.3	18.2	9.6	8.1	3.6	3.7	5.5	19.8	4.5	14.8	4.8	1.7	10.9	195.6	26.2	2.4	2.8	12.2	6.6	17.0	6.3	14.9	11.8	5.2	10.8	8.3	10.4	12.1	10.5	27.2	7.4	6.5	27.1	9.5	11.0	10.5	7.2	3.8	36.3	11.9	5.0	6.3	43.4	10.8	14.1	11.9	9.6	6.4	8.7	1.7	12.1	7.8	3.6	6.4	36.8	7.9	23.2	8.6	9.7	11.6	8.7	30.5	18.9	11.2	6.1	8.1	9.3	10.4	5.0	11.3	25.1	7.2	3.7	10.2	7.2	4.8	9.6	15.2	12.4	3.8	13.4	6.4	26.0	26.2	85.8	2.2	12.0	2.1	1.7	1.8	1.8	10.9	1.7	1.4	1.6	195.6	2.4	10.7	4.6	2.8	12.2	5.2	6.3	3.2	6.1	4.7	4.1	5.5	4.1	4.1	3.6
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666731-56668065	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"intestine: 101.1;kidney: 210.7;liver: 396.4;pancreas: 217.1;thyroid gland: 278.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	10.1	1.0	11.7	10.4	50.7	0.7	2.8	1.1	27.4	1.0	78.1	3.1	1.9	49.6	1.5	15.9	21.7	4.6	23.2	0.9	25.1	7.6	210.7	396.4	2.4	7.0	23.6	11.3	0.6	217.1	0.4	1.0	0.6	46.9	21.6	48.9	22.4	2.4	1.0	0.6	2.9	101.1	7.9	7.7	0.5	47.4	0.6	3.6	0.0	278.4	1.9	1.8	2.4	1.2	0.1	1.1	0.7	1.1	0.3	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.4	0.6	0.1	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.5	34.8	0.0	0.0	0.0	0.1	9.9	5.8	0.0	3.1	0.4	0.0	0.1	0.1	0.0	15.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	152.3	0.0	0.7	1.1	0.3	1.5	1.1	1.4	0.1	1.7	2.6	1.1	0.0	1.6	2.9	0.1	0.3	0.5	0.3	2.8	1.5	11.7	50.7	1.1	27.4	25.1	7.6	23.6	11.3	46.9	3.6
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216939-44218236	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"adipose tissue: 27.4;blood: 12.2;pancreas: 9.0"	"Cell line enriched"	"Detected in some"	31	"RH-30: 55.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"					"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	121	"dendritic cells: 12.2"	"Not detected"	"Not detected"							HPA051451	Approved		Approved	Vesicles,Mitochondria,Cytosol				Vesicles	Vesicles	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	27.4	0.0	0.0	1.0	0.0	0.0	2.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.8	0.0		1.1	0.0	0.5	1.4	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.7	0.0	2.2	0.0	0.1	0.0	0.0	1.8	3.2	0.6	0.0	2.8	0.4	0.0	0.4	0.5	0.0	0.0	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	55.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.1										
NRG4	HRG4	ENSG00000169752	"Neuregulin 4"	Q8WWG1	15	75935969-76059795	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 36.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 8.5;HL-60: 3.1;THP-1: 2.9;U-698: 2.8;U-937: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 282.0"	HPA010957	Uncertain				"Secreted to digestive system"					"HPA010957: AB_1079504"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.82e-5)"	"unprognostic (1.91e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-5)"	"unprognostic (8.28e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.06e-1)"	0.4	0.5	3.5	0.2	1.3	0.8	0.3	6.9	2.7	0.3	0.4	0.5	0.0	0.2	0.3	2.1	0.8	2.2	0.2	0.4	1.4	1.0	0.5	1.1	0.7	0.2	0.5	1.8	0.3	36.6	0.2	2.5	0.8	2.1	1.2	0.3	0.0	1.5	0.3	4.8	0.6	0.3	0.2	0.5	0.4	3.0	6.3	0.3	0.0	0.4	0.5	0.2	0.5	0.3	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.8	0.0	1.3	0.4	0.1	0.0	0.1	1.5	0.1	8.5	0.4	0.0	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	5.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.3	6.9	2.7	1.4	1.0	0.5	1.8	2.1	0.3
OR6M1		ENSG00000196099	"Olfactory receptor family 6 subfamily M member 1"	Q8NGM8	11	123805335-123806387	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"pancreas: 3.1;testis: 1.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;SCLC-21H: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA048674	Uncertain									"HPA048674: AB_2680489"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	3.1	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.0										
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920020-27926231	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 10.4;intestine: 33.0;pancreas: 24.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;CACO-2: 2.0;CAPAN-2: 2.4;HDLM-2: 6.8;HEK 293: 4.1;HeLa: 10.3"	"Group enriched"	"Detected in many"	11	"colorectal cancer: 8.4;liver cancer: 1.9;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	33.0	0.0	0.0	31.1	0.1	0.0	0.1	0.1	10.4	0.1	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.0	0.1	24.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	17.6	0.0	0.2	0.1	4.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.8	4.1	0.0	10.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 73.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	7	"monocytes: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"			Nucleoplasm	Nucleoplasm	"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	3.0	249.6	41.7	0.1	0.0	3.3	0.3	16.8	0.1	0.1	0.1	0.1	0.3	139.4	0.0	0.1	0.0	0.1	798.6	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.1	35.9	0.1	0.1	0.1	0.0	0.1	0.1	963.7	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.7	0.0	0.8	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1, fibrocystin/polyductin"	P08F94	6	51615300-52087625	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 19.8;kidney: 49.4;pancreas: 32.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 15.4"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced									"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favourable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	5.6	0.0	0.1	19.8	0.1	0.1	6.3	0.1	0.1	0.1	49.4	2.5	0.1	0.0	0.1	0.0	0.1	32.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	1.2	0.1	0.4	0.1	0.1	0.1	0.1	0.5	1.4	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	15.4	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815278	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 6.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034547, HPA035558"	Enhanced									"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.2	0.1	0.1	7.8	0.1	0.0	0.8	0.1	0.1	0.2	38.2	0.0	0.5	47.1	0.2	25.8	0.2	0.2	0.1	0.1	0.1	0.1	44.0	0.7	0.1	0.0	0.1	0.0	0.3	30.5	0.0	0.2	0.0	0.0	0.6	5.4	0.0	0.2	0.0	0.1	0.2	59.0	0.0	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
RPS14	"EMTB, S14"	ENSG00000164587	"Ribosomal protein S14"	P62263	5	150442635-150449756	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 708.0;pancreas: 483.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018504	Approved		Supported	"Endoplasmic reticulum,Cytosol"		540000	540000	"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA018504: AB_1856463"	"unprognostic (5.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.14e-2)"	60.9	43.2	50.1	64.3	39.1	92.8	111.6	22.6	37.2	85.1	70.3	28.0	50.6	33.6	59.6	86.4	79.4	91.7	57.2	59.2	35.7	30.3	53.6	74.7	57.0	96.6	39.8	32.5	115.1	483.0	17.4	38.9	62.0	35.3	69.7	61.5	41.1	61.8	50.8	93.4	95.0	60.6	67.0	37.0	68.4	58.3	48.5	33.8	84.5	93.9	71.2	83.6	87.1	65.2	360.5	205.3	51.0	166.0	157.4	465.9	708.0	87.6	160.8	83.7	170.4	128.2	241.2	137.4	67.4	113.0	110.0	100.4	219.1	113.1	199.0	99.3	127.2	70.3	125.2	299.6	74.8	92.3	151.2	72.3	149.2	164.5	182.4	206.4	74.9	183.1	117.3	112.0	264.2	152.8	95.4	78.8	139.2	236.7	89.1	174.1	86.2	136.6	87.5	96.4	213.1	143.9	161.3	92.3	105.1	48.8	244.4	193.4	107.7	226.5	94.7	59.5	50.0	50.3	90.6	107.0	150.4	130.7	74.2	202.4	39.2	51.0	166.0	36.7	186.2	114.2	261.9	360.5	313.3	226.8	181.1	299.4	465.9	319.4	25.7	157.4	97.0	205.3	196.8	708.0	50.1	39.1	22.6	37.2	35.7	30.3	39.8	32.5	35.3	33.8
RXFP3	"GPCR135, RLN3R1, RXFPR3, SALPR"	ENSG00000182631	"Relaxin/insulin like family peptide receptor 3"	Q9NSD7	5	33936386-33938237	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"adrenal gland: 3.1;brain: 1.1;pancreas: 1.7;pituitary gland: 1.1"	"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027833	Uncertain									"HPA027833: AB_1849247"	"unprognostic (1.93e-2)"					"unprognostic (3.66e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.86e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-1)"		"unprognostic (8.67e-3)"				0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3		0.0	1.7	0.0	1.1	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771952	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 15.9;RPMI-8226: 5.7;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 30.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6"	"Cell type enriched"	"Detected in some"	5	"naive CD8 T-cell: 7.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"						"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	0.9	5.1	0.0	1.3	0.8	0.4	0.6	0.5	0.4	1.8	10.9	1.1	9.1	14.7	1.1	2.8	4.3	0.6	34.9	27.1	0.7	1.8	0.2	3.2	1.9	0.4	4.5	0.1	0.3	70.4	0.2	0.1	0.2	5.6	1.9	0.5	67.6	9.2	2.4	0.4	0.9	17.8	1.0	1.9	0.3	3.4	0.4	0.3	0.0	0.2	1.6	0.3	1.3	1.4	0.0	1.5	0.0	0.0	0.0	7.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	5.7	0.0	0.0	2.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.4	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.8	0.5	0.3	0.7	1.8	4.5	0.1	5.6	0.3
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40810111	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 26.0;liver: 66.4;pancreas: 24.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042146	Approved									"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favourable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favourable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (5.46e-4)"	1.0	1.1	1.4	4.7	1.7	1.6	2.6	1.0	2.0	1.3	13.2	1.0	0.2	16.3	1.6	1.5	1.8	1.2	3.1	1.9	1.3	1.6	4.0	66.4	1.6	2.0	1.6	0.9	1.8	24.9	0.8	1.0	1.8	1.5	1.0	2.6	0.9	1.4	1.6	2.5	1.3	26.0	1.5	1.4	1.5	2.0	3.8	1.0	2.7	8.0	2.9	3.8	1.2	1.1	1.7	3.4	0.0	3.1	2.4	5.0	1.6	5.0	9.9	9.8	13.5	3.6	4.8	12.5	3.7	1.9	4.2	2.7	10.5	9.7	32.0	4.3	6.2	8.2	15.4	10.2	3.7	7.6	7.7	24.2	4.9	13.6	6.9	8.6	3.1	5.2	4.5	5.3	13.0	6.5	12.4	5.1	6.5	16.3	6.4	3.8	21.2	5.1	15.8	8.1	6.9	5.1	4.6	5.5	13.6	6.9	10.9	5.9	9.1	12.8	6.2	5.3	8.5	8.1	10.7	5.8	5.5	18.8	5.6	7.0	10.6	0.0	1.3	0.0	4.3	3.1	2.7	1.6	2.9	2.8	3.4	1.7	3.0	5.0	0.0	2.4	1.0	0.7	1.8	1.6	1.4	1.7	1.0	2.0	1.3	1.6	1.6	0.9	1.5	1.0
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470256	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 87.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 53.2;HeLa: 52.4;hTCEpi: 39.6;Karpas-707: 46.8;RPMI-8226: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	1.5	0.9	5.3	4.7	7.1	17.3	0.9	3.5	11.6	4.0	4.9	7.7	0.1	5.1	1.8	1.3	3.7	2.0	1.5	2.4	6.9	5.7	0.7	0.4	9.4	3.3	7.0	2.7	3.7	87.7	0.4	0.4	2.8	14.6	5.1	6.4	1.5	4.4	3.7	0.4	8.0	3.5	2.8	7.3	4.8	4.5	0.5	4.6	2.4	7.9	3.6	3.4	4.8	3.1	7.4	8.3	0.3	0.4	5.4	16.2	5.7	22.5	0.0	0.0	0.2	0.4	2.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	23.7	0.0	9.9	34.9	27.0	53.2	0.0	7.5	0.0	12.9	52.4	16.3	3.9	26.3	0.0	3.7	39.6	0.4	0.1	0.4	23.6	46.8	5.3	0.0	5.7	9.1	12.2	0.1	20.9	0.1	86.2	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	8.5	0.2	0.1	0.1	0.0	0.2	0.2	11.5	0.4	16.2	7.4	12.6	10.8	1.5	4.7	6.0	7.7	0.3	5.4	0.0	8.3	13.0	5.7	5.3	7.1	3.5	11.6	6.9	5.7	7.0	2.7	14.6	4.6
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515786	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 27.0;liver: 91.8;pancreas: 100.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 23.5;NB-4: 27.9;U-937: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"	"Golgi apparatus, Vesicles, Plasma membrane"	"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favourable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (7.30e-2)"	4.7	3.3	0.8	2.2	0.8	9.3	7.4	0.7	1.3	6.0	4.8	0.9	3.9	2.5	5.0	6.8	4.1	3.3	27.0	3.2	0.7	0.6	3.4	91.8	2.9	3.3	0.8	1.1	6.5	100.5	0.1	1.3	1.8	0.7	6.2	2.8	11.4	14.9	2.1	7.5	5.6	2.6	7.0	0.9	2.5	7.6	3.1	0.7	0.8	7.4	2.9	3.1	7.6	3.5	3.1	8.2	8.1	6.0	6.9	11.1	5.2	0.4	0.6	0.7	7.9	10.3	7.6	0.1	4.1	5.3	1.2	3.0	2.5	1.1	22.7	1.0	3.0	0.3	7.0	0.4	1.5	1.1	1.8	11.7	0.2	23.5	13.6	20.4	2.9	9.6	1.7	2.0	9.2	5.2	16.3	4.2	1.5	0.8	0.1	27.9	2.6	5.3	19.4	3.9	10.1	0.2	0.0	9.3	1.4	0.7	0.1	9.1	0.6	10.4	2.1	1.2	2.9	10.4	0.6	4.8	1.5	13.3	0.6	26.9	1.6	8.1	6.0	0.7	11.1	2.4	9.5	3.1	5.2	8.0	8.2	1.7	5.1	7.2	0.5	6.9	0.1	1.9	9.1	5.2	0.8	0.8	0.7	1.3	0.7	0.6	0.8	1.1	0.7	0.7
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051402-141148611	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"pancreas: 22.0"	"Cell line enhanced"	"Detected in some"		"AF22: 15.9;NTERA-2: 4.5;RH-30: 5.4;SH-SY5Y: 4.5;U-2 OS: 3.7"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favourable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.8	0.9	1.0	0.2	1.5	0.2	0.2	0.2	2.0	0.1	0.3	0.7	0.0	0.2	0.1	0.3	0.2	0.1	0.2	2.2	1.1	1.1	0.4	0.3	1.3	3.2	1.5	0.6	0.1	22.0	0.1	4.6	0.2	1.2	0.2	0.1	0.0	0.1	0.1	1.7	0.2	0.2	0.2	1.9	2.5	0.1	3.6	0.2	0.1	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.9	0.3	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.9	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	4.5	0.0	0.0	5.4	0.8	0.0	0.0	1.4	4.5	0.0	0.0	0.0	0.3	0.4	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.5	0.2	1.2	1.1	1.1	1.5	0.6	1.2	0.2
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668906-187670399	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 15.2;U-2 OS: 28.3;U-251 MG: 4.7;U-698: 5.9"	"Group enriched"	"Detected in many"	7	"ovarian cancer: 249.9;pancreatic cancer: 1039.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"					"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	2.0	13.0	28.6	1.9	53.8	1.7	0.7	0.1	47.9	0.7	45.1	1.8	21.9	105.2	0.9	0.7	1.1	0.7	1.0	0.9	17.5	102.8	2.5	0.7	0.7	1.0	6.2	15.4	0.8	105.6	0.7	1.5	0.7	16.1	1.5	7.4	0.4	0.7	7.5	0.7	3.1	36.1	1.4	18.4	0.7	90.4	0.7	8.6	0.0	0.9	0.0	0.7	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.3	0.3	4.7	0.0	1.6	5.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	53.8	0.1	47.9	17.5	102.8	6.2	15.4	16.1	8.6
THSD8		ENSG00000284491	"Thrombospondin type 1 domain containing 8"		19	12802031-12813581	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"pancreas: 2.5;testis: 8.9"	"Cell line enriched"	"Detected in single"	6	"BEWO: 3.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
UCN3	"SPC, UCNIII"	ENSG00000178473	"Urocortin 3"	Q969E3	10	5365009-5374692	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6"	"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 5.4"	"Group enriched"	"Detected in many"	5	"lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 5.9"	"Region enriched"	"Detected in single"	7	"hypothalamus: 4.7"	HPA038281	Uncertain				"Secreted to blood"					"HPA038281: AB_10672408"			"unprognostic (2.00e-2)"	"unprognostic (2.31e-1)"				"unprognostic (1.60e-1)"		"unprognostic (2.10e-1)"	"unprognostic (3.18e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-2)"				0.1	0.9	0.1	0.1	0.4	0.0	0.1	0.4	0.4	0.1	14.4	0.1	0.1	11.6	0.1	0.1	0.1	1.2	1.2	0.1	0.1	1.7	0.8	0.1	1.3	0.1	0.1	0.5	0.1	10.6	0.0	5.6	0.1	1.6	0.2	3.1	0.3	0.1	0.1	0.1	0.0	14.9	0.1	0.5	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.1	1.7	0.1	0.5	1.6	0.1
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA076515	Enhanced									"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.1	0.2	0.0	0.2	2.7	0.1	0.1	0.4	0.1	0.1			0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.3	0.1		0.2	2.1	0.0	0.1	0.0		0.1	0.0		0.7	0.0	0.2	2.3	0.1	0.0	0.1	0.1	0.4	8.4			0.4		0.0	0.7	0.1	1.1	1.9	4.1	1.1	1.2	0.8	0.6	0.1	0.7	0.8	0.3	0.0	0.0	3.3	0.0	0.0	0.1	0.1	1.7	0.0	0.9	0.0	0.0	2.0	0.0	0.0	0.0	1.0	3.2	0.8	0.0	0.0	1.1	0.0	1.9	0.9	1.0	1.4	0.0	0.0	0.3	0.9	0.0	0.7	0.0	1.2	0.0	1.0	0.9	0.0	1.0	0.0	2.1	2.0	0.7	0.6	0.4	0.2	0.8	1.3	1.5	1.2	0.5	0.0	0.0	1.6	0.5	1.5	0.5	0.8	0.0	3.1	1.1	1.1	0.8	0.7	0.6	0.5	0.7	0.3	0.3	1.1	0.7	0.7	4.1	1.2	0.4	1.9	0.5	0.6										
VWA5B2	"DKFZp761K032, LOC90113"	ENSG00000145198	"Von Willebrand factor A domain containing 5B2"	Q8N398	3	184230429-184242329	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 35.9;brain: 10.1;pancreas: 11.0"	"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 26.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036823, HPA036824, HPA061412"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: "	"unprognostic (3.92e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-1)"	0.4	35.9	9.2	0.4	4.8	0.2	0.4	9.8	10.1	0.5	2.5	0.4	0.4	1.7	0.4	0.4	0.4	1.2	0.4	0.4	9.5	3.3	0.4	0.4	2.4	0.4	1.9	0.4	3.7	11.0	1.6	3.4	0.4	0.4	0.9	0.4	0.4	0.5	2.4	0.4	0.1	2.4	0.4	0.4	0.4	2.8	1.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.0	0.0	26.5	1.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.7	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	4.8	9.8	10.1	9.5	3.3	1.9	0.4	0.4	0.4
AC008397.1		ENSG00000284797			19	18249950-18255419	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"gallbladder: 19.9;intestine: 13.8;pancreas: 12.5"	"Cell line enriched"	"Detected in single"	29	"HaCaT: 2.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.5	13.8	0.0	0.0	0.0	0.0	0.0	3.4	0.2	19.9	0.0	0.0		0.3	0.0	0.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.0	9.4	0.2	0.0	0.0	1.7	1.1	0.0	0.0	0.1	0.5	3.5	0.4	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC011479.1		ENSG00000267748			19	38289151-38304910	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	4	"blood: 14.9;pancreas: 6.4;salivary gland: 15.1"	"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 3.7;SK-BR-3: 8.6;U-266/84: 4.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.48e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.31e-1)"		"unprognostic (7.07e-2)"		"unprognostic (1.36e-1)"		"unprognostic (4.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.56e-1)"	0.0	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.9	1.4			2.5	0.2	1.7	1.9	0.0	0.1	0.0	0.0	0.0	2.8	0.0	1.0	0.1	0.0		2.5	6.4	0.0	2.1	1.2		2.1	0.5		15.1	0.9	0.0	2.2	1.1	0.0	0.0	0.3	1.9	0.6			2.9		0.0	0.6	1.2	4.6	14.9	14.5	2.9	0.3	2.9	5.2	4.4	2.0	0.0	0.3	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.3	0.0	1.4	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	1.2	1.3	0.6	3.1	0.0	0.0	0.9	1.5	0.0	0.0	0.7	8.6	0.0	1.4	2.6	1.2	0.0	0.0	0.0	0.0	1.0	4.7	0.2	0.0	0.0	0.6	11.1	2.9	14.5	0.1	1.7	0.2	3.3	1.4	0.5	11.7	4.6	2.9	2.5	1.6	0.3	1.6	14.9	0.4	5.2										
ARSE	"CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase E (chondrodysplasia punctata 1)"	P51690	X	2934632-2968310	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 43.0;pancreas: 99.4"	"Cell line enhanced"	"Detected in many"		"A549: 32.0;CACO-2: 19.8;Hep G2: 29.7;NTERA-2: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA060518: AB_2684301, HPA070651: AB_2732160"	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favourable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.2	0.1	0.9	2.4	1.1	0.0	0.4	0.3	0.7	0.8	7.9	0.7	1.3	6.5	1.1	2.3	0.3	1.3	8.4	0.4	0.9	0.8	16.6	43.0	0.8	0.2	0.6	1.0	2.5	99.4	0.0	0.4	0.7	0.7	0.4	6.4	0.6	0.2	0.9	0.2	0.1	7.8	0.5	0.6	0.2	1.2	0.7	0.6	0.2	0.2	0.3	0.2	0.2	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.9	32.0	3.0	0.0	0.9	1.7	0.5	1.3	2.8	1.4	1.7	19.8	0.0	0.0	6.0	0.0	0.0	0.0	0.2	0.8	0.0	2.1	0.0	0.0	29.7	0.8	0.0	0.0	3.2	0.0	1.1	0.0	1.3	0.0	0.0	4.0	0.0	0.0	0.0	14.9	0.0	0.9	0.4	0.1	3.5	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	3.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	0.7	0.9	0.8	0.6	1.0	0.7	0.6
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"Cystic fibrosis transmembrane conductance regulator"	P13569	7	117465784-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 103.0"	"Group enriched"	"Detected in some"	22	"CACO-2: 12.5;MOLT-4: 47.0;U-266/70: 25.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"olfactory region: 6.3"	"CAB001951, HPA021939"	Enhanced									"CAB001951: , HPA021939: AB_1846578"	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.2	0.4	10.5	0.4	0.0	0.3	0.3	0.3	2.5	19.8	0.1	0.8	10.5	0.6	2.1	0.4	0.4	15.8	0.3	0.4	0.3	1.1	1.4	5.7	0.1	0.5	0.1	0.3	103.0	0.0	0.3	0.1	0.1	1.5	12.5	0.1	22.4	0.1	0.3	1.1	24.2	0.3	0.7	0.3	0.6	0.9	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.4	0.3	0.5	0.1	0.1	0.1
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.0;pancreas: 136.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.1;Hep G2: 19.7;K-562: 38.7;NB-4: 32.1;SCLC-21H: 35.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 63.0"	"Group enriched"	"Detected in some"	13	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in many"	20	"B-cells: 24.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6"	HPA065086			Supported	Vesicles	"Secreted to extracellular matrix"	88000	88000	Vesicles	Vesicles	"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	1.1	1.4	2.1	1.1	63.0	1.3	0.9	1.1	2.3	4.0	0.8	1.4	1.6	0.6	0.6	1.0	0.6	2.2	1.2	0.9	1.2	2.9	1.8	0.5	0.5	3.1	0.8	1.9	0.6	136.8	0.4	3.3	0.9	2.1	14.7	1.0	0.8	1.8	21.8	0.6	4.6	0.7	0.7	1.4	0.8	0.8	1.8	7.9	0.0	0.6	0.7	2.4	1.1	7.8	24.0	0.0	0.1	0.3	0.0	1.1	0.6	0.0	11.0	1.0	0.0	0.2	0.0	6.9	0.0	0.0	2.0	5.5	6.5	0.3	0.1	0.5	0.0	0.0	6.9	0.0	3.4	0.0	30.1	5.5	2.5	19.7	0.0	0.5	2.3	0.4	0.0	0.2	0.0	0.1	38.7	1.6	0.5	0.2	2.7	32.1	3.7	1.1	8.1	0.0	0.2	0.3	1.0	35.7	9.6	0.8	0.1	0.0	0.0	15.0	0.2	0.0	0.0	0.1	0.0	1.8	4.7	3.4	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.6	2.1	63.0	1.1	2.3	1.2	2.9	0.8	1.9	2.1	7.9
CRYBA2		ENSG00000163499	"Crystallin beta A2"	P53672	2	218990189-218993421	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.6;intestine: 5.8;pancreas: 16.2;pituitary gland: 12.2;stomach 1: 6.1"	"Cell line enriched"	"Detected in some"	7	"BEWO: 39.9"	"Cancer enriched"	"Detected in some"	15	"pancreatic cancer: 16.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062293	Supported									"HPA062293: AB_2732680"	"unprognostic (5.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-1)"		"prognostic favourable (7.62e-4)"	"unprognostic (2.91e-1)"		"unprognostic (1.90e-1)"	"unprognostic (2.19e-1)"			0.3	4.6	0.3	0.3	2.0	0.0	0.3	0.3	0.8	0.3	5.8	0.3	0.3	3.5	0.3	0.3	0.3	0.0	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.3	0.6	0.3	0.3	16.2	0.1	12.2	0.3	0.7	0.5	2.8	0.8	0.3	0.3	0.3	0.1	4.7	0.3	0.3	0.3	6.1	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.8	1.4	1.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.3	0.8	0.6	0.5	0.6	0.3	0.7	0.3
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.7;EFO-21: 13.8;Hep G2: 22.3;RPTEC TERT1: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Cytosol"	"Mitotic spindle, Cytosol"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: "	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	1.5	0.1	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870575-6878022	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 121.1;pancreas: 219.9;salivary gland: 173.0"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 27.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.4;intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	9	"monocytes: 1.6"					"Not detected"	"Not detected"								"Secreted in other tissues"						"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favourable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	1.1	0.0	0.2	0.5	0.3	0.5	10.5	0.6	0.3	38.7	2.3	0.3	1.6	0.6	2.6	3.1	14.9	2.7	6.5	0.7	0.3	0.0	121.1	22.3	0.7	0.2	0.4	0.3	0.8	219.9	0.0	1.6	4.3	0.8	3.8	1.5	0.5	173.0	3.2	0.8	14.6	0.7	0.5	0.7	0.3	4.0	0.7	0.3	0.3	0.8	10.4	8.8	1.8	10.6	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	1.2	0.5	27.2	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.3	0.3	0.0	0.4	0.3	0.8	0.3
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912884-110012266	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;SK-BR-3: 14.6;U-251 MG: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"									25000	25000				"unprognostic (2.83e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.88e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-3)"	"unprognostic (5.06e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.64e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.80e-5)"	"unprognostic (3.92e-3)"	0.8	0.1	0.4	0.0	0.4	0.0	5.9	0.1	0.9	0.2	0.2	0.3	0.3	0.0	0.3	2.6	0.9	0.2	0.3	2.3	0.8	0.3	48.4	0.0	0.6	0.0	1.2	0.7	0.0	41.2	0.0	0.4	0.0	1.4	0.6	0.4	3.9	8.4	0.1	19.8	0.5	0.2	1.9	0.6	0.2	0.0	0.2	0.2	0.0	1.2	4.5	0.4	0.4	0.5	0.0	0.4	1.7	0.0	0.0	0.0	2.6	0.2	0.3	2.4	0.1	0.0	0.1	0.0	0.6	1.5	0.8	0.5	0.1	0.0	0.0	8.0	0.8	0.0	0.3	0.0	0.6	0.1	0.4	0.1	0.9	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.8	0.1	0.0	0.0	2.9	0.5	0.2	0.1	0.6	0.6	0.2	0.0	0.0	0.0	14.6	0.5	3.5	0.0	0.0	1.2	2.0	0.0	4.6	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	2.6	0.4	0.4	0.1	0.9	0.8	0.3	1.2	0.7	1.4	0.2
EPHA8	"EEK, Hek3"	ENSG00000070886	"EPH receptor A8"	P29322	1	22563564-22603594	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 9.4;brain: 5.3;lymphoid tissue: 10.3;pancreas: 8.3;testis: 3.5"	"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 36.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 25.0"	"CAB009660, HPA031433"	Uncertain				"Intracellular and membrane"					"CAB009660: AB_2099696, HPA031433: AB_10601371"	"unprognostic (8.58e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.69e-4)"	"unprognostic (3.58e-1)"		"unprognostic (7.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.84e-14)"	"unprognostic (2.14e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.68e-2)"	0.2	9.4	1.6	0.2	3.1	0.2	0.1	1.8	3.9	0.2	0.2	2.2	0.0	1.7	0.1	0.3	0.2	0.1	0.2	0.2	2.0	2.6	0.1	0.1	0.2	0.2	2.1	4.1	0.1	8.3	0.2	1.7	0.1	5.3	0.2	0.2	1.6	0.8	0.2	0.3	0.4	0.2	0.1	1.3	10.3	0.2	3.5	0.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	36.4	2.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.9	2.0	2.6	2.1	4.1	5.3	0.6
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953895	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"heart muscle: 10.2;pancreas: 31.0;retina: 15.7"	"Cell line enriched"	"Detected in single"	84	"RPTEC TERT1: 17.6"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041597	Uncertain		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.7	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.7	31.0	0.0	0.2	0.0	0.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.0	0.0	2.8	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.7	0.0	0.7	0.0	0.5	0.0
KRTAP4-16	"KAP4A, KRTAP4-16P, KRTAP4P1"	ENSG00000241241	"Keratin associated protein 4-16"		17	41101502-41102209	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	4	"pancreas: 1.4"	"Cell line enriched"	"Detected in single"	5	"PC-3: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.4	0.0	0.0	0.1		0.0	0.0		0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP5-2	"KRTAP5-8, KRTAP5.2"	ENSG00000205867	"Keratin associated protein 5-2"	Q701N4	11	1597177-1598294	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 6.3;pancreas: 5.2;skin 1: 10.2"	"Group enriched"	"Detected in some"	11	"HDLM-2: 1.6;MCF7: 5.8;SCLC-21H: 6.7;SH-SY5Y: 2.9;SK-BR-3: 1.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;memory CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"B-cells: 1.1;T-cells: 1.0"																																	"unprognostic (6.31e-2)"				0.0	0.8	0.8	0.2	1.3	0.0	0.0	5.4	6.3	0.0	0.6			1.2	0.2	0.9	0.0	0.0	1.5	0.3	0.7	1.4	0.0	0.0	0.3	0.1	0.4		0.0	5.2	0.0	0.4	0.0		0.0	0.0		1.6	0.0	0.1	10.2	1.5	0.0	0.1	0.0	0.8	0.0			0.0		0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	2.9	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3										
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35805293-35833874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055110	Uncertain									"HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.5	0.5	3.9	1.2	4.1	7.4	0.5	0.4	5.8	0.4	0.4	0.2	0.0	0.9	0.9	12.0	0.3	0.3	0.7	0.3	3.5	2.8	0.4	0.4	0.3	1.5	1.2	6.7	0.6	12.3	0.0	2.2	0.6	2.0	0.6	0.3	0.2	1.1	0.1	0.6	2.3	0.8	0.1	0.6	1.0	0.5	0.8	0.0	0.0	0.8	0.0	0.4	0.3	0.4	1.0	0.3	1.0	0.8	0.5	0.9	0.0	1.5	1.9	3.5	2.1	0.6	1.7	3.2	2.5	0.9	0.4	1.1	2.1	2.2	3.5	1.9	1.3	1.9	0.6	1.4	0.9	1.8	2.9	3.8	5.5	1.9	0.1	1.6	2.6	1.4	0.7	0.7	1.0	0.5	2.0	7.1	2.0	1.2	2.3	1.8	2.3	1.5	2.0	1.5	1.0	1.1	3.3	3.3	2.2	1.6	1.8	1.1	2.9	1.3	3.6	2.4	2.1	3.2	1.0	4.0	3.3	2.8	1.1	2.4	1.5	1.0	0.3	0.2	0.9	0.6	0.5	0.5	0.5	0.3	0.0	1.0	0.6	0.8	0.9	0.5	0.8	0.3	0.4	0.0	3.9	4.1	0.4	5.8	3.5	2.8	1.2	6.7	2.0	0.0
NBPF12	"COAS1, KIAA1245"	ENSG00000268043	"NBPF member 12"		1	146938744-146996202	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	4	"pancreas: 29.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.48e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (9.01e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.08e-1)"	"prognostic favourable (2.47e-5)"	2.7	1.7	2.2	4.0	3.9	5.1	3.2	4.4	4.7	2.6	1.9	5.8	2.2	2.4	6.0	3.6	1.5	2.4	3.1	0.9	2.3		1.7	6.1	2.8	3.4	4.2	4.2	4.3	29.8	4.2	5.0	1.8	3.8	2.5	1.8	4.2	3.5	4.0	0.9	2.5	1.9	3.0	3.2	3.1	5.3	7.0	1.1	3.3	2.9	0.9	2.9	1.2	3.9	3.8	2.6	6.1	2.3	0.9	3.5	0.8	6.9	5.6	11.8	10.1	5.5	5.2	7.6	7.2	5.4	5.1	5.2	5.1	6.6	15.5	4.5	6.2	5.2	8.4	4.1	5.0	5.8	5.9	6.8	12.1	4.3	4.6	5.1	10.1	5.4	7.5	5.1	11.8	4.6	10.8	2.7	4.1	10.6	10.9	6.4	6.8	7.3	10.6	4.3	3.7	3.9	15.4	5.9	12.4	9.5	8.4	4.7	7.1	15.4	5.5	4.6	7.5	10.3	10.0	9.5	7.0	6.5	4.9	3.6	5.1	6.1	2.3	1.8	3.5	1.1	2.0	3.4	2.3	1.9	1.0	3.8	2.6	2.0	0.7	0.9	1.4	2.6	2.2	0.8										
NPTX2		ENSG00000106236	"Neuronal pentraxin 2"	P47972	7	98617297-98629868	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7"	"Cell line enriched"	"Detected in some"	12	"LHCN-M2: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020801, HPA049799, HPA058320"	Enhanced		Approved	"Golgi apparatus,Actin filaments,Centrosome"	"Secreted to blood"	320000	320000	"Golgi apparatus, Actin filaments"	"Golgi apparatus, Actin filaments"	"CAB020801: , HPA049799: AB_2680889, HPA058320: "	"unprognostic (1.18e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (1.91e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (5.46e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.69e-2)"	4.3	24.0	7.1	2.3	8.4	1.0	1.4	0.2	45.6	8.2	3.8	3.2	0.1	1.1	1.8	3.9	2.2	1.5	1.6	3.2	9.2	11.0	0.9	0.9	0.8	0.7	9.4	2.2	1.5	19.5	0.8	71.6	0.8	7.0	2.1	1.4	1.3	1.5	2.2	2.9	4.0	1.3	2.9	2.9	6.1	1.9	20.7	5.0	0.0	1.6	0.1	0.9	1.4	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	125.7	0.0	0.9	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	7.1	8.4	0.2	24.6	9.2	11.0	9.4	2.2	7.0	5.0
OR10G7		ENSG00000182634	"Olfactory receptor family 10 subfamily G member 7"	Q8NGN6	11	124036013-124041325	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	4	"pancreas: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.8	0.0	0.0	0.0		0.0	0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PAK3	"bPAK, hPAK3, MRX30, MRX47"	ENSG00000077264	"P21 (RAC1) activated kinase 3"	O75914	X	110944285-111227361	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 26.2;pancreas: 46.5;pituitary gland: 37.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;HAP1: 8.7;HDLM-2: 10.9;NTERA-2: 8.5;SCLC-21H: 11.1;SH-SY5Y: 6.9;U-2197: 6.7;U-251 MG: 11.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 4.3"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044791, HPA060219"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA044791: , HPA060219: AB_2684223"	"unprognostic (1.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.27e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.63e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.89e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	2.0	6.8	17.6	2.5	17.5	1.0	6.4	1.8	24.6	3.7	1.6	0.9	9.1	1.0	6.8	7.6	1.7	3.7	2.6	1.2	26.2	20.8	1.6	1.1	1.8	2.5	7.9	21.9	7.9	46.5	0.9	37.2	1.6	12.9	4.8	1.7	1.4	3.0	7.1	2.4	2.0	1.4	6.1	5.8	2.9	3.0	3.6	1.9	0.0	7.7	0.0	1.7	2.0	1.5	0.1	0.1	0.6	0.1	0.2	4.3	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	9.7	1.0	0.0	8.7	0.5	1.2	10.9	0.3	0.0	1.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	8.5	1.9	0.1	4.0	0.0	0.8	0.0	11.1	6.9	0.0	0.4	0.0	0.0	0.0	0.0	0.6	4.3	6.7	11.6	0.0	0.1	0.1	1.2	0.0	0.1	0.6	0.1	0.1	0.1	0.0	4.3	0.0	0.7	0.4	0.0	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.0	17.6	17.5	1.8	18.5	26.2	20.8	7.9	21.9	12.9	1.9
PCDHA9	"KIAA0345, PCDH-ALPHA9"	ENSG00000204961	"Protocadherin alpha 9"	Q9Y5H5	5	140847463-141012344	"Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 1.8;brain: 3.1;pancreas: 3.4;testis: 3.5"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 11.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"																						"unprognostic (1.53e-3)"	"unprognostic (1.13e-1)"		"unprognostic (7.54e-4)"	"unprognostic (1.28e-2)"			"unprognostic (4.65e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (8.79e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-1)"		0.2	0.4	0.4	0.1	0.5	0.6	0.0	3.1	1.8	0.4	0.0			0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.3		0.2	3.4	0.2	0.3	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.1	0.0	1.9	0.1	0.0	3.5			0.2		0.0	0.0	0.0	0.9	0.5	1.8	0.4	0.7	0.5	0.2	0.0	0.1	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	11.3	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3	0.4	0.4	0.5	0.3	0.4	0.4	0.3	0.4	0.2	0.9	0.4	0.5	1.8	0.7	0.4	0.5	0.2	0.2										
PYCR1	P5C	ENSG00000183010	"Pyrroline-5-carboxylate reductase 1"	P32322	17	81932384-81942412	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 56.1;salivary gland: 53.3;stomach 1: 16.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 7.7"	"Group enriched"	"Detected in many"	7	"B-cells: 7.7;dendritic cells: 3.3;T-cells: 3.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047660	Approved									"HPA047660: AB_2680115"	"unprognostic (1.12e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (2.80e-1)"	"unprognostic (9.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (3.02e-3)"	"unprognostic (7.12e-2)"	"prognostic unfavourable (7.33e-12)"	"unprognostic (7.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.92e-2)"	2.1	1.3	4.3	5.0	5.0	4.0	6.9	2.1	4.3	10.4	9.1	2.3	10.1	5.6	4.2	2.2	6.4	3.5	5.7	3.5	3.5	3.6	2.4	3.1	4.9	2.3	6.0	2.0	7.6	56.1	0.0	7.6	8.3	6.4	10.4	5.6	1.5	53.3	4.7	3.4	1.8	4.8	4.6	2.9	2.4	16.6	8.7	4.0	1.7	3.3	4.5	6.4	4.9	4.0	7.7	3.3	0.0	0.4	0.6	3.0	2.2	19.1	20.5	11.7	43.3	7.0	13.3	22.4	32.2	15.9	10.4	14.0	23.4	21.6	29.4	7.2	34.4	8.4	27.5	12.2	6.2	7.6	3.4	17.3	10.6	63.2	41.5	11.5	13.4	11.3	24.5	12.7	33.6	17.6	55.7	27.4	6.5	67.9	12.1	9.2	9.8	31.9	0.1	19.7	37.1	9.3	7.0	45.0	31.7	6.7	38.0	41.0	39.1	21.3	12.9	10.1	38.9	17.0	11.9	34.6	24.0	27.3	10.8	0.1	33.2	0.0	0.3	0.0	0.5	0.4	0.7	7.7	1.3	0.4	2.3	3.5	3.0	2.3	0.0	0.6	0.0	3.3	0.5	2.2	4.3	5.0	2.1	3.6	3.5	3.6	6.0	2.0	6.4	4.0
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792869-4885917	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"liver: 108.1;pancreas: 37.5"	"Group enriched"	"Detected in all"	4	"HDLM-2: 34.3;HEL: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA071308: AB_2686384"	"prognostic favourable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favourable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	15.9	6.8	4.2	6.7	5.9	17.2	12.9	5.5	6.3	5.6	3.8	6.2	6.3	2.4	5.5	5.4	5.5	5.6	3.8	3.7	4.1	3.6	5.7	108.1	6.9	9.1	5.8	4.2	9.0	37.5	3.8	5.1	6.8	5.6	3.6	4.2	4.5	4.8	9.1	10.9	10.5	4.1	5.2	7.1	5.0	5.2	6.8	5.6	5.7	4.5	8.1	7.2	5.3	6.8	10.4	6.8	12.9	2.3	10.8	9.1	3.5	5.5	6.6	2.5	4.0	3.8	2.5	6.7	2.6	2.8	4.9	4.1	3.3	3.3	10.6	1.8	2.3	3.5	11.6	7.8	5.7	34.3	5.9	88.1	7.9	6.6	5.4	7.9	7.2	5.7	4.5	4.7	7.2	4.8	8.9	6.9	2.9	7.1	6.4	13.7	8.7	2.7	8.0	3.3	5.6	6.0	6.2	7.3	6.0	3.3	4.8	3.8	4.6	9.3	3.3	2.9	3.2	4.0	8.0	2.8	8.0	11.5	5.3	4.9	1.9	12.9	1.5	3.8	5.6	2.3	6.8	8.0	6.6	7.6	4.0	10.4	8.9	9.1	0.6	10.8	1.2	6.8	5.5	3.5	4.2	5.9	5.5	6.3	4.1	3.6	5.8	4.2	5.6	5.6
REG3G	"LPPM429, PAP1B, UNQ429"	ENSG00000143954	"Regenerating family member 3 gamma"	Q6UW15	2	79025686-79028505	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 262.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.0;SK-MEL-30: 3.1;U-2 OS: 1.6;U-266/84: 1.3"	"Cancer enriched"	"Detected in many"	13	"pancreatic cancer: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Uncertain		Approved	Cytosol	"Secreted to digestive system"			Cytosol	Cytosol	"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"									"unprognostic (3.29e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-1)"		"unprognostic (8.82e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.64e-2)"			0.1	3.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.8	0.6	0.1	61.1	0.1	0.0	0.1	0.1	0.1	0.0	7.1	0.1	0.1	0.1	0.1	0.1	0.1	262.6	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	2.8	0.3	0.1	0.1	0.0	19.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	1.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.9;Hep G2: 18.4;MOLT-4: 13.3;RH-30: 11.4;RPMI-8226: 23.0;SH-SY5Y: 9.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		190000	190000	Mitochondria	Mitochondria	"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.8	10.9	0.0	0.3	1.4	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.1	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.4	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.1	0.0	0.2	6.9	1.9	13.3	1.4	1.7	0.1	0.9	11.4	23.0	0.0	0.1	1.0	9.2	0.0	0.3	2.3	1.5	0.1	0.0	2.1	1.9	0.2	0.0	0.1	0.0	0.7	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8
SH2D6	FLJ35993	ENSG00000152292	"SH2 domain containing 6"	Q7Z4S9	2	85418721-85437029	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 4.2;pancreas: 1.7;testis: 6.4;thyroid gland: 2.4"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 6.5;RH-30: 2.4;SCLC-21H: 1.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA053873	Uncertain									"HPA053873: AB_2682286"	"unprognostic (4.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.06e-7)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.65e-3)"	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.4	0.0	1.9			4.2	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.6		0.0	1.7	0.0	0.1	0.0		0.0	0.4		0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.8	6.4			2.4		0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.6	0.3	0.0	0.1	0.6	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.3	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.1	0.4	0.1	2.4	0.0	0.7	0.0	1.5	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	1.2	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.5	0.6	0.0	0.0	0.3	0.0										
SMIM3	"C5orf62, MSTP150, NID67"	ENSG00000256235	"Small integral membrane protein 3"	Q9BZL3	5	150777946-150796734	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 63.1;ASC TERT1: 30.9;LHCN-M2: 28.6;U-87 MG: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075345			Approved	Vesicles				Vesicles	Vesicles	"HPA075345: AB_2686744"	"unprognostic (2.33e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.45e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.71e-3)"	"unprognostic (3.46e-3)"	"prognostic unfavourable (1.15e-8)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-3)"	24.4	5.4	6.1	3.3	5.6	11.4	3.9	3.3	6.2	2.2	3.1	1.8	0.7	1.3	3.0	2.9	2.2	3.0	3.3	3.4	2.6	1.2	2.9	1.1	3.6	0.7	3.0	1.0	3.2	45.7	1.2	1.8	6.4	6.2	3.2	2.3	1.3	1.8	3.3	2.5	2.2	3.9	3.7	2.6	1.9	2.9	1.7	4.3	1.8	2.7	0.7	0.7	3.8	1.8	0.3	18.4	22.3	13.3	3.6	7.2	11.6	2.0	0.6	1.1	9.2	63.1	30.9	2.4	7.9	16.9	2.8	11.7	3.1	5.3	0.0	0.4	8.0	1.6	1.8	1.7	4.3	0.0	0.5	2.9	0.4	1.4	11.2	2.8	20.9	25.8	3.5	8.2	3.8	0.9	0.7	0.0	28.6	1.5	4.1	3.9	0.5	1.8	2.2	0.1	0.0	3.1	1.5	0.2	0.7	1.1	0.1	2.3	3.8	17.8	1.5	13.0	2.3	10.1	4.0	0.0	0.0	0.0	46.9	10.9	1.6	17.9	13.3	22.3	7.2	5.3	4.3	0.3	5.1	4.9	6.2	0.0	5.0	4.3	13.9	3.6	4.8	18.4	0.7	11.6	6.1	5.6	3.3	6.2	2.6	1.2	3.0	1.0	6.2	4.3
SYT6		ENSG00000134207	"Synaptotagmin 6"	Q5T7P8	1	114089291-114153919	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 14.9;kidney: 3.7;pancreas: 11.1"	"Group enriched"	"Detected in some"	7	"NTERA-2: 20.6;WM-115: 14.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basal ganglia: 27.9;olfactory region: 87.2"	"Low region specificity"	"Detected in many"			HPA058362			Approved	Vesicles				Vesicles	Vesicles	"HPA058362: "	"unprognostic (7.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	0.3	2.2	2.6	0.8	6.5	0.3	2.1	0.2	10.4	0.4	0.3	5.1	0.0	0.9	0.4	0.2	0.2	0.3	0.5	0.3	2.3	14.9	3.7	0.3	0.4	0.3	2.8	1.3	2.3	11.1	0.7	0.3	1.4	3.9	1.5	0.6	0.9	1.1	0.2	0.4	0.4	0.5	0.3	4.2	0.3	0.3	0.9	3.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.6	6.5	0.2	9.3	2.3	14.9	2.8	1.3	3.9	3.3
TMEM52		ENSG00000178821	"Transmembrane protein 52"	Q8NDY8	1	1917590-1919273	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"pancreas: 67.1;skeletal muscle: 77.9;tongue: 38.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 14.3;PC-3: 7.7;RPMI-8226: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (4.39e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.04e-5)"	"unprognostic (1.46e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.68e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	1.7	12.5	0.5	0.2	0.5	0.1	1.3	1.5	0.4	0.3	0.9	0.4	0.1	1.0	0.3	1.5	2.0	0.8	0.4	0.4	0.4	0.5	0.6	3.3	1.0	0.1	0.2	0.5	0.5	67.1	0.9	0.3	0.2	0.4	0.5	0.4	0.5	13.8	0.1	77.9	0.8	1.7	0.2	0.3	0.7	1.2	7.9	0.2	0.2	0.9	38.9	2.5	0.3	0.4	0.2	2.3	0.0	0.4	0.0	0.6	0.0	2.4	0.2	0.6	1.3	0.2	0.1	5.5	0.3	0.1	1.6	1.0	4.0	1.6	0.6	1.6	2.5	0.8	4.0	1.1	0.3	0.2	2.9	0.0	0.6	14.3	0.8	0.0	0.9	0.0	2.3	0.5	0.2	0.1	3.5	1.4	0.0	4.5	0.3	1.1	2.1	7.7	1.0	0.0	26.1	0.8	0.1	2.7	1.9	0.0	2.3	0.3	1.5	0.3	0.0	0.0	1.1	0.7	0.0	1.8	0.6	0.7	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.5	1.5	0.4	0.4	0.5	0.2	0.5	0.4	0.2
TPST2	TANGO13B	ENSG00000128294	"Tyrosylprotein sulfotransferase 2"	O60704	22	26521983-26596717	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 71.0;pancreas: 192.5"	"Cell line enhanced"	"Detected in all"		"HMC-1: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021054	Enhanced				"Intracellular and membrane"	33000	33000			"HPA021054: AB_1858221"	"unprognostic (2.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.74e-2)"	"prognostic favourable (8.08e-5)"	"unprognostic (8.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavourable (2.34e-6)"	"unprognostic (9.68e-2)"	"unprognostic (9.21e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	5.8	8.4	4.7	3.7	3.6	5.2	9.0	2.1	6.9	4.6	2.9	3.0	7.4	3.5	4.7	31.8	4.5	4.1	3.2	5.2	5.2	3.2	5.7	20.0	10.7	4.8	3.7	3.6	2.4	192.5	1.1	2.9	11.0	3.2	3.8	2.3	4.0	2.8	7.9	8.6	4.0	3.1	3.2	2.8	8.9	3.0	4.8	3.1	3.0	12.2	2.2	5.2	4.5	6.7	4.3	20.0	71.0	15.1	57.2	46.4	35.2	4.2	3.1	4.1	2.0	8.8	6.7	5.7	9.6	17.3	7.8	7.2	2.1	2.2	7.2	2.5	17.2	6.7	3.0	6.6	4.5	2.9	5.8	17.4	1.9	4.4	3.6	2.0	56.0	7.2	10.6	7.9	2.7	14.4	17.4	22.7	5.9	4.8	8.0	13.6	5.3	3.1	7.5	5.5	20.1	2.3	4.8	3.1	2.1	4.4	3.9	5.3	1.8	8.4	11.4	9.7	21.9	7.9	9.2	7.4	10.2	6.9	7.3	7.8	8.7	71.0	13.4	18.6	46.4	14.5	13.0	4.1	10.9	34.5	8.4	4.3	5.4	31.4	28.4	57.2	15.1	20.0	12.2	35.2	4.7	3.6	2.1	6.9	5.2	3.2	3.7	3.6	3.2	3.1
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312539-73328082	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"pancreas: 17.2;stomach 1: 22.8"	"Cell line enriched"	"Detected in single"	33	"Hep G2: 12.0"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019862, HPA047843"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0		0.0	17.2	0.2	0.0	0.3		0.0	0.0		0.0	0.0	1.8	0.0	1.0	0.0	0.0	0.1	22.8	4.4			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZNF710	"DKFZp547K1113, FLJ00306, FLJ37393"	ENSG00000140548	"Zinc finger protein 710"	Q8N1W2	15	90001392-90082206	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"pancreas: 79.6"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.3;granulocytes: 3.0;monocytes: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030226, HPA030227, HPA030228"	Uncertain		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899"	"unprognostic (6.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.65e-2)"	2.6	2.1	5.6	8.7	6.7	4.3	3.2	2.9	5.0	3.1	4.3	6.6	1.7	5.3	3.3	4.1	9.5	2.9	4.8	5.9	3.9	3.5	2.7	3.4	6.4	7.9	4.0	4.1	3.4	79.6	1.5	2.5	3.2	5.0	4.2	4.0	3.5	5.2	2.6	18.3	6.7	4.5	4.3	6.3	8.6	5.9	2.4	4.1	11.7	3.5	5.2	7.0	4.4	4.9	0.3	2.3	3.0	7.9	0.4	0.8	0.9	5.7	6.8	13.1	4.9	1.8	2.6	6.8	6.0	5.6	4.4	5.7	4.8	5.3	5.9	2.8	5.8	4.0	3.3	8.6	2.5	3.7	6.1	10.7	2.7	8.1	3.7	3.1	16.7	4.4	4.7	9.5	5.2	7.6	3.6	4.0	1.7	14.8	6.9	8.6	10.2	4.4	8.5	2.9	6.4	1.8	7.2	12.0	8.1	8.0	29.0	4.1	6.3	10.7	10.8	9.2	4.5	2.7	4.7	3.3	1.6	5.7	7.0	9.2	4.7	0.0	2.6	1.8	0.4	5.7	0.3	0.2	0.2	0.3	1.9	0.3	0.8	0.8	3.0	0.4	7.9	2.3	0.7	0.9	5.6	6.7	2.9	4.3	3.9	3.5	4.0	4.1	5.0	4.1
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 44.3;MCF7: 28.5;RH-30: 25.1;T-47d: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		1500000	1500000	Mitochondria	Mitochondria	"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.36e-5)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	11.8	6.7	1.9	0.6	0.5	1.4	0.8	0.7	0.2	4.4	0.3	1.4	0.5	0.8	3.0	0.7	2.8	0.9	0.8	0.6	1.9	0.0	44.3	3.1	0.4	3.0	2.5	1.2	1.2	0.5	0.2	0.3	1.0	0.2	28.5	0.7	0.2	1.0	0.1	3.4	25.1	0.6	0.4	7.0	1.9	5.7	0.6	0.4	0.0	15.6	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.0	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pancreas: 25.5;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	5	"A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	Nucleoli	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	1.3	6.7	4.4	0.8	6.1	0.9	4.0	28.0	12.3	3.0	1.3	2.6	7.7	1.9	3.1	3.7	0.8	1.2	0.9	2.9	5.1	4.8	1.0	0.8	2.9	0.8	3.6	7.2	0.9	25.5	1.0	26.6	1.6	8.5	2.8	1.3	0.7	0.9	8.5	2.3	1.1	1.5	1.3	4.0	0.9	3.5	1.1	2.3	0.0	6.2	0.0	0.8	0.7	0.8	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	4.6	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.4	6.1	28.0	12.3	5.1	4.8	3.6	7.2	8.5	2.3
AC008397.2		ENSG00000285188	"CAMP-specific 3',5'-cyclic phosphodiesterase 4C "	Q08493	19	18207961-18255419	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 22.4;intestine: 15.6;pancreas: 14.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;U-2197: 1.6;U-87 MG: 4.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048975	Uncertain									"HPA048975: AB_2680581"																		0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.2	1.9	15.6	0.0	0.0	1.3	1.1	3.6	4.0	1.0	22.4	0.6	0.0		0.6	0.0	2.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.8	0.0	0.0	1.7	0.0	2.1	1.1	3.7	0.0	8.0	0.6	0.0	0.4	7.1	0.2	0.0	0.0	0.4	0.8	4.1	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	3.6	0.1	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.9	0.0	0.0	0.2	0.4	0.0	0.8	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	1.6	0.0	0.3	0.2	0.1	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC009119.2		ENSG00000260300			16	83908132-83951445	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"heart muscle: 6.3;liver: 3.9;pancreas: 3.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"basophil: 2.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.5"																				"unprognostic (3.40e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.36e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.70e-3)"	0.8	0.0		0.1		0.0	0.5		0.0	0.0	0.3			0.6	0.1	0.5	0.0	0.0	0.0	6.3			1.3	3.9	0.1	0.1			0.5	3.9	0.0		0.0		0.0	0.7		0.1	0.9	1.7	0.0	0.0	0.1		0.0	0.0	0.3			0.0		0.0	0.0		0.1	0.3	2.5	0.6	0.0	0.2	0.1	0.9	2.6	2.3	2.1	1.6	0.0	3.6	0.9	1.2	0.7	0.5	0.0	1.8	0.0	3.1	0.8	1.1	0.8	0.7	0.8	0.1	2.5	0.6	1.1	3.0	4.6	1.4	2.0	0.0	0.8	0.3	0.1	0.7	1.1	0.2	1.4	1.4	0.2	2.0	2.0	0.0	1.9	1.4	0.5	1.2	0.0	1.2	0.1	2.9	1.9	3.9	4.2	3.9	0.0	2.7	0.5	1.0	0.0	2.4	0.5	1.6	0.8	0.2	2.8	2.5	0.2	0.7	0.1	0.6	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.1										
AC025165.3		ENSG00000257921			12	57773028-57787046	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pancreas: 14.2;salivary gland: 16.5"	"Group enriched"	"Detected in some"	27	"ASC diff: 3.6;fHDF/TERT166: 1.6;HMC-1: 1.9;Karpas-707: 1.7;RH-30: 4.6"	"Cancer enriched"	"Detected in single"	6	"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.28e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.74e-2)"	"unprognostic (6.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.74e-2)"	3.0	1.2	1.4	0.8	1.3	0.8	3.4	1.4	1.5	2.4	1.3	0.0	2.8	0.8	3.3	2.3	1.7	0.8	2.5	0.8	0.9	1.0	3.7	1.7	2.1	3.3	1.2	0.1	3.6	14.2	0.8	0.8	0.9	0.4	2.3	2.0	1.6	16.5	5.3	0.8	0.8	0.8	2.0	2.5	0.8	1.0	1.0	0.0	0.0	2.4	1.1	1.7	2.3	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	1.4	1.5	0.9	1.0	1.2	0.1	0.4	0.0
AC025283.2		ENSG00000262621			16	3382113-3397745	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 2.8;pancreas: 3.0"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 3.6;SK-MEL-30: 4.3;U-698: 4.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.30e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.75e-3)"	"unprognostic (1.05e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.58e-2)"	0.0	0.0		1.7		0.0	0.4		0.0	0.1	0.0			0.2	1.4	2.0	0.0	1.2	0.0	0.0			0.2	0.0	0.0	0.4			1.1	3.0	0.5		0.7		0.2	0.0		0.4	0.8	0.8	0.8	0.4	0.1		0.1	0.5	0.5			0.4		0.0	0.0		0.9	1.9	2.4	0.8	0.2	2.8	1.6	0.0	2.2	0.1	0.0	0.5	0.5	0.8	0.0	0.5	0.1	0.3	1.7	0.8	1.2	0.4	0.4	1.8	0.0	0.3	0.1	2.2	0.0	0.0	0.0	0.8	1.6	1.4	0.7	0.4	0.1	0.3	0.0	0.7	0.1	0.4	0.7	0.0	0.4	0.3	2.8	0.0	1.5	0.0	3.6	0.0	0.0	1.7	1.5	0.0	0.0	4.3	0.4	2.7	0.0	1.0	1.2	1.3	0.3	1.9	0.3	4.7	0.0	0.8	1.6	0.0	0.8	2.4	0.5	0.8	0.7	0.9	0.4	0.4	1.9	0.1	1.2	2.8	0.7	0.2	0.2	0.9	0.2	1.6										
AC068790.8		ENSG00000274874			12	123973944-124088594	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 2.7;pancreas: 3.3"	"Cell line enhanced"	"Detected in many"		"T-47d: 5.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.99e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-1)"	0.8	0.0		0.0		0.0	0.9		1.8	0.0	0.3			0.5	0.9	1.1	0.1	0.7	0.0	0.0			0.5	0.2	0.5	0.0			0.0	3.3	1.4		0.7		0.4	0.0		0.6	0.7	0.1	0.0	0.5	0.0		0.0	1.0	0.3			0.8		0.1	0.3		0.7	1.5	0.1	0.3	0.0	2.7	0.7	2.5	0.0	1.2	2.2	1.6	0.7	0.8	1.4	1.1	0.0	0.3	0.0	0.9	1.8	0.8	1.9	1.0	1.4	0.0	2.0	1.8	0.6	0.0	0.5	1.4	0.6	0.4	1.8	1.5	2.2	0.5	1.3	1.1	0.7	0.0	1.2	1.6	0.9	0.4	0.6	2.2	0.8	1.0	0.8	3.5	2.8	2.9	3.8	0.5	1.5	1.2	5.4	0.3	1.3	0.9	1.6	2.3	0.8	0.8	1.8	3.1	0.0	0.5	1.3	0.0	0.3	0.0	2.7	0.0	2.4	0.4	1.6	0.9	1.5	0.7	1.5	1.2	0.1	0.0	0.0	0.8	0.0	0.7										
AC140504.1		ENSG00000261130			16	15395754-15515348	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pancreas: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							1.3	1.3	2.2	1.3	3.5	1.3	1.3	1.7	3.2	1.3	1.3	4.5	0.0	1.3	1.3	1.3	1.5	1.3	1.9	1.3	2.8	1.6	2.4	5.3	1.4	1.3	1.5	2.2	1.5	16.2	1.3	5.1	1.3	2.3	1.3	1.3	4.1	1.3	1.3	7.3	1.3	1.9	3.9	1.3	1.6	1.3	1.3	2.6	0.0	1.3	0.0	1.3	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.5	1.7	3.2	2.8	1.6	1.5	2.2	2.3	2.6
AC233723.1		ENSG00000262165			17	4801159-4807013	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 4.7;pancreas: 3.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.7;SCLC-21H: 14.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.6"																"unprognostic (3.93e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	0.3	0.9	0.3	0.3	0.3	0.0	0.8	0.3	1.4	0.8	0.3	0.3	0.3	0.0	0.4	0.3	0.3	1.5	0.3	1.0	0.3		0.5	0.3	0.5	0.3	0.3	0.3	4.7	3.4	0.0	0.3	0.3	0.3	1.1	0.0	0.3	0.4	0.5	1.0	2.3	0.3	0.5	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.8	0.7	1.2	1.9	0.3	2.4	1.1	0.4	0.9	0.0	4.7	0.7	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.0	0.0	0.7	1.5	1.3	0.5	1.0	0.0	1.3	0.5	0.7	0.0	0.8	0.7	1.3	0.1	0.2	0.0	1.4	0.0	14.7	0.8	0.0	0.0	0.3	0.0	0.0	2.0	0.2	0.5	0.3	0.1	0.2	0.0	0.5	0.4	0.0	0.2	0.0	1.9	0.0	1.1	0.0	1.8	1.4	1.0	0.1	0.7	1.8	1.7	2.4	1.2	0.3	1.6	0.1	0.4	1.1										
ACSM3	"SA, SAH"	ENSG00000005187	"Acyl-CoA synthetase medium chain family member 3"	Q53FZ2	16	20610243-20797581	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6;ovary: 47.7;pancreas: 46.6"	"Cell line enhanced"	"Detected in some"		"HEL: 19.9;HMC-1: 84.0;K-562: 59.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 18.3;T-cells: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041013	Uncertain									"HPA041013: AB_10671693"	"unprognostic (1.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.95e-3)"	"prognostic favourable (9.88e-6)"	"unprognostic (1.27e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-2)"	2.1	1.8	0.3	3.7	1.0	3.4	18.6	0.4	0.4	10.9	7.0	0.5	4.3	1.7	10.4	5.3	2.9	11.2	5.0	4.0	0.3	0.3	33.1	58.6	6.4	3.7	0.4	0.3	47.7	46.6	5.1	1.0	1.8	0.7	9.6	7.2	1.4	3.6	6.5	1.0	2.0	3.1	3.2	0.5	1.3	10.9	14.7	0.3	1.5	1.5	1.6	1.8	3.9	6.6	2.2	1.9	18.3	2.9	1.9	7.4	2.3	0.2	2.7	0.5	0.1	0.8	0.5	0.3	0.0	0.2	0.0	0.2	0.2	3.9	0.3	4.4	0.0	0.3	0.0	0.4	0.3	0.9	1.4	19.9	0.0	1.5	0.2	2.2	84.0	0.8	0.4	0.1	0.3	0.0	59.1	3.3	0.0	0.3	0.1	0.7	0.1	0.7	0.6	0.0	4.2	4.0	0.2	0.1	0.1	0.0	1.1	0.0	1.3	0.1	0.3	0.2	0.2	0.2	0.1	4.8	3.7	0.2	0.2	1.5	0.1	2.3	1.6	18.3	3.3	1.0	3.8	1.4	4.1	3.0	0.2	2.2	6.5	7.4	0.5	1.9	2.9	1.9	4.6	2.3	0.3	1.0	0.4	0.4	0.3	0.3	0.4	0.3	0.7	0.3
ACSM6	"bA310E22.3, C10orf129"	ENSG00000173124	"Acyl-CoA synthetase medium chain family member 6"	Q6P461	10	95194200-95228928	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.3;pancreas: 7.3;stomach 1: 6.2"	"Cell line enriched"	"Detected in single"	30	"RT4: 9.0"	"Cancer enriched"	"Detected in single"	7	"urothelial cancer: 1.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.0"	"Low lineage specificity"	"Detected in single"											HPA044593	Uncertain									"HPA044593: AB_10960261"	"unprognostic (2.91e-2)"				"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.48e-2)"		"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.75e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.71e-4)"	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.8	0.4	0.0	6.2	0.3	0.0	16.3	0.8	0.0	0.0	2.5	1.9	0.1	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADM2	"AM2, FLJ21135"	ENSG00000128165	"Adrenomedullin 2"	Q7Z4H4	22	50481556-50486440	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 30.2;salivary gland: 32.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 21.7;hTCEpi: 13.6;Karpas-707: 21.6;SK-MEL-30: 14.2;U-266/70: 15.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (1.30e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.26e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.41e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (1.06e-2)"	0.5	0.5	0.4	2.9	0.4	0.1	0.7	0.4	0.4	0.8	1.2	0.0	1.3	3.7	0.5	2.9	2.2	0.6	5.6	0.4	0.4	0.4	11.4	6.6	0.8	4.1	0.4	0.0	0.4	30.2	0.0	0.6	0.7	0.2	2.6	0.4	0.1	32.2	2.2	0.4	0.5	5.2	0.0	0.5	2.0	4.3	0.6	0.0	1.6	11.7	1.7	4.0	0.5	0.6	0.9	0.5	2.0	0.5	0.4	1.4	0.2	1.0	0.2	0.3	1.1	0.7	1.2	4.0	5.1	0.4	0.7	1.7	2.1	0.8	0.0	0.7	4.3	0.8	1.1	0.6	0.2	9.7	0.0	0.0	0.2	1.5	21.7	2.0	1.4	4.3	13.6	2.3	4.9	0.0	1.3	21.6	0.1	3.1	0.2	0.4	0.7	3.2	0.0	0.0	8.1	0.9	0.1	0.5	2.3	0.0	3.1	14.2	4.3	6.7	0.0	0.0	4.8	0.0	0.0	15.8	2.2	2.8	0.4	0.0	1.2	0.7	0.5	0.4	0.6	0.2	0.3	0.6	0.5	0.6	0.0	0.9	1.4	1.1	2.0	0.4	0.5	0.5	0.3	0.2	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.2	0.0
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135666-131283535	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 39.4;pancreas: 37.5"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.0;RPTEC TERT1: 16.6;RT4: 18.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favourable (2.56e-4)"	5.7	39.4	16.1	6.2	11.2	6.3	4.7	16.6	15.4	6.0	12.9	4.9	4.1	19.9	4.5	4.1	3.0	4.9	6.8	4.4	12.0	9.9	5.6	15.7	6.2	11.6	8.1	11.7	7.2	37.5	3.1	3.5	2.8	7.2	10.0	13.3	2.9	3.4	4.8	9.8	2.3	12.4	5.2	6.2	6.2	3.7	5.8	6.4	18.9	4.2	2.1	5.5	8.6	4.3	4.4	1.8	9.5	3.4	3.2	14.9	5.0	0.8	1.5	5.5	2.6	3.1	6.6	3.8	2.3	3.7	3.9	5.2	1.8	1.5	0.1	4.3	3.9	0.0	1.5	2.4	2.9	0.0	2.3	5.4	1.8	8.2	4.4	0.2	1.8	5.6	1.7	2.5	3.3	4.0	0.9	7.9	3.7	1.4	2.4	1.4	19.0	2.1	4.9	3.6	0.1	16.6	18.4	0.0	1.9	3.1	0.3	7.4	1.2	11.5	1.3	1.8	2.5	5.2	5.6	7.4	0.0	1.3	4.4	5.5	4.1	9.5	1.5	0.2	6.8	2.9	10.5	2.6	9.4	9.1	1.8	4.4	14.9	9.3	0.4	3.2	3.4	0.1	3.2	5.0	16.1	11.2	16.6	15.4	12.0	9.9	8.1	11.7	7.2	6.4
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282558-19289250	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 19.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"									HPA064638			Approved	Cytosol		1000000	1000000	Cytosol	Cytosol	"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favourable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	0.7	0.4	0.7	0.7	0.7	0.0	0.7	0.7	0.9	0.7	5.1	0.7	0.7	48.5	0.7	1.3	0.7	0.0	6.9	0.7	0.7	0.2	13.4	27.4	0.7	0.7	0.7	0.7	1.0	59.0	0.0	0.7	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.7	0.2	27.0	0.7	0.7	0.7	35.5	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.3	1.9	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.4	0.4	0.2	1.9	0.1	0.1	0.2	0.1	0.5	1.5	0.2	0.4	0.3	0.7	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.9	0.2	0.1	0.3	0.3	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.6	0.4	1.5	0.3	0.7	0.7	0.1	1.5	0.0	0.3	0.9	1.4	0.3	19.3	0.4	3.5	0.4	0.3	0.3	0.2	1.0	0.3	1.4	0.3	0.3	0.5	0.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.2	0.7	0.7	0.7	0.7
AMY1C	AMY1	ENSG00000187733	"Amylase, alpha 1C (salivary)"	P04745	1	103750406-103758690	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 34.3;salivary gland: 62.5"	"Cell line enriched"	"Detected in single"	4	"THP-1: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	68000000	68000000			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"																		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0			0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0		0.0	34.3	0.0	0.0	0.0		0.0	0.0		62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5			9.6		4.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374373	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.5;liver: 68.4;pancreas: 51.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;HBEC3-KT: 64.0;LHCN-M2: 17.3;TIME: 32.2;U-138 MG: 19.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 5.8;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	1500000	1500000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB033770: AB_2057427, HPA007879: "	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	55.5	9.6	23.3	13.5	24.7	2.3	33.0	5.1	37.6	3.3	11.8	9.2	0.3	10.6	5.9	1.5	11.8	3.2	8.8	11.4	17.1	5.5	9.4	68.4	9.0	2.7	21.4	3.1	2.9	51.7	2.3	3.3	21.4	36.8	6.7	2.1	2.5	3.9	3.7	5.9	6.5	23.5	6.0	20.6	2.5	4.4	3.7	27.7	0.0	7.1	2.5	3.5	10.7	6.0	0.5	0.3	5.8	0.4	0.8	0.6	0.2	0.0	0.6	0.3	0.9	16.1	3.5	0.1	1.2	0.1	0.2	0.0	0.0	5.9	0.0	8.8	2.4	0.8	0.0	64.0	0.1	0.5	0.1	0.1	0.2	0.1	0.3	0.0	0.0	1.6	0.2	9.8	0.2	4.9	0.3	0.2	17.3	0.5	0.0	0.5	0.1	0.5	0.3	0.0	0.2	3.2	1.1	0.0	0.1	7.4	0.7	1.1	1.9	0.1	32.2	19.0	0.1	9.5	0.0	0.0	0.0	0.0	13.0	0.0	3.5	5.8	0.4	0.9	0.4	0.2	0.3	0.5	0.5	0.4	0.2	0.4	0.3	0.3	2.3	0.8	0.2	0.3	0.6	0.2	23.3	24.7	5.1	37.6	17.1	5.5	21.4	3.1	36.8	27.7
ANKEF1	"ANKRD5, dJ839B4.6, FLJ21669"	ENSG00000132623	"Ankyrin repeat and EF-hand domain containing 1"	Q9NU02	20	9986126-10058303	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.0;testis: 22.7"	"Cell line enhanced"	"Detected in many"		"U-266/84: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA041151	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"				"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"HPA041151: AB_10796569"	"unprognostic (4.72e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.38e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.73e-2)"	"prognostic favourable (4.44e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (3.11e-1)"	5.6	2.9	1.4	2.3	2.4	0.5	3.7	5.7	2.0	2.7	3.1	0.8	11.3	2.9	1.9	4.2	4.7	4.9	4.0	3.2	2.3	2.5	5.7	6.7	2.3	1.3	1.5	1.1	3.6	25.0	5.3	13.6	1.7	4.1	3.4	3.0	3.0	4.2	13.0	1.7	2.9	3.6	1.0	1.2	1.8	5.1	22.7	1.0	3.2	8.6	2.5	3.9	2.1	2.6	2.5	1.6	0.7	0.1	1.5	5.4	1.3	10.1	10.3	1.4	2.5	2.1	1.2	5.9	1.9	0.1	1.8	0.9	6.0	9.2	0.0	3.2	0.4	8.8	1.8	12.1	2.2	0.0	1.6	1.3	2.0	5.5	1.4	1.1	0.2	3.7	8.6	1.6	1.7	1.5	3.8	9.0	0.4	3.2	1.6	0.0	4.3	2.4	0.0	0.0	6.9	4.4	6.5	7.8	3.9	4.7	10.3	0.0	9.0	0.9	1.1	1.3	1.5	0.1	2.0	9.3	17.9	1.6	2.6	0.3	1.7	0.0	0.0	0.0	2.8	0.1	5.4	2.5	3.3	2.6	0.2	2.3	4.1	3.0	0.7	1.5	0.0	1.6	3.8	1.3	1.4	2.4	5.7	2.0	2.3	2.5	1.5	1.1	4.1	1.0
ANKRD22	MGC22805	ENSG00000152766	"Ankyrin repeat domain 22"	Q5VYY1	10	88822132-88851818	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.2;stomach 1: 27.6;tongue: 29.0"	"Cell line enhanced"	"Detected in some"		"A-431: 8.8;CAPAN-2: 28.2;HaCaT: 6.9;HL-60: 8.3;RT4: 19.0;T-47d: 12.9;U-937: 7.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 15.4"	"Group enriched"	"Detected in many"	13	"granulocytes: 15.4;monocytes: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012922	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012922: AB_1844838"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-3)"	"unprognostic (9.73e-3)"	"prognostic favourable (8.73e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.21e-3)"	"prognostic unfavourable (6.15e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.01e-3)"	0.4	0.5	2.3	8.4	3.6	5.3	2.3	0.3	3.2	6.7	6.7	0.5	0.0	2.0	0.3	0.2	21.9	0.3	4.3	1.1	4.0	0.6	6.0	1.6	1.3	6.1	3.6	0.2	0.3	40.2	0.1	1.6	0.2	2.7	2.0	7.2	0.1	3.7	0.0	0.3	18.5	2.1	1.3	7.4	8.8	27.6	0.3	1.4	7.9	0.3	29.0	14.6	4.4	8.6	0.1	0.4	15.4	6.8	0.5	0.8	1.2	8.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.1	0.1	0.0	6.9	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	6.6	0.1	0.1	0.0	0.0	0.0	0.1	19.0	0.0	0.0	0.0	1.4	0.0	12.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.6	0.1	0.1	4.8	2.5	0.1	6.8	0.0	0.0	0.4	0.1	0.4	0.1	0.8	0.2	15.4	0.5	1.2	0.4	0.0	1.2	2.3	3.6	0.3	3.2	4.0	0.6	3.6	0.2	2.7	1.4
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.0;BJ: 76.7;BJ hTERT+: 109.7;HMC-1: 69.8;HSkMC: 67.4;HUVEC TERT2: 85.8;TIME: 85.8;U-2197: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		1500000000	1500000000	"Plasma membrane"	"Plasma membrane"	"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	4.9	0.0	0.0	60.1	77.0	0.5	76.7	109.7	9.4	8.3	0.5	0.0	0.0	0.9	65.8	0.0	0.5	0.0	3.7	0.0	0.0	14.5	0.4	11.4	35.4	1.0	69.8	67.4	0.1	29.7	0.0	85.8	0.4	0.1	3.6	0.0	0.0	34.1	0.2	5.2	0.0	0.0	0.8	42.9	0.0	0.1	0.7	0.0	0.1	0.0	0.0	6.7	85.8	41.4	0.0	93.5	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827100	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 212.1;pancreas: 160.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 67.4;Hep G2: 70.3;RPTEC TERT1: 98.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol		580000	580000	Cytosol	Cytosol	"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"prognostic unfavourable (8.55e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (2.38e-4)"	"unprognostic (7.23e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.97e-2)"	18.7	5.9	4.2	12.2	4.3	4.1	9.7	1.3	3.0	16.9	32.7	5.3	12.9	43.2	22.8	11.5	16.1	11.9	212.1	6.8	4.3	3.1	36.2	30.9	19.2	5.9	5.1	2.4	12.3	160.1	5.8	3.3	50.9	11.8	18.1	14.9	10.3	11.7	11.4	6.9	12.9	85.7	12.3	6.5	7.2	16.9	5.6	3.6	4.0	24.7	12.9	8.3	11.0	13.2	17.6	21.3	27.6	23.7	3.6	10.3	8.9	10.7	39.0	0.5	4.8	30.0	25.9	1.8	10.4	15.7	4.2	6.1	5.8	19.4	3.5	67.4	16.9	16.6	3.7	16.7	4.5	9.9	3.1	5.3	3.5	70.3	21.3	1.8	6.9	15.4	16.6	5.8	14.1	11.0	0.3	3.2	11.7	9.7	2.7	3.4	0.9	5.4	2.9	1.0	4.3	98.6	15.6	0.8	3.6	11.5	16.0	15.7	5.3	24.3	15.9	7.9	3.8	10.5	5.8	1.3	1.4	0.1	12.3	9.2	5.3	27.6	14.8	11.9	10.3	17.4	7.8	17.6	5.3	7.7	21.3	15.9	0.9	5.8	2.0	3.6	23.7	6.4	5.9	8.9	4.2	4.3	1.3	3.0	4.3	3.1	5.1	2.4	11.8	3.6
AP000350.4		ENSG00000251357			22	23862188-23895223	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 5.1;pancreas: 4.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 6.0;SK-MEL-30: 4.9;THP-1: 5.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA042960	Uncertain									"HPA042960: AB_2678241"																		0.2	1.9	0.2	0.8	0.3	0.0	0.1	1.8	0.4	0.9	0.1			0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.7	1.6	0.2	0.3	0.4	0.2		0.6	4.2	0.0	0.6	0.1		0.3	0.0		1.9	0.5	0.5	0.6	1.2	0.0	0.7	0.1	0.9	0.2			0.1		0.0	0.2	0.2	4.0	5.1	1.1	0.5	0.7	2.2	0.7	2.7	0.0	0.6	0.3	1.0	0.0	0.3	0.5	0.1	0.3	0.0	0.0	1.2	0.2	2.0	0.0	1.7	0.0	0.5	0.9	2.0	1.8	0.0	0.1	0.3	0.0	0.0	0.6	0.0	1.8	0.0	0.0	0.0	0.0	6.0	0.0	0.0	2.1	1.0	1.3	0.0	1.5	0.1	3.0	0.0	0.0	3.9	3.4	0.0	1.8	4.9	0.6	5.5	0.0	0.0	1.8	1.8	0.0	3.8	0.5	1.3	1.0	1.3	0.5	0.4	0.1	1.1	0.9	0.5	1.7	1.8	2.2	1.0	0.0	4.0	1.5	1.3	0.0	0.7	0.3	5.1	1.3	0.7										
AP000646.1		ENSG00000285509			11	121024125-121113108	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"pancreas: 2.0;parathyroid gland: 2.5"	"Cell line enhanced"	"Detected in some"		"HEL: 4.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038593, HPA038594"	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA038593: AB_10669647, HPA038594: AB_2676103"																		0.0	0.0		0.2		0.0	0.0		0.8	0.6	0.1			0.0	0.5	0.0	0.2	0.0	0.5	0.6			0.8	0.2	0.5	0.0			0.8	2.0	2.5		0.4		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	1.7			0.0		0.0	0.5		0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.3	0.7	1.7	0.4	0.3	0.4	0.2	1.9	2.4	2.3	0.3	1.1	1.2	0.6	0.7	0.8	0.0	0.8	0.5	2.5	0.1	0.4	4.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	1.1	0.0	0.6	1.6	0.0	0.0	0.2	0.1	0.3	1.4	0.2	2.5	0.7	0.2	0.7	2.2	3.0	0.8	0.1	0.0	1.4	0.2	0.0	2.0	0.2	0.5	0.9	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3										
AP002748.4		ENSG00000256349			11	66509079-66533613	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"pancreas: 3.4"	"Group enriched"	"Detected in some"	6	"NTERA-2: 15.9;THP-1: 4.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA058283	Uncertain		Uncertain	Midbody				Midbody	Midbody	"HPA058283: AB_2683667"																		0.2	0.9	0.0	0.0	0.6	0.0	0.3	0.7	0.2	0.5	0.3			0.0	1.0	0.0	0.1	0.3	0.5	0.0	0.7	0.3	0.7	1.0	0.3	1.4	0.2		0.3	3.4	0.0	0.2	0.1		0.3	0.1		0.4	0.2	0.9	0.0	0.3	0.7	0.3	0.5	0.4	0.0			0.5		0.4	0.7	0.1	0.0	0.7	0.0	1.2	0.6	0.8	1.0	0.9	0.0	0.6	0.0	0.0	0.0	0.5	0.5	0.4	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.7	0.0	0.3	1.2	0.0	0.0	0.3	1.6	0.0	0.1	0.8	0.0	0.6	0.2	0.5	15.9	0.0	0.8	0.0	0.0	0.3	0.8	0.3	0.0	0.3	0.4	0.6	1.3	4.0	0.0	0.6	0.1	0.0	0.1	0.0	0.2	0.7	0.0	0.2	0.4	0.0	0.2	0.0	0.2	1.2	0.7	0.0	0.3	0.5	0.7	0.0	0.3	0.0	0.0	0.6	0.3	0.5	0.8	1.0										
ASCL5	bHLHa47	ENSG00000232237	"Achaete-scute family bHLH transcription factor 5"	Q7RTU5	1	201113953-201127184	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 5.2;pancreas: 7.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.2;MCF7: 1.8;PC-3: 2.8;SCLC-21H: 3.2;U-2 OS: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 2.1;hippocampal formation: 1.8"																"unprognostic (9.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.84e-2)"	"unprognostic (9.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.25e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-2)"	0.2	0.4	2.5	0.3	5.2	0.1	0.2	0.4	1.8	0.2	0.2	1.3	0.2	0.3	1.6	0.2	0.2	0.3	0.2	0.2	1.2	1.8	0.2	0.2	0.6	0.5	0.6	0.2	0.9	7.3	0.1	0.5	0.2	1.9	0.5	0.1	0.2	0.2	0.2	1.4	0.1	0.5	0.2	0.2	0.5	0.5	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.9	0.6	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.2	0.3	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.0	1.1	0.0	1.1	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.2	3.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	5.2	0.4	1.8	1.2	1.8	0.6	0.2	1.9	0.2
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97852118-97872542	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;T-cells: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (8.79e-5)"	"prognostic unfavourable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	6.5	7.5	15.9	10.9	21.4	7.6	9.9	31.7	32.3	5.7	10.1	9.4	5.6	6.5	10.0	19.9	10.2	6.9	6.8	9.2	24.5	20.4	6.5	5.9	9.6	16.0	16.3	13.4	19.2	68.0	16.7	16.7	3.2	35.9	9.2	12.7	4.4	49.9	9.3	3.5	13.6	7.8	11.3	20.6	11.0	20.8	16.9	9.2	3.6	16.7	8.2	15.0	9.6	6.6	8.6	1.4	1.5	1.2	2.2	13.2	3.2	18.8	7.2	7.3	59.3	5.8	8.2	17.9	13.9	8.9	6.7	19.9	9.3	7.6	14.8	7.0	28.3	8.6	18.9	22.0	15.9	18.5	14.0	4.7	3.6	6.9	53.7	30.2	13.3	16.1	74.0	8.7	53.8	5.4	26.5	52.6	10.4	39.9	0.8	8.0	10.0	19.7	2.3	1.3	38.8	4.3	3.7	31.9	24.0	3.6	19.3	75.0	8.2	21.2	1.4	3.3	21.8	8.7	6.5	62.4	31.1	56.4	41.2	13.8	31.7	1.5	0.3	0.5	3.8	1.2	4.9	8.6	7.4	3.4	1.4	6.2	10.2	5.5	1.5	2.2	0.8	0.1	13.2	3.2	15.9	21.4	31.7	32.3	24.5	20.4	16.3	13.4	35.9	9.2
B3GALNT2	MGC39558	ENSG00000162885	"Beta-1,3-N-acetylgalactosaminyltransferase 2"	Q8NCR0	1	235449923-235504481	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 35.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012502, HPA050662"	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA012502: , HPA050662: AB_2681209"	"unprognostic (5.50e-2)"	"unprognostic (3.16e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.38e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (8.34e-3)"	5.0	6.3	3.9	4.3	5.1	1.3	8.4	4.7	4.5	5.4	7.6	3.5	5.1	3.3	8.0	8.7	10.3	6.1	9.7	7.9	2.8	2.9	3.7	4.6	3.7	3.1	3.0	3.2	5.9	35.7	9.8	8.9	4.5	4.7	8.3	5.8	8.5	8.7	7.3	21.6	6.1	6.9	16.9	2.5	3.3	9.2	5.8	3.9	4.7	7.1	7.0	5.0	9.7	5.9	1.5	5.7	2.4	2.7	1.9	1.9	1.3	10.0	6.6	7.3	10.8	11.8	10.0	17.6	8.8	8.0	6.7	6.2	5.1	9.0	5.3	11.7	10.0	12.7	14.2	10.3	8.2	10.4	9.8	3.3	8.4	5.8	7.5	10.8	3.7	7.2	6.7	6.9	16.6	10.2	8.1	7.1	6.2	4.8	6.8	3.9	10.4	3.8	7.5	12.2	13.4	4.3	12.0	9.4	12.0	15.3	5.8	7.6	11.1	11.0	10.0	5.9	9.7	9.9	11.8	10.4	8.5	3.2	3.8	7.8	13.6	2.4	2.3	1.1	1.1	2.7	1.7	1.5	0.8	1.9	5.7	1.1	1.0	1.3	0.2	1.9	2.5	3.1	0.5	1.3	3.9	5.1	4.7	4.5	2.8	2.9	3.0	3.2	4.7	3.9
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810022-24949459	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 52.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.1;NTERA-2: 58.7;RH-30: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 14.7"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.4;monocytes: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					85000	85000			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavourable (1.38e-4)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavourable (8.54e-4)"	12.5	6.1	5.2	6.9	5.7	2.6	6.3	1.3	7.8	4.3	3.0	2.6	0.0	1.4	8.6	3.9	2.9	7.8	4.7	2.4	4.7	7.9	1.8	1.8	13.8	7.4	11.3	2.9	8.3	52.7	1.1	19.1	14.0	18.5	2.0	3.1	12.3	4.4	1.4	1.3	1.2	3.8	5.9	6.3	2.4	2.4	7.3	2.0	7.1	1.7	0.7	5.3	4.3	6.3	1.1	5.4	1.0	14.7	0.0	0.2	0.8	5.9	2.4	22.1	0.0	6.4	12.5	11.4	12.2	8.2	6.9	11.6	13.4	16.9	22.2	0.0	20.3	2.4	15.8	0.1	18.6	51.1	3.1	18.0	0.4	7.2	23.2	20.4	6.6	16.2	0.4	17.6	3.7	23.3	17.3	0.2	5.8	0.1	12.8	5.7	58.7	1.6	0.0	64.1	0.2	0.0	2.1	0.0	12.1	0.0	0.0	0.1	0.0	8.8	30.6	4.1	15.5	16.5	11.4	2.7	2.6	30.9	14.5	12.3	0.0	0.0	2.1	0.0	0.0	3.4	0.1	1.1	0.0	0.1	5.4	0.0	0.0	0.0	1.0	0.0	14.7	3.3	0.2	0.8	5.2	5.7	1.3	7.4	4.7	7.9	11.3	2.9	18.5	2.0
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115269	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 12.6"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"testis cancer: 12.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	1.8	1.9	1.4	1.8	2.5	1.8	5.6	4.0	2.2	1.6	3.6	1.3	0.8	3.0	2.4	4.2	2.5	2.3	3.6	3.8	1.1	1.3	3.1	4.4	2.0	1.5	1.8	0.8	1.9	12.6	1.8	2.3	1.5	3.3	2.6	3.9	1.3	3.4	1.0	5.0	1.4	4.1	2.5	1.8	2.8	5.0	4.6	1.5	2.4	1.9	3.9	3.6	2.2	1.2	1.5	1.3	2.0	1.0	0.8	1.7	0.4	2.8	4.0	11.2	6.3	1.3	1.0	9.2	1.1	1.4	1.5	1.7	4.6	2.1	8.3	2.8	2.9	2.8	12.0	6.2	2.5	3.3	6.0	2.2	2.9	5.0	1.1	5.9	3.0	2.4	2.6	2.2	3.1	1.8	6.2	3.5	1.9	5.6	5.0	4.5	15.6	2.6	6.9	3.3	5.5	2.4	8.3	11.4	5.6	3.5	6.0	2.2	3.6	4.8	2.2	4.1	3.8	1.8	5.3	2.4	3.2	8.5	1.4	4.6	3.1	2.0	0.8	1.5	1.2	1.0	0.9	1.5	1.1	1.1	0.5	1.1	0.8	1.7	1.6	0.8	1.0	1.3	1.2	0.4	1.4	2.5	4.0	1.8	1.1	1.3	1.8	0.8	3.3	1.5
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036926	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.1;pancreas: 54.1"	"Cell line enhanced"	"Detected in some"		"A-431: 6.3;BEWO: 11.3;CAPAN-2: 10.4;HaCaT: 16.2;MCF7: 15.7;RT4: 7.4;SK-BR-3: 8.1;T-47d: 10.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.6;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"				"Intermediate filaments, Actin filaments, Cytosol"	"Intermediate filaments, Actin filaments, Cytosol"	"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favourable (9.04e-4)"	0.4	0.0	0.4	2.5	0.4	0.0	2.9	0.4	0.4	6.2	7.9	0.4	8.3	5.7	1.0	2.0	31.1	2.2	11.0	0.4	0.4	0.0	1.2	0.4	5.3	0.4	0.4	0.4	0.9	54.1	3.6	0.9	0.5	0.4	5.1	3.5	0.4	13.9	8.3	1.1	13.7	6.9	1.0	0.4	0.4	10.2	0.5	0.4	0.4	2.3	8.6	12.4	6.1	12.0	0.1	0.1	3.5	0.0	0.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.8	10.4	0.0	0.0	0.0	16.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	7.4	0.1	0.0	0.0	8.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
BNIP3	Nip3	ENSG00000176171	"BCL2 interacting protein 3"	Q12983	10	131966455-131982013	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.7"	"Cell line enhanced"	"Detected in many"		"A-431: 73.3;HBF TERT88: 51.0;U-87 MG: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003015, CAB011676"	Supported		Uncertain	Cytosol				Cytosol	Cytosol	"CAB011676: , HPA003015: AB_1078290"	"unprognostic (1.01e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-3)"	"unprognostic (6.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (4.55e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.98e-1)"	19.3	12.0	18.3	4.0	18.6	3.0	8.7	13.5	28.3	7.7	4.6	13.0	5.1	4.0	6.0	11.4	8.1	6.0	7.9	43.3	16.9	14.6	27.6	53.4	6.7	4.6	16.5	14.2	19.3	122.7	6.0	7.3	13.0	22.6	18.2	2.9	5.2	19.2	6.6	48.0	9.0	4.5	6.0	13.3	4.9	6.4	6.0	11.1	3.3	10.8	6.2	4.0	9.2	7.3	6.1	3.0	5.1	3.5	2.2	23.4	8.9	73.3	5.9	4.2	11.9	11.4	12.1	21.9	17.9	16.6	13.5	38.7	1.2	1.6	0.1	29.1	10.3	4.5	9.0	25.4	51.0	3.9	6.8	2.6	3.8	17.0	15.3	3.3	2.1	8.4	6.4	13.1	13.3	9.4	6.7	0.2	22.0	5.8	1.7	18.7	3.6	17.8	4.1	2.1	6.2	14.8	1.2	5.6	13.2	3.6	7.6	10.1	4.6	4.7	10.7	19.2	6.4	7.2	14.1	12.6	10.7	10.2	69.4	0.1	3.2	2.2	3.5	5.1	9.8	2.3	10.4	5.7	13.9	10.3	3.0	6.1	23.4	15.4	0.9	2.2	3.1	2.3	13.2	8.9	18.3	18.6	13.5	28.3	16.9	14.6	16.5	14.2	22.6	11.1
BX255925.3		ENSG00000284976			9	137217452-137219361	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"esophagus: 30.6;pancreas: 25.2"	"Low cell line specificity"	"Detected in all"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"																																			0.6	3.0	0.4	1.6	0.3	5.0	1.2	0.3	0.8	3.8	7.1	0.3	0.8	5.3	0.6	3.5	30.6	1.1	12.4	2.1	0.3		1.7	1.2	1.5	2.3	0.3	0.3	0.5	25.2	0.7	0.3	1.5	0.3	3.1	0.5	0.3	14.6	1.4	1.1	6.2	8.9	0.9	0.3	1.9	7.0	15.0	0.3	0.3	0.5	15.0	15.1	1.0	0.3	1.8	4.9	3.7	2.3	2.0	2.9	5.6	5.5	9.0	5.3	6.9	2.5	2.4	20.9	6.4	3.5	6.7	4.8	8.3	6.3	8.0	4.6	2.3	19.9	3.3	4.7	1.4	8.8	9.4	4.7	21.3	7.4	4.2	6.8	15.7	3.2	4.4	7.7	2.0	3.1	11.4	6.8	2.3	15.3	6.0	19.8	9.2	31.3	15.3	7.2	9.3	2.8	5.4	6.9	7.9	5.7	7.0	4.9	18.1	10.8	3.7	10.4	11.9	16.7	7.9	5.4	9.2	6.9	5.9	7.9	7.8	0.0	1.9	3.7	1.8	2.3	2.9	1.5	1.4	1.1	1.2	1.8	0.8	0.8	3.3	2.0	1.2	4.9	1.4	5.6										
C10orf142		ENSG00000277288	"Chromosome 10 open reading frame 142"	B7Z368	10	44292569-44294649	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 3.8;pancreas: 2.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;RPMI-8226: 4.2;U-2 OS: 1.5;U-2197: 10.5;U-87 MG: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (3.32e-3)"				"unprognostic (2.46e-2)"		"unprognostic (2.75e-1)"	"unprognostic (7.31e-2)"		"unprognostic (4.17e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-3)"		1.5	0.0		0.1		0.0	0.0		0.5	0.0	0.0			0.3	1.1	0.0	0.3	0.0	1.0	3.8			0.0	0.8	0.1	1.8			0.0	2.6	0.0		0.0		0.0	0.0		1.1	0.1	1.3	0.7	0.1	0.0		2.0	0.0	2.3			0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	1.5	10.5	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
C1orf127	FLJ37118	ENSG00000175262	"Chromosome 1 open reading frame 127"		1	10946471-10982037	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pancreas: 5.1;skeletal muscle: 17.3"	"Cell line enriched"	"Detected in some"	4	"THP-1: 7.4"	"Cancer enriched"	"Detected in single"	9	"pancreatic cancer: 2.8"					"Group enriched"	"Detected in some"	4	"classical monocyte: 1.7;myeloid DC: 4.2"	"Group enriched"	"Detected in many"	30	"dendritic cells: 4.2;monocytes: 1.7"									HPA027654	Uncertain									"HPA027654: AB_10611814"	"unprognostic (1.82e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.03e-1)"	0.1	0.6	0.0	0.0	0.4	0.0	0.0	3.3	0.0	0.0	0.2			0.6	0.0	0.0	0.5	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.3	0.5	0.8		0.0	5.1	0.0	0.2	0.1		0.0	0.5		0.2	0.0	17.3	0.0	0.2	0.0	0.1	0.5	2.5	0.6			0.1		0.0	0.0	0.0	0.0	4.2	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.4	0.5	0.0	7.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2										
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 41.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.6;U-698: 20.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.7"	"Low lineage specificity"	"Detected in single"											"HPA008119, HPA011968"	Uncertain									"HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.1	1.0	0.3	5.3	0.7	0.4	1.9	0.3	0.4	1.0	9.1	0.0	6.9	2.8	1.7	1.5	2.7	1.0	12.4	3.0	0.4	0.4	7.1	0.5	6.3	0.8	0.3	0.0	0.6	41.2	0.0	8.7	6.1	0.5	5.4	9.0	0.6	3.9	9.6	1.5	22.3	12.7	4.2	0.3	0.8	10.6	1.0	0.0	20.8	10.7	4.3	3.6	6.1	6.1	0.8	0.8	0.0	0.0	0.0	2.7	1.0	8.5	1.4	2.4	0.0	0.3	0.0	3.1	6.7	2.9	3.9	4.5	14.6	4.6	0.2	1.2	2.0	6.1	2.7	1.7	7.5	0.0	2.3	5.9	2.0	0.7	1.8	0.0	0.0	0.5	3.5	3.5	6.0	0.9	1.5	1.5	2.9	0.6	0.2	0.0	5.1	1.8	0.2	7.8	0.0	7.0	7.6	0.3	0.6	2.6	2.6	2.5	4.0	0.0	2.2	1.4	2.3	0.0	0.0	5.4	0.0	20.4	1.2	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.4	0.8	2.7	1.3	0.5	0.3	1.5	0.6	0.0	0.0	0.0	0.8	0.0	1.0	0.3	0.7	0.3	0.4	0.4	0.4	0.3	0.0	0.5	0.0
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453941-37623495	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 37.7;placenta: 38.3"	"Group enriched"	"Detected in some"	5	"RT4: 32.8;SK-BR-3: 13.1;T-47d: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 11.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA043458: AB_10960696, HPA052894: AB_2681982"	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favourable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	2.0	0.5	2.6	1.5	2.7	1.6	2.2	2.8	5.4	6.5	14.6	2.5	2.3	10.3	4.2	1.9	2.1	1.7	7.4	0.7	4.4	1.7	11.9	26.2	2.8	0.0	3.1	2.5	0.6	37.7	5.8	6.1	38.3	6.2	1.9	14.0	1.9	22.2	9.8	0.6	1.7	11.0	2.3	3.8	0.6	12.4	1.5	2.2	0.0	1.3	1.0	3.3	5.9	2.9	0.9	2.2	11.4	2.1	1.2	1.2	0.3	0.0	0.0	1.3	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	5.3	2.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.2	0.7	0.0	3.2	0.0	5.2	32.8	0.4	0.1	0.2	13.1	0.4	47.0	0.2	0.2	0.1	1.9	0.0	0.6	0.1	0.0	0.2	0.0	2.7	2.3	0.9	2.1	2.5	0.8	0.3	0.5	0.3	0.5	0.5	0.3	0.9	0.8	1.2	11.4	1.2	0.2	2.2	0.9	0.3	2.6	2.7	2.8	5.4	4.4	1.7	3.1	2.5	6.2	2.2
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720084-29731839	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 30.3;pancreas: 9.6"	"Group enriched"	"Detected in some"	12	"HEL: 12.5;SCLC-21H: 12.3;SH-SY5Y: 3.9;U-2 OS: 4.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.9"	"Region enhanced"	"Detected in all"		"hippocampal formation: 30.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 83.4;hippocampal formation: 224.8;midbrain: 72.1;pons and medulla: 115.1"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 65.6"	HPA016439	Uncertain									"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.4	6.0	2.7	0.5	2.6	0.8	0.3	7.2	6.5	0.3	0.5	1.2	0.0	1.5	0.3	1.8	0.7	0.4	0.5	0.3	30.3	2.0	0.3	0.3	0.4	0.5	3.9	1.2	0.4	9.6	0.3	0.1	0.3	16.9	0.4	0.5	2.4	0.8	0.4	0.6	1.0	3.8	0.4	4.1	0.5	0.4	1.2	2.8	0.0	0.7	0.0	0.3	0.4	0.0	0.6	0.6	1.8	1.6	0.5	1.4	0.6	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	12.5	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.3	0.0	0.0	12.3	3.9	0.1	0.2	0.1	0.5	0.0	0.1	0.2	4.1	0.1	0.2	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.8	1.8	0.8	1.3	0.5	0.6	1.1	0.5	0.6	0.4	1.0	1.4	1.3	0.5	1.6	0.6	0.5	0.6	2.7	2.6	7.2	3.0	30.3	2.0	3.9	1.2	16.9	2.8
CALHM3	"bA225H22.7, FAM26A"	ENSG00000183128	"Calcium homeostasis modulator 3"	Q86XJ0	10	103472804-103479240	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8;pancreas: 2.8;testis: 2.0"	"Cell line enriched"	"Detected in some"	5	"U-266/84: 17.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.5"					"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.8;myeloid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018205	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018205: AB_2069267"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.25e-2)"		"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.44e-1)"		"unprognostic (4.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.53e-1)"	0.2	0.1	0.5	0.0	0.6	0.0	0.0	0.2	0.7	0.3	0.1			0.8	0.3	0.9	0.0	0.3	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0		0.4	2.8	0.0	0.2	0.7		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	2.0			0.0		0.0	0.2	0.4	0.0	1.5	0.0	1.8	0.0	0.7	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.3	3.2	0.4	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	17.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4										
CAPN13	FLJ23523	ENSG00000162949	"Calpain 13"	Q6MZZ7	2	30722771-30820542	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 67.3;pancreas: 20.4;stomach 1: 17.6"	"Group enriched"	"Detected in some"	5	"RT4: 8.8;SK-BR-3: 21.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029496, HPA029497, HPA030034"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281"	"unprognostic (7.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.28e-3)"	0.2	0.0	0.5	0.5	0.4	0.0	4.8	0.2	0.2	6.2	39.6	0.3	0.2	13.0	1.1	0.6	1.1	0.5	7.4	0.2	0.8	0.4	2.0	0.2	9.4	0.2	0.7	0.3	0.4	20.4	0.6	1.2	0.2	0.2	5.2	16.0	0.2	1.0	0.2	0.2	0.1	67.3	1.6	1.0	0.2	17.6	0.2	0.2	0.2	0.2	0.5	1.0	3.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	8.8	0.1	0.4	0.0	21.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.2	0.8	0.4	0.7	0.3	0.2	0.2
CATSPERB	"C14orf161, FLJ14298"	ENSG00000133962	"Cation channel sperm associated auxiliary subunit beta"	Q9H7T0	14	91580696-91780707	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;U-937: 3.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA035134	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA035134: AB_10671510"	"unprognostic (2.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.72e-5)"	"unprognostic (1.81e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.85e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.71e-3)"	0.6	0.1	0.0	0.6	0.0	0.0	1.4	0.0	0.2	0.4	0.9			0.3	0.4	0.4	0.6	0.7	1.2	0.6	0.0	0.0	0.3	0.2	0.9	1.1	0.0		0.2	15.1	1.0	0.3	0.0		0.9	0.7		3.7	0.0	1.7	4.2	1.2	0.1	0.0	0.8	2.0	2.0			0.9		0.6	0.5	0.3	0.4	0.2	1.1	0.2	0.7	1.6	0.4	0.6	0.0	0.7	1.7	0.0	0.0	1.9	0.3	0.3	0.0	0.0	2.4	3.9	1.2	0.9	0.0	0.7	0.0	0.5	0.7	1.4	2.1	0.4	1.3	2.3	0.0	1.7	0.8	0.6	0.7	0.4	0.5	0.0	0.5	0.2	0.5	2.3	0.6	0.7	0.2	0.5	0.3	0.0	0.0	0.4	0.9	1.7	0.1	0.0	0.8	1.6	0.4	2.2	0.9	0.2	0.2	0.0	0.3	0.9	0.9	0.3	0.2	3.8	1.0	1.1	0.2	0.6	1.1	0.0	1.5	0.4	1.6	1.0	0.0	0.2	1.1	1.4	0.4	0.7	0.2	0.2	0.0	0.4										
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.2;HAP1: 38.3;HHSteC: 51.8;MCF7: 44.3;RPMI-8226: 42.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"									HPA001223	Supported		Approved	Nucleoli,Vesicles				Vesicles	Vesicles	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.3	3.8	5.0	19.6	11.3	7.3	40.2	7.8	2.0	3.2	3.3	11.8	0.3	0.0	4.2	14.7	0.4	38.3	2.7	0.6	0.0	4.8	2.6	15.3	14.2	51.8	1.6	3.8	4.4	0.4	3.5	3.1	8.6	29.6	22.3	2.4	44.3	2.7	0.0	4.7	6.7	0.0	0.0	42.4	0.1	3.5	10.4	15.3	17.2	1.0	7.4	6.1	20.0	1.1	0.2	9.9	0.1	0.8	7.8	6.2	8.8	3.6	2.3	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3
CBSL		ENSG00000274276	"Cystathionine-beta-synthase like"	P0DN79	21	6444869-6468040	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;liver: 21.2;pancreas: 18.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.7;NTERA-2: 66.2;SH-SY5Y: 21.1;U-266/70: 20.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	47	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"									HPA001223	Supported		Approved	Nucleoli,Vesicles		190000	190000	Vesicles	Vesicles	"HPA001223: AB_1846112"	"unprognostic (2.39e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.61e-1)"	0.0	0.0		0.0		0.0	0.0		11.5	1.8	0.0			0.4	0.0	0.0	0.0	0.3	0.0	1.0			0.0	21.2	0.0	0.0			1.6	18.5	0.0		0.0		1.8	0.0		0.0	3.5	0.0	0.0	0.8	0.0		0.0	0.0	0.0			5.0		0.0	0.3		0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	11.9	35.7	0.0	0.0	0.4	7.4	4.3	2.7	8.3	0.1	4.8	0.0	0.0	0.0	3.1	0.0	3.8	1.7	0.0	9.4	0.0	0.0	0.0	0.2	0.0	5.1	4.2	13.9	0.0	7.0	0.0	0.2	16.5	0.1	0.0	5.6	0.6	66.2	0.0	0.0	0.0	0.0	10.8	0.0	13.8	21.1	0.0	1.1	14.4	0.0	0.0	0.0	0.7	0.0	4.6	1.4	20.9	7.7	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0										
CCDC110	"CT52, KM-HN-1, MGC33607"	ENSG00000168491	"Coiled-coil domain containing 110"	Q8TBZ0	4	185445182-185471759	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.9;testis: 49.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 10.7;U-266/70: 8.9;U-266/84: 10.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (1.18e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.84e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.95e-5)"	"unprognostic (4.92e-2)"	"unprognostic (5.81e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (1.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.21e-2)"	0.7	0.8	0.8	1.1	5.0	0.0	1.8	3.4	1.6	1.9	1.5	0.2	2.2	0.4	0.7	2.7	1.3	1.5	0.6	0.8	1.0	1.0	1.6	0.6	0.5	0.5	0.8	1.0	2.5	15.9	0.4	8.5	0.3	3.0	2.4	0.9	0.9	4.6	1.7	2.9	0.6	0.6	0.7	0.7	0.6	1.5	49.2	1.2	0.0	6.2	0.0	0.5	2.8	1.6	0.8	0.0	0.0	0.0	0.0	2.8	0.2	0.5	0.0	0.2	0.2	2.8	3.0	0.1	0.0	0.0	0.0	0.2	0.0	1.9	3.2	0.5	0.0	0.4	2.0	0.0	0.2	1.8	2.5	0.0	0.1	0.0	1.4	0.0	0.0	0.8	0.0	1.2	0.0	1.0	0.2	0.3	3.5	0.8	0.0	0.0	0.3	1.5	0.2	0.0	0.5	0.7	0.0	10.7	2.3	0.0	1.1	1.0	4.8	0.0	0.6	0.4	0.9	0.2	0.1	8.9	10.4	0.0	5.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	1.1	0.8	0.1	0.4	0.0	0.2	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.8	5.0	3.4	1.6	1.0	1.0	0.8	1.0	3.0	1.2
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469301-57493867	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 25.8;kidney: 75.8;pancreas: 21.8"	"Group enriched"	"Detected in some"	7	"A549: 9.1;RPTEC TERT1: 27.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA029202: "		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavourable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favourable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.6	0.1	0.6	0.1	0.0	1.6	0.7	0.4	25.8	0.1	15.3	17.7	0.1	0.1	0.2	75.8	17.7	0.1	0.0	0.1	0.0	6.1	21.8	0.0	0.1	0.1	1.5	0.1	0.0	0.0	0.1	0.8	0.1	0.4	0.1	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.1	2.7	1.9	4.5	0.9	3.4	5.0	3.6	0.0	9.1	0.0	0.3	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.9	0.9	0.4	2.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	0.1	0.2	0.1	0.0	0.2	27.1	0.4	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.5	0.1	0.1	0.3	0.4	0.3	1.4	0.3	0.2	3.1	0.9	0.6	2.1	0.4	2.6	2.1	4.2	3.0	0.2	2.7	3.5	5.0	4.5	3.4	0.6	1.9	5.0	3.6	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	1.5	0.0
CEACAM16	DFNA4B	ENSG00000213892	"Carcinoembryonic antigen related cell adhesion molecule 16"	Q2WEN9	19	44699151-44710714	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.9;pancreas: 7.0"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;RH-30: 1.5;T-47d: 2.7;U-266/70: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045075	Uncertain				"Secreted in other tissues"					"HPA045075: AB_10959617"	"unprognostic (1.27e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.59e-2)"		"unprognostic (7.81e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.05e-1)"		"unprognostic (1.06e-1)"	"unprognostic (1.86e-1)"		"unprognostic (7.94e-2)"	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0		0.0	7.0	0.0	1.1	0.0		0.0	0.0		0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2			0.0		1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.7	0.0	0.0	0.0	0.0	5.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
CFAP97D2		ENSG00000283361	"CFAP97 domain containing 2"		13	114154691-114223084	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 7.7;brain: 8.4;fallopian tube: 22.4;pancreas: 7.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;NTERA-2: 1.0"									"Cell type enriched"	"Detected in single"	12	"naive CD8 T-cell: 7.7"	"Lineage enriched"	"Detected in single"	78	"T-cells: 7.7"																																					0.0	0.0	0.5	0.0	7.0	0.8	0.0	0.0	1.4	0.3	0.0	8.4	0.0	0.0	0.0	2.1	0.0	22.4	0.0	0.0	1.9		0.0	0.0	2.6	0.3	0.0	2.0	3.6	7.8	0.0	0.1	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	2.4	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.7										
CHAC1	MGC4504	ENSG00000128965	"ChaC glutathione specific gamma-glutamylcyclotransferase 1"	Q9BUX1	15	40952962-40956519	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 53.0;salivary gland: 39.9;skeletal muscle: 52.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.7;HHSteC: 26.5;hTCEpi: 42.0;SK-MEL-30: 29.6;U-266/70: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 1.8;monocytes: 1.1;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042708, HPA043505"	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA042708: AB_2678125, HPA043505: AB_2678518"	"unprognostic (6.04e-3)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.00e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.23e-7)"	"unprognostic (1.37e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.91e-2)"	6.0	1.0	2.6	1.5	2.1	1.7	1.0	1.7	5.6	1.1	1.9	0.3	1.1	1.9	1.1	1.8	18.6	1.5	5.7	2.2	2.6	4.8	3.1	14.1	1.5	1.1	2.6	2.2	11.3	53.0	0.9	1.3	1.1	6.2	1.5	1.1	0.2	39.9	1.3	52.4	1.3	1.5	1.1	5.3	1.1	11.2	0.9	1.0	0.0	1.7	4.7	4.6	2.7	2.7	1.8	0.1	0.2	1.1	0.0	1.3	0.2	2.8	1.9	0.5	8.7	1.4	1.0	3.5	16.8	34.7	1.8	5.0	4.6	0.7	0.8	1.3	1.5	1.8	3.8	1.3	1.3	3.2	0.7	0.7	0.5	0.0	26.5	2.2	0.0	11.8	42.0	5.5	7.6	1.7	2.3	4.0	1.5	1.6	1.6	0.0	1.6	6.5	1.4	0.0	3.8	0.9	1.0	1.7	2.5	0.5	3.0	29.6	1.1	15.9	0.5	0.3	5.2	0.4	3.0	26.0	5.5	3.3	1.6	3.1	3.9	0.0	0.4	0.0	1.3	0.4	0.0	1.8	0.2	0.8	0.1	0.0	0.0	1.0	0.2	0.0	1.1	0.0	0.0	0.2	2.6	2.1	1.7	5.6	2.6	4.8	2.6	2.2	6.2	1.0
CHRNB3		ENSG00000147432	"Cholinergic receptor nicotinic beta 3 subunit"	Q05901	8	42697376-42737407	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 19.6;pancreas: 6.8;testis: 5.0"	"Group enriched"	"Detected in some"	6	"NTERA-2: 3.3;U-266/84: 7.1"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 19.6;midbrain: 8.2"	"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.5;T-reg: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	32	"cerebellum: 21.0;midbrain: 30.4"	HPA045555	Enhanced									"HPA045555: AB_10960891"					"unprognostic (8.63e-2)"						"unprognostic (4.12e-1)"			"unprognostic (7.29e-2)"	"unprognostic (1.62e-1)"			0.1	0.1	0.3	0.1	0.8	0.1	0.1	19.6	2.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.4	0.1	0.1	0.1	0.8	8.2	2.3	0.1	6.8	0.1	0.9	0.1	1.1	0.1	0.1	3.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	5.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.8	19.6	2.7	0.4	0.4	8.2	2.3	1.1	0.0
CLDN10	"CPETRL3, OSP-L"	ENSG00000134873	"Claudin 10"	P78369	13	95433604-95579759	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 50.5;lymphoid tissue: 49.4;pancreas: 97.3;salivary gland: 70.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HEL: 5.4;HUVEC TERT2: 8.2;NTERA-2: 16.2;RPTEC TERT1: 33.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.8"	"Low region specificity"	"Detected in all"							"CAB012969, HPA042348"	Enhanced									"CAB012969: AB_2533386, HPA042348: AB_2677955"	"unprognostic (6.45e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.93e-2)"	"prognostic favourable (7.46e-5)"	"unprognostic (1.11e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (2.13e-4)"	"unprognostic (4.75e-3)"	0.8	0.5	28.3	0.5	17.1	1.9	2.6	5.9	17.7	26.0	0.6	4.3	0.0	1.4	8.1	15.4	2.6	16.0	23.1	0.6	18.1	6.2	50.5	1.7	0.8	0.5	10.8	12.0	1.1	97.3	0.8	1.1	0.7	5.7	1.4	0.6	3.4	70.0	0.6	0.5	4.5	0.5	0.7	2.8	0.7	1.0	0.9	6.3	0.0	0.5	2.1	49.4	0.6	0.2	1.2	0.6	7.8	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	0.0	0.0	33.4	0.0	0.2	0.2	0.0	0.0	0.0	0.3	2.9	0.6	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.6	0.0	0.1	28.3	17.1	5.9	17.7	18.1	6.2	10.8	12.0	5.7	6.3
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012456-3014505	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.5;MCF7: 19.1;SCLC-21H: 15.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076613			Supported	"Vesicles,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA076613: AB_2686808"	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.4	0.4	0.5	2.1	5.2	0.3	16.5	1.4	0.6	1.0	0.3	0.3	1.8	0.3	0.9	0.3	2.3	1.1	0.4	0.8	0.8	0.6	2.6	1.5	0.3	1.4	0.3	0.3	9.6	4.8	15.9	10.2	0.5	0.3	0.1	0.3	1.7	0.3	1.5	0.4	1.2	0.3	2.2	1.0	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	5.5	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	19.1	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.2	0.1	15.0	0.1	0.7	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.1	16.5	1.4	0.8	0.8	1.4	0.3	0.5	0.3
CMTM8	CKLFSF8	ENSG00000170293	"CKLF like MARVEL transmembrane domain containing 8"	Q8IZV2	3	32238679-32370325	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8"	"Group enriched"	"Detected in many"	4	"BEWO: 66.8;SK-BR-3: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.2;memory CD4 T-cell: 2.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.2;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055077, HPA073258"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055077: AB_2682691, HPA073258: AB_2686591"	"unprognostic (9.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.56e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	9.7	9.9	4.3	4.1	3.5	0.9	27.0	1.5	3.4	4.7	6.8	1.3	10.8	5.2	3.4	13.4	4.2	6.3	5.7	8.2	3.6	3.2	8.8	40.0	19.9	12.6	3.9	3.3	2.1	79.8	2.8	3.1	12.4	2.5	8.8	5.5	4.4	13.5	19.2	4.3	6.2	8.1	2.0	3.1	1.5	10.0	1.1	1.6	5.5	20.7	6.0	11.2	4.7	5.6	0.1	0.0	4.2	0.1	0.4	2.8	0.3	3.2	3.4	0.6	4.2	3.1	4.8	66.8	0.0	0.1	0.3	0.4	4.6	4.7	0.0	7.0	0.0	1.8	5.4	1.0	0.2	0.0	9.8	2.1	0.6	7.7	0.1	0.8	1.7	9.4	3.4	0.4	3.3	2.6	0.0	0.0	3.4	2.3	2.7	0.3	1.4	3.1	3.8	0.8	0.6	4.1	3.7	1.1	0.9	0.5	18.9	1.7	5.4	0.4	2.3	0.0	5.0	0.0	1.0	0.1	0.1	0.0	0.0	1.4	1.1	0.0	0.1	4.2	0.3	0.0	0.4	0.0	2.8	0.8	0.0	0.1	1.8	0.3	0.0	0.4	0.0	0.0	0.0	0.3	4.3	3.5	1.5	3.4	3.6	3.2	3.9	3.3	2.5	1.6
COMTD1	FLJ23841	ENSG00000165644	"Catechol-O-methyltransferase domain containing 1"	Q86VU5	10	75233969-75236030	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 57.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 22.5;PC-3: 31.2;RPMI-8226: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042165	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA042165: AB_10794042"	"unprognostic (2.53e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.23e-2)"	"unprognostic (8.08e-3)"	"unprognostic (9.35e-2)"	"unprognostic (6.74e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.35e-1)"	2.5	5.2	1.3	5.8	1.4	2.9	5.7	3.6	2.2	4.8	14.1	0.5	9.7	17.9	2.0	5.9	20.0	1.6	6.4	8.0	1.2	1.6	12.6	14.9	4.4	4.1	1.9	1.7	2.2	57.2	3.2	5.3	7.8	2.2	3.1	2.1	3.2	21.2	9.1	19.6	7.3	22.9	1.9	1.0	3.4	16.1	1.5	0.6	2.7	7.0	14.4	6.0	2.4	7.5	6.6	15.7	3.8	9.3	7.3	12.5	7.1	4.8	0.9	0.2	0.9	0.1	0.4	14.6	1.4	0.4	0.1	0.3	1.2	4.3	13.7	2.8	0.3	6.9	0.4	1.2	0.0	2.1	22.5	0.5	1.3	2.3	0.7	2.6	2.3	0.3	1.9	0.0	1.1	0.0	5.5	2.7	0.0	3.2	3.8	8.1	0.7	31.2	7.1	0.7	17.5	1.0	0.2	5.3	1.3	1.5	11.3	3.0	6.6	0.3	1.2	0.3	4.3	0.4	1.6	15.0	3.1	6.6	0.3	2.3	0.3	0.0	8.9	3.8	12.1	9.3	12.5	6.6	11.7	12.2	10.1	4.7	3.8	6.7	1.8	7.3	8.9	15.7	9.0	7.1	1.3	1.4	3.6	1.7	1.2	1.6	1.9	1.7	2.2	0.6
CREB3L1	OASIS	ENSG00000157613	"CAMP responsive element binding protein 3 like 1"	Q96BA8	11	46277661-46321422	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 60.7"	"Cell line enhanced"	"Detected in many"		"BJ: 30.0;BJ hTERT+: 29.5;BJ hTERT+ SV40 Large T+: 27.6;fHDF/TERT166: 71.4;HHSteC: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA024069, CAB026151"	Enhanced									"CAB026151: , HPA024069: AB_1854750"	"unprognostic (2.46e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (3.92e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (2.97e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (8.59e-4)"	"unprognostic (1.12e-2)"	2.5	3.6	3.7	3.1	2.3	0.0	3.0	1.6	2.9	17.2	13.1	0.9	9.5	8.6	9.7	9.2	2.2	1.7	37.6	4.8	3.3	3.5	1.4	1.5	10.4	0.5	3.4	1.7	9.7	60.7	0.0	3.3	8.2	0.6	17.6	14.1	1.8	28.3	14.3	1.6	2.3	12.9	12.8	1.8	2.2	22.1	3.8	0.2	0.4	1.8	2.2	13.0	15.1	3.4	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.3	5.9	19.1	18.3	0.1	30.0	29.5	27.6	19.2	3.0	0.0	0.0	0.1	71.4	0.0	0.3	0.0	15.4	0.0	0.3	0.4	0.1	0.0	26.6	0.0	0.4	17.5	0.0	15.6	0.5	0.2	2.4	0.0	23.1	0.0	0.0	0.0	3.8	3.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.0	14.5	4.3	11.1	18.2	0.0	0.0	0.0	17.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.7	2.3	1.6	2.9	3.3	3.5	3.4	1.7	0.6	0.2
CRELD2	MGC11256	ENSG00000184164	"Cysteine rich with EGF like domains 2"	Q6UXH1	22	49918167-49927540	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 98.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000603, CAB025604"	Approved				"Secreted to blood"	270000	270000			"CAB025604: , HPA000603: AB_1078565"	"unprognostic (1.12e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.42e-7)"	"unprognostic (5.04e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (1.34e-9)"	"unprognostic (6.13e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.02e-1)"	10.2	10.1	8.1	14.1	11.5	8.6	17.2	7.2	7.9	11.1	12.5	7.7	18.0	15.0	10.8	26.1	8.5	10.0	13.2	11.3	7.5	9.6	10.5	39.3	15.7	24.3	9.5	6.6	9.5	98.1	4.8	23.1	8.1	10.9	10.8	9.5	6.9	24.9	17.6	7.3	5.4	10.9	10.0	8.1	13.8	17.6	12.8	7.5	7.4	31.1	7.8	10.5	11.6	7.1	15.8	29.4	13.0	8.2	18.8	13.7	6.8	12.8	9.0	10.4	34.7	11.3	12.9	14.4	26.5	16.4	15.2	12.9	15.3	15.9	6.9	21.5	23.0	12.9	13.1	13.4	6.6	3.7	20.5	3.8	13.5	19.1	46.8	14.9	15.0	11.7	12.1	13.0	11.0	15.3	5.5	29.3	11.3	40.7	5.8	15.8	7.5	18.4	13.8	18.6	16.5	7.2	11.7	7.0	19.8	22.8	27.2	10.6	11.2	18.3	11.2	13.2	21.7	12.0	8.3	23.5	5.5	6.0	19.3	11.2	20.5	13.0	6.8	8.9	10.4	8.2	10.6	15.8	8.9	13.7	7.6	11.5	7.3	6.1	3.5	18.8	4.6	29.4	5.9	6.8	8.1	11.5	7.2	7.9	7.5	9.6	9.5	6.6	10.9	7.5
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073790-132076170	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;lung: 6.8;pancreas: 4.5"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 44.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA057404: AB_2683428, HPA062006: AB_2684654"	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.2	0.1	0.1	3.9	0.1	1.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.7	0.0	1.5	0.1	1.1	0.2	0.1	0.1	0.3	0.9	6.8	0.3	0.1	0.0	0.1	4.5	0.0	0.1	0.5	0.0	0.2	0.7	0.0	1.9	0.0	0.1	0.4	1.0	0.6	0.1	1.0	0.2	0.2	0.0	0.4	0.2	0.0	1.8	2.3	0.1	0.0	0.0	0.0	0.0	9.5	0.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	2.5	0.0	3.5	0.0	0.7	0.0	0.1	0.0	3.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.2	6.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CSKMT	"CS-KMT, METTL12, U99HG"	ENSG00000214756	"Citrate synthase lysine methyltransferase"	A8MUP2	11	62665309-62668496	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 17.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038533	Approved									"HPA038533: AB_10697392"	"prognostic favourable (8.73e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.17e-1)"	"unprognostic (9.43e-5)"	"unprognostic (1.55e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.28e-1)"	2.3	2.5	3.4	3.1	4.1	1.2	3.8	7.1	4.1	3.8	3.1	0.9	2.8	3.9	3.2	1.9	3.5	4.3	2.2	2.2	3.3	2.2	2.6	2.4	3.0	6.1	5.9	2.7	4.4	17.3	1.9	1.9	3.8	6.0	2.9	3.5	1.1	3.0	4.2	5.2	2.2	2.0	1.5	3.7	2.3	2.5	4.7	2.3	2.9	2.1	8.9	4.7	3.2	5.9	5.2	2.5	1.3	3.3	0.8	6.1	2.9	1.7	1.9	0.6	0.7	5.6	2.2	0.9	0.7	1.4	1.6	2.0	1.4	1.9	3.5	0.8	2.5	3.4	3.2	1.7	2.9	1.0	0.0	1.0	0.0	2.0	0.0	0.0	1.3	1.9	5.7	0.4	2.2	0.5	1.5	0.0	2.0	1.6	0.9	1.3	3.3	1.7	1.6	0.9	0.5	0.8	0.3	0.0	0.1	1.7	2.1	1.8	4.0	0.4	0.0	0.4	1.9	4.9	0.1	0.3	0.0	0.0	0.5	0.8	0.9	1.3	2.2	0.3	1.8	3.3	3.6	5.2	5.0	2.2	2.1	3.2	6.1	5.1	0.0	0.8	2.3	2.5	2.5	2.9	3.4	4.1	7.1	4.1	3.3	2.2	5.9	2.7	6.0	2.3
CYB561	"CYB561A1, FRRS2"	ENSG00000008283	"Cytochrome b561"	P49447	17	63432304-63446378	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 86.9"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 89.0;SK-BR-3: 42.6;T-47d: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014753	Approved									"HPA014753: AB_1847364"	"prognostic unfavourable (8.89e-5)"	"unprognostic (2.90e-1)"	"unprognostic (4.01e-1)"	"prognostic favourable (2.95e-5)"	"unprognostic (1.81e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.89e-1)"	4.7	46.3	7.0	5.6	12.4	1.0	16.6	2.4	12.3	16.6	11.8	3.7	43.7	12.4	5.2	20.9	16.8	19.8	13.2	9.9	7.1	14.5	10.1	12.0	14.6	9.1	4.7	7.8	8.8	86.9	21.8	26.3	12.2	9.9	22.8	7.3	6.2	26.0	32.0	2.7	11.9	13.7	3.4	3.7	2.8	16.9	4.7	1.8	1.2	17.1	8.3	8.3	5.3	8.6	0.4	1.2	3.4	4.4	12.6	16.2	3.1	19.2	6.5	0.5	4.1	2.4	11.1	8.8	1.8	2.4	2.5	1.0	5.9	19.5	0.0	4.5	15.0	16.8	4.1	1.6	1.0	4.9	1.6	2.4	4.1	0.3	4.5	0.2	0.8	1.8	17.1	2.3	0.3	4.8	7.6	3.6	0.8	27.5	0.0	0.9	4.1	9.7	0.0	0.0	6.0	8.1	9.9	15.1	89.0	5.0	42.6	1.9	34.4	1.2	0.7	5.4	5.9	12.5	0.6	0.0	0.1	0.0	4.7	1.0	2.8	0.1	1.1	0.1	12.6	3.4	16.2	0.4	9.6	8.5	1.2	0.4	0.8	2.8	3.4	12.6	4.4	0.0	0.0	3.1	7.0	12.4	2.4	12.3	7.1	14.5	4.7	7.8	9.9	1.8
DAP		ENSG00000112977	"Death associated protein"	P51397	5	10679230-10761272	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA029456	Uncertain		Approved	Nucleoplasm,Vesicles,Mitochondria				"Vesicles, Mitochondria"	"Vesicles, Mitochondria"	"HPA029456: AB_10601262"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (4.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (2.04e-2)"	17.4	36.6	13.7	17.9	12.7	10.6	23.1	3.9	11.6	23.5	25.4	11.4	63.4	26.5	21.1	34.7	14.3	18.6	44.0	22.9	13.4	9.1	40.1	78.2	21.6	22.6	10.2	10.1	26.1	178.8	30.0	28.4	26.4	21.8	24.8	20.2	22.7	71.1	76.0	5.9	15.2	42.6	18.3	10.8	23.8	31.6	23.2	9.8	15.5	31.2	12.8	18.6	25.9	16.9	18.1	32.8	27.3	33.2	13.1	17.6	22.5	18.9	13.8	17.2	15.8	32.2	39.0	19.1	46.6	72.4	35.3	41.0	9.8	16.2	8.3	30.6	57.5	3.7	10.7	27.6	39.3	43.5	7.8	11.1	26.8	24.1	30.4	20.7	8.3	20.0	9.6	23.1	41.9	65.7	12.8	28.1	34.5	15.0	11.1	13.2	6.2	31.8	15.3	7.6	13.6	46.5	35.3	11.7	15.7	47.5	19.4	12.4	15.3	30.5	32.2	21.9	23.8	14.4	24.6	15.8	20.4	12.2	21.7	40.5	32.8	14.9	33.2	18.6	14.8	29.4	17.6	18.1	15.3	13.0	32.8	12.0	11.3	11.2	27.3	13.1	28.5	26.9	16.1	22.5	13.7	12.7	3.9	11.6	13.4	9.1	10.2	10.1	21.8	9.8
DDIT4	"Dig2, FLJ20500, REDD-1, REDD1, RTP801"	ENSG00000168209	"DNA damage inducible transcript 4"	Q9NX09	10	72273920-72276036	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 159.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 65.0;hTCEpi: 220.7;hTERT-HME1: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034507, HPA034508"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA034507: AB_2674199, HPA034508: AB_10601206"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (7.65e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.96e-3)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (9.72e-2)"	"prognostic unfavourable (2.54e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.66e-1)"	29.0	43.9	27.3	28.0	28.0	35.5	88.2	23.1	27.1	38.7	18.7	6.4	14.4	7.5	16.3	13.5	37.0	14.5	21.7	23.0	28.2	8.4	13.6	27.5	33.7	26.5	45.5	11.6	73.4	159.3	5.4	16.4	16.2	34.4	15.8	5.1	10.2	41.2	29.2	29.5	21.0	13.0	11.7	22.8	17.5	19.6	8.1	34.9	30.8	13.4	11.1	34.5	37.8	47.7	25.9	40.5	9.7	2.5	70.6	57.1	40.9	12.5	9.1	1.8	16.9	12.2	7.0	5.5	3.8	4.2	1.4	5.7	1.0	27.2	1.4	11.6	0.6	14.7	2.6	65.0	3.1	20.4	3.4	1.5	20.6	6.7	48.5	4.2	6.1	29.7	220.7	5.8	81.1	5.4	12.1	33.9	4.9	5.2	2.5	5.8	0.4	2.1	1.4	2.1	24.0	11.6	3.0	3.3	4.7	9.0	14.2	51.0	2.0	9.5	11.2	0.4	3.6	0.8	2.0	24.1	13.3	3.7	24.2	9.6	2.8	9.2	1.6	9.7	50.4	2.5	48.6	17.9	32.8	27.8	7.2	25.9	57.1	42.9	5.3	70.6	2.0	40.5	24.0	40.9	27.3	28.0	23.1	27.1	28.2	8.4	45.5	11.6	34.4	34.9
DERL3	"C22orf14, derlin-3, FLJ43842, IZP6, MGC71803"	ENSG00000099958	"Derlin 3"	Q96Q80	22	23834503-23839128	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;pancreas: 80.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 33.1;RPMI-8226: 19.4;U-266/70: 35.6;U-698: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 77.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 77.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037234, HPA049306"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"CAB037234: AB_1840802, HPA049306: "	"unprognostic (2.01e-3)"	"prognostic favourable (8.70e-5)"	"unprognostic (9.72e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.77e-3)"	"prognostic favourable (8.01e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (7.76e-13)"	"unprognostic (1.53e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	1.3	1.8	1.2	27.3	2.1	4.1	2.8	1.7	1.6	3.7	21.5	1.1	20.2	18.7	1.9	2.9	4.1	3.4	5.7	3.9	1.2	1.9	2.9	4.7	7.2	25.5	1.3	1.2	1.1	80.8	0.6	4.0	7.9	2.4	1.6	6.9	1.9	44.8	29.3	1.3	0.4	14.9	0.3	1.0	28.5	21.8	12.6	1.6	1.0	9.5	3.4	36.1	15.5	1.2	8.4	77.7	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.0	3.4	0.6	0.0	0.0	0.3	0.6	0.0	0.7	1.8	0.1	2.0	0.0	0.4	3.7	0.9	0.0	0.1	0.2	0.0	0.1	0.5	33.1	0.0	0.0	0.5	2.0	0.5	0.1	2.6	0.0	19.4	0.7	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.0	35.6	4.3	8.4	0.4	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.0	0.0	77.7	0.0	1.3	1.2	2.1	1.7	1.6	1.2	1.9	1.3	1.2	2.4	1.6
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350668	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 30.0;SK-MEL-30: 46.2;WM-115: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	10.9	3.4	1.2	3.6	1.1	3.4	17.1	4.8	2.7	4.6	1.7	1.0	46.7	0.8	3.2	0.7	1.6	1.3	13.1	1.5	4.6	0.8	0.7	0.4	3.7	1.8	0.8	0.8	1.2	78.6	0.1	3.7	17.7	0.7	4.3	0.9	17.1	8.9	63.5	2.7	3.5	1.3	1.5	1.1	0.6	20.6	1.7	0.2	3.9	1.2	2.0	4.7	7.4	3.0	0.0	0.5	0.0	0.0	0.2	9.6	0.1	11.1	30.0	17.8	0.8	2.3	0.0	1.5	2.3	12.8	7.0	3.1	0.3	5.7	0.0	6.3	1.0	3.6	0.2	7.7	4.2	0.3	0.6	0.0	1.0	0.2	0.0	0.1	14.6	1.4	5.1	2.2	13.1	5.7	0.1	1.3	14.0	12.6	0.0	2.1	3.1	18.4	0.3	0.6	2.3	16.1	5.9	0.1	9.9	3.2	15.2	46.2	3.2	0.3	16.0	5.2	0.0	0.0	1.6	3.6	0.4	0.0	15.6	2.6	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	9.6	0.1	1.2	1.1	4.8	2.7	4.6	0.8	0.8	0.8	0.7	0.2
EIF4EBP1	"4E-BP1, PHAS-I"	ENSG00000187840	"Eukaryotic translation initiation factor 4E binding protein 1"	Q13541	8	38030341-38060365	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 94.7;salivary gland: 109.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 53.5;eosinophil: 31.3;intermediate monocyte: 41.2;memory B-cell: 16.3;myeloid DC: 41.3;naive B-cell: 13.5;non-classical monocyte: 31.4;plasmacytoid DC: 31.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005032, CAB005039, HPA023501"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB005032: AB_562030, CAB005039: AB_562029, HPA023501: AB_1848095"	"unprognostic (1.55e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (8.86e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.18e-3)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.72e-3)"	17.7	3.4	2.5	4.9	3.6	9.2	21.7	1.8	3.2	5.5	15.4	2.0	7.7	6.2	5.3	2.1	22.2	5.0	7.0	9.4	2.2	1.8	6.0	39.6	6.9	7.4	4.3	1.4	9.3	94.7	1.7	2.2	8.7	2.8	7.4	4.6	2.8	109.8	8.0	38.4	4.9	9.0	7.1	4.2	9.3	10.6	3.0	2.7	2.7	3.7	12.6	9.2	11.3	11.1	16.3	41.3	31.3	53.5	4.0	7.6	28.0	20.4	10.6	3.1	18.4	4.0	3.5	13.6	22.7	10.6	12.3	19.7	7.0	5.3	8.0	15.9	11.3	10.9	10.3	18.5	7.3	6.1	33.5	46.8	4.7	9.6	41.8	15.1	7.5	9.8	30.2	13.6	25.5	19.7	25.5	21.4	5.1	12.8	13.2	36.8	22.9	42.7	11.6	13.0	28.2	4.6	2.0	43.2	32.8	4.6	7.5	53.4	10.0	17.8	18.5	7.4	24.3	21.9	17.2	30.8	16.7	9.2	17.3	26.8	16.0	5.1	53.5	31.3	3.9	41.2	3.5	16.3	4.5	4.0	41.3	13.5	3.6	3.6	4.7	4.0	31.4	31.3	7.6	28.0	2.5	3.6	1.8	3.2	2.2	1.8	4.3	1.4	2.8	2.7
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387156-40428619	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.2;pancreas: 37.3"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 12.4;hTCEpi: 8.4;RT4: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.6	2.2	5.7	1.7	25.9	0.5	2.1	5.4	15.8	26.2	3.3	0.6	1.9	1.7	4.0	4.4	7.5	1.3	3.6	1.4	4.9	6.3	3.6	0.5	4.8	0.9	4.0	6.3	2.6	37.3	1.7	4.2	2.9	14.5	5.3	3.6	2.8	21.2	5.1	1.7	3.2	1.6	2.5	1.7	5.1	8.8	1.3	4.8	0.0	7.0	5.6	4.8	13.7	2.9	0.5	7.4	1.4	0.3	0.9	0.8	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	3.7	0.0	12.4	0.3	0.7	0.4	0.7	0.5	0.2	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.1	0.1	1.1	0.1	0.0	0.3	1.5	17.9	1.9	0.4	0.8	1.4	0.3	0.6	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.3	0.0	1.0	0.1	0.1	1.4	0.2	0.0	0.2	0.3	0.8	0.3	0.2	0.3	0.0	0.5	0.6	0.6	0.0	0.9	0.2	7.4	0.6	0.1	5.7	25.9	5.4	15.8	4.9	6.3	4.0	6.3	14.5	4.8
EPB41L4B	EHM2	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171975-109320964	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.1;pancreas: 59.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.4;hTCEpi: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA042862: AB_10794534"	"prognostic unfavourable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	6.5	4.2	7.3	1.2	14.6	0.0	4.8	4.9	11.4	1.1	18.4	1.5	7.1	15.1	0.7	5.9	0.7	3.2	1.8	3.5	2.9	3.5	1.9	28.1	1.7	0.2	1.6	6.8	4.7	59.8	3.3	0.9	1.1	2.7	2.2	18.7	2.4	8.0	3.5	2.2	5.6	16.1	0.3	2.2	0.2	9.4	2.7	1.3	0.4	14.6	1.3	1.2	1.2	1.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	4.5	5.7	0.4	0.4	0.4	0.0	17.4	0.6	0.2	2.0	1.0	9.8	4.5	0.0	1.2	0.5	7.5	11.6	6.1	2.1	4.8	2.7	0.0	1.8	13.9	1.2	0.2	0.0	0.1	27.3	0.8	9.4	0.1	0.1	0.0	2.8	11.6	0.2	0.1	7.5	8.5	0.0	0.0	0.3	7.0	6.9	7.2	0.7	1.8	12.1	0.0	2.8	0.0	0.2	4.1	4.2	1.3	1.6	0.0	0.0	0.0	3.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.6	4.9	11.4	2.9	3.5	1.6	6.8	2.7	1.3
EPHB3	"ETK2, Hek2, Tyro6"	ENSG00000182580	"EPH receptor B3"	P54753	3	184561784-184582409	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 49.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 17.2;HaCaT: 23.6;SK-BR-3: 18.3;T-47d: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.1;myeloid DC: 3.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;monocytes: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007698, HPA008184, CAB034350"	Enhanced					20000	20000			"CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (7.88e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.10e-3)"	1.4	0.9	4.5	5.0	2.6	0.5	9.0	9.7	5.7	22.7	8.8	2.3	1.7	5.7	10.0	1.9	19.9	3.0	9.7	1.6	4.7	1.8	1.7	1.0	4.7	1.0	3.3	3.7	9.0	49.3	1.1	1.7	6.3	7.2	7.7	9.7	3.8	27.7	3.5	0.7	32.3	5.6	3.5	1.3	1.2	16.0	1.1	4.0	0.2	1.0	15.7	8.4	4.0	13.6	0.0	3.1	0.3	1.1	0.0	0.4	0.4	3.8	1.3	8.9	0.9	2.7	0.2	17.2	0.6	1.1	1.3	0.7	1.2	0.1	0.0	1.7	3.6	23.6	3.2	1.2	0.3	0.1	0.7	0.0	0.2	0.0	0.2	0.0	0.2	0.7	7.7	1.1	0.1	0.0	0.0	0.0	0.6	10.1	0.0	3.8	0.9	1.5	0.9	5.4	0.0	0.0	3.4	1.1	1.3	0.7	18.3	0.8	12.1	0.1	0.0	2.2	3.2	1.1	1.4	0.0	0.0	0.1	0.2	0.0	8.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.4	4.5	2.6	9.7	5.7	4.7	1.8	3.3	3.7	7.2	4.0
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064311-98093610	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 27.9;retina: 26.7"	"Cell line enhanced"	"Detected in some"		"A549: 6.8;EFO-21: 5.2;HAP1: 6.3;HEK 293: 9.1;RPTEC TERT1: 6.1;RT4: 15.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.3"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favourable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favourable (9.38e-4)"	0.5	0.2	2.3	0.2	6.7	0.0	0.8	0.4	2.2	2.0	3.3	0.1	3.6	4.3	1.1	0.6	0.7	8.8	13.1	5.4	0.7	2.6	8.7	8.1	1.7	0.7	1.0	2.2	1.6	27.9	0.6	1.7	4.1	1.9	2.2	3.0	26.7	1.3	1.9	0.1	0.6	1.3	0.4	1.0	0.2	9.5	3.4	0.5	0.3	0.6	0.0	0.5	3.1	0.5	0.0	5.3	0.0	0.0	0.0	0.5	0.0	0.0	6.8	0.0	0.0	0.1	0.0	4.0	3.6	1.3	1.9	1.4	0.1	2.0	0.0	5.2	0.9	0.3	6.3	0.1	2.3	0.0	9.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	1.4	2.7	0.0	0.0	0.1	6.1	15.9	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	6.7	0.4	2.2	0.7	2.6	1.0	2.2	1.9	0.5
ERRFI1	"GENE-33, MIG-6, RALT"	ENSG00000116285	"ERBB receptor feedback inhibitor 1"	Q9UJM3	1	8004404-8026308	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 141.1;pancreas: 133.6"	"Cell line enhanced"	"Detected in many"		"HHSteC: 93.0;LHCN-M2: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	7	"monocytes: 4.9;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027206, HPA076543"			Enhanced	Cytosol				Cytosol	Cytosol	"HPA027206: AB_10600908, HPA076543: "	"unprognostic (2.13e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.03e-3)"	38.6	8.8	4.4	6.3	6.3	0.6	27.8	9.6	7.0	17.5	13.6	5.4	8.4	6.8	15.9	9.6	13.6	12.2	27.3	8.8	4.7	2.5	32.6	141.1	15.5	7.7	7.5	3.7	29.7	133.6	7.7	41.9	33.7	8.1	9.3	5.1	12.0	14.5	5.9	68.3	20.2	26.5	22.9	12.5	2.1	22.3	7.4	5.2	0.6	19.4	4.7	3.8	20.0	19.5	0.4	0.3	0.2	4.9	0.0	1.3	0.2	13.2	7.8	3.3	4.5	32.0	23.9	35.1	13.0	3.8	2.4	2.8	3.4	35.0	0.2	7.8	4.3	2.8	0.9	23.0	11.2	0.4	2.5	0.2	2.3	40.4	93.0	0.1	0.5	32.5	23.2	8.0	19.5	6.1	0.9	0.1	71.0	5.7	0.0	0.8	8.0	19.5	1.1	37.9	0.2	11.2	4.2	2.3	1.3	2.5	5.9	4.0	4.0	0.3	8.6	9.4	5.5	7.9	18.3	0.2	0.1	0.2	36.4	0.6	8.7	0.0	0.4	0.0	1.3	0.1	0.2	0.3	1.2	1.3	0.2	0.4	0.9	1.2	0.2	0.0	4.9	0.3	0.6	0.2	4.4	6.3	9.6	7.0	4.7	2.5	7.5	3.7	8.1	5.2
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 65.1"	"Cell line enhanced"	"Detected in some"		"A-431: 33.5;BEWO: 25.7;CAPAN-2: 35.3;HaCaT: 20.5;hTCEpi: 57.7;RT4: 24.5;T-47d: 27.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nuclear bodies"	"Nuclear bodies"	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavourable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.6	0.5	0.5	15.1	0.5	0.0	7.6	0.5	0.6	9.7	18.1	0.2	18.7	7.7	3.3	21.3	43.1	6.6	14.5	0.6	0.5	0.5	6.4	0.7	15.5	0.8	0.5	0.2	1.8	65.1	11.8	10.1	18.5	0.3	8.9	20.8	0.2	38.2	15.1	0.5	24.8	12.7	1.9	0.5	0.5	12.1	1.0	0.2	1.4	20.2	30.4	28.9	9.0	16.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	33.5	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	10.9	35.3	0.0	0.9	0.0	20.5	0.9	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.7	0.0	0.3	0.0	0.0	0.0	0.0	16.3	0.4	0.1	3.1	0.8	0.0	0.0	4.4	4.4	24.5	9.0	0.0	0.0	5.3	3.4	27.3	0.2	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.6	0.5	0.5	0.5	0.2	0.3	0.2
ESRP2	"FLJ21918, RBM35B"	ENSG00000103067	"Epithelial splicing regulatory protein 2"	Q9H6T0	16	68229111-68238102	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.2;pancreas: 41.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 18.1;MCF7: 35.4;RT4: 19.0;SK-BR-3: 19.0;T-47d: 29.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040751, HPA048597, HPA048618"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463"	"unprognostic (3.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (1.30e-6)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.75e-3)"	0.4	0.2	0.2	7.6	0.5	0.0	3.9	0.6	0.3	4.7	8.0	0.6	4.1	4.6	1.2	10.2	30.1	2.1	12.4	0.6	0.3	0.1	13.4	45.2	15.6	0.2	0.2	0.2	1.3	41.5	7.0	2.5	11.3	0.7	6.6	5.6	0.8	17.3	5.0	0.3	17.6	8.5	0.6	0.2	0.2	12.8	7.0	0.3	3.0	18.4	25.7	17.1	6.4	9.4	0.0	0.0	0.0	0.8	0.0	0.8	0.0	12.2	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.0	0.0	0.1	11.5	6.1	0.0	0.5	0.0	12.7	0.0	9.4	0.0	0.0	8.3	0.0	3.4	9.2	0.1	0.0	0.1	0.0	13.4	0.0	4.4	0.0	0.0	0.0	0.0	35.4	0.0	0.0	1.3	4.1	0.0	0.0	0.0	4.8	19.0	1.3	0.0	6.1	19.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.3	0.3	0.1	0.2	0.2	0.7	0.3
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.4;pancreas: 32.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;U-138 MG: 36.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"				Vesicles	Vesicles	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	0.6	0.3	0.3	0.7	0.5	0.0	1.2	0.3	0.2	3.7	0.6	0.1	11.4	0.5	1.6	5.1	0.5	1.3	0.4	0.6	0.3	0.3	23.6	69.4	15.2	0.1	0.8	0.0	0.8	32.3	0.8	0.8	26.6	0.5	0.6	0.2	5.7	14.3	13.5	0.9	1.5	1.1	0.7	0.4	5.9	0.4	2.2	0.3	3.3	1.2	0.8	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	1.1	0.7	0.3	4.6	0.5	0.1	1.0	7.1	0.5	21.7	14.6	19.3	9.9	0.1	0.4	0.0	2.0	27.1	3.0	0.5	4.6	12.2	0.0	0.3	0.0	0.8	14.3	0.7	0.0	0.0	5.0	2.7	23.8	11.0	12.0	0.0	0.0	14.8	0.0	0.0	0.0	1.0	7.5	2.4	0.0	0.0	10.7	0.1	0.3	0.5	2.0	0.1	16.5	0.0	0.1	9.8	36.4	15.3	0.6	22.6	0.2	0.0	0.0	20.6	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.3	0.3	0.8	0.0	0.5	0.3
FAAH2	"AMDD, FAAH-2, FLJ31204, RP11-479E16.1"	ENSG00000165591	"Fatty acid amide hydrolase 2"	Q6GMR7	X	57286706-57489196	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.6;pituitary gland: 42.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.5;HDLM-2: 9.4;RPMI-8226: 19.0;U-266/70: 15.9;U-266/84: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 18.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 13.6"	"Lineage enriched"	"Detected in many"	8	"T-cells: 13.6"																				"unprognostic (1.37e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.94e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.47e-13)"	"unprognostic (9.16e-3)"	"unprognostic (2.27e-1)"	"prognostic favourable (2.66e-4)"	"prognostic favourable (6.83e-5)"	1.0	1.4	1.0	6.8	1.5	0.0	6.7	18.0	1.0	3.5	3.9	0.2	3.8	2.6	1.4	4.7	5.5	5.8	2.4	0.6	1.2	2.3	9.7	20.1	3.5	5.7	1.1	0.5	1.9	43.6	12.7	42.8	1.4	1.8	9.3	3.6	3.8	9.1	5.3	0.3	10.0	6.4	0.6	1.1	2.3	4.1	0.6	0.3	8.5	15.3	2.7	11.0	3.0	3.6	1.8	1.0	0.3	0.0	0.7	13.6	1.5	2.4	0.2	0.0	0.1	0.1	0.1	2.3	0.0	0.0	0.0	0.0	1.7	10.5	0.1	3.0	0.0	0.4	0.8	1.8	0.0	9.4	5.1	0.3	2.4	0.7	0.0	1.1	0.0	0.0	3.2	0.0	0.0	0.0	1.2	4.7	0.0	1.0	0.5	0.0	1.8	0.0	0.0	1.8	19.0	6.2	3.3	1.8	0.1	0.1	3.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	0.1	15.9	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.8	7.7	3.2	0.0	0.6	7.5	0.9	0.3	0.7	0.0	1.0	13.6	1.5	1.0	1.5	18.0	1.0	1.2	2.3	1.1	0.5	1.8	0.3
FAM174B	"LOC400451, MGC102891"	ENSG00000185442	"Family with sequence similarity 174 member B"	Q3ZCQ3	15	92617443-92809884	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 57.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.0;MCF7: 25.3;RPMI-8226: 29.7;RT4: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 4.5;granulocytes: 3.7;T-cells: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015306	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA015306: AB_2669182"	"unprognostic (3.00e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.50e-1)"	"prognostic favourable (9.03e-5)"	"unprognostic (4.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.23e-3)"	"unprognostic (7.67e-3)"	"unprognostic (5.05e-3)"	"unprognostic (6.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-2)"	6.1	3.5	5.9	3.3	6.3	0.7	17.9	3.9	8.6	10.9	6.2	2.9	21.5	3.6	5.1	4.9	5.2	14.6	6.4	4.2	7.4	8.3	3.3	4.0	16.3	5.5	6.5	6.2	10.2	57.6	2.5	15.9	4.6	6.7	19.4	9.2	7.7	47.7	10.8	16.3	4.9	5.0	4.6	4.9	3.2	17.3	9.7	3.6	4.2	28.9	3.9	4.8	24.4	15.3	0.4	4.5	3.7	0.9	0.7	10.9	0.7	0.0	3.5	2.3	0.7	0.0	0.0	0.2	1.3	6.2	0.0	0.0	21.0	2.4	0.3	6.0	0.1	0.1	3.9	0.1	0.0	0.1	1.8	0.2	0.3	0.2	0.4	0.3	0.9	0.3	0.1	0.0	0.0	3.0	0.3	15.6	3.5	25.3	0.7	0.0	11.3	0.0	2.4	6.5	29.7	1.5	62.7	1.4	1.1	1.8	12.1	3.8	9.7	2.1	0.0	0.0	0.4	0.1	2.9	0.4	4.6	0.7	0.0	0.2	1.5	1.1	0.8	0.9	0.2	0.9	0.4	0.4	2.5	0.0	0.6	0.3	2.8	3.3	3.7	0.7	0.0	4.5	10.9	0.7	5.9	6.3	3.9	8.6	7.4	8.3	6.5	6.2	6.7	3.6
FAM3B	"2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44"	ENSG00000183844	"Family with sequence similarity 3 member B"	P58499	21	41304212-41357431	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.8;pancreas: 120.3;salivary gland: 67.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;CAPAN-2: 5.9;Hep G2: 15.2;RPMI-8226: 42.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 40.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015885, HPA029777"	Approved		Approved	Vesicles	"Secreted to blood"	57000	57000	Vesicles	Vesicles	"HPA015885: AB_1848396, HPA029777: AB_2673194"	"unprognostic (2.88e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.79e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-3)"	0.6	0.2	0.2	4.5	0.4	0.0	4.3	0.2	0.3	1.8	38.5	0.4	29.9	38.2	0.2	8.8	17.4	4.5	6.9	0.4	0.2	0.2	5.2	0.6	2.0	0.7	0.3	0.2	0.7	120.3	0.0	1.9	7.9	0.4	10.0	0.0	0.2	67.9	36.0	0.2	0.9	83.8	2.0	0.3	0.5	30.8	2.0	0.2	2.3	3.9	7.4	17.6	17.5	4.7	0.2	1.3	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	42.1	0.0	2.8	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	6.9	0.0	0.6	1.3	0.0	0.0	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.2
FAM46C	FLJ20202	ENSG00000183508	"Family with sequence similarity 46 member C"	Q5VWP2	1	117605934-117628372	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 114.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 73.1;RPMI-8226: 43.6;U-266/70: 20.3;U-266/84: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 16.3"	"Group enriched"	"Detected in many"	17	"B-cells: 9.7;granulocytes: 16.3;T-cells: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054049	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA054049: AB_2682356"	"unprognostic (3.76e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.24e-3)"	"prognostic favourable (3.75e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.91e-2)"	"prognostic favourable (2.77e-5)"	"unprognostic (6.26e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.10e-2)"	3.2	1.8	1.2	24.5	1.1	28.9	4.4	1.1	1.1	8.1	16.1	1.8	8.4	5.6	4.8	16.6	6.9	3.3	9.7	6.4	1.2	1.1	5.0	5.5	11.2	16.3	1.2	0.1	8.3	114.0	7.2	5.3	10.6	3.9	6.4	9.5	4.4	37.8	11.9	10.0	1.8	10.6	4.7	1.4	19.1	12.2	34.0	0.2	1.5	10.3	10.9	37.0	9.5	8.6	9.7	0.2	16.3	0.0	0.6	9.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	6.6	0.1	0.0	0.4	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	4.1	0.4	9.0	0.0	0.0	0.0	5.2	11.7	0.0	0.0	0.1	0.0	0.0	1.2	73.1	0.0	0.9	0.0	5.4	0.9	0.5	0.0	0.0	43.6	0.0	0.8	0.5	0.0	0.4	0.5	0.4	0.4	0.0	0.1	0.0	0.5	0.0	0.1	20.3	16.8	0.4	0.4	1.9	0.6	16.3	0.0	10.5	2.5	0.0	2.2	9.7	2.5	3.1	0.0	8.0	0.3	1.4	1.1	0.6	0.0	0.2	9.2	2.1	1.2	1.1	1.1	1.1	1.2	1.1	1.2	0.1	3.9	0.2
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.7;pancreas: 52.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 20.6;HBEC3-KT: 18.1;Hep G2: 43.2;SiHa: 81.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 1.4;T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favourable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	1.7	21.8	49.7	2.6	39.2	1.2	7.9	21.1	48.3	2.1	1.8	13.2	2.1	13.7	1.5	6.4	3.6	3.6	2.9	2.6	33.1	32.6	6.9	11.0	3.0	2.5	40.0	23.0	2.2	52.5	17.7	20.2	1.3	25.7	5.1	1.3	2.7	21.7	7.6	1.3	6.6	4.9	1.7	31.4	2.2	3.8	4.4	24.3	1.1	3.7	0.0	3.8	2.6	2.9	1.4	0.1	0.0	0.0	0.0	3.1	0.6	6.7	2.0	0.0	6.6	0.1	0.0	1.0	0.3	0.6	0.1	0.0	20.6	2.0	0.0	8.5	0.0	0.0	0.7	18.1	0.0	0.1	0.2	0.0	0.2	43.2	0.9	0.0	0.0	0.6	3.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.5	0.5	0.7	0.9	81.5	0.0	0.8	4.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	3.1	1.4	1.2	2.9	0.1	1.1	1.8	2.6	0.0	0.0	0.0	0.0	0.8	0.6	49.7	39.2	21.1	30.3	33.1	32.6	40.0	23.0	25.7	24.3
FFAR1	"FFA1R, GPR40"	ENSG00000126266	"Free fatty acid receptor 1"	O14842	19	35351552-35353862	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;brain: 4.1;ovary: 4.8;pancreas: 9.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;U-698: 5.4;WM-115: 2.0"	"Cancer enriched"	"Detected in single"	13	"pancreatic cancer: 2.2"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																		"unprognostic (9.49e-2)"				"unprognostic (2.08e-1)"			"unprognostic (1.59e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.51e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (9.56e-3)"		0.0	0.0	1.2	0.2	1.6	5.7	0.0	0.0	0.6	0.0	0.0			0.8	0.1	0.0	0.0	0.8	0.0	0.0	1.9	0.9	0.0	0.0	0.1	0.7	1.7		4.8	9.6	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.2	0.5	0.0	4.1	0.3	1.6	0.1			0.0		0.2	0.0	0.0	1.2	0.5	1.9	0.3	0.7	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.4	0.1	0.4	0.0	0.0	0.1	0.3	0.3	0.8	0.2	0.0	0.1	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.6	0.1	0.0	1.1	0.2	0.0	0.0	0.3	0.1	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	5.4	0.1	0.2	2.0	1.6	0.3	0.7	0.4	0.2	0.4	0.3	0.3	0.2	0.0	1.2	0.3	0.4	1.9	0.7	0.2	0.5	0.2	0.0										
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026897	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 51.1"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.5;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles				Vesicles	Vesicles	"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	21.8	22.9	16.0	6.1	20.5	5.8	21.5	13.8	20.6	8.1	6.6	9.1	5.3	6.6	6.6	5.0	4.7	19.7	9.8	12.2	16.6	3.6	11.5	25.1	6.4	4.0	8.8	8.4	14.0	51.1	12.6	9.0	3.1	17.0	7.6	4.8	12.7	29.3	3.1	9.6	3.7	6.0	4.1	14.0	5.3	15.0	3.2	11.1	1.0	33.8	3.9	3.6	6.2	11.5	0.4	0.3	1.2	3.6	0.1	1.2	0.4	8.5	11.6	4.2	12.8	4.5	4.7	1.1	15.2	2.3	4.8	3.2	8.4	17.7	0.9	19.8	23.1	2.2	8.1	5.1	4.5	3.2	7.9	0.1	15.2	22.1	9.2	4.9	2.1	9.9	4.4	8.4	3.6	4.6	9.3	3.3	2.9	11.1	5.7	13.5	5.3	31.6	9.4	6.2	6.0	8.5	1.3	0.4	0.8	14.0	0.3	5.6	8.4	4.3	9.9	26.2	10.7	13.2	36.8	3.6	4.8	1.3	6.9	5.7	8.4	1.2	0.1	0.0	0.7	3.5	0.1	0.4	1.2	0.2	0.3	0.1	0.2	0.5	0.0	0.1	3.6	0.3	0.1	0.4	16.0	20.5	13.8	20.6	16.6	3.6	8.8	8.4	17.0	11.1
FIGLA	bHLHc8	ENSG00000183733	"Folliculogenesis specific bHLH transcription factor"	Q6QHK4	2	70777310-70790643	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.5;pancreas: 2.8;testis: 3.4"	"Group enriched"	"Detected in some"	7	"AN3-CA: 3.3;SH-SY5Y: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"myeloid DC: 2.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071241	Supported									"HPA071241: "				"unprognostic (1.82e-1)"						"unprognostic (4.04e-1)"					"unprognostic (1.73e-2)"			0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.2			0.0	1.0	0.0	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.3	0.0		2.1	2.8	0.0	0.0	0.0		0.5	0.1		0.8	0.1	0.3	0.2	0.4	0.3	0.0	0.6	0.2	3.4			0.0		0.0	0.2	0.3	0.0	2.5	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1										
FKBP11	FKBP19	ENSG00000134285	"FK506 binding protein 11"	Q9NYL4	12	48921518-48926474	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 175.6;salivary gland: 62.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.2;Karpas-707: 42.0;RPMI-8226: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 37.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041709	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA041709: AB_10794487"	"unprognostic (7.45e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.40e-1)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.15e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.54e-1)"	5.6	4.6	1.1	8.2	1.4	3.7	3.7	0.9	2.2	7.5	6.9	0.9	21.6	9.2	4.4	12.9	4.4	4.8	8.1	3.4	1.3	2.4	4.8	38.4	5.8	16.6	1.0	1.3	3.7	175.6	0.2	12.3	3.3	1.6	4.8	6.3	1.9	62.0	20.9	1.4	1.7	7.6	2.9	1.0	18.7	10.0	1.9	0.9	2.2	4.7	4.9	14.5	8.2	4.3	11.1	8.3	1.1	0.3	5.1	37.6	7.3	2.1	2.8	0.5	0.7	12.6	19.1	1.0	16.6	23.9	18.4	21.8	10.7	12.0	32.4	0.5	27.2	8.9	5.8	7.3	9.6	6.8	1.2	1.2	3.0	0.1	46.2	0.6	0.9	21.3	14.2	14.1	26.3	10.4	0.4	42.0	6.7	6.0	4.8	1.1	1.4	5.3	13.3	0.8	42.0	2.3	0.4	6.9	2.0	5.5	8.3	3.7	0.5	1.0	8.3	3.6	0.7	0.3	0.3	24.6	20.3	16.4	2.2	0.7	5.9	0.9	0.2	0.6	22.5	0.3	37.6	11.1	15.6	17.7	0.3	4.8	9.4	14.4	1.1	5.1	0.1	8.3	6.4	7.3	1.1	1.4	0.9	2.2	1.3	2.4	1.0	1.3	1.6	0.9
FLRT2		ENSG00000185070	"Fibronectin leucine rich transmembrane protein 2"	O43155	14	85530144-85654426	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.8;retina: 50.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 26.6;HUVEC TERT2: 16.7;TIME: 23.6;U-138 MG: 26.0;U-2197: 18.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	18000	18000				"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.59e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.34e-2)"	"unprognostic (8.02e-6)"	"unprognostic (1.98e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.50e-5)"	10.5	5.1	6.5	4.6	13.2	0.4	3.9	0.8	16.1	12.2	3.8	1.6	2.3	1.2	6.7	4.3	3.9	7.4	9.5	6.6	4.7	3.6	2.1	1.5	2.6	6.5	3.7	5.8	31.7	34.8	1.4	2.6	1.5	1.4	5.8	3.5	50.6	2.2	3.9	6.7	6.4	2.3	7.3	4.2	5.9	2.6	9.2	0.8	0.0	6.5	2.2	2.9	6.9	12.3	0.6	0.3	2.3	0.2	0.4	0.3	0.0	0.0	0.1	3.8	0.0	3.5	6.5	0.0	4.1	2.7	3.9	3.7	0.0	0.0	0.0	0.0	12.1	0.8	5.8	7.9	9.7	0.0	3.3	0.0	2.2	0.0	11.3	0.8	0.0	3.6	4.6	3.2	26.6	16.7	0.0	0.0	9.4	0.0	0.0	0.0	1.8	0.1	0.0	4.7	0.0	0.0	0.0	0.9	0.0	0.9	0.0	1.4	0.0	0.0	23.6	26.0	4.4	18.7	7.4	0.0	0.0	0.0	8.2	0.0	2.5	2.3	0.2	2.0	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.6	0.3	0.3	1.0	0.4	0.2	0.3	0.1	0.0	6.5	13.2	0.8	16.1	4.7	3.6	3.7	5.8	1.4	0.8
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;PC-3: 15.1;SCLC-21H: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favourable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favourable (6.28e-4)"	"prognostic favourable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"liver: 36.7;pancreas: 63.3"	"Cell line enhanced"	"Detected in some"		"A549: 5.5;CACO-2: 7.5;HDLM-2: 8.8;Hep G2: 20.3;K-562: 16.2;NTERA-2: 8.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.3	0.0	0.2	5.9	0.2	0.0	0.1	0.1	0.3	0.5	9.7	0.3	0.7	4.7	0.2	0.1	0.2	0.1	13.7	0.5	0.1	0.0	0.9	36.7	0.6	0.1	0.1	0.1	0.1	63.3	0.7	0.1	0.1	0.2	0.3	8.0	0.1	1.0	0.8	0.1	0.1	9.0	0.1	0.1	0.1	17.1	0.7	0.3	0.2	0.1	0.5	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.5	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.8	0.8	0.1	0.0	20.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	16.2	0.0	0.0	0.2	0.0	0.0	8.2	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.7	3.2	0.0	0.3	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.3
FRG2B		ENSG00000225899	"FSHD region gene 2 family member B"	Q96QU4	10	133623895-133626795	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.0;kidney: 1.9;pancreas: 1.2"	"Cell line enriched"	"Detected in single"	22	"HDLM-2: 13.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"									"HPA039264, HPA047769"	Uncertain									"HPA039264: AB_2676420, HPA047769: AB_2680149"																		0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.8	0.0	0.0			0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	1.9	0.1	0.0	0.0	0.0		0.4	1.2	0.0	0.0	0.5		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8			0.0		0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0										
FUT1	"H, HSC"	ENSG00000174951	"Fucosyltransferase 1 (H blood group)"	P19526	19	48748011-48755390	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 8.1;HEL: 10.1;hTCEpi: 8.0;RT4: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																		"unprognostic (2.90e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.05e-3)"	"unprognostic (4.65e-3)"	"unprognostic (2.92e-3)"	"unprognostic (8.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (3.99e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.67e-3)"	"unprognostic (3.98e-2)"	2.5	0.8	0.9	0.9	0.9	1.5	1.6	3.5	1.4	0.9	0.9	0.9	0.9	1.0	0.9	0.9	1.5	1.2	0.9	1.4	0.9	0.2	1.1	0.9	6.8	0.9	0.9	0.9	0.9	19.5	1.0	1.7	2.8	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.8	0.9	0.9	0.9	3.4	7.6	0.9	0.9	0.9	1.0	0.9	0.9	0.9	0.9	0.9	0.9	3.3	0.7	1.5	0.6	0.3	3.2	0.1	0.1	0.2	0.0	0.0	1.7	0.2	0.1	0.2	0.2	8.1	4.7	0.3	0.3	0.2	5.5	1.6	5.0	0.1	0.0	0.8	10.1	0.4	0.1	2.4	0.4	4.5	0.0	8.0	0.4	3.7	3.5	0.5	1.5	0.0	3.7	0.2	6.2	0.9	0.4	0.3	0.0	1.6	0.3	9.7	7.6	0.5	0.4	7.0	0.1	4.6	0.2	3.5	0.3	2.5	0.2	0.3	1.4	3.6	1.0	0.1	0.3	0.3	3.3	0.7	0.5	0.5	0.3	0.3	0.8	0.6	0.4	0.3	0.9	0.6	0.5	2.1	1.5	0.3	0.9	0.2	0.3	0.9	0.9	3.5	1.4	0.9	0.2	0.9	0.9	0.9	0.9
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 258.1;pancreas: 68.9;salivary gland: 91.7"	"Group enriched"	"Detected in some"	29	"MOLT-4: 137.7;RPTEC TERT1: 315.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"midbrain: 2.6"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		26000	26000	Mitochondria	Mitochondria	"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favourable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	0.3	0.2	0.2	0.2	0.1	0.0	0.7	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.3	2.8	0.3	0.3	54.7	0.2	0.1	0.2	258.1	2.2	0.2	0.6	0.1	0.0	0.4	68.9	0.0	0.3	0.6	0.1	0.3	0.0	0.1	91.7	0.1	0.1	0.2	0.3	0.1	0.1	0.4	0.2	0.2	0.0	9.5	0.2	0.3	0.4	0.2	0.6	0.4	3.2	0.0	1.1	8.4	14.1	2.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	137.7	0.0	0.0	0.0	0.0	0.0	0.2	315.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	1.1	0.2	1.8	14.1	0.2	0.4	5.1	4.1	0.0	8.4	0.0	3.2	1.6	2.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.0
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470484	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 12.0;hTERT-HME1: 20.8;RT4: 17.7;SH-SY5Y: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA040709: AB_2677090, HPA042046: AB_2677818"	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favourable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	11.1	8.7	9.7	2.9	10.9	8.0	6.0	17.6	11.1	6.0	7.2	19.5	0.3	6.5	4.2	3.4	11.0	4.8	4.9	8.9	11.8	5.8	15.3	12.5	5.2	1.3	16.3	10.1	4.4	43.5	1.9	5.1	4.8	13.2	4.3	6.3	3.0	11.2	5.1	7.7	13.9	7.8	4.6	12.9	3.1	12.7	6.7	16.4	0.0	3.5	3.1	2.9	9.3	9.1	1.9	5.0	2.6	1.0	3.1	1.4	0.0	1.0	1.5	1.7	0.3	4.6	3.2	4.7	0.3	0.0	0.0	0.0	0.3	2.6	3.0	2.5	0.2	3.3	2.6	4.9	0.0	0.9	1.6	0.0	3.0	1.0	2.3	0.3	0.2	3.8	12.0	0.2	20.8	0.1	0.1	0.6	1.8	2.4	0.8	0.1	1.8	0.8	1.2	6.8	5.2	6.0	17.7	5.6	14.7	3.9	5.0	0.2	1.0	2.5	0.2	1.2	1.4	0.0	0.4	2.1	0.2	0.7	1.9	0.0	1.4	0.0	1.0	0.2	0.5	0.1	0.2	0.3	0.8	0.5	0.1	1.9	1.0	1.4	2.6	3.1	0.1	5.0	0.1	0.0	9.7	10.9	17.6	11.1	11.8	5.8	16.3	10.1	13.2	16.4
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Group enriched"	"Detected in some"	10	"Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favourable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	40.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	2.0	0.0	0.5	11.7	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.4	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 42.5;intestine: 29.9;ovary: 63.4;pancreas: 49.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 14.9;HHSteC: 17.4;SH-SY5Y: 16.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	16.8	0.1	0.0	13.4	0.5	0.4	0.1	1.0	15.4	42.5	0.0	0.0	0.0	26.5	0.1	0.8	0.0	0.0	63.4	49.9	0.0	0.1	4.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	13.8	18.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.9	17.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.3	16.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 81.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA020460	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"				Nucleoplasm	Nucleoplasm	"HPA020460: AB_1849548"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	2.9	6.0	8.9	2.4	8.8	8.1	4.2	8.3	12.3	4.5	4.7	5.2	8.0	3.5	3.0	4.0	6.3	3.9	6.0	21.5	8.6	8.4	8.1	19.1	2.3	2.1	10.1	7.4	4.0	81.6	3.5	3.7	2.2	7.4	12.2	3.5	4.3	12.0	5.0	10.3	3.2	3.2	3.1	6.3	1.1	4.4	5.9	4.3	2.8	10.7	9.3	4.3	3.3	2.2	0.3	2.5	0.8	1.3	2.3	7.1	2.8	8.7	2.3	5.9	33.6	12.2	9.9	4.1	12.6	13.3	9.6	8.2	5.1	1.0	2.7	5.9	5.6	5.1	5.9	8.9	2.2	1.2	10.7	6.1	7.3	20.1	19.9	10.8	8.0	11.6	5.4	6.3	14.0	7.8	15.6	3.2	4.5	7.7	11.3	20.0	2.5	9.4	11.9	1.2	16.1	12.1	6.9	12.2	8.3	9.8	15.9	6.7	12.8	5.3	5.9	9.7	5.3	6.4	4.3	10.7	5.2	5.7	6.7	10.1	10.1	0.2	1.3	0.8	1.5	1.2	0.6	0.3	3.4	1.0	2.4	0.1	7.1	2.9	0.6	2.3	0.8	2.5	3.3	2.8	8.9	8.8	8.3	12.3	8.6	8.4	10.1	7.4	7.4	4.3
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71215194-71225516	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4;liver: 114.4;pancreas: 37.1"	"Group enriched"	"Detected in some"	6	"Hep G2: 45.7;SK-MEL-30: 50.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain									"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favourable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.4	0.4	7.2	2.5	9.3	0.3	2.6	1.9	14.4	3.3	12.0	46.3	2.5	14.6	0.9	8.1	0.5	9.5	19.8	0.4	13.4	8.0	14.8	114.4	1.2	0.4	22.4	5.6	0.4	37.1	0.3	0.4	0.4	23.0	4.3	8.3	0.5	19.6	8.7	0.4	0.6	11.7	1.0	52.4	0.4	5.7	3.1	12.1	0.0	0.4	0.0	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.3	1.9	14.4	13.4	8.0	22.4	5.6	23.0	12.1
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923269-99929620	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 9.1;pancreas: 12.1;salivary gland: 9.0"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 5.7;U-2197: 4.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015024	Uncertain									"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.0	0.5	0.1	0.0	0.3	0.0	9.1	0.0	0.5	0.0	0.1			0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	1.1	2.8	0.1	0.1	0.6		0.3	12.1	0.0	0.1	1.2		4.3	0.0		9.0	0.0	0.0	2.0	0.0	0.1	0.7	0.0	0.8	1.6			0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.6	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	1.2	2.6	0.0	0.0	0.5	0.5	0.0	0.0	0.2	0.3	0.9	0.2	2.3	0.0	0.4	0.3	0.4	0.0	0.1	0.6	1.1	1.4	1.7	0.3	1.3	0.5	1.2	3.0	0.2	0.0	1.2	0.8	0.0	1.1	0.5	0.6	0.3	1.0	5.7	1.8	0.2	0.8	0.2	1.0	4.9	0.3	0.4	1.4	0.1	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	2.1	0.4										
GJD2	"CX36, GJA9"	ENSG00000159248	"Gap junction protein delta 2"	Q9UKL4	15	34751032-34754965	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.8;pancreas: 8.7;pituitary gland: 23.9;retina: 9.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.3;SCLC-21H: 3.0"	"Cancer enriched"	"Detected in single"	32	"pancreatic cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (4.30e-2)"						"unprognostic (2.87e-2)"			"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"			0.3	13.8	1.3	0.3	2.1	0.3	0.2	1.4	4.5	0.4	0.3	0.1	0.0	0.2	0.4	0.2	0.2	0.2	0.3	7.0	1.1	1.6	0.9	0.2	0.3	0.2	0.8	2.8	0.2	8.7	0.2	23.9	0.3	3.4	0.2	0.3	9.1	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.4	0.4	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.5	0.6	2.1	1.1	1.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.8	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.4	0.8	0.5	0.6	0.7	0.5	0.5	0.3	0.5	0.5	0.6	0.6	2.1	1.0	1.1	0.6	0.5	0.4	1.3	2.1	1.4	4.5	1.1	1.6	0.8	2.8	3.4	0.0
GLP1R	GLP-1R	ENSG00000112164	"Glucagon like peptide 1 receptor"	P43220	6	39048798-39087743	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 19.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;HAP1: 1.3;HMC-1: 1.5;NTERA-2: 3.2;SCLC-21H: 8.0;SH-SY5Y: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 16.1;hypothalamus: 4.8"	"Low region specificity"	"Detected in many"														"unprognostic (4.06e-3)"			"unprognostic (5.38e-6)"	"unprognostic (1.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.42e-2)"	0.2	0.1	0.1	0.0	1.8	0.0	0.9	0.1	2.2	0.1	0.1	0.8	0.0	2.4	0.1	0.6	0.1	0.0	3.5	4.8	1.4	1.4	0.1	0.0	0.5	1.0	0.1	2.3	0.0	19.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	4.1	0.0	0.4	0.3	0.1	0.0	1.4	0.1	1.8	0.4	0.0	0.4	0.8	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	3.2	0.0	0.0	0.1	0.0	0.0	0.0	8.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.7	1.4	1.4	0.1	2.3	2.0	0.0
GMNN	Gem	ENSG00000112312	"Geminin, DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 95.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: , HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favourable (4.13e-4)"	"prognostic unfavourable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	4.5	3.9	10.7	11.2	19.0	24.1	10.7	15.6	9.4	4.9	17.1	3.2	9.7	7.6	5.3	6.3	8.0	7.3	4.7	3.7	11.0	10.2	10.8	8.4	4.4	12.0	13.6	9.8	7.2	95.0	2.6	7.5	7.9	10.7	18.4	18.9	3.4	4.2	11.6	3.7	17.3	7.4	5.7	7.9	12.6	9.7	19.6	11.9	26.1	13.2	11.0	9.7	15.2	7.4	8.5	9.2	15.8	6.7	5.3	15.2	5.6	24.5	14.6	37.0	15.2	5.2	5.6	24.7	24.1	12.8	29.0	31.9	28.2	8.8	24.7	30.8	7.7	14.4	31.9	17.7	31.3	9.1	33.4	33.8	25.9	46.2	4.9	26.2	12.4	4.5	5.8	17.6	6.9	14.2	42.5	13.1	20.4	19.2	49.2	28.4	20.2	11.5	28.7	28.9	31.7	12.2	21.4	29.7	18.3	10.8	17.8	21.2	18.7	16.1	7.0	17.8	18.0	20.5	40.8	14.6	45.0	46.3	5.4	49.6	25.5	5.3	5.3	15.8	4.6	6.7	5.8	8.5	8.9	7.1	7.4	4.5	6.6	7.3	3.0	5.3	4.7	9.2	15.2	5.6	10.7	19.0	15.6	9.4	11.0	10.2	13.6	9.8	10.7	11.9
GNG14		ENSG00000283980	"G protein subunit gamma 14"	A0A1W2PPG7	19	12687998-12688422	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"pancreas: 3.1;skin 1: 3.2;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.3;MCF7: 5.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	44	"thalamus: 132.6"	"Low region specificity"	"Detected in all"																															0.1	0.0		0.0		1.0	0.0		1.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.5			0.0	0.0	0.1	0.0			0.7	3.1	0.0		0.0		0.2	0.0		0.9	0.0	0.0	3.2	0.3	0.0		0.0	0.0	2.5			1.5		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	2.4	0.0	0.0	1.8	0.9	0.0	0.0	0.0	2.0	0.3	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	5.3	0.0	2.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	5.1	0.6	1.3	0.4	1.4	0.2	0.0	0.7	0.0	1.9	0.7	1.4	0.6	0.0	0.0	2.0	0.3	0.0	0.7	0.7	2.1	0.1	0.2	2.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GOLGA8B		ENSG00000215252	"Golgin A8 family member B"	A8MQT2	15	34525207-34588503	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 25.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 14.3;Hep G2: 12.7;NB-4: 19.7"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	16	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 2.2"									HPA051808	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA051808: AB_2681620"	"unprognostic (2.12e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.06e-2)"	"unprognostic (7.90e-3)"	"unprognostic (9.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (9.38e-6)"	"unprognostic (2.14e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.31e-1)"	"prognostic favourable (5.79e-4)"	2.6	3.4	0.0	2.8	0.6	6.8	4.3	2.5	2.7	2.5	2.0			0.0	4.1	6.1	0.8	3.8	2.8	1.6	0.0	0.7	3.0	2.3	4.5	8.0	0.0		9.0	25.2	0.1	4.9	0.9		5.4	0.1		4.6	5.2	1.8	3.3	5.4	0.5	0.0	5.2	4.0	5.3			16.4		3.1	3.0	1.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	2.0	2.2	0.2	4.2	2.3	4.6	6.0	1.8	0.5	2.1	3.5	2.2	2.8	0.0	4.0	1.9	1.7	0.8	1.9	1.7	2.9	7.0	0.3	14.3	12.7	3.4	1.7	2.3	6.6	2.6	1.2	3.8	2.1	0.7	0.2	1.9	1.0	0.8	19.7	2.6	3.8	0.1	0.0	0.3	1.7	4.0	3.2	4.8	1.0	0.3	2.2	1.9	3.9	0.0	3.1	7.3	0.9	3.2	1.4	1.3	2.9	1.0	0.9	0.8	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GOLGA8N		ENSG00000232653	"Golgin A8 family member N"	F8WBI6	15	32593456-32607310	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 15.2"	"Group enriched"	"Detected in some"	5	"HEL: 34.5;THP-1: 22.5;U-937: 29.4"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	6	"gdTCR: 2.7;NK-cell: 5.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 5.9;T-cells: 2.7"																				"unprognostic (2.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	2.4	1.3	0.6	1.4	0.8	7.7	2.0	0.6	0.6	3.3	1.8			0.9	2.9	9.2	1.1	3.3	0.6	2.8	0.6	0.7	1.4	1.9	1.7	1.4	1.1		5.5	15.2	5.6	5.1	0.2		2.4	0.4		1.8	1.9	2.2	2.2	1.8	1.0	1.7	2.5	1.7	6.2			11.7		0.7	3.2	2.2	0.2	0.6	0.1	0.1	5.9	2.7	0.2	0.1	0.0	0.1	0.2	1.3	1.8	0.1	0.6	0.3	0.1	0.1	0.0	0.4	0.4	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.3	34.5	0.0	0.0	0.5	0.6	0.2	0.5	0.6	0.0	0.4	0.0	0.1	0.0	0.3	0.5	0.0	6.1	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.3	0.3	0.0	0.0	0.0	22.5	1.4	0.7	0.1	0.0	0.0	1.4	1.3	0.3	0.2	29.4	0.3	0.1	0.1	0.0	2.7	0.0	0.4	0.2	0.4	0.4	0.4	0.1	0.5	0.5	0.0	5.9	0.0	0.6	0.0	0.2										
GPR119	"GPCR2, hGPCR2"	ENSG00000147262	"G protein-coupled receptor 119"	Q8TDV5	X	130384440-130385447	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.5;pancreas: 8.0"	"Group enriched"	"Detected in some"	20	"CACO-2: 2.7;Hep G2: 5.8"	"Cancer enriched"	"Detected in single"	11	"pancreatic cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"																								"prognostic favourable (6.93e-4)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR150	PGR11	ENSG00000178015	"G protein-coupled receptor 150"	Q8NGU9	5	95620078-95622142	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 11.5;pancreas: 13.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;SiHa: 3.1;TIME: 6.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.3;memory CD4 T-cell: 2.5;NK-cell: 2.1"	"Group enriched"	"Detected in many"	12	"NK-cells: 2.1;T-cells: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA026635	Uncertain									"HPA026635: AB_1849266"	"unprognostic (3.03e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.95e-2)"	"unprognostic (5.34e-4)"	"unprognostic (1.98e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.26e-1)"	1.5	0.7	4.3	0.4	2.6	0.4	1.2	0.4	11.5	0.6	0.9	0.3	0.4	0.5	0.4	0.6	0.3	0.5	0.5	0.5	2.3	1.3	0.3	0.4	1.2	1.0	0.6	8.0	0.3	13.4	3.8	1.0	0.6	0.2	0.7	0.7	1.4	0.3	1.1	0.4	1.0	0.6	0.4	0.2	0.8	2.1	0.6	0.0	0.0	0.3	0.0	0.7	0.6	0.3	0.2	0.0	0.0	0.0	2.1	2.5	0.2	0.0	0.0	0.1	0.0	3.8	1.7	0.1	1.2	0.3	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	1.4	0.0	0.1	0.3	0.0	0.5	0.0	0.6	0.0	2.0	1.4	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	2.0	1.2	3.1	0.0	0.6	0.0	0.9	6.7	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.5	0.0	2.3	0.2	2.5	0.0	0.0	0.0	1.0	0.2	0.0	2.1	0.0	0.0	0.0	0.2	4.3	2.6	0.4	11.5	2.3	1.3	0.6	8.0	0.2	0.0
GPR39		ENSG00000183840	"G protein-coupled receptor 39"	O43194	2	132416574-132646559	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 22.0"	"Cell line enhanced"	"Detected in many"		"A-431: 17.2;CAPAN-2: 14.7;hTEC/SVTERT24-B: 17.7;RT4: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	44	"dendritic cells: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022111	Approved									"HPA022111: AB_1849298"	"unprognostic (4.06e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.58e-3)"	0.5	0.1	0.6	4.9	1.1	0.0	2.2	0.4	0.3	4.8	14.4	0.1	3.5	4.7	3.2	1.8	1.5	3.4	10.0	0.7	0.5	0.5	8.7	8.6	9.3	0.0	0.6	0.0	1.4	22.0	14.1	0.4	1.3	0.6	3.0	6.0	1.6	1.3	8.7	0.1	1.0	14.4	0.8	0.3	0.1	6.5	0.8	0.0	0.6	4.1	0.0	1.0	6.5	1.9	0.0	4.3	0.0	0.0	0.0	0.0	0.0	17.2	8.2	0.1	0.0	0.3	2.3	0.0	1.2	6.2	3.3	1.9	9.4	14.7	0.0	3.3	1.0	8.2	0.0	7.1	3.2	0.0	0.0	0.0	0.9	0.3	0.3	0.0	0.0	0.6	5.4	17.7	1.7	0.0	0.0	0.0	2.3	1.4	0.0	0.0	0.1	5.3	0.0	0.2	0.0	11.3	15.5	0.0	0.1	1.0	5.8	0.0	3.3	0.0	3.0	7.1	5.3	1.5	5.2	0.0	0.0	0.0	8.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.6	1.1	0.4	0.3	0.5	0.5	0.6	0.0	0.6	0.0
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 76.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 23.9;HMC-1: 42.1;RPTEC TERT1: 56.7;RT4: 26.2;T-47d: 31.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.2;monocytes: 4.7"	"Region enriched"	"Detected in many"	9	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"				"Centriolar satellite"	"Centriolar satellite"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	4.3	4.1	5.2	2.2	5.3	0.0	7.7	31.1	5.7	19.7	15.4	4.4	17.0	10.0	5.8	9.9	5.3	12.5	17.6	7.7	5.3	2.6	43.8	46.1	11.5	2.8	4.8	4.9	12.3	76.2	12.0	3.4	4.5	6.1	15.1	6.2	18.0	16.8	11.7	25.4	9.2	15.2	3.9	4.6	5.1	44.7	4.4	4.1	1.9	42.2	10.2	3.5	12.6	8.0	0.7	10.2	0.1	4.7	0.0	0.1	0.3	4.6	16.6	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	21.4	0.0	13.2	0.1	14.7	2.2	0.3	0.0	0.0	2.7	0.0	1.2	23.9	4.9	0.0	42.1	0.4	7.6	0.0	0.0	0.0	1.2	0.3	0.0	5.2	0.1	4.5	2.7	19.4	0.0	0.0	1.0	56.7	26.2	8.0	0.7	0.8	1.8	0.0	31.9	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.0	0.6	0.1	0.0	1.7	0.1	0.0	3.4	0.0	0.7	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	4.7	10.2	0.0	0.3	5.2	5.3	31.1	5.7	5.3	2.6	4.8	4.9	6.1	4.1
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884378-46931297	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 103.0;skeletal muscle: 60.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	19.9	4.1	20.2	2.1	17.8	1.9	6.4	3.9	15.1	2.5	3.4	11.8	10.0	1.3	2.1	13.4	30.8	3.7	4.4	3.0	13.4	8.0	9.8	40.4	1.4	2.1	12.9	7.8	1.5	103.0	4.3	4.3	1.8	11.3	10.2	2.6	1.5	27.6	8.5	60.9	14.9	1.7	1.9	11.3	1.4	15.4	6.0	12.3	0.7	3.6	19.0	14.6	1.9	2.1	4.2	1.4	1.3	0.7	0.0	0.4	0.4	12.9	5.9	7.5	28.5	10.6	2.3	13.7	9.0	3.4	9.7	6.2	20.1	5.5	9.1	7.9	6.4	10.4	13.5	13.3	6.5	4.2	6.6	3.2	3.4	48.5	7.3	22.7	3.0	4.9	11.7	9.5	14.8	4.7	2.6	7.3	3.2	23.1	4.5	19.0	7.9	17.0	0.1	8.3	21.1	3.9	6.4	23.5	12.0	4.6	24.1	12.2	6.2	20.8	3.5	6.8	13.3	4.5	7.2	35.1	10.6	25.7	10.4	14.8	3.6	1.3	0.7	0.0	0.3	0.0	0.0	4.2	0.0	0.3	1.4	2.5	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	20.2	17.8	3.9	15.1	13.4	8.0	12.9	7.8	11.3	12.3
GRB10		ENSG00000106070	"Growth factor receptor bound protein 10"	Q13322	7	50590063-50793462	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 65.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 11.4;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019423, HPA027502, HPA031818"	Approved		Supported	Vesicles				Vesicles	Vesicles	"CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057"	"unprognostic (2.82e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.31e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.73e-3)"	"unprognostic (8.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (8.50e-2)"	14.3	14.6	14.7	4.9	26.7	6.5	18.8	22.0	20.9	9.7	10.5	14.6	2.0	12.3	8.9	8.0	7.3	9.0	15.6	19.1	13.8	14.8	19.8	15.6	8.3	4.3	19.8	10.7	6.5	65.8	6.0	21.5	10.6	20.9	10.6	5.1	16.5	7.0	11.7	35.7	3.7	8.4	13.0	9.9	15.9	7.2	11.4	16.9	0.4	18.3	4.2	3.2	12.7	17.3	0.0	0.1	11.4	0.2	0.0	0.4	0.1	0.1	10.6	17.4	7.0	8.2	6.3	9.2	4.3	3.7	8.3	10.1	6.4	0.1	0.2	7.6	5.4	1.0	17.9	4.5	4.1	0.1	7.2	18.3	10.8	4.6	17.4	11.4	28.3	16.3	7.1	12.8	12.7	21.2	34.5	0.2	6.3	1.2	2.0	15.4	19.0	18.4	5.3	0.0	0.1	5.5	4.2	7.6	0.0	0.5	2.7	22.7	9.2	23.2	25.9	7.4	10.1	15.0	16.2	0.7	0.2	0.1	23.4	10.4	24.9	11.4	0.1	3.5	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.1	14.7	26.7	22.0	20.9	13.8	14.8	19.8	10.7	20.9	16.9
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123556-16153021	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 24.5"	"Group enriched"	"Detected in some"	10	"PC-3: 17.6;T-47d: 22.0;U-138 MG: 30.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 6.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA069604: AB_2686158"	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.5	0.4	3.4	4.7	2.3	0.2	3.5	0.3	3.5	3.7	1.4	0.0	2.5	0.2	1.0	2.8	7.5	0.3	0.2	0.5	3.5	0.4	0.3	0.3	0.4	0.2	0.3	1.9	0.3	24.5	0.4	0.3	0.2	1.1	0.7	0.6	2.0	0.4	0.4	0.4	0.3	0.5	1.2	0.4	0.3	2.1	0.4	0.0	0.0	0.4	0.0	0.2	0.4	0.4	0.6	0.2	0.4	1.9	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.5	0.0	2.3	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.2	17.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	22.0	0.0	0.1	30.1	0.3	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.4	0.0	1.6	0.1	0.0	0.4	3.4	2.3	0.3	3.5	3.5	0.4	0.3	1.9	1.1	0.0
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750089-52763569	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 63.4;liver: 192.2;pancreas: 54.1"	"Group enriched"	"Detected in some"	20	"CACO-2: 20.3;Hep G2: 15.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: "	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.2	1.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	6.4	0.2	0.2	13.4	0.2	0.3	0.2	0.0	9.9	0.2	0.2	0.0	63.4	192.2	5.3	0.2	0.2	0.2	0.3	54.1	0.0	0.2	0.3	0.2	0.7	0.0	0.2	0.3	0.2	0.2	0.0	27.6	0.2	0.2	0.2	1.5	14.1	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	20.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	15.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
H2AFB2		ENSG00000277858	"H2A histone family member B2"	P0C5Z0	X	155380787-155381134	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.3;pancreas: 2.4;salivary gland: 2.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;CAPAN-2: 3.2;HeLa: 4.2;NB-4: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.3		0.0		0.0	0.0		0.1	0.0	0.3			2.3	0.0	0.0	0.5	0.0	0.0	1.3			0.1	0.0	0.0	0.2			0.2	2.4	0.0		0.1		0.0	0.1		2.8	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.4			0.0		0.0	0.0		0.4	0.6	0.0	0.3	0.0	0.4	1.2	2.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.7	1.1	0.0	0.0	0.2	1.5	0.0	4.2	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.1	2.6	0.0	0.0	0.7	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.2	0.4	0.9	0.0	2.0	1.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.2										
HDLBP	"HBP, VGL"	ENSG00000115677	"High density lipoprotein binding protein"	Q00341	2	241227264-241317061	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 210.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004189, CAB026457"	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"CAB026457: , HPA004189: AB_1079044"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.58e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (6.39e-5)"	"prognostic unfavourable (4.12e-4)"	38.2	38.7	18.1	18.1	27.7	15.9	37.4	18.1	27.0	39.6	30.4	24.7	38.2	22.5	34.8	43.2	35.3	38.7	30.9	37.5	17.9	15.9	33.9	92.0	29.9	20.9	19.8	16.6	40.1	210.4	40.5	40.0	44.4	22.5	35.9	29.4	26.1	105.2	34.3	80.2	27.6	36.1	29.9	18.5	23.0	39.2	39.6	19.3	20.8	39.0	45.7	34.7	31.9	31.0	10.9	22.4	11.6	28.8	10.1	12.3	12.4	33.8	27.3	28.6	45.5	73.0	89.6	40.6	84.6	86.8	38.5	55.0	24.4	34.7	10.3	10.3	122.4	27.2	42.5	55.4	63.1	16.4	26.3	32.9	34.4	59.5	71.5	23.5	28.8	66.2	45.0	55.9	63.0	52.4	31.3	13.9	60.0	35.3	13.5	12.3	27.6	18.1	12.6	55.5	20.5	31.4	40.4	23.8	27.3	36.9	38.9	33.0	30.7	23.0	65.8	47.1	30.0	65.0	35.4	16.4	13.5	18.3	59.7	17.6	43.1	11.6	20.0	9.1	9.3	21.9	12.3	10.9	10.6	11.1	22.4	7.4	9.6	8.9	11.5	10.1	28.8	14.7	9.8	12.4	18.1	27.7	18.1	27.0	17.9	15.9	19.8	16.6	22.5	19.3
HEXDC	FLJ23825	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 30.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"				"Nucleoli fibrillar center, Mitochondria"	"Nucleoli fibrillar center, Mitochondria"	"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favourable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favourable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (2.52e-5)"	12.7	8.5	7.1	16.6	9.3	14.3	8.7	13.2	7.3	10.1	7.6	8.8	12.8	8.0	10.0	11.1	7.9	10.3	9.4	5.7	7.2	4.6	9.9	11.6	12.4	11.6	12.8	5.5	13.6	72.9	10.2	14.6	5.7	7.4	14.1	4.2	7.0	13.3	9.2	20.4	11.3	12.3	6.0	6.1	15.6	8.8	4.7	11.4	8.6	11.7	8.6	10.7	8.3	8.8	5.9	30.3	3.3	11.5	11.9	9.8	4.4	3.0	7.6	3.4	5.2	10.2	8.9	10.4	3.8	4.7	4.1	4.6	2.6	10.3	7.9	4.2	1.6	4.2	2.0	2.3	1.9	5.5	12.9	3.6	6.7	4.5	9.2	2.4	9.2	6.3	2.3	1.1	4.1	5.2	4.5	2.7	1.1	6.9	8.3	8.9	3.1	4.6	9.8	2.8	15.5	3.1	4.5	4.7	10.1	8.0	5.2	7.2	8.4	9.1	5.2	2.6	5.0	2.0	2.6	12.5	2.3	5.9	2.1	6.8	2.7	3.3	1.7	2.7	9.8	11.5	6.5	4.6	2.2	3.4	2.0	5.9	3.5	5.1	3.0	11.9	4.9	30.3	1.4	4.4	7.1	9.3	13.2	7.3	7.2	4.6	12.8	5.5	7.4	11.4
HEYL	"bHLHb33, HESR3, HEY3"	ENSG00000163909	"Hes related family bHLH transcription factor with YRPW motif-like"	Q9NQ87	1	39624153-39639945	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 66.3"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 17.3;RH-30: 21.4;THP-1: 4.9;U-266/84: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001438, HPA076960"	Approved		Approved	Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA001438: AB_1079052, HPA076960: AB_2732326"	"unprognostic (1.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.19e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (2.26e-6)"	"prognostic unfavourable (3.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.63e-5)"	10.0	8.3	2.9	4.7	6.2	0.5	6.5	1.8	4.0	14.7	4.4	2.9	5.1	1.9	21.7	13.2	4.0	11.2	13.9	28.2	3.2	4.8	12.3	3.3	12.5	2.0	6.8	2.9	14.4	66.3	1.7	8.2	22.1	7.1	8.1	2.9	10.9	2.3	11.4	8.9	1.9	2.7	18.9	2.4	4.5	3.4	25.4	4.4	0.0	11.0	6.8	1.9	6.0	8.8	1.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	2.4	3.9	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	1.6	0.2	0.0	1.4	0.4	0.0	2.2	0.0	0.2	0.0	2.6	4.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.5	17.3	1.4	0.0	0.0	0.0	0.1	1.1	21.4	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.2	0.0	0.0	0.6	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.2	1.8	4.0	3.2	4.8	6.8	2.9	7.1	4.4
HIST4H4	MGC24116	ENSG00000197837	"Histone cluster 4 H4"	P62805	12	14767999-14771131	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.7"	"Low lineage specificity"	"Detected in all"											"CAB011503, CAB037279, HPA042201"	Supported		Supported	Nucleoplasm		30000000	30000000	Nucleoplasm	Nucleoplasm	"CAB011503: AB_873863, CAB037279: AB_1079064, HPA042201: AB_2677898"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-3)"	7.1	4.6	2.3	7.4	7.6	2.5	4.7	6.7	4.9	6.9	6.2	1.1	3.3	5.0	5.4	7.1	8.9	6.0	5.4	5.9	2.8	2.5	11.0	3.3	6.3	7.2	2.5	2.1	8.3	36.7	2.1	5.1	7.1	2.1	16.0	4.8	6.1	12.7	5.5	2.8	6.4	8.9	3.3	3.1	21.8	10.1	6.6	1.7	16.9	9.9	6.8	18.6	6.6	6.8	5.5	3.6	19.7	2.1	2.1	3.4	1.1	2.1	0.8	0.1	2.6	2.8	0.0	1.5	1.3	0.1	1.0	0.9	1.4	7.9	1.9	0.5	0.7	1.3	0.0	1.0	0.6	2.5	1.1	0.0	5.1	2.0	0.8	0.5	1.9	2.0	0.6	0.2	1.1	0.0	0.0	2.5	0.1	1.1	0.5	0.7	2.7	0.3	2.2	0.0	3.9	0.0	5.8	1.0	1.4	5.2	1.3	0.3	0.9	1.0	1.7	0.5	4.2	1.1	1.6	2.8	1.6	5.8	1.9	0.0	1.3	0.0	1.9	0.2	2.0	2.1	3.4	4.1	2.3	2.2	2.1	5.5	2.0	2.2	19.7	2.1	0.7	3.6	3.2	1.1	2.3	7.6	6.7	4.9	2.8	2.5	2.5	2.1	2.1	1.7
HOMER2	"CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2"	ENSG00000103942	"Homer scaffolding protein 2"	Q9NSB8	15	82836946-82986153	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 80.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 21.1;Karpas-707: 37.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040134, CAB079014"	Uncertain	Supported	Supported	Cytosol				Cytosol	Cytosol	"CAB079014: , HPA040134: AB_10795272"	"unprognostic (7.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.75e-4)"	"unprognostic (3.31e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.16e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.45e-3)"	0.7	2.9	3.9	0.5	3.8	1.6	9.9	5.1	6.5	8.9	1.4	4.6	2.7	3.2	3.4	13.0	8.0	9.6	12.9	12.5	5.0	3.1	2.8	19.4	2.5	1.0	2.5	4.2	1.7	80.9	2.7	4.5	0.4	13.2	21.8	0.6	12.7	34.5	2.0	36.0	15.9	0.6	0.7	5.4	2.3	17.8	2.3	2.0	0.2	13.4	14.2	5.0	0.8	4.3	1.4	4.1	1.6	0.6	0.4	1.1	1.0	6.4	2.7	2.9	7.6	0.0	0.0	0.4	0.4	0.0	0.7	0.2	0.5	4.6	0.0	3.6	3.3	3.6	21.1	9.9	0.5	17.5	13.4	4.1	0.1	3.2	0.2	0.1	13.3	0.7	15.2	0.2	0.8	0.0	0.1	37.4	2.8	18.8	1.2	0.4	4.6	2.0	0.8	4.6	2.2	10.2	7.9	20.7	5.3	7.4	5.7	6.9	6.9	1.4	0.1	7.0	13.0	0.5	5.9	4.8	2.2	0.7	11.9	0.1	2.5	0.3	0.6	1.5	0.4	0.5	0.3	0.7	0.8	0.2	4.1	1.4	0.6	0.4	1.6	0.4	0.3	1.8	1.1	1.0	3.9	3.8	5.1	6.5	5.0	3.1	2.5	4.2	13.2	2.0
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204642-33206831	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.8"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.5;T-47d: 9.4;U-266/70: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					52000	52000			"HPA042132: AB_10793978"	"prognostic favourable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favourable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favourable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	3.5	11.5	4.1	5.4	4.1	3.0	6.1	3.4	5.9	5.3	12.4	5.3	17.7	6.6	3.2	14.7	11.3	8.1	8.6	11.0	4.1	3.7	13.9	24.0	8.1	7.7	5.3	4.6	3.3	47.8	12.8	6.6	3.5	4.7	4.5	5.6	9.3	16.7	30.1	14.6	10.6	11.2	4.1	5.3	5.4	5.8	5.1	2.4	10.3	11.2	15.5	10.7	5.3	5.2	4.8	4.8	0.4	3.1	4.1	7.8	6.0	1.1	2.1	0.9	1.3	0.3	0.6	0.3	0.1	0.6	0.0	0.0	1.5	2.5	6.9	1.9	0.1	4.1	1.0	3.2	0.1	1.1	1.2	0.3	2.0	3.7	3.0	0.0	0.5	0.7	4.2	0.0	7.3	0.3	0.1	6.7	0.5	2.3	5.1	0.1	0.3	0.9	3.0	0.1	14.5	4.0	0.1	2.0	1.1	0.4	5.5	1.3	9.4	0.2	0.1	0.2	1.2	0.0	0.0	14.3	6.9	2.5	0.4	0.1	0.2	0.0	1.4	0.4	4.8	3.1	7.8	4.8	7.2	7.3	2.8	3.1	7.6	7.8	0.1	4.1	3.1	4.8	5.2	6.0	4.1	4.1	3.4	5.9	4.1	3.7	5.3	4.6	4.7	2.4
HSPB9	CT51	ENSG00000260325	"Heat shock protein family B (small) member 9"	Q9BQS6	17	42121431-42123352	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;pancreas: 2.8;testis: 7.2"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 3.9"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"														"unprognostic (2.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.42e-6)"	"unprognostic (2.31e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.68e-4)"	"unprognostic (4.78e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	0.0	0.1		0.3		0.4	0.0		0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	1.5	0.0	0.0			0.4	2.8	0.0		0.0		0.0	0.0		1.3	0.0	0.5	0.3	0.1	0.0		0.1	0.1	7.2			0.0		0.0	0.0		1.2	2.3	1.9	1.2	0.3	1.2	0.2	0.6	0.9	0.9	2.1	0.0	0.0	3.4	0.8	0.0	0.2	0.5	2.5	0.7	0.8	0.3	0.0	0.8	0.5	0.2	0.0	0.4	3.1	0.8	1.2	0.6	0.0	0.7	1.7	0.1	0.1	0.1	0.0	0.0	1.4	0.8	0.0	0.5	1.1	2.6	0.9	0.0	0.7	0.9	1.2	0.0	1.2	1.7	0.6	0.1	3.9	1.0	1.1	0.4	1.1	1.0	1.1	1.4	0.8	2.3	0.7	1.0	0.4	1.0	0.5	0.6	0.5	0.4	0.4	0.1	0.9	0.4	0.8	0.2	0.7	1.2	1.2	0.5	1.9	0.3	1.2	2.3	0.3	0.2										
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 58.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.2;MCF7: 15.2;RT4: 17.8;SCLC-21H: 24.9;SH-SY5Y: 41.0;SK-BR-3: 19.5;T-47d: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"T-reg: 20.8"	"Lineage enriched"	"Detected in many"	8	"T-cells: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA017646: AB_1851382, HPA061452: AB_2684525"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favourable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	8.9	6.1	12.6	4.2	15.3	11.7	13.0	19.4	24.2	10.7	13.2	2.5	8.7	7.7	5.5	8.5	5.8	8.1	10.4	25.7	7.7	7.8	9.1	5.3	9.2	6.9	4.8	12.4	1.6	58.6	13.2	13.5	4.6	10.5	13.7	14.3	2.5	21.2	8.3	2.8	7.0	10.4	3.7	2.8	7.6	17.9	16.0	3.2	0.8	8.1	4.1	5.5	9.6	4.1	0.3	1.7	2.4	1.6	0.7	20.8	1.1	0.0	0.3	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.3	16.2	0.1	1.6	0.0	0.0	0.3	0.7	0.0	0.0	2.4	3.4	0.3	0.0	0.1	2.8	0.5	0.0	1.1	0.0	0.0	11.8	9.5	0.0	0.0	15.2	0.1	0.0	3.7	0.1	0.0	0.0	7.0	6.9	17.8	24.9	41.0	0.0	19.5	0.2	15.8	5.1	6.9	0.0	0.3	0.0	0.3	5.1	2.4	0.0	0.0	2.2	3.4	0.5	1.6	0.1	0.2	0.5	0.4	0.2	3.9	0.3	1.7	0.3	0.2	0.1	2.4	0.7	0.2	0.4	20.8	1.1	12.6	15.3	19.4	24.2	7.7	7.8	4.8	12.4	10.5	3.2
IFNL2	"IL-28A, IL28A"	ENSG00000183709	"Interferon lambda 2"	Q8IZJ0	19	39268514-39270092	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 4.1;testis: 1.7"	"Cell line enriched"	"Detected in single"	24	"HDLM-2: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025489	Uncertain				"Secreted to blood"					"CAB025489: "	"unprognostic (1.37e-1)"	"unprognostic (2.84e-1)"				"unprognostic (1.05e-1)"				"unprognostic (2.11e-2)"	"unprognostic (1.08e-1)"			"unprognostic (6.96e-2)"				0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFRD1	"PC4, TIS7"	ENSG00000006652	"Interferon related developmental regulator 1"	O00458	7	112422968-112481017	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 93.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 25.6;neutrophil: 44.2"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024122	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA024122: AB_1851452"	"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.48e-2)"	"prognostic favourable (5.45e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.70e-2)"	19.5	18.0	16.7	12.9	19.6	83.1	24.0	14.3	15.7	10.7	18.3	15.6	11.7	18.7	15.7	12.5	12.7	11.4	12.7	16.0	15.2	13.3	11.9	14.1	19.2	7.9	30.9	13.2	16.9	93.0	12.5	23.1	18.7	16.9	14.7	11.7	11.2	14.3	11.0	37.6	12.3	19.0	23.9	28.2	11.7	17.7	17.9	22.0	7.5	16.5	13.5	7.4	14.7	37.5	3.8	2.9	44.2	3.2	3.4	3.7	2.6	15.0	10.2	15.8	14.8	27.0	17.5	14.6	14.9	14.3	19.4	17.4	16.8	12.8	7.3	28.6	7.8	9.0	10.9	12.6	26.5	12.4	15.6	8.2	18.8	16.0	30.9	11.1	6.5	13.4	27.1	20.4	23.4	8.0	25.1	16.5	7.8	13.6	14.1	18.8	35.9	17.8	12.3	6.3	13.6	5.9	4.2	25.4	13.1	17.0	14.5	48.3	5.6	12.0	6.9	32.9	7.0	25.7	45.0	14.8	17.5	20.0	9.0	31.0	37.7	5.7	3.2	25.6	3.6	2.8	2.8	3.8	3.5	3.4	2.9	3.0	3.4	3.3	44.2	3.4	2.8	2.1	3.7	2.6	16.7	19.6	14.3	15.7	15.2	13.3	30.9	13.2	16.9	22.0
IFT20		ENSG00000109083	"Intraflagellar transport 20"	Q8IY31	17	28328325-28335489	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 77.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021376	Approved		Approved	Microtubules				Microtubules	Microtubules	"HPA021376: AB_1851460"	"unprognostic (1.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (8.65e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.19e-3)"	"prognostic unfavourable (5.09e-7)"	"unprognostic (1.67e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.71e-3)"	11.4	17.1	15.3	10.8	15.4	37.6	15.9	20.0	15.9	12.4	16.3	8.8	20.7	16.6	11.9	23.7	10.8	13.5	18.8	9.8	13.8	14.6	15.1	23.3	11.8	12.9	18.7	13.1	11.4	77.1	9.7	26.1	16.9	14.4	14.7	12.0	11.2	26.7	19.2	4.5	8.1	18.3	16.6	13.4	12.7	19.0	28.6	15.9	9.6	20.6	7.7	11.0	15.7	13.9	24.2	41.0	38.1	36.9	17.2	25.2	26.8	10.9	15.4	10.4	8.4	31.0	31.7	9.9	19.1	23.1	11.7	18.4	23.3	5.1	5.3	10.3	23.3	11.6	6.7	14.0	17.2	21.9	29.1	3.2	16.3	10.7	30.1	13.4	6.8	24.0	18.8	10.0	16.3	18.5	9.5	13.7	9.2	14.8	11.8	10.9	6.9	8.7	5.6	13.7	13.6	18.4	10.6	13.0	18.9	12.7	26.6	28.9	16.8	14.9	20.6	7.2	10.6	10.3	10.2	20.0	17.3	6.7	25.7	9.8	10.2	20.8	36.9	26.5	21.3	25.7	25.2	22.8	22.3	21.5	41.0	24.2	22.9	20.0	38.1	17.2	23.4	29.6	23.0	26.8	15.3	15.4	20.0	15.9	13.8	14.6	18.7	13.1	14.4	15.9
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 165.3;pancreas: 228.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 138.4;HMC-1: 322.9;NB-4: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	1000000000	1000000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA077723: AB_2686853"	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	21.7	6.4	0.9	13.7	2.8	2.6	17.5	1.0	10.4	11.9	12.6	4.5	20.6	11.4	28.7	37.7	26.4	19.4	11.8	29.6	1.5	0.9	21.3	165.3	8.7	3.8	1.4	3.4	35.7	228.7	0.8	8.2	32.0	7.6	25.7	5.2	8.0	9.1	32.6	5.3	3.1	7.8	7.5	1.8	46.7	50.2	13.7	1.0	12.1	8.4	29.3	12.9	23.4	11.4	0.0	0.3	0.0	0.4	2.0	0.8	1.3	0.0	3.2	25.3	24.6	138.4	42.3	0.5	7.7	3.8	0.3	0.0	0.0	0.0	0.0	10.8	0.0	0.7	9.0	9.6	0.0	0.0	5.2	5.5	0.0	1.5	3.4	2.3	322.9	14.1	1.0	0.1	0.4	0.0	0.2	0.7	0.1	6.2	9.6	66.6	27.3	0.3	8.3	0.5	0.1	0.1	7.1	5.3	27.9	0.0	0.2	0.1	20.7	4.1	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.5	0.3	10.6	29.5	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	1.3	0.9	2.8	1.0	10.4	1.5	0.9	1.4	3.4	7.6	1.0
IL12RB2		ENSG00000081985	"Interleukin 12 receptor subunit beta 2"	Q99665	1	67307364-67396900	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.2;pancreas: 15.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.4;SCLC-21H: 8.7;SK-MEL-30: 21.9;THP-1: 12.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 18.2"	"Group enriched"	"Detected in many"	42	"NK-cells: 18.2;T-cells: 6.1"	"Region enhanced"	"Detected in single"		"olfactory region: 1.8"	"Low region specificity"	"Detected in all"			HPA024168	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA024168: AB_1851629"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.90e-1)"	3.8	1.0	1.8	3.1	3.6	1.5	3.7	0.6	7.7	2.4	1.0	0.0	0.0	0.7	0.8	1.1	3.2	0.9	1.1	5.2	9.6	1.1	1.5	1.4	1.8	4.3	1.0	6.0	0.8	15.0	0.9	0.8	14.1	1.6	1.2	0.9	1.3	7.2	1.7	11.4	2.1	1.4	1.0	1.0	2.5	1.0	2.3	0.0	1.1	1.1	3.2	1.6	1.4	1.2	0.0	0.0	0.2	0.0	18.2	6.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.1	2.0	1.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.4	0.0	0.0	21.9	0.0	12.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	2.7	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.2	18.2	0.0	0.0	3.9	1.0	1.8	3.6	0.6	7.7	9.6	1.1	1.0	6.0	1.6	0.0
IL32	"NK4, TAIF, TAIFb, TAIFd"	ENSG00000008517	"Interleukin 32"	P24001	16	3065297-3082192	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 216.2;liver: 316.2;pancreas: 196.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 66.4;CAPAN-2: 45.1;HDLM-2: 94.6;Hep G2: 64.4;Karpas-707: 56.6;RH-30: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 216.2"	"Lineage enriched"	"Detected in many"	9	"T-cells: 216.2"									"HPA029397, CAB030029"	Uncertain				"Secreted to blood"					"CAB030029: AB_1089175, HPA029397: AB_10612120"	"unprognostic (2.00e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.86e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.29e-3)"	18.8	6.1	2.7	45.3	3.3	3.9	16.7	1.4	1.9	4.5	46.5	2.2	4.7	36.3	6.3	10.9	7.7	3.1	18.3	21.5	2.4	2.5	78.1	316.2	42.8	43.3	3.5	1.9	6.7	196.4	0.0	3.3	8.3	3.1	9.5	15.6	4.0	23.5	4.1	51.4	3.5	149.0	8.7	3.9	73.8	8.1	4.6	1.5	48.8	21.3	113.6	40.3	10.5	11.2	0.4	0.6	2.3	0.5	24.7	216.2	88.7	33.8	1.4	0.1	0.0	0.0	3.9	2.7	1.6	4.2	2.1	3.4	66.4	45.1	0.0	8.3	0.9	1.4	0.1	4.0	2.5	94.6	0.3	0.1	6.8	64.4	7.8	0.1	2.9	4.7	0.4	1.8	7.5	8.1	0.0	56.6	2.6	0.2	42.1	1.0	0.9	0.9	0.1	48.3	4.4	32.1	2.1	0.0	0.5	14.9	1.0	0.2	0.9	0.5	21.9	8.0	9.3	0.4	4.8	0.6	1.4	0.2	0.1	41.9	4.1	1.1	0.5	0.5	134.0	0.4	132.1	0.4	122.1	126.9	0.4	0.4	47.6	89.8	2.3	24.7	0.4	0.6	216.2	88.7	2.7	3.3	1.4	1.9	2.4	2.5	3.5	1.9	3.1	1.5
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030883	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 90.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 67.4;RPTEC TERT1: 32.6;SiHa: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.4;neutrophil: 18.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.3;granulocytes: 18.7;monocytes: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029561	Approved		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	6.2	2.8	1.5	5.2	1.9	6.9	10.7	0.3	1.5	6.8	12.2	0.7	1.6	5.6	7.3	3.0	40.3	4.1	17.5	20.1	1.4	0.5	41.3	21.0	6.5	4.6	2.2	0.3	3.1	90.1	1.0	5.7	35.6	1.3	17.5	7.8	3.4	9.8	2.5	55.0	30.4	9.2	40.0	1.4	4.8	13.5	1.5	2.0	3.1	8.0	31.4	10.3	22.6	14.7	0.7	5.3	18.7	6.8	0.1	0.6	1.8	6.9	10.8	2.9	5.2	3.8	2.8	67.4	1.8	4.8	0.8	1.1	8.6	5.6	1.5	4.3	2.6	4.8	3.4	1.8	0.2	8.2	4.2	0.0	14.2	7.4	2.2	11.9	0.6	6.4	9.7	2.6	1.3	1.0	1.7	0.0	2.8	7.0	4.8	6.3	10.2	8.2	8.2	8.1	7.1	32.6	3.9	3.9	0.0	40.7	9.2	3.9	8.7	14.9	0.0	1.5	2.8	19.9	1.8	5.6	14.8	4.1	6.4	8.0	2.5	3.3	6.8	14.4	0.4	4.9	0.2	0.7	0.4	0.1	5.3	0.2	0.2	0.3	18.7	0.1	3.0	3.7	0.6	1.8	1.5	1.9	0.3	1.5	1.4	0.5	2.2	0.3	1.3	2.0
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294034	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 64.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.6;U-266/70: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		72000	72000	Vesicles	Vesicles	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.9	14.7	7.1	3.5	8.2	4.5	12.0	12.0	8.2	10.3	15.2	11.7	10.6	8.4	15.5	6.1	4.7	13.1	7.7	17.7	6.4	5.8	18.7	32.5	5.3	2.2	10.1	4.9	28.3	64.5	11.6	11.6	26.2	8.0	10.5	8.9	11.0	12.0	10.6	15.1	7.3	16.0	10.6	6.8	47.3	8.7	6.9	9.7	2.2	17.1	5.0	3.2	11.3	16.0	1.1	8.8	5.1	10.5	0.8	0.7	1.3	3.7	2.1	1.9	2.9	10.6	3.7	6.4	2.1	1.9	1.2	1.2	5.3	4.3	4.7	5.3	3.8	1.0	4.6	0.9	0.7	0.0	3.7	0.0	1.5	11.5	4.6	2.2	3.8	5.7	2.4	0.1	2.8	2.1	5.7	30.6	0.9	1.7	1.6	3.8	1.8	3.3	16.3	1.1	4.1	0.1	15.5	3.7	2.8	3.8	2.0	2.1	0.9	10.8	2.0	2.2	1.4	4.7	2.8	22.6	12.3	10.9	2.6	3.8	0.0	2.0	8.2	5.1	0.2	7.8	0.3	0.8	0.3	0.1	8.8	1.1	0.7	0.1	1.7	0.8	10.5	7.4	0.0	1.3	7.1	8.2	12.0	8.2	6.4	5.8	10.1	4.9	8.0	9.7
KAAG1	"RU2, RU2AS"	ENSG00000146049	"Kidney associated antigen 1"	Q9UBP8	6	24356903-24358284	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.1;pancreas: 4.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 8.5;EFO-21: 6.8;Hep G2: 8.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036021	Approved									"HPA036021: AB_10601918"	"unprognostic (7.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"		"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.3	0.9	0.0	0.1	0.4	0.0	0.0	0.0	9.1	1.3	0.0	0.0	0.0		0.1	4.3	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			1.7		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.0;CACO-2: 3.7;Hep G2: 10.9;SCLC-21H: 5.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol				Cytosol	Cytosol	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	26.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	10.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.8	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9
KCNJ8	Kir6.1	ENSG00000121361	"Potassium voltage-gated channel subfamily J member 8"	Q15842	12	21764955-21775581	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 60.1;pancreas: 47.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 41.5;HSkMC: 8.4;SH-SY5Y: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031066	Uncertain									"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	14.6	12.9	3.2	2.7	3.4	0.0	14.7	1.7	5.1	7.7	6.6	2.3	3.6	2.0	10.6	4.5	6.7	5.9	6.3	60.1	2.2	1.7	6.4	29.7	12.4	3.5	2.9	3.0	12.4	47.6	1.7	3.8	4.9	3.7	10.6	1.6	8.8	2.9	15.7	15.0	2.4	3.8	13.2	2.6	3.8	6.5	3.4	2.8	0.9	8.4	7.0	1.2	11.4	5.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	5.1	3.4	0.0	5.6	4.5	6.4	3.3	41.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.9	0.0	2.0	1.3	0.0	0.0	0.1	0.0	0.0	8.4	0.0	2.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.8	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.4	1.7	5.1	2.2	1.7	2.9	3.0	3.7	2.8
KCNK16	"K2p16.1, TALK-1, TALK1"	ENSG00000095981	"Potassium two pore domain channel subfamily K member 16"	Q96T55	6	39314698-39322968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 22.4;stomach 1: 11.3"	"Cell line enriched"	"Detected in single"	406	"SCLC-21H: 54.6"	"Cancer enriched"	"Detected in some"	17	"pancreatic cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.6"					"Low region specificity"	"Detected in all"																								"unprognostic (3.29e-2)"					"unprognostic (3.48e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	22.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.1	11.3	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.4	4.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783814-40840452	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 40.1;retina: 23.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 5.8;K-562: 5.8;MCF7: 3.4;REH: 3.0;THP-1: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain									"HPA018305: "	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	2.5	0.9	1.1	1.5	2.9	0.4	1.3	3.8	3.6	2.5	9.1	0.9	1.5	1.5	5.8	0.9	3.5	4.6	2.8	2.1	1.6	0.7	0.4	0.4	1.4	0.4	1.4	2.1	1.6	40.1	0.5	0.6	2.1	1.3	3.3	1.7	23.0	5.4	5.3	5.9	1.1	2.3	7.5	2.0	0.4	2.9	1.2	1.4	0.5	0.6	0.9	0.4	5.3	2.5	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.3	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.6	0.0	0.0	3.9	0.0	0.0	0.1	5.8	1.9	0.3	0.0	0.4	0.4	0.2	0.5	0.0	0.0	0.0	0.0	5.8	0.1	0.0	3.4	0.7	0.0	0.4	0.1	3.0	0.0	0.0	0.6	0.0	2.6	0.5	0.0	1.5	0.6	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.4	1.1	2.9	3.8	3.6	1.6	0.7	1.4	2.1	1.3	1.4
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.1;Hep G2: 16.5;RPTEC TERT1: 26.8;U-2 OS: 12.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	Nucleoplasm	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (3.96e-5)"	"prognostic favourable (8.01e-4)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favourable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.0	0.3	0.3	0.8	0.4	2.1	1.1	0.9	2.0	5.0	7.8	5.1	0.0	5.6	0.6	0.6	0.3	15.1	5.3	0.2	7.7	0.0	1.8	16.5	3.0	0.1	0.0	2.4	0.4	8.2	6.5	0.5	0.1	0.0	0.8	0.1	0.2	0.4	3.8	0.3	0.2	0.0	0.0	26.8	2.0	1.3	0.1	0.0	0.1	2.5	0.8	0.6	0.4	0.1	12.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8
KDELR3		ENSG00000100196	"KDEL endoplasmic reticulum protein retention receptor 3"	O43731	22	38468062-38483447	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 48.5;salivary gland: 57.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.8;BJ: 36.3;BJ hTERT+: 37.4;fHDF/TERT166: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043477, HPA076405"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA043477: AB_10962952, HPA076405: AB_2686797"	"unprognostic (1.76e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (6.05e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.07e-2)"	10.5	4.0	1.3	3.4	1.4	0.2	11.6	0.9	1.3	15.7	7.7	1.8	5.3	6.6	6.2	14.8	5.5	5.7	20.9	14.2	1.5	1.1	10.9	44.5	8.6	5.8	1.0	1.2	7.2	48.5	9.3	12.4	11.6	1.8	9.2	10.3	5.5	57.2	7.1	2.1	3.6	15.1	6.6	2.2	3.0	15.5	4.1	0.9	1.1	6.7	6.5	16.9	6.8	6.5	1.2	4.3	0.9	0.1	0.3	2.4	0.3	6.9	2.2	1.8	7.7	30.6	57.8	1.3	36.3	37.4	8.9	22.3	3.9	9.2	0.0	7.7	59.0	1.0	1.8	2.2	10.8	0.0	4.1	0.5	1.9	11.0	13.5	0.0	4.9	21.3	1.7	11.2	1.2	10.7	1.7	0.0	14.7	11.4	0.0	0.2	0.4	6.3	0.0	0.5	2.3	10.8	0.9	0.1	0.9	9.3	0.5	4.6	2.7	0.4	8.2	9.6	6.0	33.0	3.6	0.3	0.1	0.0	15.5	0.0	13.3	0.0	0.1	0.0	0.8	0.1	2.4	1.2	0.8	0.2	0.2	0.4	0.8	0.8	0.9	0.3	0.1	4.3	0.7	0.3	1.3	1.4	0.9	1.3	1.5	1.1	1.0	1.2	1.8	0.9
KIAA1324	"EIG121, maba1"	ENSG00000116299	KIAA1324	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8;salivary gland: 169.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.1;SCLC-21H: 9.1;SK-BR-3: 11.0;T-47d: 37.8;U-87 MG: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favourable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favourable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.7	0.9	3.7	3.6	7.9	0.0	16.4	0.7	5.6	23.9	11.8	0.4	0.0	14.6	5.5	5.7	1.3	7.8	19.1	0.6	3.3	2.3	0.6	0.6	2.2	0.7	1.0	2.7	1.2	79.8	6.1	46.6	0.0	1.1	15.8	10.0	0.0	169.4	0.0	0.6	2.5	16.5	0.2	0.9	0.9	27.3	9.4	1.1	0.0	3.9	5.2	11.5	0.9	0.6	0.2	0.0	33.8	0.0	0.2	4.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	14.1	0.1	0.1	0.2	0.0	0.0	0.1	0.5	0.2	0.0	9.1	0.2	0.0	11.0	0.0	37.8	0.0	0.2	0.0	1.4	0.0	0.1	0.8	2.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.9	0.2	3.9	1.7	0.0	0.0	1.8	0.7	33.8	0.2	0.0	0.0	4.6	1.0	3.7	7.9	0.7	5.6	3.3	2.3	1.0	2.7	1.1	1.1
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.1;kidney: 51.5;pancreas: 42.1"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020192, HPA024127"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.4	0.0	0.8	0.8	1.2	0.0	9.1	0.8	0.6	3.3	5.8	0.4	3.3	11.8	4.7	18.0	0.5	3.8	33.1	0.4	0.4	0.2	51.5	9.8	1.0	0.4	0.4	0.5	1.1	42.1	0.0	0.6	1.3	0.4	2.4	1.7	0.8	1.8	4.2	0.4	0.4	7.3	0.4	0.4	0.4	5.5	1.5	0.4	1.0	11.6	0.4	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	3.6	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.1	0.4	0.0	0.0	0.0	30.9	0.1	4.5	0.1	0.0	0.6	0.0	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.8	0.6	0.4	0.2	0.4	0.5	0.4	0.4
KLF14	BTEB5	ENSG00000266265	"Kruppel like factor 14"		7	130731235-130734061	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.3;pancreas: 1.8;placenta: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;BJ hTERT+: 3.9;RH-30: 4.3;SK-MEL-30: 1.7"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044729	Uncertain									"HPA044729: AB_10960356"	"unprognostic (4.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.92e-1)"		"unprognostic (9.90e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	2.3	1.7		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.4	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.2	1.8	0.0		2.9		0.0	0.0		0.0	0.0	1.6	0.3	0.0	0.5		0.5	0.0	1.1			0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	2.9	0.8	3.9	1.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	1.7	0.5	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KSR1	"KSR, RSU2"	ENSG00000141068	"Kinase suppressor of ras 1"	Q8IVT5	17	27456470-27626438	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 57.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 87.7;HEL: 31.5;HMC-1: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009623, HPA011215"	Uncertain									"CAB009623: AB_2265455, HPA011215: AB_1852649"	"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-5)"	"unprognostic (8.36e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (1.00e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.61e-2)"	10.5	9.3	15.3	12.5	16.0	9.5	7.7	20.5	18.5	15.5	6.1	20.5	7.0	5.4	17.9	7.0	15.5	9.3	21.2	7.0	17.5	7.0	12.4	3.8	12.4	8.6	18.3	12.5	14.4	57.7	7.3	8.9	29.4	16.2	7.9	5.9	19.8	4.7	13.4	17.5	13.8	7.6	13.7	12.0	12.2	5.1	11.5	19.9	5.2	16.3	3.3	9.4	8.9	13.5	0.9	1.1	7.0	4.1	1.5	1.1	0.7	1.0	4.1	2.5	1.3	2.2	1.5	15.1	0.9	2.0	1.4	1.7	12.4	0.1	1.0	2.2	1.8	0.6	2.5	0.5	0.8	87.7	2.8	31.5	4.0	5.1	3.8	0.4	21.7	1.9	0.9	4.1	0.1	8.0	16.4	0.1	0.8	0.9	0.4	1.2	1.9	0.7	2.0	14.3	0.7	5.9	0.7	4.0	2.6	5.1	1.2	1.3	0.1	1.6	7.4	0.4	1.9	1.2	0.6	0.1	0.0	0.0	0.4	1.8	2.4	0.0	1.9	7.0	0.7	4.1	0.7	0.9	0.3	0.4	1.1	0.4	0.2	0.2	2.2	1.5	2.0	0.1	1.1	0.7	15.3	16.0	20.5	18.5	17.5	7.0	18.3	12.5	16.2	19.9
LARGE2	"FLJ35207, GYLTL1B, PP5656"	ENSG00000165905	"LARGE xylosyl- and glucuronyltransferase 2"	Q8N3Y3	11	45921621-45929096	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 38.9;placenta: 29.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.4;NTERA-2: 16.3;SK-BR-3: 11.7;T-47d: 35.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 2.1"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5;naive B-cell: 5.8"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA056621	Approved				"Intracellular and membrane"					"HPA056621: AB_2683194"	"unprognostic (9.82e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.94e-2)"	"prognostic favourable (3.04e-12)"	"unprognostic (2.31e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	0.2	1.4	0.2	2.8	0.2	0.1	2.8	0.2	0.4	3.5	0.8	0.8	16.0	0.6	1.6	8.3	10.5	2.5	0.4	0.4	0.4	0.1	12.2	1.7	2.5	2.8	0.2	0.2	1.8	38.9	9.5	6.6	29.6	2.1	5.8	0.2	14.8	20.7	12.7	0.2	11.1	2.3	0.7	0.2	1.6	5.2	1.2	0.2	2.0	8.1	3.9	8.1	1.3	3.7	5.8	0.0	0.1	0.0	0.8	1.1	0.2	0.6	0.7	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	4.1	0.3	0.0	0.4	0.0	4.0	0.0	7.4	0.0	0.0	2.3	0.0	0.5	4.5	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.7	0.0	0.0	1.3	0.1	0.0	16.3	0.5	0.4	0.0	1.5	0.2	0.3	4.8	0.5	0.1	11.7	0.0	35.6	0.0	0.0	0.1	5.4	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	3.5	0.3	0.9	0.0	5.8	0.2	0.4	0.1	0.8	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.2	2.1	0.2
LENG9		ENSG00000275183	"Leukocyte receptor cluster member 9"		19	54461796-54463711	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"pancreas: 19.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.3;Karpas-707: 7.0;RPMI-8226: 8.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051671, HPA053556"	Enhanced		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA051671: AB_2681568, HPA053556: AB_2682187"	"unprognostic (8.38e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (9.99e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.76e-2)"	2.9	0.6	0.0	2.6	0.9	0.2	1.8	0.0	1.0	1.4	5.7	0.9	0.7	6.8	1.3	0.3	3.0	0.7	5.0	1.9	0.4		0.5	6.4	2.1	2.0	0.8	0.2	2.2	19.3	0.1	0.0	0.2	0.7	3.4	1.5	0.0	7.0	2.2	2.6	0.2	5.8	1.0	0.5	1.7	4.7	0.7	0.2	0.2	0.7	2.8	2.6	0.7	0.4	0.5	0.0	1.9	0.4	0.0	0.7	0.0	5.0	1.5	0.1	0.1	2.1	2.1	0.0	0.8	1.9	0.3	0.3	0.6	4.7	0.0	2.4	1.8	8.3	0.5	1.5	0.1	5.0	0.0	1.1	0.0	0.2	2.8	0.0	0.0	2.9	2.5	0.0	1.6	1.0	0.0	7.0	0.7	4.6	2.2	3.0	1.1	0.0	4.3	0.5	8.8	0.8	0.0	0.9	0.3	0.0	2.9	1.3	4.8	0.0	2.2	0.2	0.1	0.0	1.6	0.7	0.0	0.7	1.3	3.0	4.2	1.9	0.4	0.1	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 55.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.9;RH-30: 23.5;U-2 OS: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved				"Intracellular and membrane"	620000	620000			"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favourable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	10.4	4.9	8.3	12.6	13.5	6.5	15.7	8.3	12.0	10.9	17.3	11.2	0.8	11.9	15.0	5.9	7.9	4.1	16.9	10.1	7.1	11.8	6.6	1.9	15.6	18.1	15.0	6.6	3.0	55.0	1.7	2.6	6.2	19.4	13.0	9.6	8.4	16.5	7.3	3.7	43.0	11.6	6.0	10.2	13.2	28.4	3.4	5.2	5.8	4.4	10.4	19.8	9.0	8.3	2.6	2.5	12.8	7.7	1.3	4.5	1.5	0.7	7.0	9.3	1.3	1.0	0.9	0.6	2.7	1.4	2.4	3.0	3.0	18.9	0.5	8.5	7.3	13.5	1.4	2.5	1.2	4.1	0.3	2.1	3.7	1.5	0.0	3.0	3.9	1.7	6.4	3.9	0.4	0.9	0.3	0.1	1.8	16.8	0.0	4.2	11.3	5.2	0.8	23.5	1.4	0.9	2.2	8.6	2.1	3.1	0.7	0.1	5.1	3.6	2.2	5.4	26.0	0.2	7.4	0.1	0.0	0.7	6.0	8.1	1.0	5.3	5.9	12.8	2.0	7.7	2.4	1.3	2.0	1.0	2.5	2.6	2.2	2.0	3.2	1.3	7.0	0.6	4.5	1.5	8.3	13.5	8.3	12.0	7.1	11.8	15.0	6.6	19.4	5.2
LMF2	"TMEM112B, TMEM153"	ENSG00000100258	"Lipase maturation factor 2"	Q9BU23	22	50502949-50507691	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062626	Approved		Approved	Centrosome				Centrosome	Centrosome	"HPA062626: AB_2684812"	"unprognostic (2.69e-1)"	"prognostic favourable (3.47e-4)"	"unprognostic (8.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.75e-2)"	18.2	13.7	7.7	14.3	10.1	20.9	16.9	14.6	16.6	16.9	20.0	16.1	11.0	18.7	14.7	19.3	17.5	13.0	19.0	11.2	8.1	8.7	18.5	34.7	14.2	15.3	10.7	10.1	18.0	122.0	8.7	20.8	14.2	11.3	15.8	5.3	16.9	27.3	16.4	10.8	17.8	21.3	11.3	7.8	19.0	12.9	12.0	7.8	12.8	20.4	13.9	19.9	13.3	14.1	10.8	25.3	16.1	17.7	12.1	21.0	12.6	17.9	13.5	7.7	14.7	11.2	9.7	18.1	32.2	17.1	20.8	23.3	13.3	9.4	8.0	8.7	16.9	21.6	2.6	10.2	2.9	6.2	28.3	4.4	24.8	14.0	14.1	8.2	17.4	14.2	9.5	14.1	3.5	11.5	5.2	26.9	9.0	12.9	5.8	9.7	4.6	16.9	13.2	12.4	21.6	8.4	9.8	6.9	10.2	21.9	19.1	14.7	10.9	5.8	16.6	29.4	16.7	21.0	1.6	10.4	3.3	4.8	21.3	5.0	23.9	10.3	13.2	16.1	21.0	17.7	15.9	10.8	17.5	19.4	14.0	7.3	10.4	10.9	12.4	12.1	14.5	25.3	15.9	12.6	7.7	10.1	14.6	16.6	8.1	8.7	10.7	10.1	11.3	7.8
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 64.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.4;hTEC/SVTERT24-B: 18.3;U-698: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.7"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		21000	21000	Cytosol	Cytosol	"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (1.50e-4)"	12.6	1.7	22.3	8.1	21.1	2.4	13.4	9.6	31.8	15.5	24.6	20.3	0.7	8.2	12.7	2.6	6.9	13.3	13.8	16.8	24.6	7.1	2.5	15.8	8.6	4.1	19.8	12.4	8.8	64.0	4.2	6.7	2.8	18.9	12.2	7.6	4.8	9.4	4.3	16.6	6.6	7.5	14.5	10.9	2.4	21.2	6.4	19.8	0.2	8.1	5.0	5.0	5.1	5.4	0.3	0.0	0.7	0.0	0.0	2.7	0.4	0.4	0.4	9.3	0.1	2.6	1.6	0.8	1.5	8.7	1.5	4.7	7.3	0.0	23.4	4.0	0.7	0.0	1.8	3.2	3.4	0.0	4.8	0.0	1.4	0.6	0.6	0.2	5.3	2.0	1.8	18.3	3.0	8.0	0.0	0.0	0.3	1.1	0.0	0.0	6.9	0.0	4.2	2.7	1.2	1.7	0.0	1.2	0.3	1.4	1.4	0.0	8.4	2.1	2.4	4.6	2.0	9.1	3.9	1.8	0.8	17.9	8.1	0.0	1.6	0.0	0.0	0.7	0.4	0.0	1.4	0.3	1.1	1.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	2.7	0.4	22.3	21.1	9.6	20.2	24.6	7.1	19.8	12.4	18.9	19.8
LSR	"ILDR3, LISCH7"	ENSG00000105699	"Lipolysis stimulated lipoprotein receptor"	Q86X29	19	35248330-35267964	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.3;pancreas: 98.6"	"Cell line enhanced"	"Detected in many"		"A-431: 89.3;CACO-2: 39.1;CAPAN-2: 41.6;HaCaT: 37.5;RT4: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007270	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		2100000	2100000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA007270: AB_1079253"	"unprognostic (3.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.42e-2)"	"prognostic favourable (8.09e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.54e-2)"	5.0	11.2	2.9	20.9	4.0	0.9	12.4	2.0	4.5	8.7	32.8	4.0	24.4	29.5	6.5	21.4	20.3	10.6	58.2	2.6	3.4	3.1	15.7	106.3	21.1	17.0	4.1	2.6	4.8	98.6	6.2	13.4	36.6	7.1	11.2	15.4	40.9	26.2	33.8	1.9	16.8	39.5	1.8	3.8	9.1	46.7	21.0	1.9	3.4	24.0	20.1	20.9	9.9	9.5	5.3	0.3	5.9	0.2	6.1	7.1	3.2	89.3	1.5	0.1	0.2	0.2	0.1	16.2	0.2	0.3	0.4	0.3	39.1	41.6	3.5	13.8	0.2	37.5	8.3	13.7	0.0	5.4	15.1	0.0	1.2	17.3	0.3	0.0	0.1	0.2	15.3	0.3	4.5	0.1	14.1	3.2	0.2	31.7	0.1	0.1	12.8	0.5	0.7	0.1	9.7	8.6	36.2	7.1	0.2	7.5	24.4	6.7	20.9	0.5	0.0	0.7	8.6	0.5	0.4	5.1	9.0	8.1	0.6	0.1	2.2	5.9	0.2	0.2	3.3	0.0	3.3	5.3	7.1	6.7	0.1	4.1	5.5	6.0	0.1	6.1	0.0	0.3	4.8	3.2	2.9	4.0	2.0	4.5	3.4	3.1	4.1	2.6	7.1	1.9
MAGEB17		ENSG00000182798	"MAGE family member B17"	A8MXT2	X	16167481-16171464	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 4.4;testis: 5.4"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 3.2;U-2 OS: 7.1;U-266/70: 17.4"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003756	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003756: AB_2250114"	"unprognostic (1.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.04e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.44e-2)"	0.1	0.0	0.1	0.4	0.0	0.0	0.6	0.1	0.0	0.6	0.4			0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	4.4	0.0	0.0	0.0		0.4	0.2		0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	1.2	5.4			0.0		0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	3.2	7.1	0.0	0.2	17.4	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0										
MAP3K21	"KIAA1804, MLK4"	ENSG00000143674	"Mitogen-activated protein kinase kinase kinase 21"	Q5TCX8	1	233327768-233385148	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 28.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.0"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007636	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA007636: AB_1079392"	"unprognostic (3.29e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.84e-2)"	0.6	3.2	2.0	3.4	2.2	1.3	2.2	10.0	3.3	1.5	11.4	0.6	9.1	9.9	0.8	5.2	2.4	3.9	3.9	0.7	1.3	2.1	12.5	13.3	5.6	0.5	0.9	1.7	0.8	28.9	4.4	2.6	1.0	1.2	1.3	6.0	1.0	3.7	2.5	0.4	2.7	17.2	0.3	0.9	0.7	10.1	12.4	0.6	0.5	2.4	0.8	1.3	1.1	1.6	0.5	0.8	0.1	0.3	5.0	0.2	0.1	7.3	12.5	0.2	0.0	0.0	0.0	6.3	0.2	0.0	0.3	0.5	6.9	6.4	0.7	5.2	0.1	3.9	9.4	3.8	0.8	13.6	18.0	0.1	7.0	0.0	0.4	11.9	2.9	0.1	5.1	0.2	7.3	0.4	0.1	2.4	0.0	1.6	3.8	4.3	8.9	5.5	0.0	0.0	13.1	8.6	3.1	9.2	2.5	4.3	0.2	0.0	3.7	3.8	0.0	0.0	1.2	0.0	7.3	2.2	2.8	0.0	1.2	3.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.8	0.5	0.0	0.0	0.1	5.0	0.0	0.2	0.2	0.1	2.0	2.2	10.0	3.3	1.3	2.1	0.9	1.7	1.2	0.6
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.9;pancreas: 34.5"	"Cell line enhanced"	"Detected in some"		"A-431: 11.5;BEWO: 17.3;CACO-2: 12.8;CAPAN-2: 12.4;HaCaT: 11.7;MCF7: 21.8;RT4: 10.2;SK-BR-3: 10.3;T-47d: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"				Vesicles	Vesicles	"HPA043514: , HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favourable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.4	0.3	0.4	12.5	0.3	0.0	5.0	0.7	1.2	2.0	35.7	0.3	5.2	17.3	1.3	8.6	4.1	2.1	15.4	0.5	0.5	0.4	14.2	4.3	3.3	0.5	0.3	0.1	1.0	34.5	5.4	1.2	5.3	2.4	6.5	10.5	2.4	10.4	4.3	0.3	3.0	52.9	0.7	0.4	0.4	2.1	1.2	0.1	1.3	8.3	2.3	4.6	3.0	3.4	1.5	1.4	4.1	0.8	1.5	0.8	0.2	11.5	0.4	0.2	0.5	0.0	0.1	17.3	0.0	0.0	0.0	0.0	12.8	12.4	0.1	1.3	0.0	11.7	1.0	5.6	0.0	0.0	6.7	0.0	0.1	3.3	0.0	0.1	0.1	0.5	7.0	0.0	0.1	0.0	0.2	0.1	0.0	21.8	0.1	0.2	1.9	0.1	0.0	0.0	4.6	0.2	10.2	2.1	0.1	0.2	10.3	0.0	14.6	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	4.1	0.8	0.8	0.7	0.5	0.4	0.8	0.8	0.6	0.3	1.5	0.7	0.7	4.0	1.5	0.5	1.4	0.7	0.2	0.4	0.3	0.7	0.5	0.5	0.4	0.3	0.1	2.4	0.1
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539165-85545280	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 205.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		950000	950000	Nucleoplasm	Nucleoplasm	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavourable (4.87e-4)"	"prognostic favourable (8.94e-4)"	"prognostic unfavourable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	55.9	68.9	37.4	35.3	54.1	20.4	30.3	37.5	50.0	28.6	35.3	74.5	39.7	33.6	35.8	59.8	33.5	44.9	51.6	35.0	41.7	28.5	52.3	26.4	32.9	27.0	74.8	37.6	44.2	205.8	38.8	60.5	29.3	48.9	40.6	36.8	35.0	28.2	31.3	51.4	33.7	35.8	47.6	57.7	24.7	44.6	34.9	69.4	22.7	94.0	34.1	30.8	46.9	33.4	13.8	15.3	4.9	17.2	16.9	22.8	14.9	29.7	44.2	51.9	32.2	35.7	43.7	30.7	37.4	34.5	39.4	42.1	36.1	100.4	69.8	24.7	45.4	46.4	65.2	55.8	50.7	35.3	47.9	41.7	64.0	31.1	65.3	61.8	46.6	39.5	56.7	42.5	29.7	37.3	46.8	55.0	89.4	25.5	56.3	68.1	34.4	56.9	60.0	49.2	45.2	59.5	47.2	40.9	37.7	33.8	32.7	60.3	27.7	33.2	36.3	48.4	29.2	26.6	44.7	33.9	26.9	50.5	31.6	77.6	25.4	4.8	15.2	4.9	15.4	17.2	22.8	13.8	17.5	16.2	15.3	12.2	16.4	14.3	1.6	16.9	13.7	10.9	15.3	14.9	37.4	54.1	37.5	50.0	41.7	28.5	74.8	37.6	48.9	69.4
MBOAT4	"FKSG89, GOAT, OACT4"	ENSG00000177669	"Membrane bound O-acyltransferase domain containing 4"	Q96T53	8	30131824-30144686	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 23.9;stomach 1: 7.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;Hep G2: 8.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044509			Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA044509: AB_2678966"	"unprognostic (4.35e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-6)"	"unprognostic (9.87e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.66e-2)"	0.4	1.8	0.3	0.5	0.6	1.0	0.3	0.3	0.3	0.3	0.5	0.3	0.3	0.8	0.9	0.3	0.3	3.9	2.1	0.4	0.3	0.1	0.4	1.5	0.9	0.8	0.3	0.3	0.5	23.9	0.0	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	1.3	0.3	0.3	1.4	7.7	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.8	0.7	2.6	1.5	2.8	4.1	0.6	0.5	1.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	2.2	0.0	0.4	0.0	0.1	0.0	0.6	0.4	0.4	0.1	8.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.1	0.6	0.3	0.0	0.0	0.3	0.2	0.0	0.1	0.2	0.2	0.8	0.0	0.1	0.0	0.2	0.2	0.0	0.2	1.5	0.0	0.2	0.1	0.0	0.0	1.3	0.9	0.4	0.6	0.6	2.1	0.5	1.5	2.4	0.0	1.6	2.0	0.7	1.8	2.4	4.1	2.6	2.8	0.2	0.4	0.5	0.6	0.3	0.6	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3
MCIDAS	"IDAS, MCI, MCIN"	ENSG00000234602	"Multiciliate differentiation and DNA synthesis associated cell cycle protein"	D6RGH6	5	55219614-55227315	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 2.6;stomach 1: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;CACO-2: 5.8;HEK 293: 4.8;U-2 OS: 3.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA049981, HPA058073"	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA049981: , HPA058073: AB_2683596"	"unprognostic (3.11e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.67e-1)"	"unprognostic (2.90e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.70e-2)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0		0.0	2.6	0.5	0.1	0.0		0.3	0.0		0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7			1.0		0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.5	5.8	2.7	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.1	4.8	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.2	0.9	0.1	0.0	0.5	0.5	0.0	1.8	0.0	1.6	2.1	0.6	0.0	0.0	3.4	0.6	0.2	1.9	2.4	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77690658-77926974	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"kidney: 8.5;pancreas: 4.1;testis: 4.7;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;TIME: 3.0;U-266/70: 1.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.0	1.3	0.4	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.3	1.0	0.2	0.9	8.5	1.7	0.0	0.0	0.8		0.0	4.1	0.0	2.6	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	4.7			4.6		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.5	0.9	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797162-8799349	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 8.5;testis: 20.1"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 13.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023164	Uncertain									"HPA023164: AB_2142777"	"prognostic favourable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.5	0.0	0.5	3.2	0.5	0.0	0.5	0.5	0.5	1.4	2.1	0.5	0.5	1.8	0.5	0.9	0.5	1.6	0.5	0.5	0.5	0.0	1.1	0.5	2.2	0.5	0.5	0.5	0.5	8.5	4.8	4.3	0.5	0.5	0.5	2.6	0.5	5.5	1.8	0.5	0.2	1.0	0.5	0.5	0.5	3.4	20.1	0.5	0.5	3.1	0.5	0.5	0.7	0.5	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.0	0.5	0.5	0.5	0.5
MKNK1	MNK1	ENSG00000079277	"MAP kinase interacting serine/threonine kinase 1"	Q9BUB5	1	46557408-46616843	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 72.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382"	"unprognostic (4.05e-3)"	"prognostic favourable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	17.6	12.0	10.7	16.2	10.5	16.8	12.1	13.7	12.3	9.2	12.6	11.0	9.6	9.7	11.9	13.3	12.2	11.1	11.4	12.3	10.8	7.0	9.4	10.8	16.1	16.3	9.9	9.8	10.7	72.3	8.6	11.3	15.4	11.0	9.9	13.3	11.9	10.6	7.7	12.8	10.2	12.7	13.3	8.1	25.6	11.7	7.6	8.7	12.5	8.8	15.8	10.9	10.9	14.5	4.9	6.0	33.3	12.1	5.0	22.0	6.1	19.3	13.1	8.7	9.6	7.8	11.6	11.6	9.8	9.8	11.9	16.2	15.1	8.0	12.8	12.1	9.8	23.5	14.5	16.0	12.7	21.9	12.9	27.0	15.0	12.9	12.2	14.4	22.0	15.2	11.1	15.5	8.5	13.9	14.1	9.4	6.4	12.7	10.3	12.9	5.9	15.6	9.5	18.2	12.8	12.7	20.3	6.1	5.5	18.9	17.1	15.8	11.5	16.1	11.2	4.3	0.9	13.5	10.9	8.0	13.3	10.9	8.4	18.6	7.9	3.9	12.1	14.3	7.5	11.5	22.0	4.6	6.6	6.8	6.0	4.9	4.8	7.0	33.3	5.0	8.1	4.4	4.4	6.1	10.7	10.5	13.7	12.3	10.8	7.0	9.9	9.8	11.0	8.7
MPV17L	"FLJ39599, MLPH1, MLPH2, MPV17L1"	ENSG00000156968	"MPV17 mitochondrial inner membrane protein like"	Q2QL34	16	15395754-15413268	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 33.1"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA041180	Uncertain		Supported	Vesicles				Vesicles	Vesicles	"HPA041180: AB_10794266"	"unprognostic (9.65e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.38e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.99e-3)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-3)"	"prognostic favourable (1.48e-11)"	"unprognostic (2.84e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.87e-2)"	3.1	4.9	6.2	3.7	8.7	8.3	16.0	6.8	8.0	7.1	4.5	10.5	1.6	7.1	4.5	3.1	2.5	3.3	5.7	3.7	7.4	5.4	8.2	12.2	2.3	4.7	5.8	6.1	4.8	33.1	10.6	11.7	1.4	6.3	3.7	2.9	9.7	10.1	5.0	16.0	9.1	5.6	9.4	7.2	3.7	4.1	2.7	7.0	0.0	5.2	1.3	1.6	4.8	2.4	4.0	2.2	5.7	3.6	3.6	2.5	1.2	0.8	1.5	0.6	0.6	0.1	0.1	1.0	0.4	0.0	0.0	0.0	1.5	2.9	1.2	1.2	0.5	1.1	2.9	0.0	0.0	0.8	0.8	5.8	3.5	3.0	0.2	2.7	29.7	0.2	0.3	0.1	0.2	0.0	1.8	2.6	0.0	1.5	0.9	1.7	1.5	1.0	1.5	0.4	1.1	0.4	0.6	4.7	1.6	2.4	6.8	0.2	1.5	2.0	1.9	1.1	0.6	0.9	0.8	1.1	0.4	1.3	0.6	1.3	0.4	3.9	3.6	0.6	2.3	2.7	1.9	2.1	1.5	2.4	1.2	4.0	1.5	2.5	5.7	3.6	1.0	2.2	1.2	1.2	6.2	8.7	6.8	8.0	7.4	5.4	5.8	6.1	6.3	7.0
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 53.9;kidney: 88.1;liver: 134.0;pancreas: 50.2;thyroid gland: 60.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;EFO-21: 8.3;NB-4: 2.9;SCLC-21H: 2.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Low lineage specificity"	"Detected in single"																						"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	0.6	0.0	1.4	1.1	20.1	0.0	0.2	0.2	4.7	0.3	21.7	0.6	0.2	9.4	0.8	3.1	4.1	0.2	2.8	0.2	7.4	0.9	88.1	134.0	0.3	1.3	4.4	1.6	0.3	50.2	0.0	0.2	0.3	8.3	2.3	11.0	1.6	0.5	0.2	0.3	0.7	53.9	1.4	1.9	0.2	6.7	0.4	1.5	0.2	60.3	0.9	0.4	1.0	0.2	0.2	0.1	0.0	1.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	2.9	0.4	0.0	0.3	0.0	1.6	0.6	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	1.4	20.1	0.2	4.7	7.4	0.9	4.4	1.6	8.3	1.5
MXRA5	DKFZp564I1922	ENSG00000101825	"Matrix remodeling associated 5"	Q9NR99	X	3308565-3346641	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 49.4;pancreas: 46.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.5;BJ hTERT+: 47.9;fHDF/TERT166: 22.4;HaCaT: 19.9;HSkMC: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA000508	Uncertain				"Secreted - unknown location"	1700000	1700000			"HPA000508: AB_2147995"	"unprognostic (7.51e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (7.05e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (8.94e-4)"	6.5	12.1	0.5	10.4	1.2	0.0	7.5	0.4	0.8	49.4	4.4	0.6	18.8	2.1	11.4	6.0	8.7	4.2	5.8	9.2	0.6	0.5	8.0	4.5	5.9	0.9	0.6	0.7	7.9	46.6	0.5	1.4	7.9	0.8	11.0	5.9	10.2	11.5	29.5	1.1	16.6	7.8	8.8	0.5	7.7	5.1	4.0	0.3	5.7	15.0	11.7	6.2	12.7	9.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	12.5	0.0	7.4	47.9	0.0	0.0	0.0	0.2	0.0	0.6	22.4	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	2.3	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.8	0.6	0.5	0.6	0.7	0.8	0.3
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 46.4;skin 1: 26.0"	"Group enriched"	"Detected in some"	7	"U-266/70: 94.1;U-266/84: 69.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	75	"dendritic cells: 15.4;monocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favourable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.3	0.3	1.2	4.4	2.1	0.1	1.7	0.8	1.7	3.6	7.5	1.8	8.5	2.6	1.0	4.0	17.8	1.6	2.3	0.7	1.1	0.9	0.8	6.4	1.9	2.9	0.6	1.4	0.5	46.4	0.0	2.1	11.2	1.8	5.3	3.6	1.8	4.6	16.6	0.6	26.0	7.3	1.2	1.1	4.0	3.3	1.5	0.6	6.4	4.2	3.1	6.0	18.4	7.3	0.0	15.4	0.1	11.5	0.0	0.1	3.8	0.2	0.0	2.9	0.7	0.0	0.0	7.0	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.3	0.0	0.7	2.0	0.5	0.1	0.4	1.0	0.1	0.0	0.1	0.0	0.0	1.7	0.2	2.3	0.0	0.2	0.2	0.7	0.0	0.1	0.2	0.0	0.0	2.7	0.1	0.2	3.3	0.6	0.2	11.3	0.5	0.7	0.2	0.4	0.1	0.7	3.6	0.0	0.0	1.1	1.3	0.1	94.1	69.1	0.1	0.0	0.4	0.0	0.0	11.5	0.0	0.0	5.5	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	0.1	0.0	2.3	15.4	0.0	3.8	1.2	2.1	0.8	1.7	1.1	0.9	0.6	1.4	1.8	0.6
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170493-101180276	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.5;SH-SY5Y: 6.8;SK-MEL-30: 5.0;U-2 OS: 5.9;U-87 MG: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Group enriched"	"Detected in many"	4	"amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA021918	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6.0	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0.0	4.6	0.0	0.0	0.1	0.0	1.2	0.7	2.2	0.6	1.3	0.8	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.5	0.1	0.1	0.8	0.6	0.2	0.1	4.5	0.0	0.4	0.1	6.8	0.0	0.3	5.0	0.3	0.0	0.0	0.4	5.9	0.5	0.1	0.1	0.0	0.1	3.4	0.0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0.0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2
NCMAP	"C1orf130, FLJ42528, MP11"	ENSG00000184454	"Non-compact myelin associated protein"	Q5T1S8	1	24556111-24609328	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 28.8;placenta: 21.2"	"Cell line enhanced"	"Detected in some"		"A549: 4.0;RPTEC TERT1: 3.3;T-47d: 7.9;U-266/70: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013656	Uncertain									"HPA013656: AB_2275006"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.79e-1)"	"prognostic favourable (2.83e-6)"	"unprognostic (3.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.28e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.27e-3)"	0.6	0.2	0.6	0.5	0.7	0.6	4.6	0.2	0.7	1.3	7.0	1.3	0.0	6.3	0.5	1.8	0.5	1.1	15.0	0.5	0.8	0.6	2.2	5.8	4.7	0.2	1.0	0.1	0.2	28.8	0.0	9.1	21.2	0.8	2.1	0.2	1.3	13.4	0.0	0.6	0.6	7.5	0.2	2.2	0.3	5.7	0.2	1.1	0.2	5.3	0.7	1.4	0.9	0.3	1.4	1.0	2.7	0.9	0.7	0.8	0.1	0.2	4.0	0.1	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	1.7	0.4	1.0	0.0	0.3	0.6	0.0	0.0	0.2	0.1	0.4	0.3	1.9	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.5	0.0	0.4	0.2	0.4	0.2	0.0	0.4	0.1	1.1	3.3	1.0	0.4	0.3	0.2	0.3	0.0	7.9	0.2	0.5	0.2	0.3	0.5	0.2	6.3	0.8	0.1	0.1	0.2	0.3	2.7	0.9	0.6	0.5	0.3	0.4	0.8	0.5	0.4	0.2	1.4	0.7	0.8	2.0	0.7	0.4	1.0	0.3	0.1	0.6	0.7	0.2	0.7	0.8	0.6	1.0	0.1	0.8	1.1
NEURL3	"Lincr, LOC93082, RNF132"	ENSG00000163121	"Neuralized E3 ubiquitin protein ligase 3"	Q96EH8	2	96497643-96508109	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 26.3;salivary gland: 22.4;seminal vesicle: 10.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;CAPAN-2: 16.6;RPMI-8226: 10.5;RT4: 5.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"														"unprognostic (4.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.57e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.9	0.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0		5.3	0.6	1.8	0.0	0.0	0.1	0.0	26.3	0.0	0.0	0.0	0.2	1.4	0.1	0.0	22.4	10.8	0.4	0.0	1.2	0.0	0.2	0.0	0.1	0.2	0.0	6.4	0.0	0.5	0.1	0.4	0.0	0.3	0.2	0.7	0.1	0.1	0.1	3.0	1.0	0.5	0.0	0.3	0.0	0.0	4.1	0.0	0.4	0.3	0.2	2.4	16.6	0.0	1.3	0.0	2.5	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	2.2	5.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.1	3.0										
NGB		ENSG00000165553	Neuroglobin	Q9NPG2	14	77265483-77271312	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 15.6;brain: 34.5;pancreas: 9.9"	"Group enriched"	"Detected in some"	29	"RPMI-8226: 7.6;SCLC-21H: 15.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042615, HPA058596"	Enhanced									"HPA042615: AB_2678079, HPA058596: AB_2683769"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-2)"		"unprognostic (8.86e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"		"unprognostic (3.14e-1)"		"unprognostic (4.08e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.58e-2)"		"unprognostic (3.37e-4)"	"unprognostic (1.80e-1)"		"unprognostic (3.12e-1)"	0.4	15.6	4.2	0.7	4.8	0.3	0.3	1.2	14.2	0.3	2.1	0.5	0.9	0.7	0.3	0.5	0.6	2.9	0.3	0.3	1.7	34.5	0.3	0.3	0.3	0.3	2.0	6.4	0.3	9.9	0.3	7.0	0.3	8.0	0.3	1.3	0.0	0.3	0.3	0.3	0.3	0.9	0.5	1.4	0.3	0.3	0.7	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.6	0.0	0.0	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.8	1.2	14.2	1.7	34.5	2.0	6.4	8.0	0.9
NKX2-2	"NKX2.2, NKX2B"	ENSG00000125820	"NK2 homeobox 2"	O95096	20	21511010-21514026	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 30.6;pancreas: 12.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.4;T-47d: 5.2;U-138 MG: 18.5;U-2 OS: 3.8;WM-115: 7.4"	"Group enriched"	"Detected in many"	5	"glioma: 9.5;pancreatic cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003468	Approved									"HPA003468: AB_1079490"	"unprognostic (5.13e-3)"		"unprognostic (5.54e-2)"		"unprognostic (3.10e-1)"	"unprognostic (2.29e-1)"			"unprognostic (1.75e-2)"		"unprognostic (2.93e-3)"	"unprognostic (1.10e-1)"		"unprognostic (3.24e-2)"	"unprognostic (3.29e-1)"			0.6	0.6	6.5	0.7	8.1	0.7	0.6	3.4	15.5	0.6	1.4	19.1	0.0	6.2	0.6	0.6	0.6	0.6	0.6	0.6	7.8	6.9	0.6	0.6	0.6	0.7	14.2	6.4	0.6	12.1	1.0	4.6	0.6	10.9	0.7	1.4	0.0	0.6	0.6	0.6	0.8	2.5	0.6	30.6	0.6	7.0	0.6	9.4	0.0	0.6	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	18.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.1	3.4	7.6	7.8	6.9	14.2	6.4	10.9	9.4
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491987-84498450	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 6.0;esophagus: 11.0;pancreas: 10.8"	"Cell line enhanced"	"Detected in some"		"AF22: 5.5;HAP1: 8.0;HEK 293: 7.0;HMC-1: 5.4;PC-3: 4.7;U-2197: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in some"			"HPA036774, CAB070169"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.2	0.0	0.3	0.2	2.2	0.0	6.0	1.0	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	11.0	0.0	0.2	0.2	0.4	1.3	0.2	0.2	0.2	0.2	2.5	0.2	0.2	10.8	0.0	0.2	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	1.3	0.2	1.5	2.1	0.2	0.2	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.2	0.0	8.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	4.7	0.0	2.3	0.0	0.0	0.3	1.5	0.0	0.7	0.0	0.0	0.0	0.7	0.1	0.0	2.4	8.8	2.2	0.0	0.0	0.0	1.5	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	1.0	1.1	0.4	1.3	2.5	0.2	0.9	0.2
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128753-35142315	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 40.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (6.39e-4)"	6.3	6.9	7.0	8.2	7.6	6.4	11.4	7.6	9.1	5.6	5.8	5.4	3.3	5.1	10.0	5.5	7.9	10.0	8.3	4.8	6.0	6.4	4.8	6.9	4.5	9.1	5.6	7.7	16.3	40.3	5.1	4.2	6.1	5.4	9.2	5.3	6.2	9.1	7.5	8.8	7.6	5.1	10.2	5.1	8.3	6.8	7.2	6.4	10.0	10.0	6.6	8.3	6.3	5.4	6.4	4.5	0.4	3.2	2.4	9.1	3.0	8.1	19.9	6.7	11.9	4.2	6.2	10.7	7.3	6.9	13.1	10.9	13.7	7.9	18.1	10.2	6.1	10.9	15.1	18.8	9.1	2.9	23.6	8.1	9.5	17.1	5.6	15.6	6.5	7.0	10.1	13.6	20.8	8.5	21.8	6.6	7.7	11.2	23.9	12.7	12.6	8.8	19.3	11.7	19.9	7.7	7.9	13.8	8.4	7.0	7.1	8.7	17.4	11.3	7.5	7.1	10.0	6.8	24.5	5.2	4.0	15.1	5.0	12.9	13.6	0.1	3.0	0.0	5.7	3.2	9.1	4.8	5.4	6.0	4.5	6.4	7.4	5.1	0.4	2.4	1.6	1.0	3.0	3.0	7.0	7.6	7.6	9.1	6.0	6.4	5.6	7.7	5.4	6.4
NOMO1	PM5	ENSG00000103512	"NODAL modulator 1"	Q15155	16	14833681-14896160	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.6;Hep G2: 36.6;RPMI-8226: 23.3;SiHa: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB025192, HPA046697, HPA061174"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB025192: , HPA046697: AB_2679758, HPA061174: "	"unprognostic (5.33e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (3.15e-4)"	4.2	3.3	4.4	10.1	11.1	0.8	4.6	7.9	10.2	2.4	3.7	5.4	1.5	1.4	6.1	3.6	3.4	8.3	2.8	12.9	5.2	6.4	11.3	8.9	4.1	3.4	4.6	10.6	11.7	40.0	1.2	3.3	9.1	6.6	5.9	10.3	2.7	4.1	5.9	12.2	6.9	7.0	9.0	3.5	1.8	5.9	15.0	2.8	1.5	9.9	1.5	2.4	2.6	1.9	1.2	3.8	5.2	4.0	1.4	1.0	1.0	0.3	12.5	15.7	20.6	0.0	1.5	10.2	1.3	3.1	3.8	3.9	0.2	0.9	1.3	0.9	2.8	0.2	2.8	0.1	3.9	1.9	0.0	1.2	16.7	36.6	13.6	1.8	0.9	0.2	0.2	2.0	2.2	2.9	7.1	0.8	17.7	0.0	0.4	0.0	0.0	0.0	0.8	1.4	23.3	0.0	0.7	0.3	11.6	42.3	0.0	0.2	17.2	0.1	0.4	0.5	0.0	1.8	14.5	0.0	0.6	1.5	0.9	0.7	0.5	5.2	0.6	0.6	0.3	1.2	0.7	0.2	0.3	0.9	0.5	1.2	0.5	0.8	1.6	1.4	4.0	3.8	1.0	1.0	4.4	11.1	7.9	10.2	5.2	6.4	4.6	10.6	6.6	2.8
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913966	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 47.2;liver: 49.4;pancreas: 52.8"	"Cell line enriched"	"Detected in some"	32	"Hep G2: 40.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 52.3;stomach cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	6	"cerebellum: 1.9"	"Low region specificity"	"Detected in all"														"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.1	7.5	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	11.8	0.3	0.1	32.6	0.1	0.8	0.1	0.0	18.5	16.6	0.1	0.0	9.3	49.4	2.4	0.1	0.1	0.1	0.1	52.8	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	3.5	0.0	47.2	0.1	0.1	5.3	8.5	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	1.0	0.6	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	40.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
NRTN	NTN	ENSG00000171119	Neurturin	Q99748	19	5823802-5828324	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.3;pancreas: 12.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;K-562: 6.9;REH: 18.2;SH-SY5Y: 9.8;U-266/70: 10.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.9;T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065260			Approved	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"HPA065260: AB_2685448"	"unprognostic (4.85e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.96e-2)"	"prognostic favourable (3.86e-4)"	"unprognostic (1.60e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (8.21e-3)"	"unprognostic (5.60e-3)"	"prognostic favourable (9.92e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.32e-2)"	0.0	3.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	4.9			1.5	0.3	0.6	2.1	0.4	0.5	15.3	0.0	0.0	1.8	7.6	0.0	0.0	0.0		0.0	12.3	0.6	0.3	0.0		1.3	0.0		6.8	1.2	0.0	3.0	1.5	0.9	0.0	0.0	5.0	0.3			0.0		0.0	1.8	1.3	0.7	1.9	0.0	0.1	0.0	1.7	0.3	0.5	0.7	0.8	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	0.1	2.9	0.0	0.0	7.1	5.1	0.0	0.0	2.3	0.9	0.1	1.9	0.1	0.7	0.0	0.0	0.0	6.9	0.0	0.0	1.4	0.6	0.7	2.4	1.8	18.2	2.4	4.2	0.3	0.0	0.5	9.8	0.1	0.9	1.0	0.3	0.6	0.0	0.0	1.5	0.0	0.0	10.4	2.2	0.5	0.0	1.2	0.7	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.7	0.1	0.4	0.7	0.3	0.3	0.0	0.0	0.0	1.9	1.7	0.3										
NUPR1	"COM1, p8"	ENSG00000176046	"Nuclear protein 1, transcriptional regulator"	O60356	16	28532708-28539174	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 297.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 50.0;hTCEpi: 82.5;SK-MEL-30: 59.0;T-47d: 35.1;U-87 MG: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 11.5;eosinophil: 4.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006349			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA006349: "	"unprognostic (2.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.72e-3)"	"unprognostic (5.77e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.80e-2)"	26.9	38.6	13.1	8.9	20.0	1.7	24.4	13.4	10.1	30.0	28.6	10.4	114.1	4.5	19.9	36.6	31.2	16.5	19.3	16.2	14.8	12.2	19.3	47.1	33.7	7.5	20.5	8.2	41.0	297.9	2.2	5.8	16.1	23.1	46.5	16.5	23.5	89.5	128.3	22.2	27.5	8.9	35.3	23.9	7.6	17.4	18.6	17.6	4.2	146.4	14.4	11.5	47.9	79.1	0.8	0.8	11.5	0.6	1.1	0.5	0.1	0.2	1.6	0.0	12.9	19.3	17.0	10.1	11.3	9.8	0.4	9.1	0.0	0.0	0.0	6.2	17.3	0.3	0.0	0.3	0.3	0.0	0.5	0.0	0.7	8.1	50.0	0.0	0.0	16.1	82.5	5.3	23.6	0.0	0.0	0.5	5.6	2.3	0.0	0.2	0.0	6.3	0.0	0.0	0.4	0.0	1.1	0.1	0.0	3.2	13.5	59.0	35.1	1.9	0.0	3.7	9.0	9.6	1.6	0.0	0.0	0.0	31.4	0.0	0.4	11.5	0.6	4.2	0.4	0.4	0.5	0.4	0.4	0.3	0.2	0.8	0.5	0.5	3.1	1.1	0.5	0.8	0.3	0.1	13.1	20.0	13.4	10.1	14.8	12.2	20.5	8.2	23.1	17.6
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.2;HaCaT: 21.3;RPMI-8226: 4.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA077718: AB_2732358"	"prognostic favourable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3
OR10G4		ENSG00000254737	"Olfactory receptor family 10 subfamily G member 4"	Q8NGN3	11	124012997-124018732	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"bone marrow: 2.7;pancreas: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.1	0.2	0.1	0.1	0.1	2.7	0.1	0.1	0.1	0.1	0.3			0.3	0.1	0.5	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.8	0.1	0.1	0.1		0.2	3.7	0.1	0.1	0.1		0.1	0.5		0.1	0.0	0.5	0.7	0.4	0.0	0.1	0.4	0.1	0.6			0.2		0.0	0.2	0.1	1.2	0.5	1.6	0.6	0.5	0.5	0.1	0.3	0.1	0.3	0.3	0.5	0.1	0.4	0.4	0.0	0.1	0.0	0.4	0.3	0.0	0.4	0.2	0.2	0.1	0.0	0.1	0.6	0.9	1.4	1.6	0.9	0.1	0.6	3.0	0.0	0.5	0.0	0.1	0.3	0.3	1.4	0.0	1.1	0.2	1.6	1.2	1.0	0.1	0.4	0.4	0.0	1.1	0.5	0.2	0.2	0.3	0.2	0.2	0.5	0.5	0.6	0.3	0.8	0.1	0.7	0.5	0.2	0.2	1.4	0.2	0.7	0.5	0.8	0.5	0.2	0.3	0.5	0.5	0.5	0.3	1.2	0.5	0.5	1.6	0.5	0.6	0.5	0.3	0.1										
OR10G6	"OR10G6P, OR10G6Q"	ENSG00000198674	"Olfactory receptor family 10 subfamily G member 6"	Q8NH81	11	123994163-123995161	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"pancreas: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.7	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR10Q1		ENSG00000180475	"Olfactory receptor family 10 subfamily Q member 1"	Q8NGQ4	11	58227882-58228918	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 1.3;placenta: 1.4"	"Cell line enhanced"	"Detected in single"		"HHSteC: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA046968	Uncertain									"HPA046968: AB_2679881"											"unprognostic (4.82e-1)"		"unprognostic (6.34e-2)"	"unprognostic (4.37e-1)"				0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1			0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0		0.0	1.3	0.0	0.0	1.4		0.0	0.3		0.6	0.0	0.7	0.2	0.5	0.4	0.0	0.1	0.0	0.3			0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR13C5		ENSG00000277556	"Olfactory receptor family 13 subfamily C member 5"	Q8NGS8	9	104598457-104599413	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"pancreas: 1.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.1;HEL: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																					"unprognostic (4.88e-2)"		0.0	0.6		0.0		0.2	0.0		0.2	0.0	0.0			0.0	0.0	0.4	0.0	0.9	0.4	0.0			0.3	0.6	0.0	0.0			0.5	1.0	0.0		0.0		0.0	0.0		0.0	0.6	0.0	0.0	0.0	0.0		0.0	0.0	0.5			0.6		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR4D5		ENSG00000171014	"Olfactory receptor family 4 subfamily D member 5"	Q8NGN0	11	123939543-123940637	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"pancreas: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045005	Uncertain									"HPA045005: AB_10959302"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	2.1	0.0	0.0	0.0		0.0	0.6		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3			0.2		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52B6		ENSG00000187747	"Olfactory receptor family 52 subfamily B member 6"	Q8NGF0	11	5580877-5581884	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"ovary: 1.4;pancreas: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			"unprognostic (1.57e-1)"				0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1			0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0		1.4	1.8	0.0	0.2	0.0		0.2	0.0		0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2			0.2		0.0	0.2	0.4	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0										
OR6B1	OR7-3	ENSG00000221813	"Olfactory receptor family 6 subfamily B member 1"	O95007	7	144000320-144008793	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 3.2;testis: 2.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.5;RPMI-8226: 2.0;U-266/84: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"olfactory region: 0.1"	HPA053164	Uncertain									"HPA053164: AB_2682065"																		0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0			0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.1	3.2	0.1	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.3			0.1		0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.3	0.0										
OR8D4		ENSG00000181518	"Olfactory receptor family 8 subfamily D member 4"	Q8NGM9	11	123902167-123909229	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8;pancreas: 2.0"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.2	0.0	0.1	1.0	0.3	0.0	0.3	0.2	0.1			0.0	0.1	0.7	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1		0.3	2.0	0.0	0.1	0.0		0.0	0.2		0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.6			0.1		0.0	0.3	0.0	0.6	0.6	1.8	0.5	0.9	0.5	0.3	0.0	0.0	0.4	0.6	0.0	0.7	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.2	0.0	0.5	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.2	0.0	0.6	0.0	0.3	0.0	0.4	0.1	0.3	0.0	0.9	0.1	0.2	0.3	0.2	0.0	0.5	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.0	0.0	1.2	0.1	0.2	0.4	0.2	0.0	0.0	0.2	0.6	0.2	1.6	0.5	0.6	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.6	0.4	0.5	1.8	0.9	0.4	0.6	0.2	0.3										
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	140000000	140000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	57.7	50.3	18.6	60.0	50.4	59.3	44.2	112.8	72.8	49.2	66.6	36.9	50.6	23.3	49.6	72.5	41.0	20.5	44.1	28.5	15.0	34.7	34.9	52.9	150.1	66.3	110.1	57.7	44.7	30.0	39.3	41.7	81.0	24.7	100.7	35.0	52.7	31.5	87.5	14.6	45.8	25.8	33.3	46.2	38.2	69.8	22.4	24.8	56.2	162.4	58.5	73.4	129.7	62.9	92.4	46.3	52.4	55.0	72.4	52.4	22.0	121.4	42.4	70.4	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560816-39576790	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 137.3;skeletal muscle: 117.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"HPA027301: AB_2672208, HPA056496: AB_2683153"	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavourable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	30.0	19.2	9.0	23.0	7.9	20.8	19.6	7.2	9.6	19.1	26.0	14.0	22.0	12.4	22.2	21.1	20.3	13.7	20.2	32.0	8.6	7.2	12.3	28.8	24.9	38.2	8.3	7.3	28.6	137.3	9.1	8.2	16.2	8.6	20.7	11.5	15.4	16.4	22.9	117.8	12.9	21.1	22.4	16.4	27.5	28.0	29.2	6.4	21.5	18.1	51.1	21.0	25.3	20.3	13.9	13.7	6.7	21.2	8.2	21.4	5.5	56.9	15.5	16.5	27.4	41.3	82.1	54.3	33.7	23.7	26.2	19.5	31.0	29.9	49.2	33.5	42.3	30.5	31.4	37.6	33.9	25.1	25.9	41.5	17.7	30.9	41.5	27.4	27.9	71.2	44.6	31.8	48.5	32.8	43.9	27.3	42.0	22.2	28.4	35.4	51.1	17.8	21.8	52.9	37.3	25.3	56.3	15.6	23.7	23.5	22.5	51.0	23.9	81.3	29.6	25.5	35.4	61.7	42.5	70.4	77.2	38.3	37.8	27.8	14.5	6.7	13.9	3.5	9.9	18.0	10.6	13.8	16.1	10.3	13.7	13.9	21.4	15.1	1.4	8.2	21.2	13.5	11.2	5.5	9.0	7.9	7.2	9.6	8.6	7.2	8.3	7.3	8.6	6.4
PAIP2B	KIAA1155	ENSG00000124374	"Poly(A) binding protein interacting protein 2B"	Q9ULR5	2	71182739-71227083	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9;pancreas: 47.8;skeletal muscle: 39.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 9.1;RPMI-8226: 13.0;SCLC-21H: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA046784, HPA072371"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA046784: AB_2679804, HPA072371: AB_2686514"	"unprognostic (8.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (8.17e-5)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (6.96e-12)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.61e-2)"	2.8	2.4	36.3	2.3	28.8	1.8	4.8	11.9	15.7	3.3	4.2	50.9	5.1	4.0	3.5	2.5	6.2	7.4	1.8	17.8	39.5	25.1	9.9	16.6	3.3	2.5	47.7	9.7	11.6	47.8	6.4	2.1	1.4	21.9	5.2	4.2	2.7	29.9	5.6	39.4	15.1	3.2	3.4	44.9	2.7	6.7	2.7	24.6	0.6	11.1	3.5	4.7	2.7	2.3	5.8	4.5	1.0	0.9	1.5	4.6	1.2	2.1	0.5	0.9	3.1	0.3	0.5	3.9	0.3	0.1	0.3	0.1	0.8	0.9	2.7	0.6	0.0	1.7	5.2	3.1	1.0	1.4	4.3	2.6	0.3	0.1	1.4	0.7	0.2	0.6	2.9	0.1	3.2	0.5	4.5	2.6	0.1	2.6	0.8	1.4	2.3	2.0	0.0	9.1	13.0	1.6	1.4	20.2	1.2	2.2	1.5	0.9	6.5	0.1	0.1	0.2	1.7	1.7	0.9	5.3	4.4	3.3	0.2	1.0	0.5	1.0	0.7	1.0	2.0	0.9	2.6	4.9	2.8	2.0	0.8	5.8	4.6	4.0	0.5	1.5	0.8	4.5	1.1	1.2	36.3	28.8	11.9	15.7	39.5	25.1	47.7	9.7	21.9	24.6
PANO1	PANO	ENSG00000274897	"Proapoptotic nucleolar protein 1"	I0J062	11	797511-799190	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.7;pancreas: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.5;SCLC-21H: 7.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																						"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-4)"	"unprognostic (1.41e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.32e-5)"	"unprognostic (5.96e-2)"	"unprognostic (2.02e-5)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (4.64e-1)"	"unprognostic (1.33e-1)"	0.2	1.2		0.5		1.9	0.0		1.4	0.0	0.0			0.3	0.2	1.0	0.1	0.1	0.2	0.0			0.0	0.0	0.0	0.8			0.3	5.0	0.0		0.0		0.2	0.0		1.0	0.0	0.0	2.1	0.1	0.0		1.0	0.5	0.9			0.0		0.0	0.0		0.8	0.8	3.7	0.6	2.2	1.3	0.2	1.7	1.6	2.5	4.4	0.6	1.1	9.5	2.9	0.4	0.6	0.3	1.0	2.0	2.1	1.2	1.0	4.2	0.6	0.2	0.2	4.4	3.4	1.5	1.2	1.0	0.6	1.4	4.6	1.5	0.6	0.3	0.4	0.2	0.8	2.3	0.8	1.9	2.1	2.7	3.1	0.9	2.7	0.8	0.2	1.2	0.5	7.3	3.3	1.1	2.1	1.2	1.5	0.8	1.2	1.9	1.3	0.9	1.4	2.2	1.3	1.9	1.8	1.7	1.9	2.4	0.5	0.3	0.7	0.5	0.6	0.4	0.6	0.8	0.3	0.8	0.7	1.3	3.7	2.2	0.6	0.8	0.2	0.2										
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662778	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.8;pancreas: 31.0"	"Cell line enhanced"	"Detected in many"		"REH: 17.6;RPMI-8226: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"				"Cell Junctions, Actin filaments"	"Cell Junctions, Actin filaments"	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favourable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	2.7	6.1	11.7	3.5	12.4	2.1	2.8	26.8	16.1	2.0	3.0	2.2	3.7	2.0	2.4	3.6	2.7	2.5	3.1	2.3	13.8	7.2	5.5	3.1	3.5	4.0	7.9	5.7	3.3	31.0	5.3	13.9	1.5	7.4	2.7	2.0	1.4	3.8	4.6	7.0	1.5	2.5	2.7	3.7	3.7	3.2	16.9	3.4	2.5	2.3	1.4	3.4	2.9	3.1	11.4	5.3	3.7	1.0	1.2	8.5	2.1	5.6	6.1	1.7	14.9	1.2	0.2	3.1	0.1	0.7	2.2	2.1	3.0	2.4	9.5	2.9	0.1	4.5	3.4	0.7	0.5	4.4	3.2	3.8	2.8	3.5	1.6	1.6	9.0	0.1	0.3	2.1	0.8	1.1	0.3	2.2	0.4	5.5	9.7	2.0	2.0	4.0	17.6	1.1	15.3	5.9	3.3	14.5	7.8	0.9	2.1	2.3	13.1	0.6	0.9	0.2	0.5	1.4	2.9	2.3	7.4	8.4	1.7	3.4	0.6	2.1	1.0	0.4	4.5	0.5	8.5	11.4	6.4	5.9	1.2	7.4	3.2	2.4	3.7	1.2	0.1	5.3	6.1	2.1	11.7	12.4	26.8	16.1	13.8	7.2	7.9	5.7	7.4	3.4
PDCD4	H731	ENSG00000150593	"Programmed cell death 4"	Q53EL6	10	110871795-110900006	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 153.1"	"Cell line enhanced"	"Detected in all"		"U-266/70: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001032, HPA027214, CAB037024"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107"	"unprognostic (4.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.25e-1)"	14.9	9.1	9.4	20.6	9.8	11.8	28.1	15.6	8.1	20.0	46.7	9.1	64.0	18.0	19.1	18.1	40.6	12.3	11.9	8.1	8.4	8.1	6.5	30.6	9.9	13.8	7.8	6.4	27.8	153.1	61.2	30.3	51.4	8.5	18.7	26.1	16.2	81.7	61.7	5.8	37.3	47.1	13.2	8.6	24.0	27.6	10.1	9.5	22.6	55.4	18.8	27.8	15.1	22.7	18.5	12.6	50.9	9.0	26.9	33.1	11.2	5.1	5.0	8.1	8.5	12.2	22.6	4.9	6.0	17.7	3.0	5.1	3.1	12.8	49.3	16.9	8.2	23.7	4.9	15.3	6.4	42.6	9.9	24.9	29.3	5.2	5.5	12.3	27.1	17.9	48.9	3.0	16.6	5.5	6.6	23.4	7.3	13.1	4.5	14.3	2.1	8.9	2.0	14.6	26.1	4.8	7.2	3.5	15.0	11.5	6.2	20.9	58.4	23.5	14.0	4.6	3.5	3.4	2.2	64.1	31.0	28.4	4.3	17.3	4.8	50.9	6.1	15.9	18.5	8.3	33.1	18.5	17.1	20.2	7.3	14.3	14.9	18.1	12.0	26.9	9.0	12.6	9.2	11.2	9.4	9.8	15.6	8.1	8.4	8.1	7.8	6.4	8.5	9.5
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963870-42979220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 73.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	13.0	14.9	12.1	11.5	18.9	9.0	11.5	21.7	19.0	14.7	16.9	14.6	15.3	9.8	11.9	8.8	18.2	23.4	13.0	10.4	12.9	12.1	11.3	18.8	7.4	17.6	17.3	9.1	20.0	73.2	21.3	18.2	10.6	16.0	17.8	8.5	10.8	15.0	12.8	15.2	14.2	24.6	10.5	9.9	12.8	10.6	10.6	17.2	22.3	21.5	6.9	10.9	11.2	12.4	4.3	4.3	4.8	3.2	4.0	6.1	2.5	17.7	8.5	4.3	16.1	16.1	15.5	4.5	3.1	4.9	2.6	5.4	5.4	5.2	7.2	4.4	7.4	16.8	15.0	16.2	2.7	14.0	7.9	2.4	12.0	3.1	10.9	2.4	5.0	19.3	18.8	10.6	2.9	12.9	12.6	7.4	5.6	2.0	6.3	8.0	5.3	7.5	13.6	7.6	2.9	6.5	5.2	13.6	5.9	2.9	11.6	16.3	22.7	10.9	7.2	8.2	1.6	4.0	7.1	11.1	9.8	9.9	2.8	12.6	6.5	2.1	3.2	4.8	3.0	2.4	5.4	2.6	4.4	6.1	4.3	4.3	5.5	5.1	2.0	4.0	1.5	2.5	2.1	2.5	12.1	18.9	21.7	19.0	12.9	12.1	17.3	9.1	16.0	17.2
PGBD5	"DKFZp761A0620, FLJ11413"	ENSG00000177614	"PiggyBac transposable element derived 5"	Q8N414	1	230314482-230426371	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.0;cervix, uterine: 21.9;pancreas: 21.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.7;NTERA-2: 18.1;RH-30: 9.8;SCLC-21H: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065010			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA065010: AB_2685402"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (8.78e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.51e-1)"	0.8	10.8	16.0	0.8	14.1	0.6	0.7	17.9	27.0	21.9	1.5	6.0	0.1	1.0	5.8	0.5	1.8	5.6	2.2	13.3	20.0	8.0	1.5	2.8	1.8	0.9	7.1	8.9	0.9	21.6	0.9	4.0	2.6	8.0	1.4	1.3	1.0	3.2	1.2	2.8	0.9	1.0	3.0	5.0	2.6	1.6	5.8	4.6	0.5	6.0	0.6	5.1	1.6	1.5	0.8	0.6	1.5	0.6	0.6	0.6	0.2	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	4.0	0.0	17.7	1.7	0.0	3.3	1.4	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.1	3.6	18.1	0.1	0.0	9.8	2.8	2.1	0.0	25.0	4.7	0.6	0.0	0.2	0.2	6.1	0.0	0.0	1.5	0.0	1.4	7.6	5.7	0.0	0.0	1.5	0.2	1.5	0.6	1.2	0.6	0.6	0.5	0.4	0.5	0.4	0.4	0.8	0.6	0.6	1.2	0.6	0.6	0.6	0.4	0.2	16.0	14.1	17.9	23.8	20.0	8.0	7.1	8.9	8.0	4.6
PLBD1	FLJ22662	ENSG00000121316	"Phospholipase B domain containing 1"	Q6P4A8	12	14503661-14568349	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.8;bone marrow: 54.7;pancreas: 51.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.6;BEWO: 25.2;CAPAN-2: 65.3;MCF7: 10.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 76.8;intermediate monocyte: 24.0;myeloid DC: 43.0;neutrophil: 53.2"	"Group enriched"	"Detected in many"	148	"dendritic cells: 43.0;granulocytes: 53.2;monocytes: 76.8"	"Not detected"	"Not detected"							HPA040303	Enhanced				"Intracellular and membrane"					"HPA040303: AB_2676922"	"unprognostic (9.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (2.81e-5)"	"unprognostic (4.80e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.44e-2)"	9.6	1.2	2.0	6.3	2.5	54.7	12.4	1.2	1.8	8.4	10.7	2.2	5.7	5.4	5.5	3.4	22.0	5.0	7.6	11.8	1.0	0.5	8.8	6.0	11.9	7.2	2.4	1.6	4.7	51.9	0.4	1.7	10.9	4.7	4.8	14.5	4.8	6.1	3.5	6.6	10.8	9.1	4.7	2.4	13.5	6.7	11.3	2.0	1.9	3.2	5.0	5.1	15.5	14.2	0.3	43.0	53.2	76.8	0.2	0.1	38.5	1.6	1.1	0.1	11.6	0.0	0.0	25.2	0.0	0.0	0.7	0.6	3.3	65.3	0.0	0.3	0.3	2.4	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.0	0.0	0.3	10.8	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	8.6	3.7	0.6	2.3	2.2	0.0	0.1	0.1	0.0	0.1	2.1	6.4	0.0	0.0	0.0	0.0	0.0	76.8	0.6	0.1	24.0	0.0	0.3	0.0	0.0	43.0	0.1	0.0	0.0	53.2	0.2	8.0	0.5	0.1	38.5	2.0	2.5	1.2	1.8	1.0	0.5	2.4	1.6	4.7	2.0
PLEKHH3	FLJ21019	ENSG00000068137	"Pleckstrin homology, MyTH4 and FERM domain containing H3"	Q7Z736	17	42667914-42676994	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 44.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046234	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA046234: AB_2679597"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.05e-3)"	"unprognostic (5.95e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (9.62e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.44e-3)"	8.1	7.7	4.0	2.6	4.1	5.1	20.4	9.0	6.1	16.9	6.0	3.3	6.2	4.6	10.0	7.6	13.6	11.0	10.7	6.5	4.4	1.6	4.4	6.6	8.1	1.8	3.9	3.8	14.7	44.9	8.2	6.6	4.4	4.3	10.9	1.8	8.1	9.2	11.3	23.7	10.6	3.4	9.9	6.7	4.0	11.5	8.1	4.1	1.9	5.6	7.3	5.1	10.3	9.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.7	6.2	3.0	4.8	3.7	1.6	5.4	2.6	2.5	2.1	2.0	3.0	3.6	1.0	3.0	3.0	12.8	2.1	3.5	0.6	5.9	4.9	0.3	12.7	2.5	4.2	0.1	4.4	2.6	5.8	2.7	0.4	1.4	7.6	16.0	0.9	12.5	0.3	5.4	1.0	5.5	1.0	2.9	22.3	0.7	7.8	10.6	11.4	4.0	5.8	5.8	25.5	5.7	2.1	6.7	6.0	7.4	4.7	18.1	20.2	5.3	4.8	1.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.0	4.1	9.0	6.1	4.4	1.6	3.9	3.8	4.3	4.1
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751454-113783429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;RH-30: 4.3;RT4: 16.9;T-47d: 5.8;U-266/70: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037583			Approved	Vesicles,Centrosome				Centrosome	Centrosome	"HPA037583: "	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (1.03e-4)"	0.2	0.1	0.2	1.6	0.2	0.0	11.7	0.2	0.2	26.8	18.5	0.2	10.2	17.0	1.0	2.2	0.8	3.4	6.4	0.2	0.2	0.1	0.6	0.2	4.8	0.2	0.2	0.2	1.3	26.6	0.0	1.9	0.3	0.3	3.5	1.8	0.4	53.1	4.9	0.2	0.7	38.8	0.2	0.2	0.2	2.9	1.1	0.2	0.2	0.2	1.3	2.0	0.8	0.2	0.8	0.5	1.3	0.3	0.7	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.3	0.2	9.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	4.3	0.1	1.4	16.9	0.1	0.2	0.1	1.4	0.1	5.8	0.0	0.0	0.3	0.1	0.0	0.3	3.4	0.1	0.0	0.0	0.0	2.0	0.8	0.1	0.2	0.3	0.1	0.1	0.8	0.2	0.2	0.0	0.5	0.2	0.3	1.3	0.7	0.3	0.5	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 77.8"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"memory B-cell: 37.2;naive B-cell: 65.4"	"Lineage enriched"	"Detected in all"	5	"B-cells: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles				Vesicles	Vesicles	"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favourable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favourable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favourable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	5.5	9.3	6.9	11.9	7.9	4.8	8.8	7.5	6.7	11.2	11.5	3.9	33.9	14.4	5.7	30.9	6.6	10.2	21.0	4.6	6.1	6.1	9.6	20.3	7.5	12.0	4.5	5.1	8.4	77.8	4.2	29.9	8.3	6.7	27.9	12.8	16.2	52.0	36.5	2.3	4.7	18.4	5.2	3.5	12.8	16.1	4.6	4.4	3.8	11.9	5.0	14.8	8.0	6.7	65.4	5.3	13.3	3.6	4.3	5.0	3.7	5.4	10.9	6.5	13.3	12.8	12.5	9.0	15.6	19.7	8.0	10.5	5.0	8.4	0.4	13.3	16.1	6.1	5.4	11.4	6.9	3.4	3.5	9.6	4.6	14.6	21.8	2.8	11.7	9.8	11.9	11.1	14.6	12.9	0.4	25.2	9.7	11.3	6.3	4.7	9.9	3.7	6.9	4.8	50.8	20.0	7.1	5.2	7.9	6.4	9.9	9.1	21.3	5.4	7.7	5.7	5.0	9.5	4.1	15.7	10.2	1.6	15.6	7.4	9.7	13.3	2.7	4.5	3.0	2.7	5.0	37.2	3.9	3.8	2.5	65.4	2.0	1.9	1.6	4.3	3.6	5.3	3.4	3.7	6.9	7.9	7.5	6.7	6.1	6.1	4.5	5.1	6.7	4.4
PLXNA2	"FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2"	ENSG00000076356	"Plexin A2"	O75051	1	208022242-208244320	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 39.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.3;HaCaT: 18.9;HUVEC TERT2: 24.1;TIME: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009763	Approved					580000	580000			"CAB009763: AB_2166388"	"unprognostic (8.25e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.88e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.40e-1)"	7.2	2.4	8.3	2.9	11.8	1.0	3.9	27.5	14.7	4.7	10.5	2.5	2.0	8.2	5.4	3.0	13.2	4.6	7.0	6.0	9.7	4.0	4.3	2.7	12.0	1.6	3.7	10.9	16.9	39.9	2.0	2.8	10.2	6.7	4.2	8.8	5.7	3.7	4.5	7.6	10.8	9.0	12.0	2.9	1.7	11.0	1.2	3.9	0.4	7.2	4.7	4.4	8.3	9.1	0.2	0.7	1.1	0.7	0.0	0.4	0.2	2.1	1.2	2.4	0.3	2.7	5.2	18.3	1.7	1.0	1.0	0.1	0.0	0.0	0.0	3.4	1.3	18.9	0.0	10.7	0.3	0.6	0.3	0.0	2.3	1.2	1.1	0.0	0.0	1.4	3.4	0.8	5.0	24.1	0.0	0.0	10.5	0.2	0.0	0.0	0.3	3.2	0.0	2.4	1.5	2.0	1.3	0.7	4.3	2.0	1.5	1.9	0.1	0.0	55.3	0.3	0.6	2.0	3.4	0.1	0.0	0.0	2.2	0.0	0.9	0.0	0.7	1.1	0.2	0.2	0.3	0.0	0.0	0.2	0.7	0.2	0.0	0.4	1.0	0.0	0.3	0.0	0.0	0.2	8.3	11.8	27.5	14.7	9.7	4.0	3.7	10.9	6.7	3.9
POU6F2	RPF-1	ENSG00000106536	"POU class 6 homeobox 2"	P78424	7	38977998-39493095	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 13.2;pancreas: 12.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.4;Karpas-707: 3.3;NTERA-2: 4.2;SK-BR-3: 3.4;T-47d: 7.5;U-266/70: 8.4;U-266/84: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.00e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	0.9	0.3	2.9	0.4	6.2	0.8	1.0	0.4	13.2	1.2	0.4	0.6	0.0	0.6	0.3	0.3	0.7	0.3	2.4	1.9	3.1	2.1	0.5	2.9	0.5	0.3	2.0	11.2	1.0	12.3	0.3	0.9	3.6	2.3	0.4	0.4	1.5	0.5	0.5	0.3	0.5	0.4	0.3	0.8	0.4	0.4	2.0	1.0	0.0	0.4	0.0	0.4	3.0	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.3	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.0	0.3	2.7	0.0	0.0	3.4	0.0	7.5	0.0	0.0	0.0	0.8	0.0	0.0	8.4	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	6.2	0.4	13.2	3.1	2.1	2.0	11.2	2.3	1.0
PPP2R2D	"B55D, B55delta, MDS026"	ENSG00000175470	"Protein phosphatase 2 regulatory subunit Bdelta"	Q66LE6	10	131900644-131959834	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA042122, HPA042770"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA042122: AB_2677859, HPA042770: AB_2678155"	"unprognostic (7.75e-3)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.90e-2)"	4.5	8.1	5.4	4.0	6.6	1.6	11.4	13.5	12.5	3.7	5.2	5.4	2.4	5.3	3.9	5.2	4.2	4.6	4.7	7.9	5.5	4.7	4.9	4.3	5.5	6.0	4.9	5.2	8.5	34.3	9.9	6.3	5.3	4.7	4.8	5.4	4.9	7.8	5.7	11.4	6.8	5.8	6.0	4.4	5.1	4.4	4.4	5.1	6.3	6.1	3.0	4.4	5.6	6.4	0.4	0.0	0.3	0.6	0.1	0.3	0.0	5.1	4.6	2.5	1.5	3.5	2.5	4.0	1.8	3.6	3.4	3.6	3.1	3.6	2.1	1.3	1.9	9.1	3.7	0.6	3.5	5.3	5.2	3.6	3.9	1.5	0.8	3.1	3.4	0.9	8.3	3.8	5.6	2.1	4.6	0.7	3.6	2.1	1.6	8.8	1.8	4.4	2.1	1.8	0.4	2.7	0.4	2.1	2.9	2.3	1.9	2.0	1.2	2.9	3.1	1.8	0.6	2.7	9.4	3.2	1.8	2.5	1.7	2.1	0.6	0.0	0.2	0.0	0.2	0.4	0.1	0.4	0.1	0.3	0.0	0.0	0.1	0.3	0.3	0.1	0.6	0.0	0.1	0.0	5.4	6.6	13.5	9.2	5.5	4.7	4.9	5.2	4.7	5.1
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957878	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.4;MCF7: 12.4;SCLC-21H: 7.8;SK-BR-3: 23.5;T-47d: 15.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 19.0"	HPA022918	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (6.29e-13)"	"prognostic favourable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	0.9	0.2	0.2	13.5	0.2	0.0	10.0	0.2	0.3	3.2	88.7	0.6	22.9	44.9	0.6	8.3	4.9	6.6	21.2	0.3	0.4	0.2	37.3	1.6	20.3	0.2	0.2	0.2	1.9	75.4	0.0	8.5	0.2	2.2	8.1	32.0	0.4	38.7	26.7	0.2	3.7	113.1	0.5	0.2	0.2	27.2	1.3	0.2	0.3	61.0	2.5	5.8	2.1	2.4	1.3	0.5	0.0	0.2	1.2	2.2	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.5	3.8	0.1	0.2	0.0	13.4	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.6	0.0	0.2	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.2	0.0	0.5	0.2	0.0	0.9	0.7	1.6	7.8	0.3	0.0	23.5	0.0	15.8	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.2	2.2	0.1	0.0	0.5	0.5	1.3	0.8	0.6	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	2.2	0.2
PRRT1B	IFITMD8	ENSG00000283526	"Proline rich transmembrane protein 1B"		9	131545514-131558620	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in many"		"fallopian tube: 9.0;lung: 16.0;pancreas: 7.6"	"Group enriched"	"Detected in some"	10	"A549: 15.6;BEWO: 10.4;MCF7: 4.1;T-47d: 7.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																															0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.5	4.7	0.0	0.0	0.3	0.6	1.0	0.0	9.0	3.9	0.0	0.0		1.3	6.1	16.0	0.0	0.0	0.0	1.7	7.6	1.7	0.0	0.1	0.1	3.4	2.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.6	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0										
PTGER4	EP4	ENSG00000171522	"Prostaglandin E receptor 4"	P35408	5	40679498-40693735	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 57.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.8;HUVEC TERT2: 13.3;LHCN-M2: 13.0;RT4: 18.9;THP-1: 12.6;TIME: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011226, HPA012756"	Approved									"HPA011226: AB_1855885, HPA012756: AB_1855884"	"unprognostic (1.79e-2)"	"unprognostic (6.53e-3)"	"unprognostic (9.43e-3)"	"unprognostic (6.77e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (2.48e-4)"	10.3	5.1	1.4	12.8	1.2	34.7	6.9	0.4	0.8	8.5	24.8	1.7	1.1	9.4	4.8	2.8	6.0	6.1	14.5	9.0	1.1	1.3	8.4	3.7	16.5	16.6	2.2	0.1	4.3	57.2	0.3	1.6	2.3	2.1	7.0	7.9	4.1	3.6	1.0	7.4	4.0	28.7	6.6	4.5	18.2	8.9	2.1	1.2	23.3	3.3	5.7	9.5	11.6	6.2	1.3	5.4	9.3	15.6	2.5	11.4	4.1	1.6	0.3	0.0	0.0	8.1	9.7	0.0	0.1	0.6	0.5	0.3	0.0	0.5	0.2	0.1	0.0	1.2	0.1	3.0	0.8	18.8	0.3	0.0	0.6	0.0	7.3	6.9	1.4	1.0	0.5	4.8	1.9	13.3	0.0	4.5	13.0	0.0	6.9	3.2	0.0	2.8	4.7	1.3	0.6	1.8	18.9	0.0	0.0	0.3	0.6	0.0	2.9	12.6	23.9	2.5	0.0	0.0	0.6	0.0	0.1	0.9	1.1	5.2	0.6	3.5	4.5	9.3	11.4	12.8	6.6	1.3	6.9	7.1	5.4	1.3	4.2	6.1	8.7	2.5	15.6	0.8	5.5	4.1	1.4	1.2	0.4	0.8	1.1	1.3	2.2	0.1	2.1	1.2
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase, receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.6;pancreas: 28.9;pituitary gland: 43.4"	"Group enriched"	"Detected in some"	8	"U-2 OS: 19.8;U-87 MG: 73.7"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavourable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	1.7	22.3	19.3	4.7	35.7	1.7	1.3	17.3	89.6	1.2	2.4	2.5	0.0	2.5	1.5	1.2	1.5	1.3	1.5	1.4	21.6	40.1	1.5	1.2	1.4	1.3	14.4	19.8	1.3	28.9	1.2	43.4	1.4	22.0	1.4	1.9	3.1	1.2	1.3	1.2	2.0	2.5	2.4	3.5	1.3	6.0	1.4	2.1	0.0	1.5	0.0	1.2	2.7	0.0	0.1	0.3	0.2	0.0	0.0	0.6	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	2.5	0.0	6.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	4.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.2	73.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	3.7	19.3	35.7	17.3	54.0	21.6	40.1	14.4	19.8	22.0	2.1
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase, receptor type N2"	Q92932	7	157539056-158587788	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;pancreas: 51.3"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;HDLM-2: 21.5;NB-4: 22.1;SCLC-21H: 12.2;SH-SY5Y: 12.4;THP-1: 10.8;U-87 MG: 15.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	2.1	10.5	20.1	1.7	33.9	1.0	1.1	6.2	40.6	1.7	4.6	2.9	0.0	5.1	2.0	2.9	1.5	6.9	4.7	1.9	18.2	21.3	2.0	1.2	3.1	2.1	11.3	22.3	5.8	51.3	0.5	20.0	1.5	10.3	10.2	3.7	1.5	3.4	2.6	0.8	0.7	4.2	1.6	5.3	7.7	24.2	2.2	5.2	0.0	5.6	0.3	1.7	2.8	0.6	3.4	1.3	14.8	1.1	1.5	3.5	1.1	0.0	0.2	15.3	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.6	0.2	0.0	0.4	0.0	0.0	21.5	0.2	0.0	0.0	2.5	0.6	0.0	0.0	1.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	6.3	22.1	3.0	0.7	0.0	0.7	0.1	0.0	0.0	12.2	12.4	0.0	0.0	0.0	0.0	10.8	3.2	5.0	1.9	0.0	0.3	0.1	0.0	0.0	15.1	9.0	3.6	8.7	1.1	1.6	0.9	0.1	0.3	2.3	1.5	1.1	1.3	3.4	1.4	0.9	14.8	1.5	0.0	0.2	3.5	1.1	20.1	33.9	6.2	40.6	18.2	21.3	11.3	22.3	10.3	5.2
RAB19	RAB19B	ENSG00000146955	"RAB19, member RAS oncogene family"	A4D1S5	7	140404043-140426250	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 14.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.8;HDLM-2: 12.5;MCF7: 5.6;RPTEC TERT1: 4.1;RT4: 8.1;SK-BR-3: 6.3;T-47d: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051077	Uncertain									"HPA051077: AB_2681336"	"unprognostic (3.40e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.53e-1)"	"prognostic favourable (2.36e-8)"	"unprognostic (1.73e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (6.09e-3)"	0.4	0.3	0.3	2.8	0.3	6.7	0.8	0.3	0.3	0.6	5.2	0.0	0.8	4.0	0.4	2.8	0.7	1.2	8.7	0.3	0.3	0.3	8.9	0.5	2.4	4.7	0.3	0.0	0.3	14.5	5.6	10.5	1.5	0.0	2.6	5.0	0.0	5.7	0.2	0.3	0.7	12.1	0.0	0.3	1.1	2.4	0.5	0.0	3.6	11.3	1.7	3.6	1.7	0.4	0.8	0.0	0.3	0.0	0.6	3.5	0.4	0.8	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.1	5.8	0.0	0.6	0.0	0.9	0.0	1.6	0.0	12.5	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.1	8.1	1.0	0.0	0.0	6.3	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.1	0.8	0.9	3.2	0.0	0.0	1.4	1.4	0.3	0.6	0.0	0.0	3.5	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
RAB26		ENSG00000167964	"RAB26, member RAS oncogene family"	Q9ULW5	16	2140803-2154165	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;liver: 21.9;pancreas: 24.6;salivary gland: 17.7"	"Cell line enhanced"	"Detected in many"		"A549: 13.6;HeLa: 14.9;MCF7: 8.9;SCLC-21H: 18.9;SK-BR-3: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075624			Uncertain	"Vesicles,Plasma membrane,Centrosome"	"Intracellular and membrane"			"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"HPA075624: "	"unprognostic (1.01e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (7.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.92e-3)"	0.6	1.0	13.6	0.4	19.9	0.5	0.9	30.5	13.5	2.0	4.1	0.5	1.5	5.7	0.4	2.3	1.2	0.9	1.1	1.2	18.0	6.2	0.7	21.9	0.6	0.6	5.6	9.1	0.6	24.6	3.1	9.2	0.3	2.5	2.2	5.4	0.7	17.7	1.6	1.1	1.2	6.0	0.4	1.9	0.6	5.3	0.6	3.2	0.0	1.2	0.0	1.1	0.9	0.0	0.8	0.2	0.0	0.1	0.0	1.1	0.7	1.1	13.6	0.0	3.5	0.2	0.1	0.1	0.6	1.1	0.5	0.9	0.4	2.7	0.2	0.9	0.8	2.2	0.7	0.2	0.0	1.5	1.4	0.5	14.9	1.2	0.6	0.0	0.4	0.5	0.1	0.1	0.2	0.3	0.3	0.0	1.6	8.9	0.0	0.6	0.8	1.2	1.1	1.1	2.3	5.2	0.9	18.9	3.7	0.3	17.1	0.6	5.6	0.2	0.6	0.0	2.5	0.2	0.2	2.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.7	13.6	19.9	30.5	13.5	18.0	6.2	5.6	9.1	2.5	3.2
RAB40C	"RARL, RASL8C"	ENSG00000197562	"RAB40C, member RAS oncogene family"	Q96S21	16	589357-629272	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 39.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.0"	"Low region specificity"	"Detected in all"							HPA076172			Approved	Vesicles				Vesicles	Vesicles	"HPA076172: "	"unprognostic (8.04e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.07e-2)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.00e-3)"	6.8	4.3	9.1	4.8	15.2	5.8	5.3	18.1	29.9	5.2	9.1	5.9	5.3	14.1	6.2	6.5	11.0	7.6	5.1	7.6	9.7	6.5	6.3	5.3	7.7	4.2	6.6	13.2	8.5	39.9	5.7	12.2	7.2	7.5	7.9	5.0	3.3	14.5	7.2	10.5	25.7	14.1	8.0	4.6	4.7	12.6	6.1	6.1	8.7	5.3	4.3	6.0	8.8	7.6	1.3	1.7	14.0	3.0	0.9	2.2	1.2	5.8	12.8	7.5	10.5	4.3	5.4	10.1	7.9	3.7	6.4	5.2	11.3	10.8	6.8	8.6	4.7	13.4	4.6	6.5	1.3	7.1	7.9	3.7	8.6	8.0	7.7	7.8	7.1	4.6	14.4	5.1	5.4	5.2	8.5	7.0	2.8	17.3	7.2	13.7	8.8	7.6	11.8	5.4	10.7	3.7	8.5	10.2	8.3	8.7	19.2	7.3	14.1	15.1	6.4	6.8	9.7	9.0	4.7	6.8	6.5	8.3	4.5	10.4	7.0	1.1	3.0	14.0	0.4	1.8	2.2	1.3	1.5	1.7	1.7	0.9	1.1	0.8	5.3	0.9	0.9	0.7	0.6	1.2	9.1	15.2	18.1	29.9	9.7	6.5	6.6	13.2	7.5	6.1
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912114	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 91.6;pancreas: 94.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.8;HDLM-2: 37.1;PC-3: 43.2;SH-SY5Y: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	16	"NK-cell: 30.0"	"Lineage enriched"	"Detected in many"	16	"NK-cells: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	3.5	13.8	22.4	9.4	23.9	1.2	1.6	7.8	22.5	34.1	38.8	9.9	8.9	24.9	91.6	21.7	8.9	29.1	19.0	61.7	19.6	15.4	3.1	13.4	3.1	3.3	18.0	12.7	8.4	94.7	1.0	1.6	4.5	14.6	25.5	3.5	1.5	1.5	25.1	62.4	2.4	14.4	51.8	19.5	2.4	14.2	4.3	17.1	0.0	1.1	5.4	2.0	18.3	14.0	0.1	0.4	0.2	0.0	30.0	1.8	1.4	7.7	0.0	0.1	0.0	3.4	5.2	0.3	0.5	0.9	0.5	0.4	0.0	12.8	0.0	0.1	0.2	0.0	2.0	0.0	0.0	37.1	1.0	0.0	0.0	0.2	10.4	0.0	0.0	4.0	6.1	0.0	0.0	0.0	0.0	0.1	1.0	0.7	0.0	0.3	0.1	43.2	0.0	0.4	0.2	0.0	0.0	0.4	54.4	0.8	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.2	0.1	0.2	30.0	0.0	0.0	0.0	1.4	22.4	23.9	7.8	15.3	19.6	15.4	18.0	12.7	14.6	17.1
RAP1GAP2	"GARNL4, KIAA1039"	ENSG00000132359	"RAP1 GTPase activating protein 2"	Q684P5	17	2755705-3037739	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.5;pancreas: 26.0"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022148, HPA022896"	Approved		Supported	"Nuclear membrane,Cytosol"		110000	110000	"Nuclear membrane, Cytosol"	"Nuclear membrane, Cytosol"	"HPA022148: AB_1849474, HPA022896: AB_1849476"	"unprognostic (1.85e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.52e-5)"	"unprognostic (1.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.36e-6)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.50e-2)"	1.2	4.6	6.7	2.9	13.5	16.8	3.1	27.5	22.9	2.7	5.3	2.2	0.0	5.9	3.7	1.0	2.5	5.8	2.7	9.9	6.5	6.3	3.9	0.7	3.4	3.4	4.3	16.4	3.3	26.0	4.5	8.0	3.3	15.8	2.6	5.6	2.6	9.0	3.5	0.8	2.7	5.5	2.3	4.3	3.2	15.4	2.3	3.1	1.6	2.1	0.3	3.0	1.6	2.2	0.5	3.0	7.2	6.3	2.9	5.2	2.0	4.4	5.6	1.1	4.6	0.0	0.0	9.2	6.0	2.8	0.8	0.7	12.3	2.0	1.6	1.7	0.7	6.2	3.6	11.3	0.2	0.0	3.9	2.0	7.8	5.5	1.1	0.4	2.2	0.2	9.8	3.2	8.1	0.1	11.6	0.8	0.0	5.0	1.6	1.1	6.7	5.4	7.4	4.0	4.3	3.4	2.3	12.5	30.3	8.7	9.1	3.9	4.5	1.3	1.3	5.3	8.4	0.9	5.0	0.0	0.0	0.6	0.3	3.8	8.6	1.5	2.3	3.3	5.2	4.7	2.0	0.5	1.7	3.7	1.8	0.4	0.3	1.9	7.2	2.9	6.3	3.0	1.6	2.0	6.7	13.5	27.5	22.9	6.5	6.3	4.3	16.4	15.8	3.1
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341674	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 145.8;liver: 184.8;pancreas: 145.4"	"Group enriched"	"Detected in some"	6	"AF22: 27.1;Hep G2: 39.3;HHSteC: 35.5;NTERA-2: 82.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 8.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	550000000	550000000				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	46.5	145.8	4.6	20.5	5.0	0.0	28.0	2.6	4.4	51.2	31.0	10.7	10.9	5.0	23.8	21.0	18.3	21.9	30.5	12.9	5.3	3.6	21.9	184.8	33.2	10.7	7.6	3.0	40.2	145.4	66.7	6.3	5.6	12.0	35.5	8.0	23.5	6.1	12.2	7.4	3.2	10.3	27.5	7.7	11.0	10.9	11.1	5.4	1.0	7.8	5.2	10.5	26.3	39.7	0.1	8.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.3	2.1	5.1	0.8	3.5	0.2	1.6	0.2	3.1	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.1	4.4	39.3	35.5	0.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.5	82.8	0.0	0.0	3.6	0.0	0.6	0.2	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	8.2	0.0	0.0	4.6	5.0	2.6	4.4	5.3	3.6	7.6	3.0	12.0	5.4
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	8.6	0.0	0.0	6.0	0.1	0.0	0.0	0.7	0.0	0.4	11.0	25.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	5.1	0.0	0.0	0.0	3.1	134.2	5.5	0.0	0.0	0.5	0.1	0.0	0.0	19.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932163	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.4;intestine: 9.2;pancreas: 8.3;stomach 1: 11.8"	"Group enriched"	"Detected in some"	7	"HEK 293: 5.2;U-266/70: 2.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved									"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favourable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.1	7.4	0.1	0.8	0.1	0.0	4.5	0.1	0.4	0.2	6.9	0.2	0.0	3.4	0.1	0.0	0.3	0.1	1.3	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.1	8.3	0.0	2.1	1.5	0.0	0.5	2.0	0.0	1.2	4.0	0.1	0.1	9.2	0.0	0.1	0.1	11.8	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0
RPL26	L26	ENSG00000161970	"Ribosomal protein L26"	P61254	17	8377516-8383250	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 586.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030449, CAB037301"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"CAB037301: AB_796168, HPA030449: AB_10602125"	"unprognostic (2.02e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.38e-1)"	122.5	64.5	70.2	102.5	49.8	132.2	170.4	44.4	52.4	127.6	131.6	34.8	68.1	53.1	76.4	97.0	161.2	87.6	98.6	68.1	54.8	42.5	100.6	138.3	97.5	117.5	61.6	32.6	183.0	586.0	32.2	41.1	82.2	47.7	129.0	84.0	41.5	95.3	87.4	170.8	106.3	98.6	103.6	62.9	129.0	75.9	53.0	45.1	104.9	131.6	145.8	107.9	154.7	127.6	154.9	120.8	25.1	92.1	93.0	158.2	165.0	101.9	93.8	92.3	109.2	174.4	287.2	90.3	88.6	131.8	120.3	90.9	99.1	52.5	178.2	101.9	104.9	113.3	117.4	181.5	141.7	66.5	211.4	69.5	103.6	114.3	203.9	103.2	90.2	244.7	363.4	99.6	299.5	148.1	78.7	53.7	126.3	70.1	113.8	141.3	86.8	62.3	113.7	93.8	110.8	161.7	76.6	38.4	82.0	47.7	89.2	204.8	91.2	138.3	92.8	48.7	60.8	67.1	155.0	43.2	50.4	77.9	79.7	146.9	72.1	25.1	92.1	18.2	89.9	78.3	130.5	154.9	134.3	116.8	120.8	140.1	158.2	136.0	10.9	93.0	69.5	104.5	111.3	165.0	70.2	49.8	44.4	52.4	54.8	42.5	61.6	32.6	47.7	45.1
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993600-51995942	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 434.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"	"Nucleoli, Endoplasmic reticulum, Cytosol"	"HPA069064: AB_2686077"	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	91.6	61.7	42.5	64.6	33.0	110.2	111.0	30.1	39.7	102.4	98.1	30.3	57.1	53.6	59.6	72.8	124.7	76.0	68.7	72.1	33.8	26.0	55.7	122.9	64.8	219.4	36.0	26.0	150.1	434.1	16.3	34.3	50.7	26.3	91.1	41.2	38.9	103.7	54.8	160.8	102.5	73.8	80.2	38.1	83.9	59.7	58.7	25.2	85.9	83.3	123.3	92.4	88.5	87.1	137.9	98.1	32.8	80.0	74.8	132.2	202.9	69.2	90.1	69.5	105.9	123.9	194.9	98.1	77.5	95.8	106.5	88.7	107.2	106.5	193.8	33.8	78.7	63.1	100.2	164.9	51.0	78.8	136.3	100.3	116.5	178.9	147.0	145.5	96.8	238.2	234.6	78.5	139.9	119.2	78.2	148.9	78.5	158.2	126.2	189.2	115.4	153.0	58.7	76.6	187.9	136.2	144.9	56.2	109.7	58.0	133.9	132.4	100.2	248.9	103.3	59.8	80.4	92.2	115.5	97.1	137.7	137.8	79.1	174.5	79.0	32.8	80.0	22.6	68.8	61.7	115.0	137.9	112.2	87.6	98.1	128.2	132.2	109.9	10.8	74.8	48.4	82.8	100.8	202.9	42.5	33.0	30.1	39.7	33.8	26.0	36.0	26.0	26.3	25.2
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841588	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 406.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		140000	140000	"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	80.5	42.2	62.9	55.4	44.5	106.7	109.0	33.2	50.8	101.5	58.9	34.9	38.3	37.3	63.1	91.5	94.8	82.3	49.5	53.5	46.5	36.5	68.4	132.9	63.7	117.4	50.1	41.1	167.0	406.2	20.4	38.6	48.6	32.8	62.6	68.4	41.8	67.9	43.3	121.4	90.5	48.6	78.0	48.4	77.7	52.0	55.9	30.7	103.9	66.9	87.7	121.5	91.2	68.9	230.3	119.2	38.8	86.1	104.4	281.7	293.2	73.3	88.3	77.1	98.2	121.3	217.4	254.8	60.7	113.1	128.3	88.0	116.6	75.3	128.1	55.5	87.1	46.1	87.4	126.1	105.6	59.1	146.3	74.4	112.0	126.0	181.4	119.9	75.6	195.0	275.4	97.8	189.2	111.9	91.3	119.1	104.7	221.5	134.7	207.3	129.9	167.7	107.7	69.3	166.7	129.6	122.3	49.0	98.0	40.8	109.8	130.4	160.7	231.2	64.5	55.7	71.2	73.1	111.3	80.6	126.5	223.9	70.9	172.2	82.9	38.8	86.1	22.9	99.1	66.7	178.3	230.3	197.2	143.1	119.2	214.7	281.7	213.1	12.7	104.4	53.6	118.2	147.0	293.2	62.9	44.5	33.2	50.8	46.5	36.5	50.1	41.1	32.8	30.7
RPL37	L37	ENSG00000145592	"Ribosomal protein L37"	P61927	5	40825262-40835335	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 216.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.18e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.03e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (2.67e-6)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.81e-2)"	"prognostic favourable (6.34e-4)"	40.5	28.5	35.0	48.5	35.9	54.8	118.9	19.7	29.2	60.2	42.8	20.9	39.5	30.2	36.0	53.6	47.1	39.9	37.6	49.3	27.3	21.5	29.2	39.2	47.9	111.6	31.7	24.4	88.7	216.3	18.9	18.5	23.3	27.4	31.3	33.5	26.1	71.5	51.6	54.5	55.9	31.0	54.8	33.5	37.5	34.3	26.4	27.8	44.5	35.0	66.9	63.2	38.5	48.0	115.9	81.4	23.3	48.8	60.2	116.9	99.4	35.9	32.3	57.4	20.3	99.3	115.9	46.8	39.3	69.2	43.5	33.5	50.9	13.4	57.4	32.9	64.3	20.7	61.0	103.9	33.5	56.1	36.2	29.1	134.3	57.0	143.7	54.3	20.7	164.6	107.3	56.8	127.4	62.9	33.4	28.5	53.7	62.5	54.2	80.3	18.1	38.8	27.1	41.6	50.3	97.5	58.3	17.1	38.5	35.3	24.2	60.8	18.0	91.3	27.5	6.9	30.6	12.3	38.4	42.0	49.3	53.5	8.0	67.9	8.2	23.3	48.8	14.8	62.5	41.2	86.8	115.9	99.3	81.8	69.2	109.3	116.9	101.2	16.0	60.2	30.3	81.4	77.6	99.4	35.0	35.9	19.7	29.2	27.3	21.5	31.7	24.4	27.4	27.8
RPLP0	"L10E, LP0, P0, PRLP0, RPP0"	ENSG00000089157	"Ribosomal protein lateral stalk subunit P0"	P05388	12	120196686-120201235	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 408.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003512, HPA073501"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA003512: AB_1079844, HPA073501: "	"unprognostic (2.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (7.66e-12)"	"unprognostic (2.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.47e-1)"	67.3	59.5	20.6	76.6	31.6	100.5	119.8	26.8	26.0	58.4	76.8	22.0	61.8	50.5	95.9	66.0	128.3	74.8	88.6	49.8	28.9	16.2	47.1	121.7	55.4	59.7	21.9	26.6	117.5	408.6	13.5	36.6	70.1	41.5	72.4	60.8	32.8	138.5	54.6	101.0	113.9	57.3	63.8	23.4	60.0	69.0	73.0	18.7	89.6	90.8	162.5	82.8	64.2	116.6	135.9	143.3	10.7	63.4	82.7	172.4	193.3	126.0	109.1	92.8	158.8	189.6	312.3	132.4	97.1	168.7	152.0	99.1	120.6	77.6	276.3	98.2	169.9	100.2	164.3	201.7	96.3	106.7	125.2	131.8	72.4	103.0	204.5	177.0	99.7	281.5	345.4	106.5	316.4	179.5	161.4	80.1	144.5	136.4	178.2	119.7	176.8	146.2	130.0	130.6	216.4	152.0	145.6	99.1	120.7	70.0	104.8	190.8	187.1	214.1	120.6	71.7	109.4	90.8	120.4	181.1	190.6	137.9	128.8	127.4	60.3	10.7	63.4	5.3	71.5	58.3	172.4	135.9	131.9	97.1	137.0	123.2	131.4	104.4	5.0	82.7	35.1	143.3	83.4	193.3	20.6	31.6	26.8	26.0	28.9	16.2	21.9	26.6	41.5	18.7
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272010-33276510	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 484.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050159, HPA055007"	Approved		Supported	Cytosol		90000	90000	Cytosol	Cytosol	"HPA050159: AB_2681035, HPA055007: AB_2682668"	"prognostic favourable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	67.0	49.1	43.4	126.4	32.2	109.6	132.5	20.9	37.7	99.8	105.5	17.8	48.6	44.6	83.1	109.2	120.3	66.7	92.9	71.5	31.2	26.1	48.1	69.1	69.1	263.7	34.5	35.4	154.5	484.7	8.9	33.0	56.3	26.6	95.9	65.2	37.0	168.4	53.7	107.6	140.4	56.9	99.6	35.8	89.9	56.8	40.2	32.3	94.1	94.3	155.9	90.6	101.6	114.8	98.8	55.7	7.8	30.3	49.6	92.4	130.1	51.4	29.8	39.6	103.9	67.9	134.5	63.8	51.6	75.2	67.9	51.4	75.1	30.1	169.7	55.6	54.7	37.9	62.1	81.7	53.4	53.2	97.6	63.3	35.6	98.8	132.5	109.3	33.8	145.3	161.9	51.8	154.9	64.4	84.0	53.3	59.9	86.2	55.1	121.7	54.5	43.1	65.9	64.0	113.6	62.4	66.7	45.5	67.1	20.1	103.4	162.3	70.9	190.5	53.2	32.0	37.4	33.9	67.5	64.0	129.8	130.0	17.9	119.2	38.9	7.8	30.3	3.9	42.7	27.4	72.8	98.8	83.0	60.9	55.7	80.2	92.4	78.5	3.1	49.6	20.2	50.6	61.4	130.1	43.4	32.2	20.9	37.7	31.2	26.1	34.5	35.4	26.6	32.3
RPS2	"LLREP3, S2"	ENSG00000140988	"Ribosomal protein S2"	P15880	16	1962052-1964860	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 284.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA055133	Approved		Approved	"Endoplasmic reticulum,Cytosol"		140000	140000	"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA055133: AB_2682708"	"unprognostic (2.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (7.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-1)"	"prognostic unfavourable (3.04e-7)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.47e-1)"	46.1	41.0	28.0	101.8	40.4	97.6	65.9	34.7	30.7	48.2	47.0	22.2	28.8	39.9	45.7	27.1	100.7	61.7	55.7	38.2	19.5	16.0	34.2	107.4	71.1	104.2	36.6	18.6	112.6	284.3	9.6	32.2	45.4	30.1	43.6	32.5	18.3	53.6	28.9	67.3	78.3	47.5	25.8	22.4	131.9	47.8	18.9	28.1	115.2	50.3	114.5	78.3	51.6	77.6	137.5	69.0	18.2	44.9	53.6	125.4	54.7	81.0	117.7	68.2	219.3	99.1	244.6	120.8	55.7	133.9	146.3	103.9	209.6	56.8	155.5	89.2	96.2	101.9	98.5	186.8	55.0	98.1	194.8	52.4	131.3	187.7	242.1	123.0	86.5	326.4	267.9	122.2	203.4	141.8	107.1	88.4	100.8	376.2	154.3	215.6	216.7	106.4	189.2	110.5	185.9	133.5	77.2	122.3	111.1	54.5	171.3	132.0	115.5	216.0	64.7	78.9	104.0	18.9	116.4	34.4	56.6	197.9	42.5	106.6	99.0	4.9	37.6	18.2	50.7	44.9	84.6	137.5	99.9	78.4	68.7	117.9	125.4	93.8	7.6	53.6	36.0	69.0	68.1	54.7	28.0	40.4	34.7	30.7	19.5	16.0	36.6	18.6	30.1	28.1
RPS29	S29	ENSG00000213741	"Ribosomal protein S29"	P62273	14	49570984-49599164	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 526.9;pancreas: 892.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA004107	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA004107: AB_1079848"	"prognostic favourable (2.66e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.48e-3)"	"unprognostic (7.71e-2)"	59.9	53.6	54.5	108.8	58.9	140.0	155.5	34.4	88.2	68.6	89.6	17.9	67.6	71.4	54.9	67.9	75.3	56.1	63.5	108.2	43.1	33.8	54.5	75.3	74.3	232.1	64.3	56.2	128.3	892.4	8.5	41.6	44.5	53.1	50.6	58.9	29.2	86.0	67.9	177.4	102.6	70.9	76.3	74.6	98.1	63.3	94.0	60.6	53.2	45.6	136.9	101.6	47.1	83.8	303.1	164.3	62.9	102.0	123.1	363.7	526.9	147.8	98.1	102.7	91.9	118.1	201.4	135.9	101.5	86.7	92.8	76.1	98.9	137.2	135.0	116.3	85.2	129.7	117.9	144.4	103.3	88.0	213.0	105.7	89.0	172.2	144.7	269.6	91.9	208.2	236.5	60.9	177.8	132.0	117.8	177.5	89.8	196.7	184.0	168.0	125.2	277.2	154.7	127.9	154.5	111.8	132.6	77.8	89.8	72.0	133.3	235.1	173.8	235.9	121.7	71.1	190.8	66.0	89.6	205.0	227.5	182.7	50.1	111.4	68.4	62.9	102.0	46.1	175.8	81.1	219.7	303.1	322.1	227.3	122.6	281.3	363.7	295.6	24.4	123.1	73.4	164.3	181.8	526.9	54.5	58.9	34.4	88.2	43.1	33.8	64.3	56.2	53.1	60.6
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 136.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.8;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"		44000	44000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.38e-4)"	19.9	18.3	6.7	16.1	11.2	5.9	13.8	4.9	7.4	22.1	23.6	17.8	49.5	18.5	16.3	24.4	17.1	12.3	37.3	15.8	7.8	6.3	27.1	88.9	20.5	10.6	13.0	5.6	23.4	136.1	24.7	18.4	51.4	10.4	19.4	16.7	14.8	84.2	56.0	7.7	11.0	32.2	13.0	13.3	20.4	30.0	12.1	12.2	5.0	32.8	11.6	19.2	18.7	18.9	0.9	23.5	18.8	4.7	5.7	2.5	1.5	31.0	22.2	6.7	14.9	30.8	33.3	35.1	48.8	41.1	20.7	28.1	49.3	29.4	12.0	16.5	46.0	31.4	7.1	39.6	16.9	5.6	5.5	13.9	6.4	50.9	44.2	5.1	17.5	44.0	11.9	33.4	19.8	20.3	5.8	11.7	30.9	14.1	2.0	11.7	7.8	21.5	3.6	17.7	41.3	17.4	10.6	3.4	2.5	27.7	65.9	20.0	11.5	7.8	36.4	44.2	16.5	22.9	16.0	21.6	16.3	3.9	16.7	5.6	22.4	5.4	4.7	18.8	2.5	2.9	1.7	0.5	0.8	1.4	2.4	0.9	0.8	0.9	4.2	5.7	4.0	23.5	0.7	1.5	6.7	11.2	4.9	7.4	7.8	6.3	13.0	5.6	10.4	12.2
RWDD2B	"C21orf6, GL011"	ENSG00000156253	"RWD domain containing 2B"	P57060	21	29004384-29019378	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 23.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018316	Uncertain									"HPA018316: AB_1845702"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	3.7	5.0	5.0	3.9	6.2	1.6	4.2	4.1	8.8	4.0	3.0	1.9	5.2	1.7	3.4	6.2	3.4	3.4	3.6	8.4	5.4	5.5	4.3	9.2	2.7	4.0	4.4	3.9	3.3	23.0	3.9	4.9	3.9	3.1	3.8	3.5	1.3	5.5	4.2	12.9	5.4	2.9	4.6	3.4	3.1	3.2	4.4	0.8	2.6	4.8	9.3	3.6	4.1	2.9	2.5	1.8	5.9	2.1	1.4	1.9	1.0	2.2	1.3	2.1	3.0	8.7	3.7	0.6	2.3	3.5	2.9	3.5	2.5	1.9	4.1	2.5	3.9	1.4	2.5	2.8	2.7	2.6	1.9	5.6	1.4	1.7	4.9	0.6	0.3	3.9	2.6	3.6	5.0	3.8	2.2	3.7	4.0	4.2	1.1	2.2	2.7	2.0	0.9	2.6	5.0	3.4	2.6	3.5	5.0	5.9	2.9	5.7	5.4	3.1	2.8	4.0	2.4	2.9	1.1	5.4	4.8	2.3	3.1	3.6	3.5	5.9	1.6	1.3	1.9	1.5	1.5	2.5	1.4	1.7	1.3	2.2	1.2	1.3	3.6	1.4	2.1	1.8	0.8	1.0	5.0	6.2	4.1	8.8	5.4	5.5	4.4	3.9	3.1	0.8
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 14.7;HSkMC: 18.2;NTERA-2: 8.2;SCLC-21H: 16.8;SH-SY5Y: 19.5;U-87 MG: 25.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 82.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	22000	22000			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavourable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.2	30.7	24.0	2.2	47.2	0.9	2.5	36.4	71.1	1.0	4.4	13.0	0.0	9.0	3.4	21.8	1.0	2.4	3.4	1.0	30.5	36.9	1.2	2.2	2.5	1.3	25.2	23.1	2.0	63.5	60.1	74.6	0.9	30.5	3.2	5.5	15.4	0.7	1.2	0.7	1.3	3.3	3.9	24.1	1.0	21.0	3.0	9.5	0.0	1.8	0.0	0.9	2.5	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.2	0.1	0.0	0.1	0.3	2.5	0.0	2.2	0.2	0.2	0.2	0.0	0.0	0.2	1.0	0.2	0.6	0.3	0.1	0.6	0.3	0.1	0.3	0.0	0.0	14.7	0.1	0.4	18.2	0.1	0.4	0.2	0.3	0.1	0.3	0.4	0.0	0.1	0.1	8.2	0.4	0.0	0.2	0.3	0.2	0.0	16.8	19.5	0.1	0.0	0.1	0.0	0.2	0.0	2.8	1.9	0.1	0.2	0.3	1.1	0.2	25.5	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	24.0	47.2	36.4	50.8	30.5	36.9	25.2	23.1	30.5	9.5
SCGB1C1	RYD5	ENSG00000188076	"Secretoglobin family 1C member 1"	Q8TD33	11	193080-194573	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 7.0;pancreas: 5.9;salivary gland: 7.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.1;RPMI-8226: 1.8;SK-BR-3: 2.1;U-266/70: 1.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"basophil: 5.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.0"														"Secreted - unknown location"															"unprognostic (5.09e-3)"								0.1	0.7	0.1	0.1	0.1	2.5	0.4	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.1	5.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.7	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	5.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	7.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"			Cytosol	Cytosol	"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1
SEBOX	"OG9, OG9X"	ENSG00000274529	"SEBOX homeobox"		17	28364268-28365244	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"liver: 2.6;pancreas: 1.1;testis: 1.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.1;CACO-2: 3.3;HL-60: 1.0;T-47d: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 40.5"	"Not detected"	"Not detected"			HPA045689	Uncertain									"HPA045689: AB_2679419"							"unprognostic (8.66e-2)"							"unprognostic (3.10e-3)"				0.0	0.0		0.0		0.1	0.0		0.1	0.0	0.0			0.9	0.0	0.0	0.1	0.0	0.0	0.0			0.0	2.6	0.0	0.1			0.0	1.1	0.0		0.0		0.0	0.0		0.0	0.0	0.4	0.1	0.0	0.0		0.1	0.0	1.5			0.0		0.0	0.0		0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.5	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
SEC61A1		ENSG00000058262	"Sec61 translocon alpha 1 subunit"	P61619	3	128051641-128071683	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favourable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	28.6	38.2	15.2	23.2	16.2	18.5	38.4	12.8	16.2	45.0	24.2	15.9	77.9	22.1	32.6	52.8	31.1	28.3	34.4	27.6	14.3	13.5	37.6	132.2	33.2	44.9	17.4	10.3	28.5	178.4	31.5	36.5	51.6	15.2	26.2	26.0	19.0	87.1	81.7	22.7	22.7	32.5	31.3	15.4	28.8	33.8	21.2	15.4	22.9	35.5	28.8	36.6	24.2	26.4	13.8	35.6	40.0	25.1	18.7	39.3	29.0	39.5	20.8	20.9	37.2	59.4	51.3	38.5	63.9	74.1	55.7	60.1	39.5	28.8	26.4	38.6	82.4	35.2	32.7	45.1	54.0	23.8	17.9	30.1	23.2	41.5	87.6	38.1	34.3	56.3	54.6	52.5	67.8	48.9	19.7	64.7	64.5	36.1	19.6	12.6	28.2	29.2	20.7	18.8	51.8	29.0	34.7	23.8	23.4	31.5	30.1	40.2	28.0	32.6	48.0	43.9	24.9	51.0	29.8	59.3	28.2	38.0	71.9	24.8	56.7	40.0	25.1	19.1	28.3	23.0	39.3	13.8	20.5	24.8	24.7	8.5	13.0	15.0	6.6	18.7	22.4	35.6	13.1	29.0	15.2	16.2	12.8	16.2	14.3	13.5	17.4	10.3	15.2	15.4
SEL1L	"IBD2, SEL1L1"	ENSG00000071537	"SEL1L ERAD E3 ligase adaptor subunit"	Q9UBV2	14	81471549-81533861	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 121.3"	"Cell line enhanced"	"Detected in all"		"U-266/70: 76.7;U-266/84: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024267	Enhanced				"Intracellular and membrane"					"HPA024267: AB_1856659"	"unprognostic (4.94e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.86e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.25e-2)"	13.2	8.5	9.5	9.2	11.3	4.9	9.1	6.6	9.4	7.5	10.8	8.4	7.1	11.3	10.9	6.1	6.4	7.7	7.0	8.5	8.1	7.1	9.8	33.5	9.0	7.0	10.4	9.0	7.3	121.3	10.0	6.3	18.2	10.2	10.3	10.2	4.9	9.1	8.3	10.9	7.3	10.7	9.0	10.7	11.2	10.6	3.9	10.5	6.5	17.0	4.3	8.8	10.3	11.4	8.9	12.1	29.3	16.4	10.5	11.4	8.4	7.5	15.3	6.1	7.9	13.8	13.6	10.9	12.0	11.6	7.0	7.5	5.8	11.9	7.8	13.3	13.8	7.2	4.2	6.7	12.8	12.0	3.0	5.6	5.0	7.2	19.9	11.4	13.6	11.0	16.3	7.0	15.5	11.5	3.4	43.7	8.6	9.3	6.5	3.2	1.9	6.6	4.5	8.7	6.1	5.4	11.8	3.5	5.8	9.4	8.8	10.0	15.3	7.7	19.1	20.0	11.4	11.0	7.4	76.7	64.7	7.7	22.0	5.2	7.6	16.6	12.9	15.4	11.4	16.4	9.4	8.9	9.0	9.0	12.1	8.3	8.4	9.0	29.3	10.5	13.6	8.9	8.7	8.4	9.5	11.3	6.6	9.4	8.1	7.1	10.4	9.0	10.2	10.5
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747427-25863760	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 48.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 68.0;U-698: 44.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 45.9"	"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9"	"Group enriched"	"Detected in many"	4	"B-cells: 20.8;dendritic cells: 17.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 191.0"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (4.33e-4)"	5.4	3.3	4.0	36.3	5.6	2.3	3.8	45.9	6.4	13.7	19.3	1.5	1.5	19.3	2.2	18.1	6.2	3.6	22.0	2.4	3.3	2.8	6.9	3.6	14.3	27.7	2.1	1.7	3.1	48.0	10.9	2.9	13.7	3.0	4.2	16.7	12.9	23.1	1.0	1.3	1.7	30.3	3.4	2.1	33.5	24.6	2.2	1.1	2.8	12.5	3.8	46.7	14.8	2.2	20.8	17.9	0.4	0.1	3.7	4.3	1.4	5.0	5.5	4.1	1.3	0.6	0.8	0.6	2.5	6.8	1.9	6.2	3.4	23.4	68.0	12.0	17.1	3.2	3.0	10.8	2.6	3.6	1.7	0.7	9.0	4.6	17.6	9.3	0.4	1.4	8.7	6.8	2.6	25.5	4.4	0.0	1.3	3.8	0.0	0.6	11.7	4.9	0.3	22.3	9.4	15.0	16.9	10.1	1.9	16.6	0.2	1.7	0.8	11.5	11.1	0.1	8.1	0.1	7.1	0.4	0.1	44.4	30.9	3.9	4.6	0.4	0.1	0.0	2.8	0.0	3.4	20.8	3.5	3.1	0.7	20.8	1.5	2.4	0.3	3.7	0.1	17.9	4.3	1.4	4.0	5.6	45.9	6.4	3.3	2.8	2.1	1.7	3.0	1.1
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561091-94569913	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 24.8;liver: 118.6;pancreas: 36.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 22.4"	"Group enriched"	"Detected in many"	8	"liver cancer: 94.8;pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA003607	Approved				"Secreted to blood"	22000000000	22000000000			"HPA003607: AB_1079914"	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favourable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	3.2	0.3	0.1	7.9	0.1	0.1	24.8	0.1	0.0	0.0	1.4	118.6	0.0	0.0	0.0	0.0	0.1	36.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	8.2	0.0	0.1	0.1	0.0	0.0	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SH3YL1	"DKFZP586F1318, Ray"	ENSG00000035115	"SH3 and SYLF domain containing 1"	Q96HL8	2	217730-266398	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 94.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 26.0;hTCEpi: 27.0;RT4: 27.0;SK-BR-3: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030926, HPA030927"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA030926: AB_10670148, HPA030927: AB_10669874"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"prognostic favourable (7.70e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-3)"	3.6	11.7	10.3	8.7	10.1	2.6	16.0	8.7	9.7	9.6	12.9	8.6	16.1	9.8	7.9	12.4	17.4	12.8	22.9	4.1	10.5	8.0	42.5	3.8	14.9	10.4	10.9	11.8	9.9	94.7	13.9	20.7	11.4	7.9	17.7	15.8	7.3	35.3	26.9	3.2	21.5	32.1	7.6	13.1	5.5	23.6	6.0	8.2	5.7	22.5	15.3	14.4	18.0	9.5	7.2	3.3	14.0	2.3	12.4	20.6	5.2	4.7	0.9	5.3	2.3	7.2	6.8	3.5	6.1	6.8	2.3	2.4	12.8	17.8	0.2	2.9	5.3	19.9	1.3	26.0	2.1	4.0	0.9	1.2	1.4	4.0	5.8	0.6	1.5	7.5	27.0	1.3	4.4	3.3	0.3	0.7	4.7	13.8	5.0	2.6	1.7	1.0	2.3	1.6	0.3	16.2	27.0	2.1	3.6	1.0	25.2	4.3	17.2	4.0	2.5	1.1	0.3	6.7	2.6	0.7	0.0	0.5	11.5	7.9	3.8	14.0	1.3	1.0	2.6	1.6	8.4	7.2	13.3	6.7	3.3	5.5	20.6	11.9	0.8	12.4	2.3	2.9	16.2	5.2	10.3	10.1	8.7	9.7	10.5	8.0	10.9	11.8	7.9	8.2
SHC2	"SCK, SHCB, SLI"	ENSG00000129946	"SHC adaptor protein 2"	P98077	19	416583-460996	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 44.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.4;HHSteC: 6.3;SCLC-21H: 13.8;SH-SY5Y: 12.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006136	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA006136: AB_1856827"	"unprognostic (2.54e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.36e-1)"	"prognostic favourable (8.53e-4)"	"unprognostic (4.45e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.37e-1)"	"unprognostic (8.86e-2)"	"unprognostic (4.43e-2)"	9.8	11.3	18.5	2.7	15.1	1.0	6.8	5.0	17.6	7.9	6.3	10.2	3.7	8.9	11.7	5.9	2.6	8.1	14.6	7.9	15.7	15.2	3.8	20.6	6.5	2.8	15.2	11.3	5.1	44.8	7.8	18.6	10.7	15.6	13.7	1.4	9.9	19.5	8.2	3.4	8.5	6.2	4.7	9.6	11.5	10.5	6.0	15.0	0.0	9.7	0.7	1.3	3.8	6.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.6	0.5	2.7	0.3	0.0	0.0	0.5	0.0	5.4	0.0	0.4	1.2	0.0	0.0	1.1	1.8	0.0	0.0	3.0	6.3	0.0	2.1	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	2.0	0.0	13.8	12.5	0.0	0.0	0.0	0.3	2.1	0.0	0.5	3.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.5	15.1	5.0	17.6	15.7	15.2	15.2	11.3	15.6	15.0
SHISAL2B	FAM159B	ENSG00000145642	"Shisa like 2B"	A6NKW6	5	64690308-64718090	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 7.3;pancreas: 16.1;stomach 1: 7.7"	"Group enriched"	"Detected in some"	4	"NTERA-2: 5.8;RPTEC TERT1: 12.1"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 3.9"	"Group enriched"	"Detected in some"	14	"basal ganglia: 1.9;hypothalamus: 7.3;pons and medulla: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011778	Enhanced									"HPA011778: AB_1848382"	"unprognostic (5.83e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.01e-2)"		"unprognostic (1.49e-1)"		"unprognostic (9.12e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.36e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.60e-1)"	"unprognostic (6.99e-2)"	0.1	0.0	0.3	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.3	0.2	0.0	0.2	0.0	0.2	0.0	0.2	16.1	0.0	0.1	0.5	4.9	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.6	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	12.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.3	7.3	0.2	0.0	4.9	0.2
SIDT2	CGI-40	ENSG00000149577	"SID1 transmembrane family member 2"	Q8NBJ9	11	117178733-117197445	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 83.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 25.6;non-classical monocyte: 41.6"	"Lineage enriched"	"Detected in many"	6	"monocytes: 41.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052352	Approved									"HPA052352: AB_2681797"	"unprognostic (3.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (4.18e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.22e-3)"	23.9	12.1	9.6	12.5	15.9	7.0	23.5	16.2	18.0	12.7	19.2	28.0	19.4	27.1	16.6	14.3	8.7	13.0	15.6	14.9	11.2	10.0	10.0	21.2	29.7	21.3	15.0	14.5	30.6	83.9	12.0	17.4	13.8	17.4	24.5	14.9	14.1	25.5	16.7	11.1	19.5	31.7	18.2	25.4	17.3	35.4	13.8	13.0	6.2	15.4	8.4	12.5	16.1	9.7	7.3	3.5	0.5	41.6	0.4	0.6	2.8	4.3	4.6	5.7	7.9	19.1	17.2	18.8	7.9	10.4	5.1	4.7	12.3	17.5	4.6	12.6	20.7	4.8	5.5	6.1	4.2	6.8	6.6	3.0	8.1	9.0	9.9	2.7	8.4	21.2	6.8	6.5	7.1	10.2	6.1	10.4	11.8	9.5	3.8	3.2	2.6	3.5	2.9	3.9	13.1	6.7	4.8	1.7	4.2	8.4	20.6	1.3	16.6	3.3	6.3	6.7	4.4	4.4	1.8	7.3	2.6	4.8	3.8	5.7	4.9	0.1	4.2	0.1	0.6	25.6	0.5	5.7	0.3	0.4	3.5	7.3	0.5	0.4	0.5	0.4	41.6	1.9	0.4	2.8	9.6	15.9	16.2	18.0	11.2	10.0	15.0	14.5	17.4	13.0
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 28.8;HEK 293: 12.4;RPMI-8226: 23.8"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"	"Vesicles, Cell Junctions"	"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.3	0.0	0.1	0.5	0.7	5.0	0.2	4.0	0.9	0.1	0.0	28.8	0.0	0.5	0.0	12.4	4.7	0.3	4.7	0.0	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	2.0	6.1	0.6	8.9	1.8	3.5	4.3	23.8	0.0	0.4	6.7	2.1	0.1	0.6	1.1	1.1	0.7	0.0	0.1	1.1	0.3	1.6	1.9	0.0	1.0	0.2	3.7	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798333	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.0;pancreas: 43.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	4.9	5.2	23.3	8.3	19.0	5.7	2.7	32.2	45.0	3.5	4.1	3.4	2.5	10.3	3.2	2.3	4.4	5.0	3.8	3.2	27.8	13.2	4.1	14.2	4.6	7.5	9.6	22.8	4.8	43.0	4.0	13.4	4.4	13.5	5.2	2.9	4.6	11.4	4.2	1.1	5.8	8.5	3.3	2.8	5.3	6.8	6.6	2.6	3.5	3.1	3.0	5.1	4.5	2.4	2.5	3.1	4.0	5.7	3.6	7.2	2.3	23.2	15.1	8.9	7.9	3.7	6.8	8.4	11.1	9.4	12.4	7.9	14.9	16.0	7.0	8.4	9.3	20.6	9.8	13.4	2.8	13.1	17.9	6.4	7.4	9.1	16.1	10.3	10.8	6.8	8.1	9.4	10.1	5.7	13.0	11.0	5.5	14.1	10.7	9.7	19.2	23.2	12.7	4.8	16.5	7.4	3.9	43.9	19.7	6.4	15.4	7.9	7.4	5.2	5.5	13.9	9.3	6.4	10.4	9.7	5.6	8.9	16.7	9.2	8.3	0.0	2.4	4.0	6.6	5.6	4.2	2.5	4.1	7.2	3.1	2.1	2.5	4.2	1.5	3.6	5.7	0.9	2.2	2.3	23.3	19.0	32.2	37.4	27.8	13.2	9.6	22.8	13.5	2.6
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 60.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.7;Karpas-707: 18.6;RPMI-8226: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA050821	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA050821: AB_2681249"	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favourable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	2.2	1.8	2.1	4.0	2.3	3.1	3.2	1.0	2.6	1.7	4.5	4.0	4.7	4.1	1.0	5.4	1.5	1.3	1.3	2.8	2.5	1.1	3.9	7.7	5.3	9.4	1.8	2.3	1.3	60.5	4.2	4.7	1.2	2.3	2.5	1.2	3.5	5.0	1.3	4.1	2.0	11.0	1.5	2.3	9.6	1.9	2.4	2.0	5.8	9.0	2.8	8.2	1.9	1.7	10.8	19.2	6.0	10.1	13.5	11.4	2.5	0.3	4.6	0.2	6.8	1.3	0.6	3.4	0.8	2.1	0.4	0.4	1.0	2.2	4.1	3.9	1.9	0.5	0.5	0.3	0.0	13.7	1.0	4.4	2.5	0.3	0.8	1.4	4.7	1.6	0.1	0.5	0.4	0.7	0.6	18.6	0.7	1.5	3.2	0.1	0.3	2.1	6.0	0.9	13.4	0.7	0.0	2.3	3.0	1.4	3.6	0.7	1.8	0.7	1.3	0.5	1.7	4.4	0.3	7.7	4.8	1.1	1.4	1.0	2.6	6.0	5.5	3.9	7.9	9.0	8.4	8.9	7.0	7.5	5.7	10.8	11.4	8.5	3.3	13.5	10.1	19.2	6.3	2.5	2.1	2.3	1.0	2.6	2.5	1.1	1.8	2.3	2.3	2.0
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340683	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 36.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"pons and medulla: 6.0"	"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved									"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favourable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.1	0.0	0.1	0.8	0.3	9.9	10.2	0.1	0.1	1.2	1.3	0.7	34.8	1.0	0.8	2.8	4.5	2.6	12.2	0.6	0.3	0.2	0.2	0.4	1.1	0.1	0.1	0.1	2.0	24.6	0.0	2.5	0.1	6.0	1.0	2.9	0.6	12.5	29.1	0.1	9.8	2.0	0.1	0.1	0.4	0.8	0.5	0.1	0.9	0.2	6.4	3.3	0.3	1.4	0.2	0.0	0.0	2.7	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.9	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	36.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.3	0.0	5.4	0.0	0.1	3.6	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.1	6.0	0.1
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046133	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 78.0;placenta: 20.0"	"Group enriched"	"Detected in some"	5	"BEWO: 4.6;RPTEC TERT1: 10.4;WM-115: 6.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Low region specificity"	"Detected in some"			HPA017979			Approved	Vesicles				Vesicles	Vesicles	"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	0.7	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.0	1.3	1.1	0.1	0.1	4.0	2.2	0.1	0.1	10.4	0.1	0.2	0.1	0.1	0.1	0.1	78.0	0.1	0.1	20.0	0.1	0.3	0.0	2.0	1.0	1.4	1.7	0.4	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0.1	12.8	0.2	0.1	0.5	0.1	1.5	1.1	3.1	1.0	1.5	0.9	0.4	0.2	0.2	0.2	0.9	0.3	0.1	4.6	0.4	0.1	0.1	0.1	0.9	1.0	0.2	0.9	0.1	0.8	0.2	0.3	0.1	0.6	0.3	0.6	0.7	0.1	0.1	0.6	0.7	0.0	0.2	0.1	0.1	0.0	0.6	1.4	0.0	0.7	0.5	0.9	0.7	0.2	0.3	0.7	0.6	10.4	0.4	0.9	0.5	0.6	1.1	0.4	0.7	0.5	0.5	0.7	1.1	0.6	0.3	1.0	0.5	0.7	0.5	0.6	6.3	3.1	1.0	0.4	0.9	0.4	0.5	0.7	0.6	0.8	0.2	1.5	0.6	0.8	3.1	1.5	0.5	1.1	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367249-22434129	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 135.5;pancreas: 77.2"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA016508	Approved		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		950000	950000	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"	"HPA016508: AB_1857148"	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favourable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	15.0	16.1	2.6	7.7	5.4	0.1	45.5	2.4	6.1	3.6	13.7	1.9	2.8	31.6	6.7	2.8	3.9	5.6	9.8	41.1	2.8	2.4	10.4	135.5	4.8	5.3	3.7	1.9	10.6	77.2	3.0	6.4	4.0	9.2	5.1	11.4	4.1	20.2	4.4	46.1	4.4	18.2	14.1	4.7	2.3	16.2	5.9	2.8	0.7	25.1	2.1	1.4	11.3	19.0	5.0	1.8	2.5	0.5	2.9	8.7	3.9	10.6	14.3	4.0	8.0	14.3	12.1	8.7	15.4	68.2	24.1	38.0	47.3	10.1	10.7	8.7	18.0	11.8	19.7	19.2	39.7	11.1	11.2	8.5	11.4	47.7	34.1	5.8	9.4	12.9	15.6	42.7	29.8	10.7	7.4	10.9	12.2	4.9	8.8	3.7	24.3	11.0	12.6	7.5	22.8	8.8	4.6	6.8	10.6	15.7	6.7	31.8	5.4	8.5	5.9	30.0	15.2	18.8	15.7	6.3	5.7	14.0	42.4	7.8	17.4	0.0	0.5	2.5	8.3	0.1	8.7	5.0	4.8	6.3	1.8	2.6	5.7	7.6	0.2	2.9	0.1	0.8	3.8	3.9	2.6	5.4	2.4	6.1	2.8	2.4	3.7	1.9	9.2	2.8
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 77.8;liver: 38.2;pancreas: 101.1"	"Group enriched"	"Detected in some"	60	"CACO-2: 22.2;Hep G2: 32.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Low region specificity"	"Detected in many"			HPA018423			Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favourable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.2	0.1	0.2	4.1	0.2	0.0	0.2	0.2	0.2	0.2	40.5	0.2	0.2	48.6	0.2	2.3	0.2	0.1	5.9	0.2	0.2	0.1	22.5	38.2	0.2	0.2	0.2	0.2	0.2	101.1	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.2	0.2	0.2	0.1	77.8	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	22.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	32.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 48.7"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"				Mitochondria	Mitochondria	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favourable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.2	48.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789093-205813748	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.1;pancreas: 36.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	6.0	7.2	6.2	4.0	7.3	3.3	3.4	9.0	8.3	3.6	3.9	10.8	4.0	1.6	5.0	5.9	3.8	7.3	4.7	78.1	7.2	3.8	6.1	1.2	5.3	4.5	7.8	4.9	7.5	36.8	5.8	3.6	2.6	6.9	5.1	1.5	5.8	2.8	4.8	26.5	2.6	2.7	4.0	8.5	3.3	6.6	11.6	7.3	2.1	11.2	11.9	4.5	5.2	5.0	1.8	0.0	0.1	0.3	1.0	4.6	2.0	10.7	9.5	6.0	9.6	7.5	7.4	8.1	11.0	10.9	11.3	9.9	4.7	6.1	15.5	7.0	10.1	11.2	5.9	8.1	3.9	28.4	8.8	3.8	9.4	0.7	7.2	0.0	10.9	9.4	6.8	12.8	9.2	6.9	6.9	6.5	9.0	6.6	6.9	1.1	7.2	4.3	8.2	18.1	3.7	2.6	13.4	5.0	6.4	8.5	7.6	6.9	5.4	4.0	8.6	13.4	8.7	12.2	11.4	21.7	14.4	5.1	10.4	4.9	8.3	0.0	0.1	0.1	3.6	0.3	4.6	1.5	3.4	3.4	0.0	1.8	3.2	3.3	0.0	1.0	0.0	0.0	3.3	2.0	6.2	7.3	9.0	8.3	7.2	3.8	7.8	4.9	6.9	7.3
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71186757-71572087	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.4;pancreas: 113.8"	"Cell line enhanced"	"Detected in some"		"BJ: 13.7;fHDF/TERT166: 6.2;HBF TERT88: 5.7;RPTEC TERT1: 14.7;U-138 MG: 7.8;U-2197: 5.6"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.8;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629"	Enhanced									"CAB022493: , HPA035628: AB_2674708, HPA035629: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favourable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	2.4	0.9	14.3	4.3	19.9	0.7	1.1	18.1	15.2	5.8	17.2	4.5	0.1	22.4	0.8	0.7	1.1	1.0	24.9	2.9	13.1	8.1	47.4	9.4	5.8	0.6	9.7	11.2	1.0	113.8	10.0	4.1	1.6	18.1	14.6	17.1	11.1	1.5	1.1	1.3	0.7	10.4	1.3	21.6	0.9	8.3	0.7	8.0	0.0	9.5	0.0	0.6	2.6	0.9	0.0	0.1	0.0	0.0	0.5	2.8	0.3	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.7	1.8	2.3	1.8	0.0	0.1	0.0	0.1	6.2	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	4.6	0.2	0.1	0.0	0.0	0.0	0.9	14.7	4.1	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	7.8	0.7	5.6	0.6	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.8	2.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.3	14.3	19.9	18.1	12.4	13.1	8.1	9.7	11.2	18.1	8.0
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.6;CAPAN-2: 17.4;NTERA-2: 13.5;RPMI-8226: 14.0;SK-BR-3: 22.6;T-47d: 16.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	330000	330000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA030561: "	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.5	1.2	0.0	0.1	0.0	0.0	22.6	0.0	0.5	0.3	1.7	5.7	17.4	0.8	4.1	0.0	2.8	1.8	1.5	0.2	0.0	11.6	3.7	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.4	0.2	0.4	0.5	0.2	0.0	9.2	0.0	0.3	13.5	2.1	0.2	0.1	14.0	12.2	4.5	11.7	0.2	0.0	22.6	0.6	16.3	0.7	0.0	0.0	3.9	0.0	0.0	0.1	5.9	0.3	0.3	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3
SPAG4	"CT127, SUN4"	ENSG00000061656	"Sperm associated antigen 4"	Q9NPE6	20	35615892-35621049	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 54.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 16.8;U-87 MG: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA048393, HPA061789"	Approved									"HPA048393: AB_2680385, HPA061789: AB_2684609"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (1.09e-5)"	"prognostic favourable (9.52e-8)"	"prognostic unfavourable (6.31e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (3.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.79e-1)"	"prognostic favourable (6.66e-4)"	1.7	2.9	1.6	4.8	1.4	3.8	3.7	0.4	5.3	2.7	13.9	0.2	3.3	4.0	1.5	4.4	2.8	2.5	3.4	2.6	1.1	2.0	3.1	3.0	3.2	4.9	1.3	1.6	5.2	54.3	3.2	5.0	7.0	2.3	2.6	2.0	2.8	4.5	2.5	0.4	0.4	3.4	1.2	2.9	6.9	4.6	16.9	1.5	0.0	1.3	0.0	7.5	7.2	1.8	0.9	3.9	0.0	0.7	0.0	1.0	0.4	2.3	1.0	0.5	1.4	1.3	0.6	6.7	1.0	1.1	0.9	1.4	2.4	5.1	0.2	16.8	1.3	0.7	0.3	3.2	1.1	2.5	0.5	1.9	2.2	2.4	6.6	1.3	3.3	3.2	0.6	1.0	0.8	1.9	0.5	4.7	2.4	4.9	0.5	3.7	0.0	4.6	0.3	0.5	6.6	1.7	1.0	0.3	2.4	1.1	0.8	1.8	3.4	0.6	2.0	4.8	0.7	1.0	0.9	9.0	3.5	1.9	30.5	0.5	0.7	0.0	0.1	0.0	0.0	0.7	0.5	0.9	0.1	0.4	0.4	0.0	0.5	0.0	0.0	0.0	0.0	3.9	1.0	0.4	1.6	1.4	0.4	5.3	1.1	2.0	1.3	1.6	2.3	1.5
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887360-72892158	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 61.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 9.9;monocytes: 9.3"	"Low region specificity"	"Detected in all"							HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol		52000	52000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	13.3	22.6	6.3	6.1	8.2	0.0	36.2	2.0	6.4	6.0	17.1	3.1	8.9	11.4	5.7	19.1	13.4	13.2	11.4	16.1	6.4	6.0	20.3	43.5	7.2	5.3	7.9	5.0	8.7	61.7	16.7	5.5	3.9	7.9	17.3	16.2	4.5	20.9	8.8	16.0	3.3	15.1	9.5	4.9	4.7	15.4	4.9	7.2	1.0	31.7	6.2	3.6	9.5	41.4	0.0	9.9	0.7	9.3	0.0	0.4	2.5	13.9	39.2	0.2	6.1	16.1	5.8	9.8	6.6	9.6	4.9	4.6	24.9	14.5	10.2	7.9	7.8	13.2	17.5	10.5	4.1	2.9	13.6	15.3	9.7	25.5	6.0	2.4	4.2	5.2	11.8	5.4	6.1	12.9	15.7	2.0	6.4	29.4	0.9	9.1	3.3	37.5	0.0	25.5	6.0	26.0	21.9	2.4	4.6	12.1	27.3	8.9	12.3	2.9	15.8	5.4	13.2	9.4	11.5	2.2	4.9	0.7	7.7	5.2	9.3	0.0	9.3	0.7	0.4	2.6	0.4	0.0	0.2	0.1	9.9	0.0	0.2	0.4	0.0	0.0	1.0	0.9	0.0	2.5	6.3	8.2	2.0	6.4	6.4	6.0	7.9	5.0	7.9	7.2
SRM	"SPS1, SRML1"	ENSG00000116649	"Spermidine synthase"	P19623	1	11054584-11060024	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 107.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA015746	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA015746: AB_1857472"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (2.25e-5)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavourable (3.80e-8)"	"unprognostic (1.74e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.98e-2)"	26.7	17.7	20.3	29.0	35.4	15.2	16.9	10.2	30.8	14.3	13.3	14.0	11.5	10.8	18.8	9.8	17.7	15.8	14.2	24.9	19.6	16.9	13.9	45.3	14.0	31.0	15.3	15.0	22.8	107.4	8.0	14.5	14.8	15.6	13.1	11.7	15.0	36.0	17.6	43.6	18.2	9.8	22.9	11.7	21.1	14.5	14.4	14.1	17.9	11.9	21.2	20.8	20.2	19.8	10.7	10.2	0.3	6.0	5.0	10.3	2.0	24.9	36.3	12.1	40.4	24.1	26.1	19.0	38.8	19.9	55.5	29.8	44.7	15.1	48.2	22.9	33.6	19.6	38.6	31.2	18.4	23.7	58.3	30.4	40.2	50.4	35.5	50.9	27.9	26.2	22.6	53.7	47.1	23.4	49.4	40.9	26.9	54.7	43.4	44.5	26.3	70.4	32.7	12.5	78.7	19.7	9.9	23.3	22.3	20.0	43.3	30.3	15.1	25.9	19.4	36.2	28.5	62.7	43.5	33.0	33.2	72.2	25.2	68.5	41.7	0.0	5.4	0.3	7.0	6.0	10.3	10.7	7.1	9.1	6.4	9.3	8.4	9.7	0.2	5.0	3.1	10.2	7.5	2.0	20.3	35.4	10.2	30.8	19.6	16.9	15.3	15.0	15.6	14.1
SRPRB	"APMCF1, SR-beta"	ENSG00000144867	"SRP receptor beta subunit"	Q9Y5M8	3	133784033-133825772	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 104.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011173	Approved		Approved	"Plasma membrane"		54000	54000	"Plasma membrane"	"Plasma membrane"	"HPA011173: AB_1857484"	"unprognostic (5.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (1.99e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.07e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.79e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.26e-2)"	10.4	15.7	8.7	10.2	9.3	5.8	12.5	5.2	10.2	14.4	11.3	5.1	33.2	8.9	8.0	25.6	16.8	9.1	11.0	10.9	9.0	10.7	17.2	56.3	9.2	17.3	10.4	7.7	8.9	104.0	11.7	15.6	7.7	8.8	9.5	13.4	7.6	53.3	29.9	10.6	8.6	7.4	10.3	7.4	9.5	12.5	14.7	5.4	6.3	16.5	10.2	13.7	8.7	10.4	15.4	20.0	3.8	15.2	14.3	29.0	18.0	12.2	9.9	6.3	20.0	26.4	18.3	11.8	25.9	13.5	14.4	12.5	18.0	9.5	23.2	38.4	19.8	17.9	19.6	14.0	13.7	15.7	15.8	20.7	9.8	17.1	32.1	32.4	16.9	16.5	23.6	13.1	38.9	12.2	17.6	27.0	15.4	17.8	11.1	15.4	12.0	17.1	13.6	11.8	49.5	17.4	8.4	20.9	8.7	19.8	18.5	7.2	21.0	15.1	12.1	14.2	8.4	22.4	13.8	34.8	34.6	35.0	12.7	21.6	15.9	3.8	11.6	1.4	21.4	15.2	29.0	15.4	18.3	19.0	13.2	13.4	18.0	21.2	0.8	14.3	9.9	20.0	10.6	18.0	8.7	9.3	5.2	10.2	9.0	10.7	10.4	7.7	8.8	5.4
SSFA2	"CS-1, KIAA1927, KRAP, SPAG13"	ENSG00000138434	"Sperm specific antigen 2"	P28290	2	181891833-181930738	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 85.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favourable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (5.79e-5)"	14.2	10.1	23.3	11.8	27.0	16.1	21.6	25.8	22.5	17.7	24.4	26.2	9.4	17.5	13.0	8.9	12.0	10.7	18.7	13.6	23.7	19.1	22.8	36.0	23.0	11.2	31.3	17.7	7.2	85.5	10.5	10.2	40.9	24.8	18.1	24.1	22.3	29.2	10.0	16.6	50.6	19.5	14.2	27.8	14.7	26.0	16.7	23.8	9.3	19.6	12.2	7.9	14.3	23.5	1.2	3.8	8.1	6.4	1.0	1.4	1.8	16.1	8.1	23.6	4.0	20.6	17.1	6.7	28.7	27.9	10.1	13.4	8.3	18.7	0.3	9.3	20.2	14.0	5.7	13.8	19.6	7.4	6.4	16.3	34.7	6.7	15.2	8.3	15.3	10.1	20.3	17.4	23.7	52.8	7.3	9.0	28.1	8.1	7.3	11.7	1.6	19.1	5.5	9.5	5.6	28.6	4.9	4.1	3.6	16.8	6.0	25.7	4.3	18.3	21.0	24.0	11.6	8.6	14.9	6.2	2.7	6.5	11.2	5.0	17.8	8.1	3.9	5.7	1.4	3.9	0.9	0.6	1.0	0.9	3.8	1.2	1.3	1.1	6.6	1.0	6.4	3.1	0.6	1.8	23.3	27.0	25.8	22.5	23.7	19.1	31.3	17.7	24.8	23.8
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798505	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 699.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced					600000	600000			"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favourable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavourable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	17.4	30.0	13.2	29.5	22.6	37.5	46.0	12.2	20.6	30.4	31.7	9.0	152.0	30.7	19.1	81.4	21.4	18.3	30.2	40.7	23.0	17.7	21.8	48.0	42.1	136.9	14.5	11.6	18.4	699.0	7.2	67.7	30.3	26.0	24.0	24.0	11.7	83.7	192.6	12.1	16.9	24.1	19.5	26.3	37.9	43.6	19.6	8.2	15.3	22.6	21.0	29.4	27.7	20.0	67.1	171.0	50.7	58.6	62.0	78.7	108.1	34.3	44.2	15.0	84.2	80.9	43.1	31.4	29.4	43.5	30.6	41.7	54.9	30.4	48.9	77.8	44.5	34.0	26.1	27.3	11.1	19.9	22.3	13.8	41.4	43.0	70.1	37.8	36.7	53.6	38.0	26.3	35.9	32.8	15.1	104.0	23.7	61.4	21.5	56.4	9.1	72.1	24.2	19.5	90.6	38.6	41.0	29.3	24.2	17.4	30.1	31.8	19.5	81.7	27.2	18.0	19.9	34.7	38.1	154.4	75.5	57.3	38.3	64.7	30.1	50.7	58.6	26.1	63.6	44.4	78.7	67.1	65.5	62.9	58.5	56.6	57.0	58.4	9.3	62.0	35.5	171.0	47.9	108.1	13.2	22.6	12.2	20.6	23.0	17.7	14.5	11.6	26.0	8.2
ST6GALNAC4	"SIAT3C, SIAT7D, ST6GALNACIV"	ENSG00000136840	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4"	Q9H4F1	9	127907886-127917038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;pancreas: 61.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.9;RPMI-8226: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 58.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009042			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA009042: "	"unprognostic (2.05e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (8.63e-7)"	"unprognostic (1.62e-2)"	"unprognostic (4.26e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.04e-1)"	"prognostic unfavourable (8.39e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.03e-2)"	8.0	7.8	5.6	7.9	5.6	26.2	12.1	9.8	8.5	9.2	9.3	4.8	28.9	11.7	8.7	9.6	6.9	8.7	12.2	18.4	5.2	3.4	9.4	5.0	13.5	9.7	4.2	4.7	14.9	61.0	2.4	9.4	4.3	4.8	6.1	5.4	4.8	9.3	30.0	12.6	4.0	9.7	6.1	3.9	18.2	7.2	4.3	4.7	4.7	6.3	5.9	12.5	8.9	8.3	6.7	58.8	0.8	3.2	4.3	3.4	2.4	3.1	5.4	1.4	6.9	9.7	7.4	1.0	5.5	6.1	5.6	3.3	3.0	5.8	20.1	8.4	6.8	7.7	2.8	5.8	0.9	34.9	2.4	6.4	17.2	11.4	11.9	0.5	6.7	9.1	6.2	5.0	4.5	14.9	4.6	13.5	2.7	1.4	1.2	0.7	1.6	13.3	6.0	3.6	49.4	5.7	0.1	11.8	2.6	8.0	17.3	1.0	3.5	4.1	10.6	4.6	5.3	14.3	8.6	21.9	11.3	6.3	9.2	2.8	0.6	0.8	2.1	0.0	2.9	1.9	3.3	6.7	1.8	3.4	2.8	4.9	2.3	3.1	0.2	4.3	3.2	58.8	3.3	2.4	5.6	5.6	9.8	8.5	5.2	3.4	4.2	4.7	4.8	4.7
STC2	STC-2	ENSG00000113739	"Stanniocalcin 2"	O76061	5	173314713-173329503	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.5;pancreas: 51.8"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 114.1;T-47d: 108.3;U-138 MG: 44.8"	"Cancer enriched"	"Detected in all"	6	"breast cancer: 91.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA045372	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	15000000	15000000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA045372: AB_10961040"	"prognostic favourable (7.40e-5)"	"unprognostic (2.40e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-3)"	"prognostic unfavourable (1.76e-6)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (5.28e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (4.17e-8)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (8.56e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.93e-3)"	3.6	0.7	0.3	1.4	0.8	0.2	68.5	0.4	2.4	6.5	2.4	0.1	1.4	0.5	1.6	2.4	3.1	1.3	5.8	17.4	0.9	0.4	1.7	0.6	17.3	0.7	2.4	0.0	2.0	51.8	1.5	1.2	12.1	2.8	3.0	0.6	0.1	0.6	5.7	10.8	7.4	1.7	8.8	7.1	14.8	2.2	0.8	1.0	0.0	4.5	0.7	0.4	9.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.8	0.3	1.5	5.5	2.3	15.2	26.1	26.0	6.6	12.9	8.3	4.2	0.0	4.0	15.4	2.4	3.8	8.1	11.6	0.0	2.2	0.0	2.8	5.6	34.8	1.8	0.5	5.0	13.0	15.4	1.1	1.8	0.2	0.0	114.1	4.6	0.0	0.0	0.9	8.8	0.0	3.9	3.0	0.0	0.4	4.1	1.1	1.1	0.1	4.5	108.3	1.8	16.6	44.8	0.1	26.1	5.5	5.1	2.7	1.2	8.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.4	2.4	0.9	0.4	2.4	0.0	2.8	1.0
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102258-17131372	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.8;pancreas: 9.1"	"Group enriched"	"Detected in some"	5	"HEK 293: 4.0;SCLC-21H: 9.6;T-47d: 11.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"				"Actin filaments"	"Actin filaments"	"HPA067970: AB_2685934"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.1	0.0	0.4	0.1	0.8	0.0	3.7	0.6	0.6	1.6	1.0	2.8	1.4	0.1	0.6	4.7	0.1	21.8	6.0	0.1	0.7	0.9	0.1	0.1	7.7	0.1	0.1	0.1	3.5	9.1	0.0	0.7	0.1	2.5	0.1	1.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	7.4	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.9	1.6	2.8	1.1	0.8	0.8	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.6	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.2	0.8	0.0	4.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	9.6	0.0	0.0	0.1	0.0	11.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.7	0.3	0.8	0.6	0.4	0.7	0.3	0.2	0.9	0.8	0.7	2.8	0.8	0.8	1.6	0.2	0.4	0.4	0.8	0.6	0.6	0.7	0.9	0.1	0.1	2.5	0.1
SYBU	"FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL"	ENSG00000147642	Syntabulin	Q9NX95	8	109573978-109691791	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 82.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.2;PC-3: 14.9;SK-BR-3: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"memory B-cell: 9.4;naive B-cell: 4.4"	"Lineage enriched"	"Detected in single"	29	"B-cells: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053057	Uncertain		Supported	Vesicles				Vesicles	Vesicles	"HPA053057: AB_2682028"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-1)"	"prognostic favourable (7.74e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.89e-2)"	"unprognostic (4.27e-2)"	17.6	19.7	18.2	2.5	25.5	0.8	13.3	36.8	31.3	7.7	8.7	4.0	11.5	7.1	3.4	7.9	4.1	12.8	6.9	2.6	15.2	23.0	3.3	26.6	5.2	3.1	13.5	17.9	5.5	82.7	1.6	12.4	2.1	14.7	5.1	12.5	3.5	12.6	10.0	2.5	5.3	7.4	5.1	7.2	1.2	8.7	1.7	5.1	0.3	7.6	1.1	5.1	2.9	3.8	9.4	0.1	0.0	0.0	0.0	0.3	0.1	5.1	2.6	2.1	0.0	0.3	0.3	1.4	1.8	0.0	0.0	0.0	4.6	3.1	0.4	0.3	1.4	13.2	0.4	3.5	0.0	0.0	7.1	0.0	7.8	4.6	3.4	0.0	0.0	1.2	4.5	0.0	4.3	1.9	0.2	0.9	2.0	0.1	0.1	0.0	0.4	14.9	0.0	0.0	0.0	5.7	1.2	10.0	1.1	4.7	30.4	1.0	3.8	0.2	2.7	0.1	1.1	0.0	0.8	0.8	0.0	0.3	6.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	18.2	25.5	36.8	31.3	15.2	23.0	13.5	17.9	14.7	5.1
TAS2R60	T2R60	ENSG00000185899	"Taste 2 receptor member 60"	P59551	7	143443453-143444409	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.3;liver: 1.4;pancreas: 1.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.3;U-937: 1.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030416	Uncertain									"HPA030416: AB_10603344"						"unprognostic (1.78e-2)"								"unprognostic (7.98e-2)"				0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.0	0.2	0.3			0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.2	0.0		0.0	1.3	0.5	0.0	0.3		0.0	0.1		0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.5	0.1	0.0			0.0		0.2	0.1	0.2	0.0	0.0	1.0	0.9	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.5	1.0	0.0	0.9	0.0	0.0	0.3										
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64781193-64881032	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 23.0;RPMI-8226: 13.6;RT4: 17.7;SCLC-21H: 16.6;SK-BR-3: 17.0;T-47d: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favourable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.8	1.6	4.7	2.3	11.4	0.5	5.3	13.4	15.8	7.6	3.3	1.5	12.4	5.0	3.1	2.5	1.2	2.1	4.8	1.1	7.1	5.5	3.9	1.7	3.9	0.9	4.7	7.0	1.5	19.8	8.9	6.5	1.4	16.5	3.7	3.5	2.0	14.4	11.6	0.9	1.3	3.5	2.4	3.0	2.5	6.9	3.2	2.8	0.0	3.3	0.2	0.7	4.9	1.9	0.0	0.0	2.4	1.1	0.0	1.3	0.3	6.9	1.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.1	6.5	2.2	0.3	1.1	0.0	0.1	6.8	0.1	0.0	0.0	6.7	0.3	1.2	0.3	0.1	2.3	1.4	0.4	0.0	0.0	0.2	5.7	0.0	2.4	0.2	23.0	0.0	0.4	0.9	6.8	0.1	0.1	13.6	0.8	17.7	16.6	1.3	1.4	17.0	0.2	12.4	1.1	5.4	0.0	1.0	0.5	3.4	0.0	0.0	0.2	0.1	0.7	0.3	0.0	1.1	0.0	0.4	1.1	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.3	4.7	11.4	13.4	15.8	7.1	5.5	4.7	7.0	16.5	2.8
TBC1D3E		ENSG00000278599	"TBC1 domain family member 3E"	A0A087X179	17	38127951-38138862	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1"	"Cell line enriched"	"Detected in some"	4	"HHSteC: 9.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "	"unprognostic (1.18e-1)"	"unprognostic (3.35e-1)"			"unprognostic (3.51e-1)"					"unprognostic (4.22e-2)"	"unprognostic (6.28e-2)"		"unprognostic (1.87e-2)"	"unprognostic (5.07e-3)"			"unprognostic (1.32e-3)"	0.0	0.0		0.0		3.9	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.0	0.0			0.0	0.0	0.0	1.7			0.0	4.3	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.5	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	9.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0										
TBL1Y	TBL1	ENSG00000092377	"Transducin beta like 1 Y-linked"	Q9BQ87	Y	6910686-7091683	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.1;thyroid gland: 10.8"	"Cell line enriched"	"Detected in some"	6	"U-698: 14.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 1.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"									HPA060073	Uncertain									"HPA060073: AB_2684196"						"unprognostic (2.81e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.06e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"		"unprognostic (3.24e-2)"	1.0	0.0	0.1	0.2	0.5	0.1	1.0	0.1	0.4	0.0	0.4	0.5	0.0	0.2	0.1	1.5	1.3	0.1	3.8	0.1	0.1	0.2	1.4	3.3	3.0	0.8	0.1	0.0	0.1	15.1	0.0	0.1	0.3	0.7	7.2	0.4	1.6	5.8	0.7	1.3	0.6	0.3	0.1	0.0	0.1	0.7	3.5	0.0	0.1	10.8	2.9	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	2.2	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.4	0.1	0.2	0.1	0.0	0.7	0.0
TBX6		ENSG00000149922	"T-box 6"	O95947	16	30085793-30091887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8"	"Cell line enhanced"	"Detected in many"		"RT4: 10.0;U-266/70: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062498			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062498: AB_2732686"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.62e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.05e-3)"	"unprognostic (4.26e-2)"	1.2	1.4	1.4	1.0	1.5	0.6	0.9	0.9	1.5	2.7	1.2	0.9	0.9	1.8	0.9	1.0	22.8	1.6	1.3	0.9	1.5	1.0	1.8	1.2	1.2	1.2	1.7	0.9	1.9	19.8	3.2	2.3	0.9	2.1	3.2	0.3	2.3	3.9	2.2	2.8	5.0	1.7	0.9	1.5	1.8	7.8	2.4	1.2	1.6	2.3	5.1	16.3	5.5	8.6	4.4	1.3	3.3	2.6	1.3	1.9	1.1	0.9	1.1	0.6	1.2	1.5	0.8	0.8	0.3	0.2	0.0	0.2	1.3	4.3	1.9	2.3	0.2	1.3	0.5	0.9	0.0	1.4	0.8	1.2	1.7	1.0	1.1	0.2	2.6	0.3	1.2	0.3	0.5	0.6	0.1	4.3	0.1	3.7	0.7	0.5	0.9	0.9	2.8	0.1	3.2	0.0	10.0	1.4	2.1	0.2	0.9	1.2	1.8	1.7	0.5	1.2	0.7	0.6	0.0	10.5	2.4	0.3	1.2	1.8	0.4	3.1	2.6	0.8	1.8	2.3	1.2	1.3	0.9	1.3	1.3	4.4	1.9	1.7	3.3	1.3	0.8	1.1	1.8	1.1	1.4	1.5	0.9	1.4	1.5	1.0	1.7	0.9	2.1	1.2
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779751-91867536	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 100.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.1;MCF7: 9.2;RT4: 21.0;SK-BR-3: 25.4;T-47d: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 32.2"	"Group enriched"	"Detected in many"	46	"NK-cells: 12.9;T-cells: 32.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavourable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favourable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	6.6	1.5	0.9	15.8	0.9	1.9	12.3	0.4	1.9	8.9	10.2	0.6	16.7	5.4	7.6	7.0	11.6	5.4	24.9	4.7	0.9	1.0	3.7	6.8	13.5	11.3	0.8	0.5	5.5	100.1	12.4	8.4	13.1	1.6	9.3	7.0	6.6	29.8	20.1	2.1	6.9	11.7	3.2	1.1	12.3	10.8	4.9	0.1	8.7	10.3	5.8	27.9	8.3	9.5	0.2	0.0	0.4	0.0	12.9	32.2	7.7	5.1	0.8	0.0	0.0	1.0	0.0	7.2	0.0	0.1	0.0	0.0	3.7	11.1	3.4	0.2	0.0	0.6	5.1	5.2	0.0	0.0	2.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	5.3	0.0	0.2	0.0	0.1	2.7	0.0	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.5	21.0	3.9	0.0	0.4	25.4	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.7	0.0	32.2	0.2	16.2	18.6	0.0	0.1	13.3	11.0	0.4	12.9	0.0	0.0	5.2	7.7	0.9	0.9	0.4	1.9	0.9	1.0	0.8	0.5	1.6	0.1
TECPR1	"DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358"	ENSG00000205356	"Tectonin beta-propeller repeat containing 1"	Q7Z6L1	7	98214624-98252251	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 63.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021061	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA021061: AB_1847687"	"unprognostic (8.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (8.12e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.12e-2)"	6.5	4.7	11.5	8.9	10.6	5.2	6.3	9.0	15.8	4.1	5.9	6.2	5.1	8.4	4.5	5.5	5.8	4.8	7.6	5.9	10.4	9.0	4.6	5.4	9.0	11.0	6.8	12.8	4.0	63.9	4.2	10.2	7.7	9.8	6.9	4.9	8.0	29.5	5.0	6.9	5.4	8.1	4.6	8.5	11.2	9.3	3.3	7.0	6.4	5.9	5.9	6.4	5.1	5.4	3.4	4.1	6.1	7.4	1.6	8.7	3.1	2.9	4.1	5.8	12.5	5.1	3.0	4.3	6.2	3.4	4.9	6.0	3.9	3.7	2.4	10.0	7.1	1.9	3.9	2.9	2.1	5.8	5.6	3.5	5.8	4.2	6.0	4.2	6.9	5.3	2.3	4.7	3.7	17.2	2.3	13.8	3.7	4.8	6.1	4.5	2.3	4.0	5.1	5.9	17.3	3.7	3.2	10.5	11.7	3.6	11.0	5.7	3.3	6.1	17.6	4.7	8.1	12.0	5.1	17.6	6.3	1.2	9.8	3.7	8.7	2.6	4.7	1.4	3.9	5.2	2.4	3.4	5.1	3.1	2.9	3.2	8.7	7.2	6.1	1.6	7.4	4.1	5.1	3.1	11.5	10.6	9.0	15.8	10.4	9.0	6.8	12.8	9.8	7.0
TGIF2-C20orf24		ENSG00000259399	"TGIF2-C20orf24 readthrough"		20	36574553-36612384	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pancreas: 22.1"	"Cell line enhanced"	"Detected in many"		"AF22: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.57e-3)"	"unprognostic (3.97e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	2.1	1.4	1.9	8.5	1.9	4.9	2.3	0.9	3.1	3.1	2.1	1.7	0.6	2.1	4.1	2.6	1.4	4.2	1.7	2.2	1.4	1.1	2.0	5.3	2.2	1.8	2.5	1.7	3.8	22.1	3.1	1.3	2.7	1.9	1.9	1.5	2.0	3.2	2.2	2.7	1.5	1.6	4.7	1.6	3.0	1.4	6.1	1.3	4.1	4.0	1.4	5.7	1.3	2.8	3.4	3.6	2.8	2.2	1.9	3.3	0.9	3.6	1.6	20.6	10.3	3.0	1.6	1.5	0.7	4.7	7.2	5.5	8.8	7.7	1.7	2.1	4.2	1.5	17.4	2.6	11.0	4.7	2.0	4.6	5.3	9.9	1.5	5.3	1.1	1.2	2.9	3.9	7.2	4.8	1.3	10.6	1.9	9.2	12.2	2.8	4.3	0.4	9.2	2.1	7.5	2.9	4.4	2.5	6.9	1.2	9.1	5.2	8.2	14.7	1.3	2.6	0.9	0.2	2.7	2.3	1.2	6.8	0.2	6.1	4.3	0.0	1.9	0.0	2.6	2.2	2.4	3.4	0.6	0.5	3.6	3.4	3.2	3.3	2.8	1.9	0.4	2.6	0.5	0.9	1.9	1.9	0.9	3.1	1.4	1.1	2.5	1.7	1.9	1.3
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269994-43274002	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 73.6;salivary gland: 47.8"	"Cell line enhanced"	"Detected in some"		"A-431: 13.5;BEWO: 11.6;CACO-2: 10.6;CAPAN-2: 25.2;SK-BR-3: 21.7;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015796			Approved	Midbody,Cytosol				"Midbody, Cytosol"	"Midbody, Cytosol"	"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favourable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.8	0.0	5.3	4.6	7.1	0.0	4.9	0.9	5.0	7.4	14.4	1.0	20.7	15.1	1.8	12.5	3.3	6.6	18.9	1.0	8.9	4.3	9.4	1.4	42.5	0.8	10.7	0.8	2.0	73.6	9.6	15.7	5.6	1.1	8.8	9.1	1.5	47.8	19.0	0.8	3.7	29.4	0.8	21.1	0.8	11.6	1.2	0.8	1.1	33.6	3.8	5.0	1.4	3.5	0.0	0.8	0.0	0.0	1.8	0.9	0.2	13.5	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.6	25.2	0.0	0.6	0.0	6.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.2	4.3	6.6	0.0	0.0	21.7	0.0	17.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.9	0.2	0.0	1.8	0.0	0.8	0.0	0.2	5.3	7.1	0.9	1.9	8.9	4.3	10.7	0.8	1.1	0.8
TMEM163	"DKFZP566N034, SV31"	ENSG00000152128	"Transmembrane protein 163"	Q8TC26	2	134455759-134719000	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;pancreas: 19.7"	"Cell line enhanced"	"Detected in some"		"HEL: 10.5;RPTEC TERT1: 36.1;SCLC-21H: 16.4;U-937: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.0;T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007224	Uncertain									"HPA007224: AB_2667780"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.08e-3)"	"prognostic favourable (7.94e-4)"	"unprognostic (9.05e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.75e-3)"	"prognostic favourable (3.15e-4)"	3.8	6.4	8.1	5.4	5.7	0.5	1.5	31.8	13.4	0.5	0.8	5.8	0.0	0.9	0.8	0.7	0.4	3.4	10.4	7.2	9.1	13.7	1.8	1.7	16.4	10.9	6.9	3.8	1.2	19.7	0.4	11.2	4.2	14.8	0.5	0.9	2.6	3.5	0.5	0.6	0.4	0.8	0.7	13.9	1.9	8.3	6.9	5.0	0.0	1.3	0.0	17.4	9.9	0.3	1.6	0.3	0.1	0.0	2.0	2.5	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.1	0.0	0.3	0.0	0.0	2.8	1.2	0.0	0.0	0.0	36.1	5.3	16.4	0.5	0.0	0.0	0.8	0.0	0.0	3.7	0.0	0.2	0.0	0.8	0.8	0.0	0.0	0.0	6.5	0.7	0.0	0.0	0.0	1.3	0.0	1.7	1.6	0.5	2.4	0.3	0.6	0.1	0.5	0.1	2.0	0.0	0.0	2.5	0.8	8.1	5.7	31.8	9.7	9.1	13.7	6.9	3.8	14.8	5.0
TMEM238		ENSG00000233493	"Transmembrane protein 238"	C9JI98	19	55379245-55384598	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.8"	"Cell line enhanced"	"Detected in many"		"A-431: 15.5;CAPAN-2: 9.8;HaCaT: 14.3;RPMI-8226: 9.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.90e-2)"	"unprognostic (7.93e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.33e-2)"	"prognostic favourable (8.84e-6)"	"unprognostic (1.78e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.17e-3)"	1.6	1.4	0.6	13.1	0.7	1.8	3.6	0.9	1.0	3.8	29.5	0.0	11.8	14.6	1.2	4.5	15.8	2.2	19.1	0.7	0.5	0.5	10.3	27.0	12.4	12.2	0.6	0.0	2.7	43.8	2.0	3.7	0.7	0.7	6.4	2.5	1.3	25.2	11.9	1.6	7.0	36.5	0.7	0.5	3.5	17.1	1.0	0.0	9.3	23.3	13.5	14.8	4.4	3.3	1.5	0.6	0.3	0.2	0.5	3.0	0.4	15.5	1.5	0.0	1.1	0.1	0.0	1.0	0.6	0.1	0.0	0.0	1.1	9.8	7.3	2.9	0.0	14.3	0.4	0.3	0.0	2.2	1.0	0.3	1.2	0.0	0.0	2.0	0.6	0.0	1.9	0.1	0.3	0.0	1.0	6.6	0.0	3.2	2.6	0.8	0.6	4.8	3.8	0.4	9.6	0.6	4.9	5.5	1.7	0.7	7.8	1.1	6.1	0.9	0.0	0.3	1.7	0.1	0.2	4.3	2.5	1.9	0.1	1.3	0.2	0.0	0.2	0.3	1.3	0.0	2.4	1.5	2.4	1.7	0.1	1.2	1.9	1.5	0.0	0.5	0.0	0.6	3.0	0.4	0.6	0.7	0.9	0.6	0.5	0.5	0.6	0.0	0.7	0.0
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464551-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.6;pancreas: 64.5;prostate: 68.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.6;MCF7: 6.3;RT4: 35.2;SK-BR-3: 7.2;T-47d: 5.4"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA034493, HPA035787"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"			"Cell Junctions"	"Cell Junctions"	"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favourable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.2	0.1	0.2	15.5	0.4	0.0	6.1	0.2	0.5	1.3	38.7	0.4	24.4	17.5	0.5	0.9	10.7	2.2	17.3	0.2	0.3	0.1	19.4	18.4	20.7	0.2	0.2	0.2	0.7	64.5	0.0	1.3	1.0	0.4	68.2	18.5	0.3	52.3	35.7	0.2	2.1	75.6	0.9	0.2	0.3	36.7	0.8	0.3	0.5	19.9	3.9	10.2	5.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.6	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.5	1.3	0.0	0.0	0.0	1.4	0.6	35.2	0.0	0.4	0.0	7.2	0.1	5.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.5	0.3	0.1	0.2	0.2	0.4	0.3
TPRN	"C9orf75, DFNB79, FLJ90254"	ENSG00000176058	Taperin	Q4KMQ1	9	137191617-137204193	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.8;pancreas: 45.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 28.4;T-47d: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.9"	"HPA020899, HPA076667"	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA020899: AB_1845835, HPA076667: "	"unprognostic (5.41e-2)"	"prognostic favourable (2.13e-4)"	"unprognostic (2.94e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.77e-2)"	"prognostic favourable (5.16e-9)"	"unprognostic (1.96e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.44e-2)"	3.2	3.8	8.5	5.0	16.8	3.2	3.3	26.1	17.9	3.4	18.5	32.8	2.3	23.6	2.8	1.8	8.2	4.2	4.8	3.6	11.2	7.0	12.1	10.0	5.8	3.0	25.3	7.1	4.7	45.3	2.8	2.7	4.3	11.0	4.4	8.1	13.1	8.7	4.8	5.0	8.0	29.0	2.4	11.9	3.7	10.8	4.7	21.7	0.2	2.5	2.3	3.5	3.8	2.7	1.2	2.3	0.2	2.9	2.9	2.2	0.6	4.6	5.3	1.8	8.1	2.5	2.7	14.4	3.3	2.0	3.3	1.8	17.8	5.7	8.6	4.9	1.6	14.2	3.7	1.8	0.4	5.4	5.2	4.0	8.0	11.6	3.8	6.1	5.2	2.3	3.6	3.0	2.0	2.1	7.2	3.0	1.0	28.4	4.0	13.2	6.4	7.0	12.0	4.3	13.0	7.5	9.8	11.7	4.3	5.0	23.6	5.8	27.4	9.7	2.3	6.2	2.9	9.6	6.9	2.5	4.9	4.4	4.4	5.6	3.4	0.0	2.9	0.2	1.3	2.6	0.4	1.1	1.3	1.8	2.1	1.2	0.6	1.2	0.0	2.9	1.5	2.3	2.2	0.6	8.5	16.8	26.1	17.9	11.2	7.0	25.3	7.1	11.0	21.7
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;pancreas: 19.4"	"Cell line enhanced"	"Detected in some"		"BJ: 20.5;BJ hTERT+: 19.9;EFO-21: 10.7;HBF TERT88: 7.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebellum: 30.3"	"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									6200000	6200000				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favourable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	6.2	2.2	2.9	1.0	4.7	1.0	7.6	30.3	12.3	10.2	2.4	0.1	2.5	4.8	2.7	1.7	0.9	2.5	2.5	2.2	7.3	2.8	9.9	1.5	3.0	0.6	1.2	5.5	6.5	19.4	0.4	1.6	0.7	1.5	5.5	1.5	1.0	2.4	5.8	0.7	0.8	4.2	1.2	0.9	4.8	1.1	1.7	0.5	0.0	0.5	0.4	1.0	2.8	7.6	0.2	0.0	1.0	0.3	0.3	0.0	0.0	2.4	0.0	0.4	0.0	1.1	0.0	6.6	20.5	19.9	2.0	1.3	0.0	0.0	0.0	10.7	2.9	0.2	3.7	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.9	0.0	0.0	0.0	6.8	4.5	2.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	2.9	4.7	30.3	12.3	7.3	2.8	1.2	5.5	1.5	0.5
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.2;RPMI-8226: 1.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043315	Uncertain									"HPA043315: AB_2678422"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			6.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.5	0.0		0.2	0.5		0.0	4.0	0.0	0.0	6.3	0.0	0.0	0.0	0.5	0.9			3.1		0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0										
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871203-142885762	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 26.1;placenta: 65.1;salivary gland: 34.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.5;HaCaT: 10.2;RT4: 18.3;SK-BR-3: 13.5;T-47d: 30.1"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA062864	Approved									"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.3	0.0	0.3	0.3	0.3	0.0	2.1	0.3	0.3	0.4	1.2	0.3	0.3	4.1	0.3	0.4	1.7	0.1	4.1	0.3	0.3	0.2	2.5	0.6	0.8	0.3	0.8	0.3	0.3	26.1	0.0	0.4	65.1	0.4	12.6	0.0	0.4	34.2	0.7	0.3	3.7	1.0	0.5	2.0	0.3	2.4	0.7	0.3	0.3	0.7	0.6	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.1	0.0	0.0	13.5	0.3	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.8	0.3	0.4	0.3
VHLL	"VHLP, VLP"	ENSG00000189030	"VHL like"	Q6RSH7	1	156298624-156299299	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.6;pancreas: 1.6;skeletal muscle: 1.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;Daudi: 2.4;hTCEpi: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (1.61e-1)"									"unprognostic (2.45e-1)"				0.1	0.1	0.1	0.0	0.3	0.0	0.0	2.6	0.2	0.0	0.1			0.0	0.3	0.0	1.2	0.1	0.8	0.1	0.2	0.2	0.0	0.4	0.1	0.1	0.0		0.2	1.6	0.0	0.1	0.1		0.2	0.1		0.0	0.0	1.5	0.3	0.0	0.2	0.1	0.2	0.1	0.6			0.1		0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.5	0.7	0.0	3.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VTCN1	"B7-H4, B7H4, B7S1, B7X, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 72.8"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"				"Plasma membrane"	"Plasma membrane"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	46.4	0.1	0.1	6.7	0.1	0.1	7.0	0.0	2.6	29.9	0.4	14.2	1.9	0.2	0.1	0.1	27.0	0.9	0.3	0.1	0.1	0.1	4.5	35.9	0.0	1.4	3.0	0.1	1.5	0.0	0.1	17.5	3.6	0.2	2.2	0.1	0.8	0.1	0.1	1.5	2.5	0.1	0.2	0.1	0.5	1.5	2.1	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	72.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.2;Hep G2: 18.4;SCLC-21H: 23.4"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.8	8.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	1.6	0.1	11.2	1.5	0.0	0.2	6.4	0.0	0.0	0.0	7.4	0.0	3.5	18.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	5.8	0.1	0.1	7.1	0.2	0.0	0.0	9.1	0.0	0.6	23.4	9.2	1.4	6.3	0.6	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0										
XBP1	XBP2	ENSG00000100219	"X-box binding protein 1"	P17861	22	28794555-28800597	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 321.9;salivary gland: 176.0"	"Cell line enhanced"	"Detected in all"		"MCF7: 108.1;SK-BR-3: 101.6;T-47d: 118.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																																			15.6	14.3	5.4	20.5	7.2	20.6	75.2	4.2	5.9	39.3	21.9	4.2	73.1	15.6	14.7	26.4	16.9	17.6	22.1	22.9	4.8	5.3	23.1	104.0	23.7	37.3	7.4	3.6	19.0	321.9	10.9	27.4	31.3	8.7	29.3	19.6	8.7	176.0	72.2	15.5	12.6	27.8	10.1	7.3	37.2	39.7	7.4	6.7	30.5	42.7	12.1	47.5	29.2	24.9	10.0	22.1	44.2	7.6	25.0	29.9	9.6	8.6	5.8	8.4	12.9	15.9	17.5	21.3	15.1	25.9	15.1	20.1	9.4	12.1	32.9	7.4	13.9	12.0	15.5	7.4	13.1	14.6	9.8	9.9	5.2	40.1	34.5	18.5	9.5	10.9	44.5	10.0	43.3	12.0	8.8	41.5	9.1	108.1	2.5	17.6	5.8	9.2	18.9	9.2	44.6	13.8	12.0	11.1	10.7	9.1	101.6	39.3	118.2	21.4	6.8	8.7	8.4	9.2	5.3	70.7	49.9	19.7	11.6	23.8	13.0	44.2	7.6	6.1	22.9	4.0	29.9	10.0	16.5	23.6	6.9	8.2	16.4	13.7	0.6	25.0	2.8	22.1	5.5	9.6	5.4	7.2	4.2	5.9	4.8	5.3	7.4	3.6	8.7	6.7
ZBTB42	ZNF925	ENSG00000179627	"Zinc finger and BTB domain containing 42"	B2RXF5	14	104800596-104804712	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.2;MCF7: 22.3;T-47d: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000703, HPA066961"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA000703: AB_2666075, HPA066961: AB_2685756"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.99e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.42e-1)"	"prognostic favourable (2.30e-9)"	"unprognostic (1.34e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-3)"	"unprognostic (5.45e-2)"	4.8	4.1	1.1	2.4	1.3	0.1	3.8	0.7	1.2	4.5	4.7	0.9	7.7	3.9	2.6	6.2	5.4	5.6	10.1	4.1	0.8	0.6	4.8	9.9	9.0	4.6	1.2	0.6	5.1	25.8	2.0	1.7	2.4	1.7	7.5	2.1	3.2	10.6	7.3	6.9	2.8	5.2	1.5	1.3	2.9	6.6	2.4	0.3	3.7	6.7	4.5	4.8	3.1	2.3	0.8	0.7	8.4	0.3	0.2	0.9	0.3	0.9	2.9	0.9	3.6	0.7	0.8	3.8	1.3	1.4	2.4	2.1	1.9	3.5	0.3	2.6	1.3	4.0	0.8	1.3	0.4	13.2	0.9	1.2	1.5	2.2	1.2	0.3	7.3	1.4	1.4	0.9	0.4	1.0	2.0	1.9	0.4	22.3	2.4	1.8	0.5	2.8	3.4	0.2	1.8	1.7	5.8	4.1	1.8	1.0	5.4	2.4	18.5	1.4	1.6	0.9	2.1	0.2	0.4	2.2	1.2	0.2	3.1	1.2	1.9	0.0	0.3	8.4	0.5	0.1	0.9	0.8	0.7	0.1	0.1	0.6	0.5	0.8	0.1	0.2	0.1	0.7	0.6	0.3	1.1	1.3	0.7	1.2	0.8	0.6	1.2	0.6	1.7	0.3
ZNF98	"F7175, ZNF739"	ENSG00000197360	"Zinc finger protein 98"	A6NK75	19	22391019-22532485	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 36.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;NB-4: 8.2;RPMI-8226: 3.4;T-47d: 6.0;U-2197: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.0;naive B-cell: 1.5;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	5	"B-cells: 1.5;dendritic cells: 1.9"																				"unprognostic (1.11e-1)"			"unprognostic (1.31e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.56e-1)"		"unprognostic (7.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.56e-2)"	1.3	1.0	3.2	0.6	9.2	0.6	4.2	0.9	13.2	3.9	0.8	2.1	2.1	0.5	1.8	6.3	0.6	2.7	0.8	1.5	4.2	1.6	3.7	0.5	0.6	0.7	2.6	7.2	12.6	36.9	4.5	1.1	0.9	3.8	1.3	0.5	0.4	1.1	1.2	0.5	0.6	0.6	1.7	1.4	0.6	0.7	10.2	3.1	0.0	5.1	0.0	0.4	1.2	0.8	1.5	1.9	0.2	0.1	0.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	3.3	0.2	0.0	0.4	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.1	0.0	0.3	0.2	8.2	1.7	0.4	0.5	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.0	2.0	0.0	0.0	0.7	6.3	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.0	1.0	0.3	0.0	0.0	1.5	0.3	0.2	0.0	0.2	0.1	1.9	0.1	0.0	3.2	9.2	0.9	13.2	4.2	1.6	2.6	7.2	3.8	3.1
ZSCAN2	"FLJ20595, ZFP29, ZNF854"	ENSG00000176371	"Zinc finger and SCAN domain containing 2"	Q7Z7L9	15	84600986-84627796	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 36.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007296, HPA024331"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA007296: , HPA024331: AB_1859497"	"unprognostic (4.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.49e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (3.52e-4)"	"unprognostic (4.24e-1)"	"prognostic favourable (7.46e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.98e-1)"	"prognostic favourable (4.16e-5)"	9.8	7.6	5.2	7.2	7.4	9.7	15.0	5.9	6.3	7.3	6.2	5.8	9.0	4.1	9.5	8.4	3.4	5.3	8.2	8.2	4.8	4.7	9.1	10.1	4.5	8.0	6.2	5.0	10.2	36.9	6.9	6.3	2.8	5.1	7.1	4.3	6.7	12.4	5.1	9.5	3.4	5.5	9.0	5.1	8.1	8.5	12.0	6.0	24.4	6.3	3.9	6.9	6.5	9.7	7.1	10.5	10.0	12.2	9.0	12.1	6.4	1.7	9.8	7.7	12.7	4.5	3.0	6.7	1.9	5.3	4.1	5.5	7.5	4.0	3.6	5.4	3.0	4.3	6.5	3.7	3.6	7.4	10.0	4.6	5.7	15.8	3.9	2.9	3.7	4.5	4.5	5.2	5.0	12.1	6.1	2.9	4.9	4.8	13.4	6.8	14.1	5.8	14.0	4.4	6.8	4.3	12.5	10.8	19.1	5.9	3.3	9.1	6.8	8.2	7.9	5.0	9.6	2.4	2.4	5.0	6.6	12.1	3.3	6.8	3.1	10.0	9.6	8.3	10.9	10.5	5.4	7.1	9.2	8.2	10.5	7.1	7.6	8.2	5.4	9.0	12.2	10.2	12.1	6.4	5.2	7.4	5.9	6.3	4.8	4.7	6.2	5.0	5.1	6.0
